406960195 | GWAS609171_H | reticulocyte count QTL GWAS609171 (human) | | 5e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 7157433 | 7157434 | Human |
406960197 | GWAS609173_H | reticulocyte count QTL GWAS609173 (human) | | 2e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16322747 | 16322748 | Human |
407377997 | GWAS1026973_H | obsolete_red blood cell distribution width QTL GWAS1026973 (human) | | 2e-08 | obsolete_red blood cell distribution width | | 6 | 3369739 | 3369740 | Human |
597050259 | GWAS1146333_H | uterine fibroid QTL GWAS1146333 (human) | | 0.000006 | uterine fibroid | | 6 | 12510798 | 12510799 | Human |
597279647 | GWAS1375721_H | hypothyroidism QTL GWAS1375721 (human) | | 4e-12 | hypothyroidism | | 6 | 403799 | 403800 | Human |
597607320 | GWAS1664180_H | systolic blood pressure QTL GWAS1664180 (human) | | 6e-22 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597263262 | GWAS1359336_H | serum metabolite measurement QTL GWAS1359336 (human) | | 0.000006 | serum metabolite measurement | | 6 | 13060336 | 13060337 | Human |
597058462 | GWAS1154536_H | open-angle glaucoma QTL GWAS1154536 (human) | | 2e-15 | open-angle glaucoma | | 6 | 642017 | 642018 | Human |
597402514 | GWAS1498588_H | emphysema imaging measurement QTL GWAS1498588 (human) | | 0.000004 | emphysema imaging measurement | | 6 | 18575069 | 18575070 | Human |
406992969 | GWAS641945_H | mean corpuscular hemoglobin concentration QTL GWAS641945 (human) | | 2e-70 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597074822 | GWAS1170896_H | type 2 diabetes mellitus QTL GWAS1170896 (human) | | 1e-09 | type 2 diabetes mellitus | | 6 | 7290204 | 7290205 | Human |
597279627 | GWAS1375701_H | rheumatoid arthritis QTL GWAS1375701 (human) | | 7e-11 | rheumatoid arthritis | | 6 | 426268 | 426269 | Human |
597091204 | GWAS1187278_H | body mass index QTL GWAS1187278 (human) | | 0.0000003 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597058434 | GWAS1154508_H | multiple sclerosis QTL GWAS1154508 (human) | | 6e-08 | multiple sclerosis | | 6 | 520595 | 520596 | Human |
597271436 | GWAS1367510_H | response to lithium ion QTL GWAS1367510 (human) | | 0.000003 | response to lithium ion | | 6 | 16985077 | 16985078 | Human |
597107599 | GWAS1203673_H | Red cell distribution width QTL GWAS1203673 (human) | | 1e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16285830 | 16285831 | Human |
597107598 | GWAS1203672_H | Red cell distribution width QTL GWAS1203672 (human) | | 2e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16267244 | 16267245 | Human |
597107597 | GWAS1203671_H | Red cell distribution width QTL GWAS1203671 (human) | | 3e-17 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5260461 | 5260462 | Human |
597369729 | GWAS1465803_H | hematocrit QTL GWAS1465803 (human) | | 3e-32 | hematocrit | hematocrit (CMO:0000037) | 6 | 7255417 | 7255418 | Human |
597369728 | GWAS1465802_H | hematocrit QTL GWAS1465802 (human) | | 3e-14 | hematocrit | hematocrit (CMO:0000037) | 6 | 2522574 | 2522575 | Human |
597107596 | GWAS1203670_H | Red cell distribution width QTL GWAS1203670 (human) | | 3e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5095395 | 5095396 | Human |
597107595 | GWAS1203669_H | Red cell distribution width QTL GWAS1203669 (human) | | 1e-17 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3439463 | 3439464 | Human |
597107594 | GWAS1203668_H | Red cell distribution width QTL GWAS1203668 (human) | | 2e-24 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3427849 | 3427850 | Human |
597107593 | GWAS1203667_H | Red cell distribution width QTL GWAS1203667 (human) | | 2e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3369275 | 3369276 | Human |
597107592 | GWAS1203666_H | Red cell distribution width QTL GWAS1203666 (human) | | 2e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3162144 | 3162145 | Human |
597607359 | GWAS1664219_H | squamous cell carcinoma QTL GWAS1664219 (human) | | 1e-207 | squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597050290 | GWAS1146364_H | Eczematoid dermatitis QTL GWAS1146364 (human) | | 9e-09 | Eczematoid dermatitis | | 6 | 209159 | 209160 | Human |
597181374 | GWAS1277448_H | body mass index QTL GWAS1277448 (human) | | 6e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13191958 | 13191959 | Human |
597107633 | GWAS1203707_H | testosterone measurement QTL GWAS1203707 (human) | | 1e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 17416027 | 17416028 | Human |
597402556 | GWAS1498630_H | myocardial infarction QTL GWAS1498630 (human) | | 6e-08 | myocardial infarction | | 6 | 1619802 | 1619803 | Human |
597296049 | GWAS1392123_H | cholesteryl ester 24:6 measurement QTL GWAS1392123 (human) | | 2e-13 | cholesteryl ester 24:6 measurement | | 6 | 11011172 | 11011173 | Human |
407042158 | GWAS691134_H | pathological myopia QTL GWAS691134 (human) | | 0.0000004 | pathological myopia | | 6 | 7743430 | 7743431 | Human |
597377975 | GWAS1474049_H | stroke, coronary artery disease QTL GWAS1474049 (human) | | 4e-11 | stroke, coronary artery disease | | 6 | 12903203 | 12903204 | Human |
597156793 | GWAS1252867_H | sex hormone-binding globulin measurement QTL GWAS1252867 (human) | | 0.000004 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597238710 | GWAS1334784_H | retinal vasculature measurement QTL GWAS1334784 (human) | | 4e-08 | retina blood vessel morphology trait (VT:0002792) | | 6 | 1409974 | 1409975 | Human |
597361581 | GWAS1457655_H | low density lipoprotein cholesterol measurement QTL GWAS1457655 (human) | | 8e-17 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16108932 | 16108933 | Human |
597517227 | GWAS1613301_H | major depressive disorder QTL GWAS1613301 (human) | | 5e-09 | major depressive disorder | | 6 | 17016169 | 17016170 | Human |
597607337 | GWAS1664197_H | cutaneous melanoma QTL GWAS1664197 (human) | | 4e-234 | cutaneous melanoma | | 6 | 396321 | 396322 | Human |
597304227 | GWAS1400301_H | mean corpuscular hemoglobin QTL GWAS1400301 (human) | | 1e-32 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15194877 | 15194878 | Human |
597107629 | GWAS1203703_H | lymphoid leukemia QTL GWAS1203703 (human) | | 1e-08 | lymphoid leukemia | | 6 | 410848 | 410849 | Human |
597263268 | GWAS1359342_H | serum metabolite measurement QTL GWAS1359342 (human) | | 0.000007 | serum metabolite measurement | | 6 | 14558747 | 14558748 | Human |
597304228 | GWAS1400302_H | mean corpuscular hemoglobin QTL GWAS1400302 (human) | | 3e-139 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16294491 | 16294492 | Human |
597074857 | GWAS1170931_H | intelligence QTL GWAS1170931 (human) | | 0.000003 | intelligence | | 6 | 3446029 | 3446030 | Human |
597369819 | GWAS1465893_H | disease recurrence, malaria QTL GWAS1465893 (human) | | 0.0000004 | disease recurrence, malaria | | 6 | 2606805 | 2606806 | Human |
407083011 | GWAS731987_H | obsolete_red blood cell distribution width QTL GWAS731987 (human) | | 2e-18 | obsolete_red blood cell distribution width | | 6 | 3162144 | 3162145 | Human |
406960133 | GWAS609109_H | progressive supranuclear palsy QTL GWAS609109 (human) | | 6e-15 | progressive supranuclear palsy | | 6 | 396321 | 396322 | Human |
407083013 | GWAS731989_H | obsolete_red blood cell distribution width QTL GWAS731989 (human) | | 2e-24 | obsolete_red blood cell distribution width | | 6 | 3427849 | 3427850 | Human |
407083012 | GWAS731988_H | obsolete_red blood cell distribution width QTL GWAS731988 (human) | | 2e-13 | obsolete_red blood cell distribution width | | 6 | 3369275 | 3369276 | Human |
597132254 | GWAS1228328_H | memory performance QTL GWAS1228328 (human) | | 0.000006 | memory performance | | 6 | 11729184 | 11729185 | Human |
597205970 | GWAS1302044_H | insulin measurement QTL GWAS1302044 (human) | | 2e-09 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 6 | 5952708 | 5952709 | Human |
596952004 | GWAS1071523_H | body mass index QTL GWAS1071523 (human) | | 6e-11 | body mass index | | 6 | 19082432 | 19082433 | Human |
597468107 | GWAS1564181_H | worry measurement QTL GWAS1564181 (human) | | 3e-09 | worry measurement | | 6 | 11996817 | 11996818 | Human |
597377988 | GWAS1474062_H | large artery stroke, coronary artery disease QTL GWAS1474062 (human) | | 2e-11 | large artery stroke, coronary artery disease | | 6 | 12903203 | 12903204 | Human |
597312504 | GWAS1408578_H | memory performance QTL GWAS1408578 (human) | | 0.0000006 | memory performance | | 6 | 660754 | 660755 | Human |
597582838 | GWAS1639698_H | head and neck malignant neoplasia QTL GWAS1639698 (human) | | 5e-18 | head and neck malignant neoplasia | | 6 | 396321 | 396322 | Human |
597091326 | GWAS1187400_H | intelligence QTL GWAS1187400 (human) | | 0.000008 | intelligence | | 6 | 19078043 | 19078044 | Human |
597591028 | GWAS1647888_H | phototoxic dermatitis QTL GWAS1647888 (human) | | 9e-80 | phototoxic dermatitis | | 6 | 396321 | 396322 | Human |
596968441 | GWAS1087960_H | body mass index QTL GWAS1087960 (human) | | 3e-09 | body mass index | | 6 | 16398686 | 16398687 | Human |
597066724 | GWAS1162798_H | memory performance QTL GWAS1162798 (human) | | 0.000003 | memory performance | | 6 | 11233802 | 11233803 | Human |
597378019 | GWAS1474093_H | atopic eczema, psoriasis QTL GWAS1474093 (human) | | 4e-10 | atopic eczema, psoriasis | | 6 | 1510423 | 1510424 | Human |
597189601 | GWAS1285675_H | free androgen index QTL GWAS1285675 (human) | | 8e-09 | free androgen index | | 6 | 17416027 | 17416028 | Human |
407050303 | GWAS699279_H | HIV-1 infection, Susceptibility to viral and mycobacterial infections QTL GWAS699279 (human) | | 0.000002 | response to viral infection trait (VT:0010439) | | 6 | 11310186 | 11310187 | Human |
597615585 | GWAS1672445_H | systolic blood pressure QTL GWAS1672445 (human) | | 4e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
596976404 | GWAS1095923_H | Red cell distribution width QTL GWAS1095923 (human) | | 4e-13 | Red cell distribution width | | 6 | 16290617 | 16290620 | Human |
596976401 | GWAS1095920_H | Red cell distribution width QTL GWAS1095920 (human) | | 3e-17 | Red cell distribution width | | 6 | 5260461 | 5260462 | Human |
596976400 | GWAS1095919_H | Red cell distribution width QTL GWAS1095919 (human) | | 3e-12 | Red cell distribution width | | 6 | 5095395 | 5095396 | Human |
597148434 | GWAS1244508_H | systolic blood pressure QTL GWAS1244508 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 10330129 | 10330140 | Human |
407369922 | GWAS1018898_H | mean corpuscular hemoglobin concentration QTL GWAS1018898 (human) | | 6e-18 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 13920307 | 13920308 | Human |
407050437 | GWAS699413_H | ornithine measurement QTL GWAS699413 (human) | | 0.000009 | ornithine measurement | blood amino acid measurement (CMO:0003730) | 6 | 2780727 | 2780728 | Human |
596976403 | GWAS1095922_H | Red cell distribution width QTL GWAS1095922 (human) | | 1e-14 | Red cell distribution width | | 6 | 16285830 | 16285831 | Human |
596976402 | GWAS1095921_H | Red cell distribution width QTL GWAS1095921 (human) | | 2e-13 | Red cell distribution width | | 6 | 16267244 | 16267245 | Human |
597091102 | GWAS1187176_H | type 2 diabetes mellitus QTL GWAS1187176 (human) | | 5e-08 | type 2 diabetes mellitus | | 6 | 7226726 | 7226727 | Human |
597525264 | GWAS1621338_H | BPI fold-containing family B member 1 measurement QTL GWAS1621338 (human) | | 4e-12 | BPI fold-containing family B member 1 measurement | | 6 | 2479876 | 2479877 | Human |
597107482 | GWAS1203556_H | testosterone measurement QTL GWAS1203556 (human) | | 4e-09 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 17416027 | 17416028 | Human |
597426963 | GWAS1523037_H | gout QTL GWAS1523037 (human) | | 9e-12 | gout | | 6 | 6749556 | 6749557 | Human |
406968529 | GWAS617505_H | reticulocyte count QTL GWAS617505 (human) | | 3e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16322747 | 16322748 | Human |
596976399 | GWAS1095918_H | Red cell distribution width QTL GWAS1095918 (human) | | 6e-14 | Red cell distribution width | | 6 | 4717531 | 4717532 | Human |
596976398 | GWAS1095917_H | Red cell distribution width QTL GWAS1095917 (human) | | 1e-17 | Red cell distribution width | | 6 | 3439463 | 3439464 | Human |
597336833 | GWAS1432907_H | R-warfarin measurement QTL GWAS1432907 (human) | | 0.000009 | R-warfarin measurement | | 6 | 5604813 | 5604814 | Human |
597525254 | GWAS1621328_H | protein measurement QTL GWAS1621328 (human) | | 2e-109 | protein measurement | | 6 | 16224441 | 16224442 | Human |
597590786 | GWAS1647646_H | examination for neoplasm QTL GWAS1647646 (human) | | 1e-11 | examination for neoplasm | | 6 | 396321 | 396322 | Human |
597492480 | GWAS1588554_H | COVID-19 QTL GWAS1588554 (human) | | 0.0000004 | COVID-19 | | 6 | 6911245 | 6911246 | Human |
597590784 | GWAS1647644_H | HPV seropositivity, common wart QTL GWAS1647644 (human) | | 1e-12 | HPV seropositivity, common wart | eye morphological measurement (CMO:0003080) | 6 | 396321 | 396322 | Human |
597214013 | GWAS1310087_H | shigellosis QTL GWAS1310087 (human) | | 0.000006 | shigellosis | | 6 | 2743777 | 2743778 | Human |
597214014 | GWAS1310088_H | shigellosis QTL GWAS1310088 (human) | | 0.000007 | shigellosis | | 6 | 7395251 | 7395252 | Human |
597369640 | GWAS1465714_H | risk-taking behaviour QTL GWAS1465714 (human) | | 2e-11 | risk-taking behaviour | | 6 | 12009023 | 12009024 | Human |
597017377 | GWAS1113451_H | basophil count QTL GWAS1113451 (human) | | 1e-09 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 7058283 | 7058284 | Human |
597123875 | GWAS1219949_H | smoking status measurement, chronic obstructive pulmonary disease QTL GWAS1219949 (human) | | 4e-09 | lung integrity trait (VT:0010906) | | 6 | 7211585 | 7211586 | Human |
597345070 | GWAS1441144_H | color vision disorder QTL GWAS1441144 (human) | | 0.000004 | color vision disorder | | 6 | 13208199 | 13208200 | Human |
597590818 | GWAS1647678_H | temporal measurement QTL GWAS1647678 (human) | | 3e-11 | temporal measurement | | 6 | 10872529 | 10872530 | Human |
597287716 | GWAS1383790_H | serum gamma-glutamyl transferase measurement QTL GWAS1383790 (human) | | 7e-18 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 6 | 7231610 | 7231611 | Human |
597132074 | GWAS1228148_H | diastolic blood pressure QTL GWAS1228148 (human) | | 6e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 18327072 | 18327073 | Human |
597132073 | GWAS1228147_H | diastolic blood pressure QTL GWAS1228147 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 17477194 | 17477195 | Human |
597132072 | GWAS1228146_H | diastolic blood pressure QTL GWAS1228146 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 16755537 | 16755538 | Human |
597492575 | GWAS1588649_H | low density lipoprotein cholesterol measurement QTL GWAS1588649 (human) | | 5e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16107636 | 16107637 | Human |
597418844 | GWAS1514918_H | FEV/FVC ratio QTL GWAS1514918 (human) | | 1e-22 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6742916 | 6742917 | Human |
596976477 | GWAS1095996_H | body height QTL GWAS1095996 (human) | | 2e-43 | body height | | 6 | 7801378 | 7801379 | Human |
596960093 | GWAS1079612_H | glomerular filtration rate QTL GWAS1079612 (human) | | 3e-18 | glomerular filtration rate | | 6 | 2050557 | 2050558 | Human |
596960094 | GWAS1079613_H | glomerular filtration rate QTL GWAS1079613 (human) | | 3e-13 | glomerular filtration rate | | 6 | 2582714 | 2582715 | Human |
596960095 | GWAS1079614_H | glomerular filtration rate QTL GWAS1079614 (human) | | 5e-53 | glomerular filtration rate | | 6 | 7109432 | 7109433 | Human |
597369676 | GWAS1465750_H | erectile dysfunction QTL GWAS1465750 (human) | | 0.000003 | erectile dysfunction | | 6 | 1397958 | 1397959 | Human |
597058382 | GWAS1154456_H | rosacea severity measurement QTL GWAS1154456 (human) | | 2e-17 | rosacea severity measurement | | 6 | 396321 | 396322 | Human |
597410627 | GWAS1506701_H | response to ketogenic diet QTL GWAS1506701 (human) | | 4e-08 | response to ketogenic diet | | 6 | 4644367 | 4644368 | Human |
407009432 | GWAS658408_H | body mass index QTL GWAS658408 (human) | | 7e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12142584 | 12142585 | Human |
597271416 | GWAS1367490_H | schizophrenia QTL GWAS1367490 (human) | | 0.000005 | schizophrenia | | 6 | 11553948 | 11553949 | Human |
596960118 | GWAS1079637_H | glomerular filtration rate QTL GWAS1079637 (human) | | 2e-09 | glomerular filtration rate | | 6 | 9547364 | 9547365 | Human |
596960119 | GWAS1079638_H | glomerular filtration rate QTL GWAS1079638 (human) | | 9e-10 | glomerular filtration rate | | 6 | 12292539 | 12292540 | Human |
597599098 | GWAS1655958_H | HbA1c measurement QTL GWAS1655958 (human) | | 2e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597082994 | GWAS1179068_H | reticulocyte measurement QTL GWAS1179068 (human) | | 2e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16247791 | 16247792 | Human |
597082995 | GWAS1179069_H | reticulocyte measurement QTL GWAS1179069 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16322747 | 16322748 | Human |
597082992 | GWAS1179066_H | reticulocyte measurement QTL GWAS1179066 (human) | | 6e-14 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7143626 | 7143627 | Human |
597082993 | GWAS1179067_H | reticulocyte measurement QTL GWAS1179067 (human) | | 2e-15 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7231953 | 7231954 | Human |
597295997 | GWAS1392071_H | lymphocyte count QTL GWAS1392071 (human) | | 3e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 13519202 | 13519203 | Human |
597476214 | GWAS1572288_H | mortality QTL GWAS1572288 (human) | | 0.000001 | mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 2634705 | 2634706 | Human |
596960120 | GWAS1079639_H | glomerular filtration rate QTL GWAS1079639 (human) | | 3e-08 | glomerular filtration rate | | 6 | 18777454 | 18777455 | Human |
597582705 | GWAS1639565_H | skin neoplasm QTL GWAS1639565 (human) | | 1e-323 | skin neoplasm | | 6 | 396321 | 396322 | Human |
597189495 | GWAS1285569_H | sex hormone-binding globulin measurement QTL GWAS1285569 (human) | | 1e-10 | sex hormone-binding globulin measurement | | 6 | 7229386 | 7229387 | Human |
597132135 | GWAS1228209_H | erythrocyte count QTL GWAS1228209 (human) | | 2e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16295116 | 16295121 | Human |
597082991 | GWAS1179065_H | reticulocyte measurement QTL GWAS1179065 (human) | | 2e-17 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 6679939 | 6679944 | Human |
597295968 | GWAS1392042_H | phosphatidylinositol measurement QTL GWAS1392042 (human) | | 3e-08 | phosphatidylinositol measurement | | 6 | 10994782 | 10994783 | Human |
597205860 | GWAS1301934_H | wellbeing measurement QTL GWAS1301934 (human) | | 4e-11 | wellness/fitness trait (VT:1000152) | | 6 | 11714917 | 11714918 | Human |
597377895 | GWAS1473969_H | total cholesterol measurement QTL GWAS1473969 (human) | | 3e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597320347 | GWAS1416421_H | body surface area QTL GWAS1416421 (human) | | 2e-15 | body surface area | | 6 | 2190612 | 2190613 | Human |
597123732 | GWAS1219806_H | clear cell renal carcinoma QTL GWAS1219806 (human) | | 3e-12 | clear cell renal carcinoma | | 6 | 1746787 | 1746788 | Human |
597271197 | GWAS1367271_H | systolic blood pressure QTL GWAS1367271 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1618731 | 1618732 | Human |
597320350 | GWAS1416424_H | body surface area QTL GWAS1416424 (human) | | 4e-10 | body surface area | | 6 | 19078043 | 19078044 | Human |
597320348 | GWAS1416422_H | body surface area QTL GWAS1416422 (human) | | 3e-35 | body surface area | | 6 | 7715456 | 7715457 | Human |
597320349 | GWAS1416423_H | body surface area QTL GWAS1416423 (human) | | 2e-09 | body surface area | | 6 | 12158092 | 12158093 | Human |
597238420 | GWAS1334494_H | neutrophil count QTL GWAS1334494 (human) | | 5e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7140598 | 7140599 | Human |
597197448 | GWAS1293522_H | hemoglobin measurement QTL GWAS1293522 (human) | | 2e-08 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 1997631 | 1997632 | Human |
597287561 | GWAS1383635_H | cholesterol:total lipids ratio, cholesteryl esters:total lipids ratio QTL GWAS1383635 (human) | | 3e-15 | cholesterol:total lipids ratio, cholesteryl esters:total lipids ratio | | 6 | 16114017 | 16114018 | Human |
597197449 | GWAS1293523_H | hemoglobin measurement QTL GWAS1293523 (human) | | 1e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16295116 | 16295121 | Human |
597033604 | GWAS1129678_H | heel bone mineral density QTL GWAS1129678 (human) | | 1e-30 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597279371 | GWAS1375445_H | docosahexaenoic acid measurement QTL GWAS1375445 (human) | | 5e-18 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11005453 | 11005454 | Human |
596976257 | GWAS1095776_H | Crohn's disease QTL GWAS1095776 (human) | | 0.000004 | Crohn's disease | | 6 | 3433084 | 3433085 | Human |
597033602 | GWAS1129676_H | heel bone mineral density QTL GWAS1129676 (human) | | 7e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 6961338 | 6961339 | Human |
596976256 | GWAS1095775_H | Crohn's disease QTL GWAS1095775 (human) | | 0.0000002 | Crohn's disease | | 6 | 246629 | 246630 | Human |
597033603 | GWAS1129677_H | heel bone mineral density QTL GWAS1129677 (human) | | 5e-41 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7050702 | 7050703 | Human |
597033600 | GWAS1129674_H | heel bone mineral density QTL GWAS1129674 (human) | | 7e-18 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2055443 | 2055444 | Human |
597033601 | GWAS1129675_H | heel bone mineral density QTL GWAS1129675 (human) | | 1e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2729370 | 2729371 | Human |
596976258 | GWAS1095777_H | Crohn's disease QTL GWAS1095777 (human) | | 1e-08 | Crohn's disease | | 6 | 14719265 | 14719266 | Human |
597426818 | GWAS1522892_H | gout QTL GWAS1522892 (human) | | 1e-09 | gout | | 6 | 13518497 | 13518498 | Human |
597377721 | GWAS1473795_H | cholesteryl ester 20:5 measurement QTL GWAS1473795 (human) | | 0.000009 | blood lipid amount (VT:0003949) | | 6 | 1344767 | 1344768 | Human |
597598905 | GWAS1655765_H | HbA1c measurement QTL GWAS1655765 (human) | | 1e-14 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 7231610 | 7231611 | Human |
407370094 | GWAS1019070_H | monocyte percentage of leukocytes QTL GWAS1019070 (human) | | 8e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 6 | 10526140 | 10526141 | Human |
597050045 | GWAS1146119_H | prostate carcinoma QTL GWAS1146119 (human) | | 1e-10 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
597418677 | GWAS1514751_H | NRF2 measurement QTL GWAS1514751 (human) | | 0.0000007 | NRF2 measurement | | 6 | 4957941 | 4957942 | Human |
597508786 | GWAS1604860_H | QT interval QTL GWAS1604860 (human) | | 9e-14 | QT interval | QT interval (CMO:0000235) | 6 | 6901623 | 6901624 | Human |
597213865 | GWAS1309939_H | protein measurement QTL GWAS1309939 (human) | | 2e-09 | protein measurement | | 6 | 7864356 | 7864357 | Human |
597385891 | GWAS1481965_H | erythrocyte count QTL GWAS1481965 (human) | | 4e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 6706613 | 6706614 | Human |
597385890 | GWAS1481964_H | erythrocyte count QTL GWAS1481964 (human) | | 3e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2516256 | 2516257 | Human |
597385889 | GWAS1481963_H | erythrocyte count QTL GWAS1481963 (human) | | 2e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2386679 | 2386680 | Human |
597582501 | GWAS1639361_H | cutaneous melanoma QTL GWAS1639361 (human) | | 2e-298 | cutaneous melanoma | | 6 | 396321 | 396322 | Human |
597230247 | GWAS1326321_H | age at menopause QTL GWAS1326321 (human) | | 9e-51 | age at menopause | | 6 | 10966900 | 10966901 | Human |
597058262 | GWAS1154336_H | eosinophil count QTL GWAS1154336 (human) | | 2e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 563210 | 563211 | Human |
597033686 | GWAS1129760_H | balding measurement QTL GWAS1129760 (human) | | 5e-20 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 16757771 | 16757772 | Human |
597058263 | GWAS1154337_H | eosinophil count QTL GWAS1154337 (human) | | 6e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 577820 | 577821 | Human |
597443294 | GWAS1539368_H | lipid measurement QTL GWAS1539368 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 8227141 | 8227142 | Human |
597336798 | GWAS1432872_H | COVID-19 QTL GWAS1432872 (human) | | 0.00001 | COVID-19 | | 6 | 17920558 | 17920559 | Human |
597459673 | GWAS1555747_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1555747 (human) | | 3e-17 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16113090 | 16113091 | Human |
597205726 | GWAS1301800_H | frontal fibrosing alopecia QTL GWAS1301800 (human) | | 0.000009 | frontal fibrosing alopecia | | 6 | 10220209 | 10220210 | Human |
597435093 | GWAS1531167_H | myocardial infarction QTL GWAS1531167 (human) | | 4e-63 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
407402754 | GWAS1051730_H | unipolar depression, bipolar disorder, seasonality measurement QTL GWAS1051730 (human) | | 0.000001 | unipolar depression, bipolar disorder, seasonality measurement | | 6 | 1128802 | 1128803 | Human |
597361361 | GWAS1457435_H | reticulocyte count QTL GWAS1457435 (human) | | 4e-11 | reticulocyte quantity (VT:0003135) | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 2488103 | 2488106 | Human |
597140188 | GWAS1236262_H | erythrocyte count QTL GWAS1236262 (human) | | 1e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16295116 | 16295121 | Human |
597115611 | GWAS1211685_H | cognitive function measurement QTL GWAS1211685 (human) | | 6e-14 | cognitive behavior trait (VT:0010450) | | 6 | 19028557 | 19028558 | Human |
597115610 | GWAS1211684_H | cognitive function measurement QTL GWAS1211684 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 6 | 16309799 | 16309800 | Human |
597058264 | GWAS1154338_H | eosinophil count QTL GWAS1154338 (human) | | 1e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 588426 | 588427 | Human |
597115609 | GWAS1211683_H | cognitive function measurement QTL GWAS1211683 (human) | | 4e-11 | cognitive behavior trait (VT:0010450) | | 6 | 11543109 | 11543110 | Human |
597615309 | GWAS1672169_H | respiratory system disease QTL GWAS1672169 (human) | | 2e-30 | respiratory system disease | | 6 | 7562999 | 7563000 | Human |
597607114 | GWAS1663974_H | male reproductive organ cancer QTL GWAS1663974 (human) | | 1e-11 | male reproductive organ cancer | | 6 | 5666366 | 5666367 | Human |
597230285 | GWAS1326359_H | electrocardiography QTL GWAS1326359 (human) | | 4e-10 | electrocardiography | | 6 | 12555642 | 12555643 | Human |
597492427 | GWAS1588501_H | breast density QTL GWAS1588501 (human) | | 0.000002 | breast density | | 6 | 12657480 | 12657481 | Human |
597164736 | GWAS1260810_H | isoleucine measurement QTL GWAS1260810 (human) | | 0.000004 | isoleucine measurement | blood amino acid measurement (CMO:0003730) | 6 | 5337550 | 5337551 | Human |
597525189 | GWAS1621263_H | osteoarthritis, hand QTL GWAS1621263 (human) | | 4e-11 | osteoarthritis, hand | | 6 | 8945086 | 8945087 | Human |
407083295 | GWAS732271_H | obsolete_red blood cell distribution width QTL GWAS732271 (human) | | 1e-17 | obsolete_red blood cell distribution width | | 6 | 3439463 | 3439464 | Human |
407083299 | GWAS732275_H | obsolete_red blood cell distribution width QTL GWAS732275 (human) | | 2e-13 | obsolete_red blood cell distribution width | | 6 | 16267244 | 16267245 | Human |
407083298 | GWAS732274_H | obsolete_red blood cell distribution width QTL GWAS732274 (human) | | 3e-17 | obsolete_red blood cell distribution width | | 6 | 5260461 | 5260462 | Human |
407083297 | GWAS732273_H | obsolete_red blood cell distribution width QTL GWAS732273 (human) | | 3e-12 | obsolete_red blood cell distribution width | | 6 | 5095395 | 5095396 | Human |
597484286 | GWAS1580360_H | circadian rhythm QTL GWAS1580360 (human) | | 0.000002 | circadian rhythm | | 6 | 18557146 | 18557147 | Human |
407083296 | GWAS732272_H | obsolete_red blood cell distribution width QTL GWAS732272 (human) | | 6e-14 | obsolete_red blood cell distribution width | | 6 | 4717531 | 4717532 | Human |
597181179 | GWAS1277253_H | body mass index QTL GWAS1277253 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5978836 | 5978837 | Human |
597517049 | GWAS1613123_H | peak expiratory flow QTL GWAS1613123 (human) | | 2e-12 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 2507667 | 2507668 | Human |
597181180 | GWAS1277254_H | body mass index QTL GWAS1277254 (human) | | 5e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
597181181 | GWAS1277255_H | body mass index QTL GWAS1277255 (human) | | 4e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
407083302 | GWAS732278_H | obsolete_red blood cell distribution width QTL GWAS732278 (human) | | 4e-13 | obsolete_red blood cell distribution width | | 6 | 16290617 | 16290620 | Human |
407083301 | GWAS732277_H | obsolete_red blood cell distribution width QTL GWAS732277 (human) | | 1e-14 | obsolete_red blood cell distribution width | | 6 | 16285830 | 16285831 | Human |
597410556 | GWAS1506630_H | glucose measurement QTL GWAS1506630 (human) | | 0.0000004 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7255417 | 7255418 | Human |
597328627 | GWAS1424701_H | sexual dimorphism measurement QTL GWAS1424701 (human) | | 9e-21 | sexual dimorphism measurement | | 6 | 7704376 | 7704377 | Human |
407083304 | GWAS732280_H | obsolete_red blood cell distribution width QTL GWAS732280 (human) | | 1e-11 | mean corpuscular volume | | 6 | 18757083 | 18757084 | Human |
597410549 | GWAS1506623_H | high density lipoprotein cholesterol measurement QTL GWAS1506623 (human) | | 3e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 7255417 | 7255418 | Human |
597402356 | GWAS1498430_H | Crohn's disease QTL GWAS1498430 (human) | | 2e-08 | intestine integrity trait (VT:0010554) | | 6 | 14719265 | 14719266 | Human |
597385962 | GWAS1482036_H | mean corpuscular hemoglobin concentration QTL GWAS1482036 (human) | | 2e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 6923601 | 6923602 | Human |
597181162 | GWAS1277236_H | hemoglobin measurement QTL GWAS1277236 (human) | | 9e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2036941 | 2036942 | Human |
597484271 | GWAS1580345_H | triglyceride measurement QTL GWAS1580345 (human) | | 0.000004 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 10112347 | 10112348 | Human |
597164781 | GWAS1260855_H | lymphoma QTL GWAS1260855 (human) | | 8e-09 | lymphoma | | 6 | 485991 | 485992 | Human |
597336806 | GWAS1432880_H | COVID-19 QTL GWAS1432880 (human) | | 0.000009 | COVID-19 | | 6 | 7466421 | 7466422 | Human |
597058282 | GWAS1154356_H | intelligence QTL GWAS1154356 (human) | | 0.0000009 | intelligence | | 6 | 11586202 | 11586203 | Human |
406919486 | GWAS568462_H | cup-to-disc ratio measurement QTL GWAS568462 (human) | | 2e-10 | cup-to-disc ratio measurement | | 6 | 1950901 | 1950902 | Human |
597180952 | GWAS1277026_H | protein measurement QTL GWAS1277026 (human) | | 6e-12 | protein measurement | | 6 | 2836639 | 2836640 | Human |
597139985 | GWAS1236059_H | metabolite measurement QTL GWAS1236059 (human) | | 8e-11 | metabolite measurement | | 6 | 18345404 | 18345405 | Human |
597459483 | GWAS1555557_H | age at menarche QTL GWAS1555557 (human) | | 1e-08 | age at menarche | | 6 | 5041236 | 5041237 | Human |
597598745 | GWAS1655605_H | HbA1c measurement QTL GWAS1655605 (human) | | 6e-14 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597172745 | GWAS1268819_H | peroxisome proliferator-activated receptor alpha measurement QTL GWAS1268819 (human) | | 2e-12 | peroxisome proliferator-activated receptor alpha measurement | | 6 | 13611846 | 13611847 | Human |
597205504 | GWAS1301578_H | handedness QTL GWAS1301578 (human) | | 2e-12 | handedness | | 6 | 3143632 | 3143633 | Human |
597615108 | GWAS1671968_H | Red cell distribution width QTL GWAS1671968 (human) | | 1e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16289417 | 16289418 | Human |
597615107 | GWAS1671967_H | Red cell distribution width QTL GWAS1671967 (human) | | 3e-16 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597279290 | GWAS1375364_H | QT interval QTL GWAS1375364 (human) | | 2e-37 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 6 | 18209878 | 18209879 | Human |
597312060 | GWAS1408134_H | urinary uromodulin measurement QTL GWAS1408134 (human) | | 0.000005 | urinary uromodulin measurement | | 6 | 13188489 | 13188490 | Human |
597344817 | GWAS1440891_H | FEV/FVC ratio QTL GWAS1440891 (human) | | 2e-38 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7109200 | 7109201 | Human |
597033531 | GWAS1129605_H | lean body mass QTL GWAS1129605 (human) | | 6e-14 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7718832 | 7718833 | Human |
597393972 | GWAS1490046_H | balding measurement QTL GWAS1490046 (human) | | 8e-13 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 413389 | 413390 | Human |
597123622 | GWAS1219696_H | chronic obstructive pulmonary disease QTL GWAS1219696 (human) | | 8e-10 | lung integrity trait (VT:0010906) | | 6 | 7211585 | 7211586 | Human |
407001585 | GWAS650561_H | pulse pressure measurement QTL GWAS650561 (human) | | 2e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7727979 | 7727980 | Human |
407124466 | GWAS773442_H | indoxyl sulfate measurement QTL GWAS773442 (human) | | 0.000004 | indoxyl sulfate measurement | | 6 | 5884519 | 5884520 | Human |
597606949 | GWAS1663809_H | systolic blood pressure QTL GWAS1663809 (human) | | 6e-37 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597082667 | GWAS1178741_H | type 2 diabetes mellitus QTL GWAS1178741 (human) | | 2e-14 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597377572 | GWAS1473646_H | low density lipoprotein cholesterol measurement QTL GWAS1473646 (human) | | 1e-11 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597582428 | GWAS1639288_H | leukemia QTL GWAS1639288 (human) | | 2e-13 | leukemia | | 6 | 411064 | 411065 | Human |
597205595 | GWAS1301669_H | electrocardiography QTL GWAS1301669 (human) | | 3e-09 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597205596 | GWAS1301670_H | electrocardiography QTL GWAS1301670 (human) | | 2e-08 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597205597 | GWAS1301671_H | electrocardiography QTL GWAS1301671 (human) | | 1e-08 | electrocardiography | | 6 | 18387461 | 18387462 | Human |
597336668 | GWAS1432742_H | COVID-19 QTL GWAS1432742 (human) | | 0.000008 | COVID-19 | | 6 | 18853436 | 18853437 | Human |
597607001 | GWAS1663861_H | basal cell carcinoma QTL GWAS1663861 (human) | | 2e-179 | basal cell carcinoma | | 6 | 396321 | 396322 | Human |
597434965 | GWAS1531039_H | BMI-adjusted waist-hip ratio QTL GWAS1531039 (human) | | 0.0000002 | body size trait (VT:0100005) | | 6 | 6736698 | 6736699 | Human |
597525074 | GWAS1621148_H | 1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) measurement QTL GWAS1621148 (human) | | 5e-10 | glycerophosphocholine amount (VT:0011004) | | 6 | 11089296 | 11089297 | Human |
597492303 | GWAS1588377_H | neuroticism measurement, cognitive function measurement QTL GWAS1588377 (human) | | 5e-20 | cognitive behavior trait (VT:0010450) | | 6 | 11502113 | 11502116 | Human |
597328449 | GWAS1424523_H | sexual dimorphism measurement QTL GWAS1424523 (human) | | 3e-16 | sexual dimorphism measurement | | 6 | 7728195 | 7728196 | Human |
597443139 | GWAS1539213_H | open-angle glaucoma QTL GWAS1539213 (human) | | 3e-51 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
406960549 | GWAS609525_H | synophrys measurement QTL GWAS609525 (human) | | 1e-10 | coat/hair morphology trait (VT:0000367) | | 6 | 396321 | 396322 | Human |
597049970 | GWAS1146044_H | cutaneous squamous cell carcinoma QTL GWAS1146044 (human) | | 1e-221 | cutaneous squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597598842 | GWAS1655702_H | hemoglobin measurement QTL GWAS1655702 (human) | | 6e-33 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7195451 | 7195452 | Human |
597377662 | GWAS1473736_H | response to statin, LDL cholesterol change measurement QTL GWAS1473736 (human) | | 0.0000005 | blood LDL cholesterol amount (VT:0000181) | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16161194 | 16161195 | Human |
597033598 | GWAS1129672_H | heel bone mineral density QTL GWAS1129672 (human) | | 6e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 1247695 | 1247696 | Human |
597181040 | GWAS1277114_H | hemoglobin measurement QTL GWAS1277114 (human) | | 0.0000002 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2198093 | 2198094 | Human |
597033599 | GWAS1129673_H | heel bone mineral density QTL GWAS1129673 (human) | | 2e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 1613451 | 1613452 | Human |
596968062 | GWAS1087581_H | body mass index QTL GWAS1087581 (human) | | 5e-09 | body mass index | | 6 | 12086593 | 12086594 | Human |
597164648 | GWAS1260722_H | type 2 diabetes mellitus QTL GWAS1260722 (human) | | 1e-21 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597402222 | GWAS1498296_H | protein measurement QTL GWAS1498296 (human) | | 6e-21 | protein measurement | | 6 | 2993701 | 2993702 | Human |
597320303 | GWAS1416377_H | executive function measurement QTL GWAS1416377 (human) | | 2e-14 | executive function measurement | | 6 | 19035804 | 19035805 | Human |
597369447 | GWAS1465521_H | short-term memory QTL GWAS1465521 (human) | | 0.000002 | short-term memory | | 6 | 8282300 | 8282301 | Human |
597221787 | GWAS1317861_H | alkaline phosphatase measurement QTL GWAS1317861 (human) | | 4e-18 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 15526186 | 15526187 | Human |
597221777 | GWAS1317851_H | HbA1c measurement QTL GWAS1317851 (human) | | 4e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7250037 | 7250038 | Human |
407231054 | GWAS880030_H | asthma, response to diisocyanate QTL GWAS880030 (human) | | 0.000001 | asthma, response to diisocyanate | | 6 | 16110152 | 16110153 | Human |
597139865 | GWAS1235939_H | total cholesterol measurement QTL GWAS1235939 (human) | | 4e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16126703 | 16126704 | Human |
597336458 | GWAS1432532_H | COVID-19 QTL GWAS1432532 (human) | | 0.000006 | COVID-19 | | 6 | 19208246 | 19208247 | Human |
597467533 | GWAS1563607_H | keratinocyte carcinoma QTL GWAS1563607 (human) | | 5e-15 | keratinocyte carcinoma | | 6 | 4979722 | 4979723 | Human |
597516686 | GWAS1612760_H | migraine disorder, Headache QTL GWAS1612760 (human) | | 5e-25 | migraine disorder, Headache | | 6 | 12903725 | 12903726 | Human |
406944345 | GWAS593321_H | eosinophil percentage of leukocytes QTL GWAS593321 (human) | | 7e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 577820 | 577821 | Human |
597369219 | GWAS1465293_H | hemoglobin measurement QTL GWAS1465293 (human) | | 5e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12288189 | 12288190 | Human |
406944344 | GWAS593320_H | eosinophil percentage of leukocytes QTL GWAS593320 (human) | | 4e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 514991 | 514992 | Human |
596951437 | GWAS1070956_H | dementia QTL GWAS1070956 (human) | | 0.000008 | dementia | | 6 | 12455913 | 12455914 | Human |
406944346 | GWAS593322_H | eosinophil percentage of leukocytes QTL GWAS593322 (human) | | 2e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 588426 | 588427 | Human |
597590400 | GWAS1647260_H | diabetes mellitus QTL GWAS1647260 (human) | | 1e-12 | pancreas integrity trait (VT:0010560) | | 6 | 7245225 | 7245226 | Human |
597311928 | GWAS1408002_H | vaginal microbiome measurement QTL GWAS1408002 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9569840 | 9569841 | Human |
597074357 | GWAS1170431_H | type 2 diabetes mellitus QTL GWAS1170431 (human) | | 2e-08 | type 2 diabetes mellitus | | 6 | 7290204 | 7290205 | Human |
597590458 | GWAS1647318_H | postinflammatory pulmonary fibrosis QTL GWAS1647318 (human) | | 2e-23 | postinflammatory pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597057968 | GWAS1154042_H | type 2 diabetes mellitus QTL GWAS1154042 (human) | | 2e-15 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597311927 | GWAS1408001_H | vaginal microbiome measurement QTL GWAS1408001 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9567839 | 9567840 | Human |
407173737 | GWAS822713_H | Cleft palate, cleft lip QTL GWAS822713 (human) | | 0.000009 | Cleft palate, cleft lip | | 6 | 10390870 | 10390887 | Human |
597262775 | GWAS1358849_H | word reading QTL GWAS1358849 (human) | | 0.0000005 | word reading | | 6 | 16418331 | 16418332 | Human |
597410219 | GWAS1506293_H | neuroticism measurement QTL GWAS1506293 (human) | | 4e-08 | neuroticism measurement | | 6 | 11999060 | 11999061 | Human |
597393834 | GWAS1489908_H | pulse pressure measurement QTL GWAS1489908 (human) | | 4e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7213674 | 7213675 | Human |
597336495 | GWAS1432569_H | susceptibility to common cold measurement QTL GWAS1432569 (human) | | 0.000003 | susceptibility to common cold measurement | | 6 | 18149914 | 18149915 | Human |
597492135 | GWAS1588209_H | gluteofemoral adipose tissue measurement QTL GWAS1588209 (human) | | 4e-08 | gluteofemoral adipose tissue measurement | | 6 | 6749556 | 6749557 | Human |
597500327 | GWAS1596401_H | waist-hip ratio QTL GWAS1596401 (human) | | 1e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7217284 | 7217285 | Human |
597336480 | GWAS1432554_H | phosphatidylcholine diacyl C42:5 measurement QTL GWAS1432554 (human) | | 7e-19 | lipid metabolism trait (VT:0010633) | | 6 | 11005609 | 11005610 | Human |
597336481 | GWAS1432555_H | phosphatidylcholine diacyl C42:6 measurement QTL GWAS1432555 (human) | | 2e-13 | lipid metabolism trait (VT:0010633) | | 6 | 11005609 | 11005610 | Human |
597377447 | GWAS1473521_H | white matter hyperintensity measurement QTL GWAS1473521 (human) | | 0.000003 | white matter hyperintensity measurement | | 6 | 1366620 | 1366621 | Human |
597033385 | GWAS1129459_H | balding measurement QTL GWAS1129459 (human) | | 8e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 403799 | 403800 | Human |
597279197 | GWAS1375271_H | phospholipids in medium LDL measurement QTL GWAS1375271 (human) | | 3e-14 | phospholipids in medium LDL measurement | blood low density lipoprotein phospholipid level (CMO:0001568) | 6 | 16131066 | 16131067 | Human |
597590486 | GWAS1647346_H | idiopathic pulmonary fibrosis QTL GWAS1647346 (human) | | 4e-20 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597295574 | GWAS1391648_H | phosphatidylcholine measurement QTL GWAS1391648 (human) | | 5e-14 | phosphatidylcholine measurement | | 6 | 11040190 | 11040191 | Human |
597295573 | GWAS1391647_H | phosphatidylcholine measurement QTL GWAS1391647 (human) | | 4e-13 | phosphatidylcholine measurement | | 6 | 11008389 | 11008390 | Human |
597418443 | GWAS1514517_H | bipolar disorder, seasonality measurement, major depressive disorder QTL GWAS1514517 (human) | | 0.000001 | bipolar disorder, seasonality measurement, major depressive disorder | eye physiological measurement (CMO:0003652) | 6 | 1128802 | 1128803 | Human |
407222806 | GWAS871782_H | niacinamide measurement QTL GWAS871782 (human) | | 0.000007 | vitamin metabolism trait (VT:0015087) | | 6 | 890039 | 890040 | Human |
596951495 | GWAS1071014_H | HbA1c measurement QTL GWAS1071014 (human) | | 4e-09 | HbA1c measurement | | 6 | 7247111 | 7247112 | Human |
597590477 | GWAS1647337_H | respiratory system disease QTL GWAS1647337 (human) | | 7e-29 | respiratory system disease | | 6 | 7562999 | 7563000 | Human |
597148099 | GWAS1244173_H | COVID-19 QTL GWAS1244173 (human) | | 9e-08 | COVID-19 | | 6 | 6161827 | 6161828 | Human |
597115331 | GWAS1211405_H | reticulocyte count QTL GWAS1211405 (human) | | 6e-37 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16290617 | 16290620 | Human |
597115330 | GWAS1211404_H | reticulocyte count QTL GWAS1211404 (human) | | 3e-31 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16285830 | 16285831 | Human |
597098956 | GWAS1195030_H | spondylosis QTL GWAS1195030 (human) | | 9e-09 | spondylosis | | 6 | 7805683 | 7805684 | Human |
597311937 | GWAS1408011_H | vaginal microbiome measurement QTL GWAS1408011 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9567399 | 9567400 | Human |
597090761 | GWAS1186835_H | mammographic density percentage QTL GWAS1186835 (human) | | 5e-15 | mammographic density percentage | | 6 | 16399326 | 16399327 | Human |
596976116 | GWAS1095635_H | Red cell distribution width QTL GWAS1095635 (human) | | 2e-24 | Red cell distribution width | | 6 | 3427849 | 3427850 | Human |
597402111 | GWAS1498185_H | schizophrenia QTL GWAS1498185 (human) | | 0.000006 | schizophrenia | | 6 | 1371322 | 1371323 | Human |
597484026 | GWAS1580100_H | mean corpuscular hemoglobin concentration QTL GWAS1580100 (human) | | 5e-08 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 2883081 | 2883082 | Human |
596976115 | GWAS1095634_H | Red cell distribution width QTL GWAS1095634 (human) | | 2e-13 | Red cell distribution width | | 6 | 3369275 | 3369276 | Human |
597590520 | GWAS1647380_H | hyperparathyroidism QTL GWAS1647380 (human) | | 1e-18 | hyperparathyroidism | | 6 | 10853114 | 10853115 | Human |
596976114 | GWAS1095633_H | Red cell distribution width QTL GWAS1095633 (human) | | 2e-18 | Red cell distribution width | | 6 | 3162144 | 3162145 | Human |
597606903 | GWAS1663763_H | HbA1c measurement QTL GWAS1663763 (human) | | 1e-24 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597336560 | GWAS1432634_H | dyslexia QTL GWAS1432634 (human) | | 4e-08 | dyslexia | | 6 | 17009359 | 17009360 | Human |
597451248 | GWAS1547322_H | apolipoprotein B measurement QTL GWAS1547322 (human) | | 5e-24 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16127176 | 16127177 | Human |
597115386 | GWAS1211460_H | intraocular pressure measurement QTL GWAS1211460 (human) | | 7e-15 | intraocular pressure measurement | | 6 | 2040937 | 2040938 | Human |
597017061 | GWAS1113135_H | educational attainment QTL GWAS1113135 (human) | | 7e-09 | educational attainment | | 6 | 19293200 | 19293201 | Human |
406977074 | GWAS626050_H | body composition measurement QTL GWAS626050 (human) | | 0.000009 | body composition measurement | | 6 | 7652484 | 7652485 | Human |
597017057 | GWAS1113131_H | educational attainment QTL GWAS1113131 (human) | | 7e-45 | educational attainment | | 6 | 16965821 | 16965822 | Human |
597320175 | GWAS1416249_H | triglyceride measurement QTL GWAS1416249 (human) | | 4e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 7247111 | 7247112 | Human |
597017056 | GWAS1113130_H | educational attainment QTL GWAS1113130 (human) | | 7e-16 | educational attainment | | 6 | 16924043 | 16924044 | Human |
597017059 | GWAS1113133_H | educational attainment QTL GWAS1113133 (human) | | 2e-09 | educational attainment | | 6 | 17282184 | 17282185 | Human |
597017058 | GWAS1113132_H | educational attainment QTL GWAS1113132 (human) | | 3e-14 | educational attainment | | 6 | 17015407 | 17015408 | Human |
407050810 | GWAS699786_H | lactate measurement QTL GWAS699786 (human) | | 0.000009 | blood lactate amount (VT:0010616) | blood lactate level (CMO:0001303) | 6 | 2776069 | 2776070 | Human |
597615075 | GWAS1671935_H | platelet count QTL GWAS1671935 (human) | | 9e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597590497 | GWAS1647357_H | encounter with health service QTL GWAS1647357 (human) | | 7e-15 | encounter with health service | | 6 | 16415625 | 16415626 | Human |
597369115 | GWAS1465189_H | Uveal Melanoma QTL GWAS1465189 (human) | | 0.000003 | Uveal Melanoma | | 6 | 7080590 | 7080591 | Human |
406993603 | GWAS642579_H | reticulocyte count QTL GWAS642579 (human) | | 8e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2016607 | 2016608 | Human |
596951312 | GWAS1070831_H | sex hormone-binding globulin measurement QTL GWAS1070831 (human) | | 2e-10 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597614875 | GWAS1671735_H | Red cell distribution width QTL GWAS1671735 (human) | | 1e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 19171488 | 19171489 | Human |
597025053 | GWAS1121127_H | erythrocyte count QTL GWAS1121127 (human) | | 6e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7232156 | 7232157 | Human |
406993610 | GWAS642586_H | reticulocyte count QTL GWAS642586 (human) | | 2e-27 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16290617 | 16290620 | Human |
597025052 | GWAS1121126_H | erythrocyte count QTL GWAS1121126 (human) | | 6e-19 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2050557 | 2050558 | Human |
406993608 | GWAS642584_H | reticulocyte count QTL GWAS642584 (human) | | 1e-28 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16282287 | 16282288 | Human |
597025054 | GWAS1121128_H | erythrocyte count QTL GWAS1121128 (human) | | 7e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176868 | 15176869 | Human |
406993609 | GWAS642585_H | reticulocyte count QTL GWAS642585 (human) | | 2e-31 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16285830 | 16285831 | Human |
597295382 | GWAS1391456_H | phosphatidylcholine measurement QTL GWAS1391456 (human) | | 9e-13 | phosphatidylcholine measurement | | 6 | 11021921 | 11021922 | Human |
597369110 | GWAS1465184_H | Uveal Melanoma QTL GWAS1465184 (human) | | 0.000002 | Uveal Melanoma | | 6 | 7080590 | 7080591 | Human |
597369099 | GWAS1465173_H | heel bone mineral density QTL GWAS1465173 (human) | | 1e-40 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2501594 | 2501595 | Human |
597205259 | GWAS1301333_H | rheumatoid arthritis QTL GWAS1301333 (human) | | 9e-11 | rheumatoid arthritis | | 6 | 382537 | 382538 | Human |
596984070 | GWAS1103589_H | memory performance QTL GWAS1103589 (human) | | 0.0000008 | memory performance | | 6 | 11732434 | 11732435 | Human |
597205260 | GWAS1301334_H | rheumatoid arthritis QTL GWAS1301334 (human) | | 1e-11 | rheumatoid arthritis | | 6 | 14106966 | 14106967 | Human |
597360910 | GWAS1456984_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1456984 (human) | | 2e-10 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 6 | 8689984 | 8689985 | Human |
597459210 | GWAS1555284_H | dementia QTL GWAS1555284 (human) | | 0.000004 | dementia | | 6 | 1520806 | 1520807 | Human |
597369101 | GWAS1465175_H | heel bone mineral density QTL GWAS1465175 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 10052356 | 10052357 | Human |
597377292 | GWAS1473366_H | suntan QTL GWAS1473366 (human) | | 5e-14 | suntan | | 6 | 475489 | 475490 | Human |
597369100 | GWAS1465174_H | heel bone mineral density QTL GWAS1465174 (human) | | 9e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2577841 | 2577842 | Human |
597074190 | GWAS1170264_H | intelligence, self reported educational attainment QTL GWAS1170264 (human) | | 2e-09 | mean platelet volume | | 6 | 3446029 | 3446030 | Human |
597033229 | GWAS1129303_H | lean body mass QTL GWAS1129303 (human) | | 1e-21 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7718832 | 7718833 | Human |
596984074 | GWAS1103593_H | memory performance QTL GWAS1103593 (human) | | 0.0000009 | memory performance | | 6 | 16089836 | 16089837 | Human |
597475646 | GWAS1571720_H | blood protein measurement QTL GWAS1571720 (human) | | 2e-22 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6332851 | 6332852 | Human |
406977251 | GWAS626227_H | reticulocyte count QTL GWAS626227 (human) | | 7e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 7157433 | 7157434 | Human |
597057855 | GWAS1153929_H | eosinophil count QTL GWAS1153929 (human) | | 4e-27 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 245096 | 245097 | Human |
597328179 | GWAS1424253_H | sexual dimorphism measurement QTL GWAS1424253 (human) | | 3e-08 | sexual dimorphism measurement | | 6 | 2139216 | 2139217 | Human |
596951358 | GWAS1070877_H | birth weight QTL GWAS1070877 (human) | | 0.0000001 | birth weight | | 6 | 7231610 | 7231611 | Human |
597279029 | GWAS1375103_H | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio QTL GWAS1375103 (human) | | 7e-15 | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597074232 | GWAS1170306_H | major depressive disorder QTL GWAS1170306 (human) | | 0.000003 | major depressive disorder | | 6 | 10818696 | 10818697 | Human |
597344552 | GWAS1440626_H | lymphocyte measurement QTL GWAS1440626 (human) | | 7e-09 | lymphocyte measurement | | 6 | 410417 | 410418 | Human |
597508399 | GWAS1604473_H | COVID-19 QTL GWAS1604473 (human) | | 0.000009 | COVID-19 | | 6 | 1243222 | 1243223 | Human |
597360928 | GWAS1457002_H | migraine disorder QTL GWAS1457002 (human) | | 6e-22 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597434658 | GWAS1530732_H | HWESASXX measurement QTL GWAS1530732 (human) | | 0.000006 | HWESASXX measurement | | 6 | 7214266 | 7214267 | Human |
597360932 | GWAS1457006_H | migraine without aura, susceptibility to, 4 QTL GWAS1457006 (human) | | 2e-09 | alcohol consumption measurement | | 6 | 12903725 | 12903726 | Human |
597147991 | GWAS1244065_H | COVID-19 QTL GWAS1244065 (human) | | 6e-08 | COVID-19 | | 6 | 3439100 | 3439101 | Human |
597147988 | GWAS1244062_H | COVID-19 QTL GWAS1244062 (human) | | 5e-08 | COVID-19 | | 6 | 18407322 | 18407323 | Human |
597475673 | GWAS1571747_H | cognitive function measurement, self reported educational attainment QTL GWAS1571747 (human) | | 4e-10 | cognitive behavior trait (VT:0010450) | | 6 | 11508438 | 11508439 | Human |
597320028 | GWAS1416102_H | squamous cell carcinoma QTL GWAS1416102 (human) | | 3e-45 | squamous cell carcinoma | | 6 | 390658 | 390659 | Human |
597107037 | GWAS1203111_H | systemic lupus erythematosus QTL GWAS1203111 (human) | | 1e-15 | systemic lupus erythematosus | | 6 | 243302 | 243303 | Human |
597385552 | GWAS1481626_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1481626 (human) | | 1e-12 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6736698 | 6736699 | Human |
597492049 | GWAS1588123_H | breast density QTL GWAS1588123 (human) | | 0.000001 | breast density | | 6 | 8464622 | 8464623 | Human |
407132811 | GWAS781787_H | melanoma QTL GWAS781787 (human) | | 9e-14 | melanoma | | 6 | 421281 | 421282 | Human |
597426511 | GWAS1522585_H | substance abuse QTL GWAS1522585 (human) | | 0.000002 | substance abuse | | 6 | 1019127 | 1019128 | Human |
407386779 | GWAS1035755_H | obsolete_red blood cell distribution width QTL GWAS1035755 (human) | | 3e-11 | obsolete_red blood cell distribution width | | 6 | 2501301 | 2501302 | Human |
597057858 | GWAS1153932_H | eosinophil count QTL GWAS1153932 (human) | | 1e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
407386780 | GWAS1035756_H | obsolete_red blood cell distribution width QTL GWAS1035756 (human) | | 3e-25 | obsolete_red blood cell distribution width | | 6 | 5260461 | 5260462 | Human |
597590346 | GWAS1647206_H | parathyroid disease QTL GWAS1647206 (human) | | 3e-19 | parathyroid disease | | 6 | 10850079 | 10850080 | Human |
597057856 | GWAS1153930_H | eosinophil count QTL GWAS1153930 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 294268 | 294269 | Human |
597057857 | GWAS1153931_H | eosinophil count QTL GWAS1153931 (human) | | 1e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 390658 | 390659 | Human |
407042718 | GWAS691694_H | breast carcinoma QTL GWAS691694 (human) | | 8e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 13722291 | 13722292 | Human |
597156169 | GWAS1252243_H | testosterone measurement QTL GWAS1252243 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 7841888 | 7841889 | Human |
597025140 | GWAS1121214_H | Orofacial cleft QTL GWAS1121214 (human) | | 0.000008 | Orofacial cleft | | 6 | 10296103 | 10296104 | Human |
407386795 | GWAS1035771_H | vital capacity QTL GWAS1035771 (human) | | 2e-22 | vital capacity | | 6 | 7719826 | 7719827 | Human |
597401981 | GWAS1498055_H | corneal topography QTL GWAS1498055 (human) | | 0.000003 | corneal topography | | 6 | 10028593 | 10028594 | Human |
406977191 | GWAS626167_H | reticulocyte count QTL GWAS626167 (human) | | 7e-14 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16322747 | 16322748 | Human |
597492080 | GWAS1588154_H | X-13435 measurement QTL GWAS1588154 (human) | | 4e-38 | X-13435 measurement | | 6 | 4145964 | 4145965 | Human |
597336424 | GWAS1432498_H | dyslexia QTL GWAS1432498 (human) | | 0.0000006 | dyslexia | | 6 | 19071080 | 19071081 | Human |
597139821 | GWAS1235895_H | migraine disorder, type 2 diabetes mellitus QTL GWAS1235895 (human) | | 1e-08 | migraine disorder, type 2 diabetes mellitus | | 6 | 7204195 | 7204196 | Human |
597508455 | GWAS1604529_H | 1-docosahexaenoyl-GPE (22:6) measurement QTL GWAS1604529 (human) | | 1e-12 | 1-docosahexaenoyl-GPE (22:6) measurement | | 6 | 11044425 | 11044426 | Human |
596951190 | GWAS1070709_H | Red cell distribution width QTL GWAS1070709 (human) | | 8e-18 | Red cell distribution width | | 6 | 16267244 | 16267245 | Human |
597336216 | GWAS1432290_H | COVID-19 QTL GWAS1432290 (human) | | 0.00001 | COVID-19 | | 6 | 19208246 | 19208247 | Human |
596951191 | GWAS1070710_H | Red cell distribution width QTL GWAS1070710 (human) | | 1e-15 | Red cell distribution width | | 6 | 18757083 | 18757084 | Human |
597409949 | GWAS1506023_H | Alzheimer disease QTL GWAS1506023 (human) | | 0.00001 | Alzheimer disease | | 6 | 18585056 | 18585057 | Human |
597344413 | GWAS1440487_H | immature reticulocyte measurement QTL GWAS1440487 (human) | | 4e-18 | immature reticulocyte measurement | | 6 | 16294491 | 16294492 | Human |
597581970 | GWAS1638830_H | hypertension QTL GWAS1638830 (human) | | 4e-11 | hypertension | | 6 | 1614132 | 1614133 | Human |
597590160 | GWAS1647020_H | open-angle glaucoma QTL GWAS1647020 (human) | | 6e-28 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
596959386 | GWAS1078905_H | glomerular filtration rate QTL GWAS1078905 (human) | | 0.000005 | glomerular filtration rate | | 6 | 18777454 | 18777455 | Human |
596983942 | GWAS1103461_H | telomere length QTL GWAS1103461 (human) | | 3e-14 | telomere length | | 6 | 202777 | 202778 | Human |
597450885 | GWAS1546959_H | cystatin C measurement QTL GWAS1546959 (human) | | 8e-12 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 6 | 2522961 | 2522962 | Human |
597467269 | GWAS1563343_H | insomnia QTL GWAS1563343 (human) | | 0.0000001 | insomnia | | 6 | 3919326 | 3919327 | Human |
597074063 | GWAS1170137_H | interleukin 10 measurement QTL GWAS1170137 (human) | | 7e-08 | interleukin 10 measurement | | 6 | 6126612 | 6126613 | Human |
597598341 | GWAS1655201_H | mean corpuscular hemoglobin concentration QTL GWAS1655201 (human) | | 2e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597328006 | GWAS1424080_H | sexual dimorphism measurement QTL GWAS1424080 (human) | | 1e-13 | sexual dimorphism measurement | | 6 | 7733826 | 7733827 | Human |
597426304 | GWAS1522378_H | urate measurement QTL GWAS1522378 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 15371012 | 15371013 | Human |
597532861 | GWAS1628935_H | metabolite measurement QTL GWAS1628935 (human) | | 3e-33 | metabolite measurement | | 6 | 4122015 | 4122016 | Human |
597434552 | GWAS1530626_H | Inguinal hernia QTL GWAS1530626 (human) | | 4e-15 | Inguinal hernia | | 6 | 6742916 | 6742917 | Human |
597582009 | GWAS1638869_H | monocyte count QTL GWAS1638869 (human) | | 8e-23 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7134168 | 7134169 | Human |
597311670 | GWAS1407744_H | vaginal microbiome measurement QTL GWAS1407744 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 12841524 | 12841525 | Human |
597139643 | GWAS1235717_H | hemoglobin measurement QTL GWAS1235717 (human) | | 2e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16295116 | 16295121 | Human |
597205173 | GWAS1301247_H | type 2 diabetes mellitus QTL GWAS1301247 (human) | | 1e-13 | Drugs used in diabetes use measurement | | 6 | 7231610 | 7231611 | Human |
597491891 | GWAS1587965_H | waist-hip ratio QTL GWAS1587965 (human) | | 0.0000006 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6744465 | 6744466 | Human |
597524653 | GWAS1620727_H | intelligence QTL GWAS1620727 (human) | | 5e-13 | intelligence | | 6 | 11470461 | 11470462 | Human |
596959396 | GWAS1078915_H | glomerular filtration rate QTL GWAS1078915 (human) | | 2e-10 | glomerular filtration rate | | 6 | 12292539 | 12292540 | Human |
596959392 | GWAS1078911_H | glomerular filtration rate QTL GWAS1078911 (human) | | 1e-19 | glomerular filtration rate | | 6 | 2050557 | 2050558 | Human |
596951200 | GWAS1070719_H | COVID-19 QTL GWAS1070719 (human) | | 0.000007 | COVID-19 | | 6 | 6170992 | 6170993 | Human |
596959393 | GWAS1078912_H | glomerular filtration rate QTL GWAS1078912 (human) | | 4e-14 | glomerular filtration rate | | 6 | 2582714 | 2582715 | Human |
597278895 | GWAS1374969_H | hypothyroidism QTL GWAS1374969 (human) | | 7e-11 | hypothyroidism | | 6 | 408079 | 408080 | Human |
596959394 | GWAS1078913_H | glomerular filtration rate QTL GWAS1078913 (human) | | 1e-40 | glomerular filtration rate | | 6 | 7109432 | 7109433 | Human |
596959395 | GWAS1078914_H | glomerular filtration rate QTL GWAS1078914 (human) | | 8e-08 | glomerular filtration rate | | 6 | 9547364 | 9547365 | Human |
597213359 | GWAS1309433_H | empathy measurement QTL GWAS1309433 (human) | | 0.000009 | empathy measurement | | 6 | 16526062 | 16526063 | Human |
597246114 | GWAS1342188_H | HbA1c measurement QTL GWAS1342188 (human) | | 3e-29 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7247111 | 7247112 | Human |
597049512 | GWAS1145586_H | urate measurement QTL GWAS1145586 (human) | | 4e-23 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7101851 | 7101852 | Human |
597426396 | GWAS1522470_H | phosphatidylinositol measurement QTL GWAS1522470 (human) | | 1e-13 | phosphatidylinositol measurement | | 6 | 11047243 | 11047244 | Human |
597426397 | GWAS1522471_H | phosphatidylinositol measurement QTL GWAS1522471 (human) | | 1e-13 | phosphatidylinositol measurement | | 6 | 11074455 | 11074456 | Human |
597139669 | GWAS1235743_H | neuroimaging measurement QTL GWAS1235743 (human) | | 3e-19 | neuroimaging measurement | | 6 | 7112586 | 7112587 | Human |
597426398 | GWAS1522472_H | phosphatidylinositol measurement QTL GWAS1522472 (human) | | 7e-11 | phosphatidylinositol measurement | | 6 | 11074967 | 11074968 | Human |
597287133 | GWAS1383207_H | body weight QTL GWAS1383207 (human) | | 4e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 2091741 | 2091742 | Human |
597311710 | GWAS1407784_H | vaginal microbiome measurement QTL GWAS1407784 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9560287 | 9560288 | Human |
597614810 | GWAS1671670_H | lower urinary tract calculus QTL GWAS1671670 (human) | | 2e-11 | lower urinary tract calculus | | 6 | 14932632 | 14932633 | Human |
597311711 | GWAS1407785_H | vaginal microbiome measurement QTL GWAS1407785 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9561584 | 9561585 | Human |
597385438 | GWAS1481512_H | coronary artery disease QTL GWAS1481512 (human) | | 4e-104 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597311709 | GWAS1407783_H | vaginal microbiome measurement QTL GWAS1407783 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9559154 | 9559155 | Human |
597295314 | GWAS1391388_H | phosphatidylcholine 38:7 measurement QTL GWAS1391388 (human) | | 2e-08 | phosphatidylcholine 38:7 measurement | | 6 | 11005453 | 11005454 | Human |
597229783 | GWAS1325857_H | smoking status measurement QTL GWAS1325857 (human) | | 4e-10 | smoking status measurement | | 6 | 18955573 | 18955574 | Human |
597229782 | GWAS1325856_H | smoking status measurement QTL GWAS1325856 (human) | | 4e-08 | smoking status measurement | | 6 | 12977619 | 12977620 | Human |
597287126 | GWAS1383200_H | body weight QTL GWAS1383200 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 13188261 | 13188262 | Human |
596951236 | GWAS1070755_H | COVID-19 QTL GWAS1070755 (human) | | 0.000008 | COVID-19 | | 6 | 6536985 | 6536986 | Human |
597016780 | GWAS1112854_H | FEV/FVC ratio QTL GWAS1112854 (human) | | 0.0000004 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 9940990 | 9940991 | Human |
597532871 | GWAS1628945_H | metabolite measurement QTL GWAS1628945 (human) | | 2e-18 | metabolite measurement | | 6 | 4115524 | 4115525 | Human |
597115085 | GWAS1211159_H | neuroticism measurement, wellbeing measurement, depressive symptom measurement QTL GWAS1211159 (human) | | 4e-08 | wellness/fitness trait (VT:1000152) | | 6 | 11727825 | 11727826 | Human |
597532870 | GWAS1628944_H | X-21339 measurement QTL GWAS1628944 (human) | | 2e-10 | X-21339 measurement | | 6 | 4114554 | 4114555 | Human |
597369029 | GWAS1465103_H | autism spectrum disorder QTL GWAS1465103 (human) | | 0.0000004 | autism spectrum disorder | | 6 | 11731766 | 11731767 | Human |
597311736 | GWAS1407810_H | vaginal microbiome measurement QTL GWAS1407810 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 1906694 | 1906695 | Human |
597311742 | GWAS1407816_H | vaginal microbiome measurement QTL GWAS1407816 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9553004 | 9553005 | Human |
597311743 | GWAS1407817_H | vaginal microbiome measurement QTL GWAS1407817 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9556163 | 9556164 | Human |
597311741 | GWAS1407815_H | vaginal microbiome measurement QTL GWAS1407815 (human) | | 0.000005 | vaginal microbiome measurement | | 6 | 9552301 | 9552302 | Human |
597311730 | GWAS1407804_H | vaginal microbiome measurement QTL GWAS1407804 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9566881 | 9566882 | Human |
597311731 | GWAS1407805_H | vaginal microbiome measurement QTL GWAS1407805 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9567108 | 9567109 | Human |
597311728 | GWAS1407802_H | vaginal microbiome measurement QTL GWAS1407802 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9565250 | 9565251 | Human |
597311729 | GWAS1407803_H | vaginal microbiome measurement QTL GWAS1407803 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9566015 | 9566016 | Human |
597270772 | GWAS1366846_H | type 2 diabetes mellitus QTL GWAS1366846 (human) | | 1e-08 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597311722 | GWAS1407796_H | vaginal microbiome measurement QTL GWAS1407796 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9570926 | 9570927 | Human |
596967652 | GWAS1087171_H | body height QTL GWAS1087171 (human) | | 1e-129 | body height | | 6 | 7727038 | 7727039 | Human |
597311723 | GWAS1407797_H | vaginal microbiome measurement QTL GWAS1407797 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9571055 | 9571056 | Human |
597237995 | GWAS1334069_H | lymphocyte count QTL GWAS1334069 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 7144958 | 7144959 | Human |
597311720 | GWAS1407794_H | vaginal microbiome measurement QTL GWAS1407794 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9569840 | 9569841 | Human |
597311721 | GWAS1407795_H | vaginal microbiome measurement QTL GWAS1407795 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9569990 | 9569991 | Human |
597311726 | GWAS1407800_H | vaginal microbiome measurement QTL GWAS1407800 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9563052 | 9563053 | Human |
597467369 | GWAS1563443_H | basal cell carcinoma QTL GWAS1563443 (human) | | 1e-51 | basal cell carcinoma | | 6 | 475489 | 475490 | Human |
597311727 | GWAS1407801_H | vaginal microbiome measurement QTL GWAS1407801 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9564166 | 9564167 | Human |
597033187 | GWAS1129261_H | generalised epilepsy QTL GWAS1129261 (human) | | 2e-09 | generalised epilepsy | | 6 | 16971344 | 16971345 | Human |
407272240 | GWAS921216_H | migraine disorder, endometriosis QTL GWAS921216 (human) | | 6e-08 | migraine disorder, endometriosis | | 6 | 625188 | 625189 | Human |
597311724 | GWAS1407798_H | vaginal microbiome measurement QTL GWAS1407798 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9572200 | 9572201 | Human |
597311725 | GWAS1407799_H | vaginal microbiome measurement QTL GWAS1407799 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9573047 | 9573048 | Human |
407059252 | GWAS708228_H | phospholipid measurement QTL GWAS708228 (human) | | 1e-11 | phospholipid measurement | | 6 | 10982126 | 10982127 | Human |
597221600 | GWAS1317674_H | chronic obstructive pulmonary disease QTL GWAS1317674 (human) | | 5e-08 | lung integrity trait (VT:0010906) | | 6 | 7211585 | 7211586 | Human |
597311714 | GWAS1407788_H | vaginal microbiome measurement QTL GWAS1407788 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9565250 | 9565251 | Human |
597311715 | GWAS1407789_H | vaginal microbiome measurement QTL GWAS1407789 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9566015 | 9566016 | Human |
597311712 | GWAS1407786_H | vaginal microbiome measurement QTL GWAS1407786 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9563052 | 9563053 | Human |
597377248 | GWAS1473322_H | celiac disease QTL GWAS1473322 (human) | | 6e-08 | celiac disease | | 6 | 383546 | 383547 | Human |
597311713 | GWAS1407787_H | vaginal microbiome measurement QTL GWAS1407787 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9564166 | 9564167 | Human |
597311718 | GWAS1407792_H | vaginal microbiome measurement QTL GWAS1407792 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9567399 | 9567400 | Human |
597311719 | GWAS1407793_H | vaginal microbiome measurement QTL GWAS1407793 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9567839 | 9567840 | Human |
597311716 | GWAS1407790_H | vaginal microbiome measurement QTL GWAS1407790 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9566881 | 9566882 | Human |
597278951 | GWAS1375025_H | rheumatoid arthritis QTL GWAS1375025 (human) | | 3e-09 | rheumatoid arthritis | | 6 | 14106966 | 14106967 | Human |
597311717 | GWAS1407791_H | vaginal microbiome measurement QTL GWAS1407791 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9567108 | 9567109 | Human |
597311514 | GWAS1407588_H | vaginal microbiome measurement QTL GWAS1407588 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9561584 | 9561585 | Human |
597172248 | GWAS1268322_H | intelligence QTL GWAS1268322 (human) | | 4e-08 | intelligence | | 6 | 19102055 | 19102056 | Human |
596983828 | GWAS1103347_H | memory performance QTL GWAS1103347 (human) | | 0.000003 | memory performance | | 6 | 16209404 | 16209405 | Human |
597311512 | GWAS1407586_H | vaginal microbiome measurement QTL GWAS1407586 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9559154 | 9559155 | Human |
597278746 | GWAS1374820_H | eosinophil count QTL GWAS1374820 (human) | | 6e-31 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 245096 | 245097 | Human |
597434399 | GWAS1530473_H | BMI-adjusted waist-hip ratio QTL GWAS1530473 (human) | | 0.000001 | body size trait (VT:0100005) | | 6 | 6736698 | 6736699 | Human |
597311513 | GWAS1407587_H | vaginal microbiome measurement QTL GWAS1407587 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9560287 | 9560288 | Human |
597311519 | GWAS1407593_H | vaginal microbiome measurement QTL GWAS1407593 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9572200 | 9572201 | Human |
596951059 | GWAS1070578_H | dementia QTL GWAS1070578 (human) | | 0.000004 | dementia | | 6 | 1520806 | 1520807 | Human |
597336093 | GWAS1432167_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432167 (human) | | 0.0000007 | S-warfarin to R-warfarin ratio measurement | | 6 | 19007171 | 19007172 | Human |
597311506 | GWAS1407580_H | vaginal microbiome measurement QTL GWAS1407580 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9571055 | 9571056 | Human |
597311507 | GWAS1407581_H | vaginal microbiome measurement QTL GWAS1407581 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9573047 | 9573048 | Human |
597360656 | GWAS1456730_H | reticulocyte count QTL GWAS1456730 (human) | | 2e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2488103 | 2488106 | Human |
597311505 | GWAS1407579_H | vaginal microbiome measurement QTL GWAS1407579 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9570926 | 9570927 | Human |
597475344 | GWAS1571418_H | blood protein measurement QTL GWAS1571418 (human) | | 4e-15 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 8190653 | 8190654 | Human |
597311510 | GWAS1407584_H | vaginal microbiome measurement QTL GWAS1407584 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9556163 | 9556164 | Human |
407043022 | GWAS691998_H | gambling behaviour QTL GWAS691998 (human) | | 0.000005 | gambling behaviour | | 6 | 16342825 | 16342826 | Human |
597311511 | GWAS1407585_H | vaginal microbiome measurement QTL GWAS1407585 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9557964 | 9557965 | Human |
597458961 | GWAS1555035_H | Progressive visual loss QTL GWAS1555035 (human) | | 1e-09 | Progressive visual loss | | 6 | 10035850 | 10035851 | Human |
597311509 | GWAS1407583_H | vaginal microbiome measurement QTL GWAS1407583 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9553004 | 9553005 | Human |
597229577 | GWAS1325651_H | heel bone mineral density QTL GWAS1325651 (human) | | 5e-36 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597229576 | GWAS1325650_H | heel bone mineral density QTL GWAS1325650 (human) | | 2e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 6961338 | 6961339 | Human |
597377034 | GWAS1473108_H | total cholesterol measurement QTL GWAS1473108 (human) | | 2e-15 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597229578 | GWAS1325652_H | heel bone mineral density QTL GWAS1325652 (human) | | 2e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7250804 | 7250805 | Human |
597016579 | GWAS1112653_H | BMI-adjusted hip circumference QTL GWAS1112653 (human) | | 2e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6738519 | 6738520 | Human |
407026650 | GWAS675626_H | freckles QTL GWAS675626 (human) | | 2e-91 | freckles | | 6 | 396321 | 396322 | Human |
597360640 | GWAS1456714_H | daytime rest measurement QTL GWAS1456714 (human) | | 0.000001 | sleep behavior trait (VT:0001501) | | 6 | 11655737 | 11655738 | Human |
597172228 | GWAS1268302_H | smoking initiation QTL GWAS1268302 (human) | | 4e-12 | smoking initiation | | 6 | 17012781 | 17012782 | Human |
597172229 | GWAS1268303_H | smoking initiation QTL GWAS1268303 (human) | | 3e-12 | smoking initiation | | 6 | 17013198 | 17013199 | Human |
597229575 | GWAS1325649_H | heel bone mineral density QTL GWAS1325649 (human) | | 1e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2729370 | 2729371 | Human |
597172230 | GWAS1268304_H | smoking initiation QTL GWAS1268304 (human) | | 4e-11 | smoking initiation | | 6 | 18834425 | 18834426 | Human |
597229574 | GWAS1325648_H | heel bone mineral density QTL GWAS1325648 (human) | | 8e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2101679 | 2101680 | Human |
597172231 | GWAS1268305_H | smoking initiation QTL GWAS1268305 (human) | | 2e-20 | smoking initiation | | 6 | 19030499 | 19030500 | Human |
596951094 | GWAS1070613_H | dementia QTL GWAS1070613 (human) | | 0.000002 | dementia | | 6 | 15519654 | 15519655 | Human |
597377086 | GWAS1473160_H | response to radiation, breast carcinoma QTL GWAS1473160 (human) | | 0.000004 | mammary gland integrity trait (VT:0010552) | | 6 | 6550516 | 6550517 | Human |
596951100 | GWAS1070619_H | dementia QTL GWAS1070619 (human) | | 0.000004 | dementia | | 6 | 17738146 | 17738147 | Human |
597286962 | GWAS1383036_H | glucose measurement QTL GWAS1383036 (human) | | 2e-21 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7236430 | 7236431 | Human |
597614643 | GWAS1671503_H | seborrheic keratosis QTL GWAS1671503 (human) | | 9e-105 | seborrheic keratosis | | 6 | 396321 | 396322 | Human |
597409835 | GWAS1505909_H | inflammatory bowel disease QTL GWAS1505909 (human) | | 5e-09 | inflammatory bowel disease | | 6 | 246629 | 246630 | Human |
597336104 | GWAS1432178_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432178 (human) | | 0.000006 | S-warfarin to R-warfarin ratio measurement | | 6 | 6222016 | 6222017 | Human |
597590060 | GWAS1646920_H | atrial fibrillation QTL GWAS1646920 (human) | | 2e-18 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597295145 | GWAS1391219_H | carnitine measurement QTL GWAS1391219 (human) | | 2e-16 | blood carnitine amount (VT:0003977) | | 6 | 14133342 | 14133343 | Human |
597336105 | GWAS1432179_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432179 (human) | | 0.000006 | S-warfarin to R-warfarin ratio measurement | | 6 | 18266261 | 18266262 | Human |
597090351 | GWAS1186425_H | mammographic density measurement QTL GWAS1186425 (human) | | 4e-14 | mammographic density measurement | | 6 | 16399326 | 16399327 | Human |
406977531 | GWAS626507_H | eosinophil percentage of granulocytes QTL GWAS626507 (human) | | 1e-19 | eosinophil quantity (VT:0002602) | | 6 | 376329 | 376330 | Human |
597377057 | GWAS1473131_H | cyclic adenosine monophosphate measurement QTL GWAS1473131 (human) | | 0.0000002 | cyclic adenosine monophosphate measurement | | 6 | 9807519 | 9807520 | Human |
597245987 | GWAS1342061_H | BMI-adjusted waist-hip ratio QTL GWAS1342061 (human) | | 2e-09 | body size trait (VT:0100005) | | 6 | 14594779 | 14594780 | Human |
597614626 | GWAS1671486_H | magnesium measurement QTL GWAS1671486 (human) | | 1e-12 | magnesium measurement | serum magnesium level (CMO:0000541) | 6 | 7085279 | 7085280 | Human |
407092222 | GWAS741198_H | hair color QTL GWAS741198 (human) | | 2e-11 | hair color | | 6 | 408833 | 408834 | Human |
406977532 | GWAS626508_H | eosinophil percentage of granulocytes QTL GWAS626508 (human) | | 4e-17 | eosinophil quantity (VT:0002602) | | 6 | 577820 | 577821 | Human |
596975703 | GWAS1095222_H | body height QTL GWAS1095222 (human) | | 2e-13 | body height | | 6 | 1771984 | 1771990 | Human |
597450841 | GWAS1546915_H | conotruncal heart malformations QTL GWAS1546915 (human) | | 0.000007 | conotruncal heart malformations | | 6 | 11961718 | 11961719 | Human |
596951132 | GWAS1070651_H | Red cell distribution width QTL GWAS1070651 (human) | | 1e-10 | Red cell distribution width | | 6 | 13920785 | 13920786 | Human |
407051145 | GWAS700121_H | sphingomyelin 22:0 measurement QTL GWAS700121 (human) | | 0.000008 | blood phospholipid amount (VT:0006084) | | 6 | 12371479 | 12371480 | Human |
597114971 | GWAS1211045_H | DNA methylation QTL GWAS1211045 (human) | | 1e-08 | DNA methylation | | 6 | 6141025 | 6141026 | Human |
597246036 | GWAS1342110_H | low density lipoprotein cholesterol measurement QTL GWAS1342110 (human) | | 6e-11 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16190155 | 16190156 | Human |
597016645 | GWAS1112719_H | heel bone mineral density QTL GWAS1112719 (human) | | 8e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2500586 | 2500587 | Human |
407026579 | GWAS675555_H | hair color QTL GWAS675555 (human) | | 0.0000004 | hair color | | 6 | 396321 | 396322 | Human |
597590093 | GWAS1646953_H | open-angle glaucoma QTL GWAS1646953 (human) | | 6e-33 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597016646 | GWAS1112720_H | heel bone mineral density QTL GWAS1112720 (human) | | 2e-20 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7058624 | 7058625 | Human |
597467210 | GWAS1563284_H | interleukin 10 measurement QTL GWAS1563284 (human) | | 0.000002 | interleukin 10 measurement | | 6 | 183900 | 183901 | Human |
597598280 | GWAS1655140_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1655140 (human) | | 7e-17 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 13525133 | 13525134 | Human |
407026581 | GWAS675557_H | hair color QTL GWAS675557 (human) | | 2e-28 | hair color | | 6 | 396321 | 396322 | Human |
597327949 | GWAS1424023_H | level of pterin in blood QTL GWAS1424023 (human) | | 1e-36 | level of pterin in blood | | 6 | 3001024 | 3001025 | Human |
597360707 | GWAS1456781_H | response to anti-thyroid drug, Drug-induced agranulocytosis QTL GWAS1456781 (human) | | 7e-11 | response to anti-thyroid drug, Drug-induced agranulocytosis | | 6 | 1388743 | 1388744 | Human |
597041229 | GWAS1137303_H | low density lipoprotein cholesterol measurement QTL GWAS1137303 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11856023 | 11856026 | Human |
597393479 | GWAS1489553_H | high density lipoprotein cholesterol measurement QTL GWAS1489553 (human) | | 1e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 7255377 | 7255378 | Human |
597426300 | GWAS1522374_H | urate measurement QTL GWAS1522374 (human) | | 3e-12 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2517881 | 2517882 | Human |
597426301 | GWAS1522375_H | urate measurement QTL GWAS1522375 (human) | | 6e-15 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 6727130 | 6727131 | Human |
597262459 | GWAS1358533_H | serum metabolite measurement QTL GWAS1358533 (human) | | 0.000008 | serum metabolite measurement | | 6 | 3073477 | 3073478 | Human |
597426302 | GWAS1522376_H | urate measurement QTL GWAS1522376 (human) | | 1e-100 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7214443 | 7214444 | Human |
597426303 | GWAS1522377_H | urate measurement QTL GWAS1522377 (human) | | 4e-10 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 10533759 | 10533760 | Human |
597426299 | GWAS1522373_H | urate measurement QTL GWAS1522373 (human) | | 2e-17 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2050557 | 2050558 | Human |
597409907 | GWAS1505981_H | adolescent idiopathic scoliosis QTL GWAS1505981 (human) | | 2e-16 | adolescent idiopathic scoliosis | | 6 | 6356249 | 6356250 | Human |
597581942 | GWAS1638802_H | pulse pressure measurement QTL GWAS1638802 (human) | | 2e-22 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
407198637 | GWAS847613_H | gut microbiome measurement, bone density QTL GWAS847613 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15889100 | 15889101 | Human |
597409906 | GWAS1505980_H | adolescent idiopathic scoliosis QTL GWAS1505980 (human) | | 6e-18 | adolescent idiopathic scoliosis | | 6 | 8706288 | 8706289 | Human |
407198636 | GWAS847612_H | gut microbiome measurement, bone density QTL GWAS847612 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15887058 | 15887059 | Human |
407198639 | GWAS847615_H | gut microbiome measurement, bone density QTL GWAS847615 (human) | | 2e-08 | gut microbiome measurement, bone density | | 6 | 15900980 | 15900981 | Human |
597409904 | GWAS1505978_H | adolescent idiopathic scoliosis QTL GWAS1505978 (human) | | 2e-28 | adolescent idiopathic scoliosis | | 6 | 3915216 | 3915217 | Human |
407198638 | GWAS847614_H | gut microbiome measurement, bone density QTL GWAS847614 (human) | | 2e-08 | gut microbiome measurement, bone density | | 6 | 15900976 | 15900977 | Human |
597393515 | GWAS1489589_H | intraocular pressure measurement QTL GWAS1489589 (human) | | 4e-18 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597434476 | GWAS1530550_H | angina pectoris QTL GWAS1530550 (human) | | 6e-11 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597016676 | GWAS1112750_H | heel bone mineral density QTL GWAS1112750 (human) | | 7e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7058624 | 7058625 | Human |
597131366 | GWAS1227440_H | phosphatidylcholine measurement QTL GWAS1227440 (human) | | 2e-10 | phosphatidylcholine measurement | | 6 | 11008389 | 11008390 | Human |
597131365 | GWAS1227439_H | phosphatidylcholine measurement QTL GWAS1227439 (human) | | 3e-10 | phosphatidylcholine measurement | | 6 | 11005609 | 11005610 | Human |
597147746 | GWAS1243820_H | body composition measurement QTL GWAS1243820 (human) | | 1e-14 | body composition measurement | | 6 | 7710819 | 7710820 | Human |
597016675 | GWAS1112749_H | heel bone mineral density QTL GWAS1112749 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2500586 | 2500587 | Human |
597164129 | GWAS1260203_H | Uveal Melanoma QTL GWAS1260203 (human) | | 4e-08 | age at first sexual intercourse measurement | | 6 | 396321 | 396322 | Human |
597155949 | GWAS1252023_H | estradiol measurement QTL GWAS1252023 (human) | | 6e-09 | estradiol measurement | blood estradiol level (CMO:0000513) | 6 | 10949814 | 10949815 | Human |
597043094 | GWAS1139168_H | eye colour measurement QTL GWAS1139168 (human) | | 3e-14 | eye colour measurement | eye morphological measurement (CMO:0003080) | 6 | 396321 | 396322 | Human |
597149591 | GWAS1245665_H | eye color QTL GWAS1245665 (human) | | 3e-11 | eye color | | 6 | 396321 | 396322 | Human |
597297050 | GWAS1393124_H | BMI-adjusted hip circumference QTL GWAS1393124 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7208899 | 7208900 | Human |
597591966 | GWAS1648826_H | psoriatic arthritis QTL GWAS1648826 (human) | | 3e-35 | psoriatic arthritis | | 6 | 17602639 | 17602640 | Human |
597297051 | GWAS1393125_H | BMI-adjusted hip circumference QTL GWAS1393125 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7192401 | 7192402 | Human |
597297048 | GWAS1393122_H | BMI-adjusted hip circumference QTL GWAS1393122 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 2190612 | 2190613 | Human |
597419929 | GWAS1516003_H | cognitive behavioural therapy QTL GWAS1516003 (human) | | 0.000003 | cognitive behavioural therapy | | 6 | 9207484 | 9207485 | Human |
597133205 | GWAS1229279_H | systolic blood pressure QTL GWAS1229279 (human) | | 0.000007 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 18327072 | 18327073 | Human |
597297049 | GWAS1393123_H | BMI-adjusted hip circumference QTL GWAS1393123 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6637628 | 6637629 | Human |
597133204 | GWAS1229278_H | systolic blood pressure QTL GWAS1229278 (human) | | 0.0000005 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16324091 | 16324092 | Human |
597297054 | GWAS1393128_H | BMI-adjusted hip circumference QTL GWAS1393128 (human) | | 3e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7220727 | 7220728 | Human |
597297055 | GWAS1393129_H | BMI-adjusted hip circumference QTL GWAS1393129 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7225441 | 7225442 | Human |
597133202 | GWAS1229276_H | systolic blood pressure QTL GWAS1229276 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12445615 | 12445616 | Human |
597297052 | GWAS1393126_H | BMI-adjusted hip circumference QTL GWAS1393126 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7197113 | 7197114 | Human |
597133201 | GWAS1229275_H | systolic blood pressure QTL GWAS1229275 (human) | | 1e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12295754 | 12295755 | Human |
597297053 | GWAS1393127_H | BMI-adjusted hip circumference QTL GWAS1393127 (human) | | 2e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7247111 | 7247112 | Human |
597133200 | GWAS1229274_H | systolic blood pressure QTL GWAS1229274 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7723729 | 7723730 | Human |
597018514 | GWAS1114588_H | household income QTL GWAS1114588 (human) | | 2e-11 | household income | | 6 | 14719012 | 14719013 | Human |
597608342 | GWAS1665202_H | Chondrocalcinosis QTL GWAS1665202 (human) | | 3e-43 | Chondrocalcinosis | | 6 | 18399163 | 18399164 | Human |
597297047 | GWAS1393121_H | BMI-adjusted hip circumference QTL GWAS1393121 (human) | | 4e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 2061025 | 2061026 | Human |
406969423 | GWAS618399_H | eosinophil percentage of leukocytes QTL GWAS618399 (human) | | 8e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 577820 | 577821 | Human |
406969422 | GWAS618398_H | eosinophil percentage of leukocytes QTL GWAS618398 (human) | | 7e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 376329 | 376330 | Human |
406985814 | GWAS634790_H | mean corpuscular hemoglobin concentration QTL GWAS634790 (human) | | 6e-15 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 8002426 | 8002427 | Human |
406985815 | GWAS634791_H | mean corpuscular hemoglobin concentration QTL GWAS634791 (human) | | 1e-186 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597067648 | GWAS1163722_H | neutrophil count QTL GWAS1163722 (human) | | 6e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16749780 | 16749781 | Human |
597133199 | GWAS1229273_H | systolic blood pressure QTL GWAS1229273 (human) | | 2e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 6996928 | 6996929 | Human |
597084046 | GWAS1180120_H | migraine disorder, pulse pressure measurement QTL GWAS1180120 (human) | | 1e-21 | migraine disorder, pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12767986 | 12767987 | Human |
597215104 | GWAS1311178_H | total cholesterol measurement QTL GWAS1311178 (human) | | 6e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16126703 | 16126704 | Human |
596952972 | GWAS1072491_H | Red cell distribution width QTL GWAS1072491 (human) | | 2e-18 | Red cell distribution width | | 6 | 16288384 | 16288385 | Human |
597133198 | GWAS1229272_H | systolic blood pressure QTL GWAS1229272 (human) | | 0.000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 2003456 | 2003457 | Human |
596952973 | GWAS1072492_H | Red cell distribution width QTL GWAS1072492 (human) | | 2e-22 | Red cell distribution width | | 6 | 5260461 | 5260462 | Human |
597084047 | GWAS1180121_H | migraine disorder, pulse pressure measurement QTL GWAS1180121 (human) | | 3e-33 | migraine disorder, pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12888772 | 12888773 | Human |
597133197 | GWAS1229271_H | systolic blood pressure QTL GWAS1229271 (human) | | 2e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1648798 | 1648799 | Human |
596952974 | GWAS1072493_H | Red cell distribution width QTL GWAS1072493 (human) | | 3e-12 | Red cell distribution width | | 6 | 13930123 | 13930124 | Human |
597591998 | GWAS1648858_H | rosacea QTL GWAS1648858 (human) | | 7e-20 | rosacea | | 6 | 396321 | 396322 | Human |
597084086 | GWAS1180160_H | monocyte percentage of leukocytes QTL GWAS1180160 (human) | | 5e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 6 | 6924278 | 6924279 | Human |
597608382 | GWAS1665242_H | crystal arthropathy QTL GWAS1665242 (human) | | 4e-39 | crystal arthropathy | | 6 | 18403902 | 18403903 | Human |
597084087 | GWAS1180161_H | monocyte percentage of leukocytes QTL GWAS1180161 (human) | | 2e-23 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 6 | 10533230 | 10533231 | Human |
597460926 | GWAS1557000_H | response to angiotensin-converting enzyme inhibitor, Cough QTL GWAS1557000 (human) | | 0.0000005 | response to angiotensin-converting enzyme inhibitor, Cough | | 6 | 11438722 | 11438723 | Human |
597084085 | GWAS1180159_H | monocyte percentage of leukocytes QTL GWAS1180159 (human) | | 1e-10 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 6 | 403799 | 403800 | Human |
597297086 | GWAS1393160_H | hematocrit QTL GWAS1393160 (human) | | 1e-26 | hematocrit | hematocrit (CMO:0000037) | 6 | 2050557 | 2050558 | Human |
596985777 | GWAS1105296_H | memory performance, sex interaction measurement QTL GWAS1105296 (human) | | 0.000004 | memory performance, sex interaction measurement | | 6 | 12866296 | 12866297 | Human |
596953010 | GWAS1072529_H | Red cell distribution width QTL GWAS1072529 (human) | | 1e-15 | Red cell distribution width | | 6 | 18747474 | 18747475 | Human |
597297085 | GWAS1393159_H | hematocrit QTL GWAS1393159 (human) | | 6e-24 | hematocrit | hematocrit (CMO:0000037) | 6 | 7229386 | 7229387 | Human |
597460916 | GWAS1556990_H | type 2 diabetes mellitus QTL GWAS1556990 (human) | | 0.000004 | type 2 diabetes mellitus | | 6 | 6593462 | 6593463 | Human |
597329843 | GWAS1425917_H | xanthosine measurement QTL GWAS1425917 (human) | | 2e-21 | xanthosine measurement | | 6 | 16289677 | 16289680 | Human |
597018558 | GWAS1114632_H | eosinophil count QTL GWAS1114632 (human) | | 2e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 434364 | 434365 | Human |
406977645 | GWAS626621_H | hemoglobin measurement QTL GWAS626621 (human) | | 2e-38 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2093889 | 2093890 | Human |
597387190 | GWAS1483264_H | forced expiratory volume, response to bronchodilator QTL GWAS1483264 (human) | | 0.0000008 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 8450770 | 8450771 | Human |
597084088 | GWAS1180162_H | monocyte percentage of leukocytes QTL GWAS1180162 (human) | | 2e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 6 | 16710829 | 16710830 | Human |
406977646 | GWAS626622_H | hemoglobin measurement QTL GWAS626622 (human) | | 4e-39 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7232156 | 7232157 | Human |
406977648 | GWAS626624_H | hemoglobin measurement QTL GWAS626624 (human) | | 2e-27 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16288384 | 16288385 | Human |
597591983 | GWAS1648843_H | psoriasis QTL GWAS1648843 (human) | | 3e-101 | psoriasis | | 6 | 17602639 | 17602640 | Human |
597272493 | GWAS1368567_H | low density lipoprotein cholesterol measurement QTL GWAS1368567 (human) | | 2e-76 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597272492 | GWAS1368566_H | low density lipoprotein cholesterol measurement QTL GWAS1368566 (human) | | 2e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11850521 | 11850522 | Human |
597092256 | GWAS1188330_H | squamous cell carcinoma QTL GWAS1188330 (human) | | 8e-97 | squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597100463 | GWAS1196537_H | gut microbiome measurement QTL GWAS1196537 (human) | | 0.000008 | gut microbiome measurement | | 6 | 16638889 | 16638890 | Human |
597501860 | GWAS1597934_H | fish consumption measurement QTL GWAS1597934 (human) | | 2e-08 | fish consumption measurement | | 6 | 16753143 | 16753146 | Human |
597297056 | GWAS1393130_H | BMI-adjusted hip circumference QTL GWAS1393130 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7258290 | 7258291 | Human |
597592030 | GWAS1648890_H | intermediate coronary syndrome QTL GWAS1648890 (human) | | 1e-11 | intermediate coronary syndrome | | 6 | 12903725 | 12903726 | Human |
597116884 | GWAS1212958_H | mean corpuscular hemoglobin concentration QTL GWAS1212958 (human) | | 8e-80 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290617 | 16290620 | Human |
597116883 | GWAS1212957_H | mean corpuscular hemoglobin concentration QTL GWAS1212957 (human) | | 6e-54 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16285830 | 16285831 | Human |
597592020 | GWAS1648880_H | coronary artery disease QTL GWAS1648880 (human) | | 7e-82 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597411786 | GWAS1507860_H | hypertension QTL GWAS1507860 (human) | | 0.000005 | hypertension | | 6 | 12903725 | 12903726 | Human |
597329865 | GWAS1425939_H | color vision disorder QTL GWAS1425939 (human) | | 0.000007 | color vision disorder | | 6 | 12460734 | 12460735 | Human |
597411784 | GWAS1507858_H | systolic blood pressure QTL GWAS1507858 (human) | | 6e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597608395 | GWAS1665255_H | HbA1c measurement QTL GWAS1665255 (human) | | 4e-23 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597346242 | GWAS1442316_H | peak expiratory flow QTL GWAS1442316 (human) | | 6e-15 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 7102367 | 7102368 | Human |
597084111 | GWAS1180185_H | migraine disorder, systolic blood pressure QTL GWAS1180185 (human) | | 1e-19 | migraine disorder, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12888772 | 12888773 | Human |
597411777 | GWAS1507851_H | diastolic blood pressure QTL GWAS1507851 (human) | | 0.000006 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 12903725 | 12903726 | Human |
597084109 | GWAS1180183_H | migraine disorder, systolic blood pressure QTL GWAS1180183 (human) | | 3e-12 | migraine disorder, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12767986 | 12767987 | Human |
406977565 | GWAS626541_H | hemoglobin measurement QTL GWAS626541 (human) | | 7e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2050557 | 2050558 | Human |
406977566 | GWAS626542_H | hemoglobin measurement QTL GWAS626542 (human) | | 3e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16287961 | 16287962 | Human |
597133299 | GWAS1229373_H | memory performance, sex interaction measurement QTL GWAS1229373 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 1133457 | 1133458 | Human |
597018608 | GWAS1114682_H | multiple sclerosis QTL GWAS1114682 (human) | | 2e-08 | multiple sclerosis | | 6 | 7099796 | 7099797 | Human |
597592059 | GWAS1648919_H | myocardial infarction QTL GWAS1648919 (human) | | 1e-38 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
407387171 | GWAS1036147_H | acute myeloid leukemia QTL GWAS1036147 (human) | | 3e-32 | leukocyte integrity trait (VT:0010898) | | 6 | 5736510 | 5736511 | Human |
407387172 | GWAS1036148_H | acute myeloid leukemia QTL GWAS1036148 (human) | | 3e-21 | leukocyte integrity trait (VT:0010898) | | 6 | 5736510 | 5736511 | Human |
407026732 | GWAS675708_H | eye color QTL GWAS675708 (human) | | 2e-15 | eye color | | 6 | 396321 | 396322 | Human |
597600241 | GWAS1657101_H | basophil measurement QTL GWAS1657101 (human) | | 1e-19 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597592042 | GWAS1648902_H | skin disease QTL GWAS1648902 (human) | | 3e-19 | skin disease | | 6 | 396321 | 396322 | Human |
597256173 | GWAS1352247_H | schizophrenia QTL GWAS1352247 (human) | | 3e-08 | schizophrenia | | 6 | 11987848 | 11987849 | Human |
597600235 | GWAS1657095_H | basophil measurement QTL GWAS1657095 (human) | | 1e-11 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597379043 | GWAS1475117_H | parasitemia measurement QTL GWAS1475117 (human) | | 0.000008 | parasitemia measurement | | 6 | 8169567 | 8169568 | Human |
597362657 | GWAS1458731_H | acute myeloid leukemia QTL GWAS1458731 (human) | | 7e-09 | leukocyte integrity trait (VT:0010898) | | 6 | 11951628 | 11951629 | Human |
596977646 | GWAS1097165_H | body height QTL GWAS1097165 (human) | | 3e-15 | body height | | 6 | 1619802 | 1619803 | Human |
597362656 | GWAS1458730_H | acute myeloid leukemia QTL GWAS1458730 (human) | | 3e-13 | leukocyte integrity trait (VT:0010898) | | 6 | 10316748 | 10316749 | Human |
597133292 | GWAS1229366_H | memory performance QTL GWAS1229366 (human) | | 0.000005 | memory performance | | 6 | 13657579 | 13657580 | Human |
597100524 | GWAS1196598_H | protein measurement QTL GWAS1196598 (human) | | 1e-08 | protein measurement | | 6 | 15192266 | 15192267 | Human |
597264354 | GWAS1360428_H | high density lipoprotein cholesterol measurement QTL GWAS1360428 (human) | | 5e-13 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 16810396 | 16810397 | Human |
597370650 | GWAS1466724_H | major depressive disorder QTL GWAS1466724 (human) | | 0.000007 | major depressive disorder | | 6 | 6612234 | 6612235 | Human |
596977432 | GWAS1096951_H | Red cell distribution width QTL GWAS1096951 (human) | | 1e-12 | Red cell distribution width | | 6 | 3166734 | 3166735 | Human |
597370645 | GWAS1466719_H | waist-hip ratio QTL GWAS1466719 (human) | | 2e-17 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
597337876 | GWAS1433950_H | systolic blood pressure QTL GWAS1433950 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12296022 | 12296023 | Human |
597337877 | GWAS1433951_H | systolic blood pressure QTL GWAS1433951 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16321561 | 16321562 | Human |
597509900 | GWAS1605974_H | electrocardiography QTL GWAS1605974 (human) | | 3e-08 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597100291 | GWAS1196365_H | protein measurement QTL GWAS1196365 (human) | | 5e-10 | protein measurement | | 6 | 1781862 | 1781863 | Human |
597509897 | GWAS1605971_H | electrocardiography QTL GWAS1605971 (human) | | 1e-09 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597509896 | GWAS1605970_H | electrocardiography QTL GWAS1605970 (human) | | 6e-10 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597591816 | GWAS1648676_H | erythematosquamous dermatosis QTL GWAS1648676 (human) | | 1e-71 | erythematosquamous dermatosis | | 6 | 396321 | 396322 | Human |
597509899 | GWAS1605973_H | electrocardiography QTL GWAS1605973 (human) | | 9e-09 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597509898 | GWAS1605972_H | electrocardiography QTL GWAS1605972 (human) | | 9e-10 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597108495 | GWAS1204569_H | protein measurement QTL GWAS1204569 (human) | | 8e-09 | protein measurement | | 6 | 5851113 | 5851114 | Human |
597509895 | GWAS1605969_H | electrocardiography QTL GWAS1605969 (human) | | 7e-10 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597509894 | GWAS1605968_H | electrocardiography QTL GWAS1605968 (human) | | 5e-10 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597067571 | GWAS1163645_H | mean corpuscular hemoglobin concentration QTL GWAS1163645 (human) | | 3e-08 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16251828 | 16251829 | Human |
597403442 | GWAS1499516_H | myocardial infarction QTL GWAS1499516 (human) | | 1e-27 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
406985961 | GWAS634937_H | mean corpuscular hemoglobin concentration QTL GWAS634937 (human) | | 4e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 620222 | 620223 | Human |
597387056 | GWAS1483130_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1483130 (human) | | 3e-10 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6736698 | 6736699 | Human |
597247797 | GWAS1343871_H | chronic lymphocytic leukemia QTL GWAS1343871 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 6 | 411064 | 411065 | Human |
597591858 | GWAS1648718_H | erythematosquamous dermatosis QTL GWAS1648718 (human) | | 5e-14 | erythematosquamous dermatosis | | 6 | 17602639 | 17602640 | Human |
597485356 | GWAS1581430_H | radiation-induced disorder QTL GWAS1581430 (human) | | 0.00001 | radiation-induced disorder | | 6 | 8851361 | 8851362 | Human |
597387055 | GWAS1483129_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1483129 (human) | | 1e-13 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6736698 | 6736699 | Human |
597387054 | GWAS1483128_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1483128 (human) | | 5e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6736698 | 6736699 | Human |
596952877 | GWAS1072396_H | Red cell distribution width QTL GWAS1072396 (human) | | 2e-22 | Red cell distribution width | | 6 | 3423313 | 3423314 | Human |
597149484 | GWAS1245558_H | lifestyle measurement, depressive symptom measurement QTL GWAS1245558 (human) | | 1e-08 | lifestyle measurement, depressive symptom measurement | | 6 | 12795801 | 12795802 | Human |
407387273 | GWAS1036249_H | monocyte count QTL GWAS1036249 (human) | | 4e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10526140 | 10526141 | Human |
596961118 | GWAS1080637_H | metabolic syndrome QTL GWAS1080637 (human) | | 2e-09 | metabolic syndrome | | 6 | 13171047 | 13171048 | Human |
596961119 | GWAS1080638_H | metabolic syndrome QTL GWAS1080638 (human) | | 9e-11 | metabolic syndrome | | 6 | 13180222 | 13180223 | Human |
597362516 | GWAS1458590_H | stroke QTL GWAS1458590 (human) | | 1e-08 | stroke | | 6 | 1337158 | 1337159 | Human |
597329749 | GWAS1425823_H | neuroticism measurement, cognitive function measurement QTL GWAS1425823 (human) | | 7e-12 | cognitive behavior trait (VT:0010450) | | 6 | 12013846 | 12013847 | Human |
597452627 | GWAS1548701_H | size QTL GWAS1548701 (human) | | 6e-10 | size | | 6 | 18548535 | 18548536 | Human |
597346123 | GWAS1442197_H | body mass index QTL GWAS1442197 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
597313352 | GWAS1409426_H | vaginal microbiome measurement QTL GWAS1409426 (human) | | 0.000005 | vaginal microbiome measurement | | 6 | 1146735 | 1146736 | Human |
597124933 | GWAS1221007_H | renal carcinoma QTL GWAS1221007 (human) | | 2e-08 | renal carcinoma | | 6 | 1749548 | 1749549 | Human |
597018439 | GWAS1114513_H | intelligence QTL GWAS1114513 (human) | | 0.000001 | intelligence | | 6 | 16965821 | 16965822 | Human |
597116739 | GWAS1212813_H | chronic kidney disease QTL GWAS1212813 (human) | | 7e-15 | chronic kidney disease | | 6 | 7230882 | 7230883 | Human |
597092160 | GWAS1188234_H | Alzheimer disease, age at onset QTL GWAS1188234 (human) | | 2e-08 | Alzheimer disease, age at onset | | 6 | 18173684 | 18173685 | Human |
597247811 | GWAS1343885_H | BMI-adjusted waist-hip ratio QTL GWAS1343885 (human) | | 2e-09 | body size trait (VT:0100005) | | 6 | 7066248 | 7066249 | Human |
597477191 | GWAS1573265_H | intraocular pressure measurement QTL GWAS1573265 (human) | | 4e-21 | intraocular pressure measurement | | 6 | 1540248 | 1540249 | Human |
597247810 | GWAS1343884_H | BMI-adjusted waist-hip ratio QTL GWAS1343884 (human) | | 8e-09 | body size trait (VT:0100005) | | 6 | 7010463 | 7010464 | Human |
597247813 | GWAS1343887_H | BMI-adjusted waist-hip ratio QTL GWAS1343887 (human) | | 8e-14 | body size trait (VT:0100005) | | 6 | 7109432 | 7109433 | Human |
597346119 | GWAS1442193_H | body mass index QTL GWAS1442193 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5978836 | 5978837 | Human |
597436225 | GWAS1532299_H | BMI-adjusted waist-hip ratio QTL GWAS1532299 (human) | | 5e-15 | body size trait (VT:0100005) | | 6 | 6727130 | 6727131 | Human |
597247812 | GWAS1343886_H | BMI-adjusted waist-hip ratio QTL GWAS1343886 (human) | | 3e-09 | body size trait (VT:0100005) | | 6 | 7076458 | 7076459 | Human |
597247814 | GWAS1343888_H | BMI-adjusted waist-hip ratio QTL GWAS1343888 (human) | | 1e-09 | body size trait (VT:0100005) | | 6 | 7159781 | 7159782 | Human |
597436284 | GWAS1532358_H | lipid measurement QTL GWAS1532358 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 11200924 | 11200925 | Human |
597264249 | GWAS1360323_H | educational attainment QTL GWAS1360323 (human) | | 1e-09 | educational attainment | | 6 | 12927613 | 12927614 | Human |
597264248 | GWAS1360322_H | educational attainment QTL GWAS1360322 (human) | | 1e-13 | educational attainment | | 6 | 12767986 | 12767987 | Human |
597264251 | GWAS1360325_H | educational attainment QTL GWAS1360325 (human) | | 1e-15 | educational attainment | | 6 | 13279275 | 13279276 | Human |
597616509 | GWAS1673369_H | Abnormality of the gastrointestinal tract QTL GWAS1673369 (human) | | 3e-12 | Abnormality of the gastrointestinal tract | | 6 | 13053411 | 13053412 | Human |
597264250 | GWAS1360324_H | educational attainment QTL GWAS1360324 (human) | | 5e-13 | educational attainment | | 6 | 13180222 | 13180223 | Human |
597264253 | GWAS1360327_H | educational attainment QTL GWAS1360327 (human) | | 2e-09 | educational attainment | | 6 | 16398686 | 16398687 | Human |
597264252 | GWAS1360326_H | educational attainment QTL GWAS1360326 (human) | | 4e-08 | educational attainment | | 6 | 13455205 | 13455206 | Human |
597190516 | GWAS1286590_H | sex hormone-binding globulin measurement QTL GWAS1286590 (human) | | 1e-18 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597264247 | GWAS1360321_H | educational attainment QTL GWAS1360321 (human) | | 0.0000002 | educational attainment | | 6 | 12747625 | 12747626 | Human |
597264246 | GWAS1360320_H | educational attainment QTL GWAS1360320 (human) | | 8e-12 | educational attainment | | 6 | 12125539 | 12125540 | Human |
597223275 | GWAS1319349_H | COVID-19 QTL GWAS1319349 (human) | | 0.000005 | COVID-19 | | 6 | 11643655 | 11643656 | Human |
597141348 | GWAS1237422_H | chronic obstructive pulmonary disease QTL GWAS1237422 (human) | | 2e-09 | lung integrity trait (VT:0010906) | | 6 | 17898894 | 17898895 | Human |
596961120 | GWAS1080639_H | metabolic syndrome QTL GWAS1080639 (human) | | 1e-09 | metabolic syndrome | | 6 | 15371012 | 15371013 | Human |
596961121 | GWAS1080640_H | metabolic syndrome QTL GWAS1080640 (human) | | 2e-09 | metabolic syndrome | | 6 | 18559456 | 18559457 | Human |
597403491 | GWAS1499565_H | coronary artery disease QTL GWAS1499565 (human) | | 1e-08 | coronary artery disease | | 6 | 12934070 | 12934071 | Human |
596977516 | GWAS1097035_H | small vessel stroke QTL GWAS1097035 (human) | | 0.000003 | small vessel stroke | | 6 | 1356681 | 1356682 | Human |
597387106 | GWAS1483180_H | primary biliary cirrhosis QTL GWAS1483180 (human) | | 0.0000002 | primary biliary cirrhosis | | 6 | 3296763 | 3296764 | Human |
597591909 | GWAS1648769_H | seborrheic dermatitis QTL GWAS1648769 (human) | | 4e-71 | seborrheic dermatitis | | 6 | 396321 | 396322 | Human |
597436263 | GWAS1532337_H | angina pectoris QTL GWAS1532337 (human) | | 3e-30 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597067412 | GWAS1163486_H | age at menopause QTL GWAS1163486 (human) | | 2e-12 | age at menopause | | 6 | 10886352 | 10886353 | Human |
597042836 | GWAS1138910_H | erythrocyte count QTL GWAS1138910 (human) | | 3e-28 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15173989 | 15173990 | Human |
597591709 | GWAS1648569_H | seborrheic keratosis QTL GWAS1648569 (human) | | 3e-158 | seborrheic keratosis | | 6 | 396321 | 396322 | Human |
597042837 | GWAS1138911_H | erythrocyte count QTL GWAS1138911 (human) | | 2e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16280956 | 16280957 | Human |
597042834 | GWAS1138908_H | erythrocyte count QTL GWAS1138908 (human) | | 5e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 9547364 | 9547365 | Human |
597042835 | GWAS1138909_H | erythrocyte count QTL GWAS1138909 (human) | | 3e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12294629 | 12294630 | Human |
407305539 | GWAS954515_H | lymphocyte count QTL GWAS954515 (human) | | 2e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 15326571 | 15326572 | Human |
407305536 | GWAS954512_H | lymphocyte count QTL GWAS954512 (human) | | 4e-38 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 410417 | 410418 | Human |
597042832 | GWAS1138906_H | erythrocyte count QTL GWAS1138906 (human) | | 8e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7098023 | 7098024 | Human |
597067408 | GWAS1163482_H | age at menarche QTL GWAS1163482 (human) | | 0.0000003 | age at menarche | | 6 | 10895027 | 10895028 | Human |
597042833 | GWAS1138907_H | erythrocyte count QTL GWAS1138907 (human) | | 7e-31 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7232156 | 7232157 | Human |
407305537 | GWAS954513_H | lymphocyte count QTL GWAS954513 (human) | | 4e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 11770472 | 11770473 | Human |
597124765 | GWAS1220839_H | childhood onset asthma QTL GWAS1220839 (human) | | 0.000001 | childhood onset asthma | | 6 | 6276196 | 6276197 | Human |
597304982 | GWAS1401056_H | total blood protein measurement QTL GWAS1401056 (human) | | 1e-14 | total blood protein measurement | | 6 | 7231610 | 7231611 | Human |
597468817 | GWAS1564891_H | self reported educational attainment QTL GWAS1564891 (human) | | 9e-14 | self reported educational attainment | | 6 | 3468644 | 3468645 | Human |
597468818 | GWAS1564892_H | self reported educational attainment QTL GWAS1564892 (human) | | 8e-18 | self reported educational attainment | | 6 | 14721666 | 14721667 | Human |
597386888 | GWAS1482962_H | waist-hip ratio QTL GWAS1482962 (human) | | 0.000009 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 11415415 | 11415416 | Human |
597042816 | GWAS1138890_H | eye colour measurement QTL GWAS1138890 (human) | | 1e-12 | eye colour measurement | | 6 | 396321 | 396322 | Human |
597231233 | GWAS1327307_H | electrocardiography QTL GWAS1327307 (human) | | 1e-09 | electrocardiography | | 6 | 12555642 | 12555643 | Human |
597042831 | GWAS1138905_H | erythrocyte count QTL GWAS1138905 (human) | | 1e-30 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2050557 | 2050558 | Human |
597403264 | GWAS1499338_H | low density lipoprotein cholesterol measurement QTL GWAS1499338 (human) | | 2e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597345926 | GWAS1442000_H | hemoglobin measurement QTL GWAS1442000 (human) | | 9e-18 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16290530 | 16290531 | Human |
597616259 | GWAS1673119_H | Hallux rigidus QTL GWAS1673119 (human) | | 7e-12 | Hallux rigidus | | 6 | 7741699 | 7741700 | Human |
597608065 | GWAS1664925_H | cutaneous melanoma QTL GWAS1664925 (human) | | 1e-39 | cutaneous melanoma | | 6 | 396321 | 396322 | Human |
597468862 | GWAS1564936_H | protein measurement QTL GWAS1564936 (human) | | 7e-10 | protein measurement | | 6 | 6851173 | 6851174 | Human |
597026480 | GWAS1122554_H | loneliness measurement QTL GWAS1122554 (human) | | 9e-09 | emotion/affect behavior trait (VT:0002572) | | 6 | 11959603 | 11959604 | Human |
597083836 | GWAS1179910_H | lymphocyte percentage of leukocytes QTL GWAS1179910 (human) | | 9e-17 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 6 | 13520498 | 13520499 | Human |
597083835 | GWAS1179909_H | lymphocyte percentage of leukocytes QTL GWAS1179909 (human) | | 4e-16 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 6 | 12159466 | 12159467 | Human |
597313194 | GWAS1409268_H | cortical thickness QTL GWAS1409268 (human) | | 9e-13 | cortical thickness | | 6 | 7736184 | 7736185 | Human |
597067428 | GWAS1163502_H | limited scleroderma QTL GWAS1163502 (human) | | 0.000006 | limited scleroderma | | 6 | 434915 | 434916 | Human |
596960981 | GWAS1080500_H | metabolic syndrome QTL GWAS1080500 (human) | | 3e-10 | metabolic syndrome | | 6 | 12124622 | 12124623 | Human |
596960982 | GWAS1080501_H | metabolic syndrome QTL GWAS1080501 (human) | | 1e-10 | metabolic syndrome | | 6 | 12794799 | 12794800 | Human |
597264083 | GWAS1360157_H | type 2 diabetes mellitus QTL GWAS1360157 (human) | | 1e-11 | type 2 diabetes mellitus | | 6 | 7196090 | 7196091 | Human |
407059721 | GWAS708697_H | balding measurement QTL GWAS708697 (human) | | 4e-15 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 10236542 | 10236543 | Human |
597608144 | GWAS1665004_H | Hypercalcemia QTL GWAS1665004 (human) | | 1e-26 | Hypercalcemia | | 6 | 10853307 | 10853308 | Human |
597518034 | GWAS1614108_H | migraine disorder QTL GWAS1614108 (human) | | 6e-15 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597059270 | GWAS1155344_H | metabolic syndrome QTL GWAS1155344 (human) | | 3e-10 | metabolic syndrome | | 6 | 12124622 | 12124623 | Human |
597518029 | GWAS1614103_H | migraine disorder QTL GWAS1614103 (human) | | 4e-38 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597059271 | GWAS1155345_H | metabolic syndrome QTL GWAS1155345 (human) | | 1e-10 | metabolic syndrome | | 6 | 12794799 | 12794800 | Human |
597124805 | GWAS1220879_H | type 1 diabetes mellitus QTL GWAS1220879 (human) | | 6e-14 | type 1 diabetes mellitus | | 6 | 410417 | 410418 | Human |
597067461 | GWAS1163535_H | age at menarche QTL GWAS1163535 (human) | | 1e-08 | age at menarche | | 6 | 10951504 | 10951505 | Human |
597018305 | GWAS1114379_H | intelligence QTL GWAS1114379 (human) | | 2e-08 | intelligence | | 6 | 11591562 | 11591563 | Human |
597493451 | GWAS1589525_H | breast density QTL GWAS1589525 (human) | | 0.000007 | breast density | | 6 | 8586587 | 8586588 | Human |
597092033 | GWAS1188107_H | chronic lymphocytic leukemia QTL GWAS1188107 (human) | | 9e-22 | leukocyte integrity trait (VT:0010898) | | 6 | 409119 | 409120 | Human |
597591746 | GWAS1648606_H | Epidermal Inclusion Cyst QTL GWAS1648606 (human) | | 1e-19 | Epidermal Inclusion Cyst | | 6 | 396321 | 396322 | Human |
597059274 | GWAS1155348_H | metabolic syndrome QTL GWAS1155348 (human) | | 1e-09 | metabolic syndrome | | 6 | 15371012 | 15371013 | Human |
597059272 | GWAS1155346_H | metabolic syndrome QTL GWAS1155346 (human) | | 2e-09 | metabolic syndrome | | 6 | 13171047 | 13171048 | Human |
597059273 | GWAS1155347_H | metabolic syndrome QTL GWAS1155347 (human) | | 9e-11 | metabolic syndrome | | 6 | 13180222 | 13180223 | Human |
597067465 | GWAS1163539_H | cancer QTL GWAS1163539 (human) | | 0.0000007 | cancer | | 6 | 18224942 | 18224943 | Human |
597018357 | GWAS1114431_H | BMI-adjusted waist circumference QTL GWAS1114431 (human) | | 2e-08 | body size trait (VT:0100005) | | 6 | 7058086 | 7058087 | Human |
597362425 | GWAS1458499_H | blood protein measurement QTL GWAS1458499 (human) | | 2e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 7899503 | 7899504 | Human |
597329662 | GWAS1425736_H | sexual dimorphism measurement QTL GWAS1425736 (human) | | 1e-08 | sexual dimorphism measurement | | 6 | 7775903 | 7775904 | Human |
597018352 | GWAS1114426_H | BMI-adjusted waist circumference QTL GWAS1114426 (human) | | 1e-09 | body size trait (VT:0100005) | | 6 | 6748836 | 6748837 | Human |
407043365 | GWAS692341_H | alcohol and nicotine codependence QTL GWAS692341 (human) | | 0.000002 | alcohol and nicotine codependence | | 6 | 12048594 | 12048595 | Human |
597346034 | GWAS1442108_H | urate measurement QTL GWAS1442108 (human) | | 7e-72 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7118901 | 7118902 | Human |
597059324 | GWAS1155398_H | cup-to-disc ratio measurement QTL GWAS1155398 (human) | | 8e-08 | cup-to-disc ratio measurement | | 6 | 593109 | 593110 | Human |
597346033 | GWAS1442107_H | urate measurement QTL GWAS1442107 (human) | | 9e-14 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2050557 | 2050558 | Human |
597591794 | GWAS1648654_H | skin disease QTL GWAS1648654 (human) | | 2e-40 | skin disease | | 6 | 396321 | 396322 | Human |
597395191 | GWAS1491265_H | aspirin use measurement QTL GWAS1491265 (human) | | 2e-08 | aspirin use measurement | | 6 | 12903725 | 12903726 | Human |
597280503 | GWAS1376577_H | ceramide measurement QTL GWAS1376577 (human) | | 1e-10 | ceramide measurement | | 6 | 14238280 | 14238281 | Human |
597395178 | GWAS1491252_H | BMI-adjusted waist-hip ratio QTL GWAS1491252 (human) | | 0.000008 | body size trait (VT:0100005) | | 6 | 6770863 | 6770864 | Human |
597108453 | GWAS1204527_H | HMG CoA reductase inhibitor use measurement QTL GWAS1204527 (human) | | 4e-10 | HMG CoA reductase inhibitor use measurement | | 6 | 16131066 | 16131067 | Human |
597018348 | GWAS1114422_H | BMI-adjusted waist circumference QTL GWAS1114422 (human) | | 3e-10 | body size trait (VT:0100005) | | 6 | 14595642 | 14595643 | Human |
597386977 | GWAS1483051_H | multiple system atrophy QTL GWAS1483051 (human) | | 0.0000004 | multiple system atrophy | | 6 | 12345461 | 12345462 | Human |
597018350 | GWAS1114424_H | BMI-adjusted waist circumference QTL GWAS1114424 (human) | | 5e-10 | body size trait (VT:0100005) | | 6 | 6886064 | 6886065 | Human |
597386976 | GWAS1483050_H | multiple system atrophy QTL GWAS1483050 (human) | | 0.000003 | multiple system atrophy | | 6 | 7216251 | 7216252 | Human |
597075690 | GWAS1171764_H | heel bone mineral density QTL GWAS1171764 (human) | | 3e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597518051 | GWAS1614125_H | able to hear with hearing aids QTL GWAS1614125 (human) | | 0.0000001 | able to hear with hearing aids | | 6 | 8597223 | 8597224 | Human |
597403167 | GWAS1499241_H | alopecia QTL GWAS1499241 (human) | | 2e-11 | alopecia | | 6 | 453415 | 453416 | Human |
597304855 | GWAS1400929_H | erythrocyte count QTL GWAS1400929 (human) | | 1e-19 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176027 | 15176028 | Human |
597304853 | GWAS1400927_H | erythrocyte count QTL GWAS1400927 (human) | | 5e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12294629 | 12294630 | Human |
597280265 | GWAS1376339_H | xanthosine measurement QTL GWAS1376339 (human) | | 1e-18 | xanthosine measurement | | 6 | 16287961 | 16287962 | Human |
597345803 | GWAS1441877_H | neutrophil measurement QTL GWAS1441877 (human) | | 8e-09 | neutrophil measurement | | 6 | 17686881 | 17686882 | Human |
597411336 | GWAS1507410_H | endometrial carcinoma QTL GWAS1507410 (human) | | 8e-08 | endometrial carcinoma | | 6 | 6615596 | 6615597 | Human |
597403148 | GWAS1499222_H | corneal topography QTL GWAS1499222 (human) | | 4e-35 | corneal topography | | 6 | 10028593 | 10028594 | Human |
597468678 | GWAS1564752_H | obsessive-compulsive symptom measurement QTL GWAS1564752 (human) | | 0.000009 | anxiety-related behavior trait (VT:0010716) | | 6 | 8180053 | 8180054 | Human |
597329409 | GWAS1425483_H | basal cell carcinoma QTL GWAS1425483 (human) | | 4e-254 | basal cell carcinoma | | 6 | 421281 | 421282 | Human |
597141003 | GWAS1237077_H | X-17676 measurement QTL GWAS1237077 (human) | | 5e-20 | X-17676 measurement | | 6 | 3140822 | 3140823 | Human |
597091850 | GWAS1187924_H | entorhinal cortical volume QTL GWAS1187924 (human) | | 0.0000003 | entorhinal cortical volume | | 6 | 6283433 | 6283434 | Human |
597141000 | GWAS1237074_H | X-17676 measurement QTL GWAS1237074 (human) | | 6e-20 | X-17676 measurement | | 6 | 3143926 | 3143927 | Human |
597411332 | GWAS1507406_H | endometrial carcinoma QTL GWAS1507406 (human) | | 9e-08 | endometrial carcinoma | | 6 | 6615596 | 6615597 | Human |
597263928 | GWAS1360002_H | eosinophil count QTL GWAS1360002 (human) | | 8e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 534527 | 534528 | Human |
596977207 | GWAS1096726_H | stroke QTL GWAS1096726 (human) | | 1e-09 | stroke | | 6 | 1356681 | 1356682 | Human |
597288506 | GWAS1384580_H | blood urea nitrogen measurement QTL GWAS1384580 (human) | | 3e-10 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 6 | 9531569 | 9531570 | Human |
597026353 | GWAS1122427_H | loneliness measurement QTL GWAS1122427 (human) | | 3e-09 | emotion/affect behavior trait (VT:0002572) | voluntary social interaction measurement (CMO:0002676) | 6 | 11959603 | 11959604 | Human |
597304887 | GWAS1400961_H | platelet count QTL GWAS1400961 (human) | | 6e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597149241 | GWAS1245315_H | hair color QTL GWAS1245315 (human) | | 5e-09 | hair color | | 6 | 617474 | 617475 | Human |
597149240 | GWAS1245314_H | hair color QTL GWAS1245314 (human) | | 3e-12 | hair color | | 6 | 615736 | 615737 | Human |
597394987 | GWAS1491061_H | vaginal microbiome measurement QTL GWAS1491061 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 7025637 | 7025638 | Human |
597460520 | GWAS1556594_H | diastolic blood pressure QTL GWAS1556594 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 17302626 | 17302627 | Human |
597247535 | GWAS1343609_H | platelet-to-lymphocyte ratio QTL GWAS1343609 (human) | | 1e-12 | platelet-to-lymphocyte ratio | | 6 | 7144958 | 7144959 | Human |
597116449 | GWAS1212523_H | reticulocyte count QTL GWAS1212523 (human) | | 8e-35 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16290617 | 16290620 | Human |
597394988 | GWAS1491062_H | vaginal microbiome measurement QTL GWAS1491062 (human) | | 0.0000006 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597116448 | GWAS1212522_H | reticulocyte count QTL GWAS1212522 (human) | | 9e-33 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16285830 | 16285831 | Human |
597599782 | GWAS1656642_H | mean corpuscular hemoglobin concentration QTL GWAS1656642 (human) | | 2e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597460519 | GWAS1556593_H | diastolic blood pressure QTL GWAS1556593 (human) | | 2e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 1619912 | 1619913 | Human |
407125381 | GWAS774357_H | urate measurement QTL GWAS774357 (human) | | 1e-23 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7101851 | 7101852 | Human |
597304912 | GWAS1400986_H | phosphatidylcholine measurement QTL GWAS1400986 (human) | | 0.0000004 | phosphatidylcholine measurement | | 6 | 10985097 | 10985098 | Human |
597100123 | GWAS1196197_H | sex hormone-binding globulin measurement QTL GWAS1196197 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 6 | 15398100 | 15398101 | Human |
597444178 | GWAS1540252_H | serum metabolite measurement QTL GWAS1540252 (human) | | 0.0000003 | serum metabolite measurement | | 6 | 10305692 | 10305693 | Human |
597386827 | GWAS1482901_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1482901 (human) | | 4e-16 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6738122 | 6738123 | Human |
597583437 | GWAS1640297_H | mean corpuscular hemoglobin concentration QTL GWAS1640297 (human) | | 1e-38 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16287961 | 16287962 | Human |
597427787 | GWAS1523861_H | phosphatidylcholine measurement QTL GWAS1523861 (human) | | 7e-10 | phosphatidylcholine measurement | | 6 | 11043835 | 11043836 | Human |
597239364 | GWAS1335438_H | eosinophil count QTL GWAS1335438 (human) | | 2e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 503851 | 503852 | Human |
597608001 | GWAS1664861_H | gout QTL GWAS1664861 (human) | | 9e-28 | gout | | 6 | 7109432 | 7109433 | Human |
597378682 | GWAS1474756_H | triacylglycerol 54:8 measurement QTL GWAS1474756 (human) | | 0.000006 | blood triglyceride amount (VT:0002644) | | 6 | 8206902 | 8206903 | Human |
597231229 | GWAS1327303_H | electrocardiography QTL GWAS1327303 (human) | | 1e-08 | electrocardiography | | 6 | 12555642 | 12555643 | Human |
597231231 | GWAS1327305_H | electrocardiography QTL GWAS1327305 (human) | | 8e-10 | electrocardiography | | 6 | 12555642 | 12555643 | Human |
597083760 | GWAS1179834_H | pulse pressure measurement, migraine without aura, susceptibility to, 4 QTL GWAS1179834 (human) | | 3e-28 | pulse pressure measurement, migraine without aura, susceptibility to, 4 | pulse pressure (CMO:0000292) | 6 | 12888772 | 12888773 | Human |
597231230 | GWAS1327304_H | electrocardiography QTL GWAS1327304 (human) | | 4e-09 | electrocardiography | | 6 | 12555642 | 12555643 | Human |
597280369 | GWAS1376443_H | hemoglobin A1 measurement QTL GWAS1376443 (human) | | 3e-13 | hemoglobin A1 measurement | | 6 | 3439124 | 3439125 | Human |
597263987 | GWAS1360061_H | pulse pressure measurement QTL GWAS1360061 (human) | | 9e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7708819 | 7708820 | Human |
597280372 | GWAS1376446_H | hemoglobin A1 measurement QTL GWAS1376446 (human) | | 1e-26 | hemoglobin A1 measurement | | 6 | 7247111 | 7247112 | Human |
597591659 | GWAS1648519_H | sebaceous gland disease QTL GWAS1648519 (human) | | 3e-47 | sebaceous gland disease | | 6 | 396321 | 396322 | Human |
597059169 | GWAS1155243_H | open-angle glaucoma QTL GWAS1155243 (human) | | 2e-10 | open-angle glaucoma | | 6 | 1989370 | 1989371 | Human |
597083758 | GWAS1179832_H | migraine without aura, susceptibility to, 4, systolic blood pressure QTL GWAS1179832 (human) | | 1e-13 | migraine without aura, susceptibility to, 4, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12909642 | 12909643 | Human |
597476966 | GWAS1573040_H | asthma exacerbation measurement, response to corticosteroid QTL GWAS1573040 (human) | | 0.000007 | asthma exacerbation measurement, response to corticosteroid | | 6 | 15909294 | 15909295 | Human |
597476967 | GWAS1573041_H | asthma exacerbation measurement, response to corticosteroid QTL GWAS1573041 (human) | | 0.000003 | asthma exacerbation measurement, response to corticosteroid | | 6 | 15909294 | 15909295 | Human |
597083754 | GWAS1179828_H | white matter hyperintensity measurement QTL GWAS1179828 (human) | | 0.000008 | white matter hyperintensity measurement | | 6 | 1129965 | 1129966 | Human |
597583458 | GWAS1640318_H | mean corpuscular hemoglobin concentration QTL GWAS1640318 (human) | | 1e-82 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597583456 | GWAS1640316_H | mean corpuscular hemoglobin concentration QTL GWAS1640316 (human) | | 4e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597378660 | GWAS1474734_H | allantoin measurement QTL GWAS1474734 (human) | | 0.0000004 | allantoin measurement | | 6 | 10460505 | 10460506 | Human |
597583457 | GWAS1640317_H | mean corpuscular hemoglobin concentration QTL GWAS1640317 (human) | | 2e-24 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 15115770 | 15115771 | Human |
597239193 | GWAS1335267_H | abdominal fat cell number QTL GWAS1335267 (human) | | 0.000008 | abdominal fat cell number | | 6 | 5394284 | 5394285 | Human |
597050769 | GWAS1146843_H | glucagon measurement QTL GWAS1146843 (human) | | 0.000007 | glucagon measurement | blood glucagon level (CMO:0001294) | 6 | 11945800 | 11945801 | Human |
597296528 | GWAS1392602_H | clonal hematopoiesis mutation measurement QTL GWAS1392602 (human) | | 0.0000004 | clonal hematopoiesis mutation measurement | | 6 | 7330656 | 7330657 | Human |
597050778 | GWAS1146852_H | hypothyroidism QTL GWAS1146852 (human) | | 5e-13 | hypothyroidism | | 6 | 408079 | 408080 | Human |
597280150 | GWAS1376224_H | hemoglobin A1 measurement QTL GWAS1376224 (human) | | 1e-09 | hemoglobin A1 measurement | | 6 | 18747474 | 18747475 | Human |
597501325 | GWAS1597399_H | diastolic blood pressure, systolic blood pressure QTL GWAS1597399 (human) | | 8e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7487883 | 7487884 | Human |
597050759 | GWAS1146833_H | response to anticonvulsant QTL GWAS1146833 (human) | | 0.000002 | response to anticonvulsant | | 6 | 6163975 | 6163976 | Human |
597075332 | GWAS1171406_H | body mass index QTL GWAS1171406 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597443983 | GWAS1540057_H | testosterone measurement QTL GWAS1540057 (human) | | 0.0000002 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1376813 | 1376814 | Human |
597501326 | GWAS1597400_H | diastolic blood pressure, systolic blood pressure QTL GWAS1597400 (human) | | 2e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12418998 | 12418999 | Human |
407043668 | GWAS692644_H | breast carcinoma QTL GWAS692644 (human) | | 7e-09 | mammary gland integrity trait (VT:0010552) | | 6 | 1318643 | 1318644 | Human |
597362050 | GWAS1458124_H | daytime rest measurement QTL GWAS1458124 (human) | | 0.000001 | sleep behavior trait (VT:0001501) | | 6 | 1539849 | 1539850 | Human |
597386625 | GWAS1482699_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1482699 (human) | | 4e-08 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6738122 | 6738123 | Human |
596952463 | GWAS1071982_H | size QTL GWAS1071982 (human) | | 8e-09 | size | | 6 | 2670364 | 2670365 | Human |
597386624 | GWAS1482698_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1482698 (human) | | 0.0000008 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6738122 | 6738123 | Human |
597616000 | GWAS1672860_H | systolic blood pressure QTL GWAS1672860 (human) | | 2e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
406994530 | GWAS643506_H | mean corpuscular hemoglobin concentration QTL GWAS643506 (human) | | 1e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 602983 | 602984 | Human |
406994531 | GWAS643507_H | mean corpuscular hemoglobin concentration QTL GWAS643507 (human) | | 1e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 8001745 | 8001746 | Human |
597394879 | GWAS1490953_H | low density lipoprotein cholesterol measurement QTL GWAS1490953 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16108932 | 16108933 | Human |
597149105 | GWAS1245179_H | hair color QTL GWAS1245179 (human) | | 3e-46 | hair color | | 6 | 396321 | 396322 | Human |
597599673 | GWAS1656533_H | mean corpuscular hemoglobin concentration QTL GWAS1656533 (human) | | 1e-17 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597263793 | GWAS1359867_H | mean corpuscular hemoglobin QTL GWAS1359867 (human) | | 1e-42 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16295116 | 16295121 | Human |
597059007 | GWAS1155081_H | open-angle glaucoma QTL GWAS1155081 (human) | | 3e-10 | open-angle glaucoma | | 6 | 637465 | 637466 | Human |
597124541 | GWAS1220615_H | phosphatidylethanolamine measurement QTL GWAS1220615 (human) | | 1e-10 | phosphatidylcholine measurement | | 6 | 11088670 | 11088671 | Human |
597591477 | GWAS1648337_H | actinic keratosis QTL GWAS1648337 (human) | | 7e-21 | actinic keratosis | | 6 | 396321 | 396322 | Human |
597124540 | GWAS1220614_H | phosphatidylethanolamine measurement QTL GWAS1220614 (human) | | 4e-12 | phosphatidylethanolamine measurement | | 6 | 11042676 | 11042677 | Human |
597124539 | GWAS1220613_H | phosphatidylethanolamine measurement QTL GWAS1220613 (human) | | 2e-10 | phosphatidylethanolamine measurement | | 6 | 11040190 | 11040191 | Human |
597124538 | GWAS1220612_H | phosphatidylethanolamine measurement QTL GWAS1220612 (human) | | 3e-11 | phosphatidylethanolamine measurement | | 6 | 10982126 | 10982127 | Human |
407395941 | GWAS1044917_H | gut microbiome measurement, bone density QTL GWAS1044917 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15886888 | 15886889 | Human |
597157305 | GWAS1253379_H | total cholesterol measurement QTL GWAS1253379 (human) | | 5e-08 | blood lipid amount (VT:0003949) | blood total cholesterol level (CMO:0000051) | 6 | 16134016 | 16134017 | Human |
597116344 | GWAS1212418_H | DNA methylation QTL GWAS1212418 (human) | | 4e-08 | DNA methylation | | 6 | 17164577 | 17164578 | Human |
597149095 | GWAS1245169_H | freckles QTL GWAS1245169 (human) | | 7e-40 | freckles | | 6 | 396321 | 396322 | Human |
597206443 | GWAS1302517_H | colorectal cancer QTL GWAS1302517 (human) | | 4e-09 | colorectal cancer | | 6 | 12292539 | 12292540 | Human |
596952487 | GWAS1072006_H | size QTL GWAS1072006 (human) | | 8e-13 | size | | 6 | 15432886 | 15432887 | Human |
597312942 | GWAS1409016_H | Antiglaucoma preparations and miotics use measurement QTL GWAS1409016 (human) | | 1e-10 | Antiglaucoma preparations and miotics use measurement | | 6 | 597203 | 597204 | Human |
596977059 | GWAS1096578_H | body height QTL GWAS1096578 (human) | | 3e-09 | body height | | 6 | 2233087 | 2233088 | Human |
597042607 | GWAS1138681_H | intraocular pressure measurement QTL GWAS1138681 (human) | | 5e-10 | intraocular pressure measurement | | 6 | 597203 | 597204 | Human |
596960685 | GWAS1080204_H | metabolic syndrome QTL GWAS1080204 (human) | | 5e-13 | metabolic syndrome | | 6 | 7255417 | 7255418 | Human |
597460384 | GWAS1556458_H | waist-hip ratio QTL GWAS1556458 (human) | | 5e-27 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6744794 | 6744795 | Human |
597525983 | GWAS1622057_H | protein measurement QTL GWAS1622057 (human) | | 3e-773 | protein measurement | | 6 | 4112889 | 4112890 | Human |
597591516 | GWAS1648376_H | coronary atherosclerosis QTL GWAS1648376 (human) | | 2e-96 | coronary atherosclerosis | | 6 | 12903725 | 12903726 | Human |
597255625 | GWAS1351699_H | total cholesterol measurement QTL GWAS1351699 (human) | | 9e-79 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16130925 | 16130926 | Human |
597255624 | GWAS1351698_H | total cholesterol measurement QTL GWAS1351698 (human) | | 6e-18 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 11868449 | 11868450 | Human |
597108165 | GWAS1204239_H | urate measurement QTL GWAS1204239 (human) | | 5e-18 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7109432 | 7109433 | Human |
597214666 | GWAS1310740_H | body mass index QTL GWAS1310740 (human) | | 3e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597173706 | GWAS1269780_H | intelligence QTL GWAS1269780 (human) | | 2e-11 | intelligence | | 6 | 19065449 | 19065450 | Human |
597337545 | GWAS1433619_H | osteoarthritis QTL GWAS1433619 (human) | | 5e-08 | osteoarthritis | | 6 | 7797607 | 7797608 | Human |
597255626 | GWAS1351700_H | total cholesterol measurement QTL GWAS1351700 (human) | | 1e-11 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 18747474 | 18747475 | Human |
597394880 | GWAS1490954_H | low density lipoprotein cholesterol measurement QTL GWAS1490954 (human) | | 3e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
407051819 | GWAS700795_H | proline measurement QTL GWAS700795 (human) | | 0.000003 | proline measurement | blood amino acid measurement (CMO:0003730) | 6 | 13317798 | 13317799 | Human |
597247475 | GWAS1343549_H | complement factor H-related protein 1 measurement QTL GWAS1343549 (human) | | 0.000006 | complement factor H-related protein 1 measurement | | 6 | 11286497 | 11286498 | Human |
597485040 | GWAS1581114_H | body mass index QTL GWAS1581114 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18578721 | 18578722 | Human |
597419509 | GWAS1515583_H | phosphatidylinositol measurement QTL GWAS1515583 (human) | | 2e-10 | phosphatidylinositol measurement | | 6 | 11047723 | 11047724 | Human |
597419508 | GWAS1515582_H | phosphatidylinositol measurement QTL GWAS1515582 (human) | | 1e-10 | phosphatidylinositol measurement | | 6 | 11052185 | 11052186 | Human |
407387687 | GWAS1036663_H | bone mineral content measurement QTL GWAS1036663 (human) | | 0.000009 | bone mineral content measurement | | 6 | 14097233 | 14097234 | Human |
597321195 | GWAS1417269_H | JT interval QTL GWAS1417269 (human) | | 1e-10 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 6 | 7419689 | 7419690 | Human |
597476843 | GWAS1572917_H | intraocular pressure measurement QTL GWAS1572917 (human) | | 2e-27 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597493221 | GWAS1589295_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1589295 (human) | | 0.000005 | S-warfarin to R-warfarin ratio measurement | | 6 | 10040508 | 10040509 | Human |
597591522 | GWAS1648382_H | angina pectoris QTL GWAS1648382 (human) | | 4e-28 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597525984 | GWAS1622058_H | protein measurement QTL GWAS1622058 (human) | | 0.0000002 | protein measurement | | 6 | 4156195 | 4156196 | Human |
597247460 | GWAS1343534_H | loneliness measurement QTL GWAS1343534 (human) | | 2e-08 | emotion/affect behavior trait (VT:0002572) | | 6 | 11959603 | 11959604 | Human |
597411301 | GWAS1507375_H | response to interferon QTL GWAS1507375 (human) | | 0.000003 | immune response trait (VT:0010139) | | 6 | 8204180 | 8204181 | Human |
597280231 | GWAS1376305_H | QT interval QTL GWAS1376305 (human) | | 9e-18 | QT interval | QT interval (CMO:0000235) | 6 | 16280956 | 16280957 | Human |
407051836 | GWAS700812_H | triacylglycerol 58:8 measurement QTL GWAS700812 (human) | | 0.000007 | blood triglyceride amount (VT:0002644) | | 6 | 7555002 | 7555003 | Human |
407224007 | GWAS872983_H | orotic acid measurement QTL GWAS872983 (human) | | 0.000004 | orotic acid measurement | | 6 | 18891464 | 18891465 | Human |
597591310 | GWAS1648170_H | glaucoma QTL GWAS1648170 (human) | | 1e-39 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597525773 | GWAS1621847_H | X-17676 measurement QTL GWAS1621847 (human) | | 1e-12 | X-17676 measurement | | 6 | 3138265 | 3138266 | Human |
597402894 | GWAS1498968_H | alopecia QTL GWAS1498968 (human) | | 8e-09 | alopecia | | 6 | 470930 | 470931 | Human |
597402893 | GWAS1498967_H | alopecia QTL GWAS1498967 (human) | | 3e-09 | alopecia | | 6 | 10186099 | 10186100 | Human |
597402892 | GWAS1498966_H | alopecia QTL GWAS1498966 (human) | | 1e-09 | alopecia | | 6 | 9725037 | 9725038 | Human |
597452036 | GWAS1548110_H | blautia seropositivity QTL GWAS1548110 (human) | | 4e-08 | blautia seropositivity | | 6 | 16909763 | 16909764 | Human |
597140745 | GWAS1236819_H | low density lipoprotein cholesterol measurement QTL GWAS1236819 (human) | | 4e-11 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597067057 | GWAS1163131_H | susceptibility to measles measurement QTL GWAS1163131 (human) | | 0.0000002 | susceptibility to measles measurement | | 6 | 19089482 | 19089483 | Human |
597615922 | GWAS1672782_H | prostate specific antigen amount QTL GWAS1672782 (human) | | 1e-21 | prostate specific antigen amount | | 6 | 16512112 | 16512113 | Human |
597484849 | GWAS1580923_H | diglyceride measurement QTL GWAS1580923 (human) | | 1e-09 | diglyceride measurement | | 6 | 11060050 | 11060051 | Human |
597091641 | GWAS1187715_H | BMI-adjusted hip circumference QTL GWAS1187715 (human) | | 0.000004 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7789710 | 7789711 | Human |
597615921 | GWAS1672781_H | prostate specific antigen amount QTL GWAS1672781 (human) | | 2e-24 | prostate specific antigen amount | | 6 | 15502592 | 15502593 | Human |
597411114 | GWAS1507188_H | urinary metabolite measurement QTL GWAS1507188 (human) | | 3e-88 | urinary metabolite measurement | | 6 | 2996087 | 2996088 | Human |
597247279 | GWAS1343353_H | BMI-adjusted waist-hip ratio QTL GWAS1343353 (human) | | 5e-08 | body size trait (VT:0100005) | | 6 | 7237836 | 7237837 | Human |
597591336 | GWAS1648196_H | parasitic infection QTL GWAS1648196 (human) | | 3e-12 | parasitic infection | | 6 | 11925014 | 11925015 | Human |
407092987 | GWAS741963_H | hair color QTL GWAS741963 (human) | | 2e-10 | hair color | | 6 | 386933 | 386934 | Human |
597402915 | GWAS1498989_H | aspartate aminotransferase measurement QTL GWAS1498989 (human) | | 4e-18 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 6 | 13512277 | 13512278 | Human |
406937339 | GWAS586315_H | heel bone mineral density QTL GWAS586315 (human) | | 6e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 1613451 | 1613452 | Human |
407092990 | GWAS741966_H | hair color QTL GWAS741966 (human) | | 2e-59 | hair color | | 6 | 542159 | 542160 | Human |
406937340 | GWAS586316_H | heel bone mineral density QTL GWAS586316 (human) | | 5e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 1725558 | 1725559 | Human |
597411110 | GWAS1507184_H | urinary metabolite measurement QTL GWAS1507184 (human) | | 1e-29 | urinary metabolite measurement | | 6 | 2996087 | 2996088 | Human |
597157161 | GWAS1253235_H | sex hormone-binding globulin measurement QTL GWAS1253235 (human) | | 0.000007 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
407051904 | GWAS700880_H | metabolite measurement QTL GWAS700880 (human) | | 2e-14 | metabolite measurement | | 6 | 11042676 | 11042677 | Human |
597443935 | GWAS1540009_H | lipid measurement QTL GWAS1540009 (human) | | 0.000009 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 13733333 | 13733334 | Human |
597443928 | GWAS1540002_H | Caffeic acid measurement QTL GWAS1540002 (human) | | 0.000008 | Caffeic acid measurement | | 6 | 14615258 | 14615259 | Human |
597239132 | GWAS1335206_H | eosinophil count QTL GWAS1335206 (human) | | 1e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 245096 | 245097 | Human |
597149021 | GWAS1245095_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1245095 (human) | | 3e-08 | blood lipid amount (VT:0003949) | blood total cholesterol level (CMO:0000051) | 6 | 16134016 | 16134017 | Human |
597362004 | GWAS1458078_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS1458078 (human) | | 1e-11 | intestine integrity trait (VT:0010554) | | 6 | 14715651 | 14715652 | Human |
597607758 | GWAS1664618_H | lymphoid leukemia QTL GWAS1664618 (human) | | 3e-19 | lymphoid leukemia | | 6 | 410417 | 410418 | Human |
597484876 | GWAS1580950_H | phosphatidylethanolamine measurement QTL GWAS1580950 (human) | | 4e-08 | phosphatidylethanolamine measurement | | 6 | 10975563 | 10975564 | Human |
597435727 | GWAS1531801_H | aspirin use measurement QTL GWAS1531801 (human) | | 3e-09 | aspirin use measurement | | 6 | 12903725 | 12903726 | Human |
597394767 | GWAS1490841_H | intelligence QTL GWAS1490841 (human) | | 0.000002 | intelligence | | 6 | 14598077 | 14598078 | Human |
597296463 | GWAS1392537_H | low density lipoprotein cholesterol measurement QTL GWAS1392537 (human) | | 4e-20 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16134016 | 16134017 | Human |
597181767 | GWAS1277841_H | synaptotagmin-11 measurement QTL GWAS1277841 (human) | | 1e-16 | synaptotagmin-11 measurement | | 6 | 7245225 | 7245226 | Human |
597599614 | GWAS1656474_H | mean corpuscular hemoglobin concentration QTL GWAS1656474 (human) | | 9e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597288313 | GWAS1384387_H | myocardial infarction QTL GWAS1384387 (human) | | 2e-09 | myocardial infarction | | 6 | 12903906 | 12903907 | Human |
597607807 | GWAS1664667_H | body weight QTL GWAS1664667 (human) | | 3e-17 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12117111 | 12117112 | Human |
597099890 | GWAS1195964_H | alopecia QTL GWAS1195964 (human) | | 4e-09 | alopecia | | 6 | 537157 | 537158 | Human |
597099889 | GWAS1195963_H | alopecia QTL GWAS1195963 (human) | | 3e-09 | alopecia | | 6 | 9509023 | 9509024 | Human |
597099888 | GWAS1195962_H | alopecia QTL GWAS1195962 (human) | | 1e-09 | alopecia | | 6 | 385735 | 385736 | Human |
597607794 | GWAS1664654_H | lymphoid leukemia QTL GWAS1664654 (human) | | 4e-22 | lymphoid leukemia | | 6 | 421281 | 421282 | Human |
597288309 | GWAS1384383_H | myocardial infarction QTL GWAS1384383 (human) | | 2e-20 | myocardial infarction | | 6 | 12891069 | 12891070 | Human |
597337462 | GWAS1433536_H | systolic blood pressure QTL GWAS1433536 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16306520 | 16306521 | Human |
597337463 | GWAS1433537_H | systolic blood pressure QTL GWAS1433537 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16321561 | 16321562 | Human |
597337461 | GWAS1433535_H | systolic blood pressure QTL GWAS1433535 (human) | | 0.0000003 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12296022 | 12296023 | Human |
597607791 | GWAS1664651_H | myeloid leukemia QTL GWAS1664651 (human) | | 5e-12 | myeloid leukemia | | 6 | 10488465 | 10488466 | Human |
597271905 | GWAS1367979_H | triglyceride measurement QTL GWAS1367979 (human) | | 1e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 7247111 | 7247112 | Human |
597271906 | GWAS1367980_H | triglyceride measurement QTL GWAS1367980 (human) | | 4e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 18747474 | 18747475 | Human |
597362023 | GWAS1458097_H | Red cell distribution width QTL GWAS1458097 (human) | | 3e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3466533 | 3466534 | Human |
597386599 | GWAS1482673_H | QT interval QTL GWAS1482673 (human) | | 0.0000003 | QT interval | QT interval (CMO:0000235) | 6 | 17368796 | 17368797 | Human |
407027520 | GWAS676496_H | chronic lymphocytic leukemia QTL GWAS676496 (human) | | 8e-14 | leukocyte integrity trait (VT:0010898) | | 6 | 411064 | 411065 | Human |
406937413 | GWAS586389_H | heel bone mineral density QTL GWAS586389 (human) | | 2e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2098146 | 2098147 | Human |
406937415 | GWAS586391_H | heel bone mineral density QTL GWAS586391 (human) | | 1e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2719745 | 2719746 | Human |
597451930 | GWAS1548004_H | BMI-adjusted waist-hip ratio QTL GWAS1548004 (human) | | 3e-13 | body size trait (VT:0100005) | | 6 | 6742316 | 6742317 | Human |
597599384 | GWAS1656244_H | mean corpuscular hemoglobin concentration QTL GWAS1656244 (human) | | 5e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597075088 | GWAS1171162_H | coronary artery calcification QTL GWAS1171162 (human) | | 0.0000001 | coronary artery calcification | | 6 | 16745008 | 16745009 | Human |
407125827 | GWAS774803_H | age at menopause QTL GWAS774803 (human) | | 5e-08 | age at menopause | | 6 | 10897255 | 10897256 | Human |
406937416 | GWAS586392_H | heel bone mineral density QTL GWAS586392 (human) | | 8e-36 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597509265 | GWAS1605339_H | BMI-adjusted waist circumference QTL GWAS1605339 (human) | | 2e-13 | body size trait (VT:0100005) | | 6 | 6740133 | 6740134 | Human |
597509264 | GWAS1605338_H | BMI-adjusted waist circumference QTL GWAS1605338 (human) | | 7e-10 | body size trait (VT:0100005) | | 6 | 6739691 | 6739692 | Human |
597509267 | GWAS1605341_H | BMI-adjusted waist circumference QTL GWAS1605341 (human) | | 1e-12 | body size trait (VT:0100005) | | 6 | 6782065 | 6782066 | Human |
597386389 | GWAS1482463_H | coronary artery disease QTL GWAS1482463 (human) | | 1e-35 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597509266 | GWAS1605340_H | BMI-adjusted waist circumference QTL GWAS1605340 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 6756172 | 6756173 | Human |
597369992 | GWAS1466066_H | adiponectin measurement QTL GWAS1466066 (human) | | 0.000004 | adiponectin measurement | blood adiponectin level (CMO:0000485) | 6 | 9853686 | 9853687 | Human |
597394622 | GWAS1490696_H | glaucoma QTL GWAS1490696 (human) | | 1e-10 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597320895 | GWAS1416969_H | opioid dependence QTL GWAS1416969 (human) | | 0.000005 | opioid dependence | | 6 | 6276795 | 6276796 | Human |
597255350 | GWAS1351424_H | heel bone mineral density, urate measurement QTL GWAS1351424 (human) | | 6e-09 | heel bone mineral density, urate measurement | blood uric acid level (CMO:0000501) | 6 | 6621533 | 6621534 | Human |
597165224 | GWAS1261298_H | total cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1261298 (human) | | 6e-09 | total cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16134016 | 16134017 | Human |
596968615 | GWAS1088134_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement QTL GWAS1088134 (human) | | 0.000002 | aspartate aminotransferase measurement, serum alanine aminotransferase measurement | | 6 | 18130687 | 18130688 | Human |
597345440 | GWAS1441514_H | generalised epilepsy QTL GWAS1441514 (human) | | 5e-08 | generalised epilepsy | | 6 | 16971344 | 16971345 | Human |
406978426 | GWAS627402_H | hematocrit QTL GWAS627402 (human) | | 3e-36 | hematocrit | hematocrit (CMO:0000037) | 6 | 2050557 | 2050558 | Human |
597460180 | GWAS1556254_H | body mass index QTL GWAS1556254 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18492119 | 18492120 | Human |
597320913 | GWAS1416987_H | X-21441 measurement QTL GWAS1416987 (human) | | 0.0000003 | X-21441 measurement | | 6 | 12767816 | 12767817 | Human |
406994703 | GWAS643679_H | reticulocyte measurement QTL GWAS643679 (human) | | 3e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7143626 | 7143627 | Human |
597607633 | GWAS1664493_H | drug use measurement, gout QTL GWAS1664493 (human) | | 1e-18 | drug use measurement, gout | | 6 | 7118757 | 7118758 | Human |
407224074 | GWAS873050_H | lymphocyte count QTL GWAS873050 (human) | | 3e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 7140598 | 7140599 | Human |
406994706 | GWAS643682_H | reticulocyte measurement QTL GWAS643682 (human) | | 5e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 13530168 | 13530169 | Human |
597288137 | GWAS1384211_H | cholesterol in very small VLDL measurement QTL GWAS1384211 (human) | | 4e-10 | cholesterol in very small VLDL measurement | | 6 | 16130925 | 16130926 | Human |
406994704 | GWAS643680_H | reticulocyte measurement QTL GWAS643680 (human) | | 3e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7157433 | 7157434 | Human |
406994705 | GWAS643681_H | reticulocyte measurement QTL GWAS643681 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7221210 | 7221211 | Human |
597468367 | GWAS1564441_H | androgenetic alopecia QTL GWAS1564441 (human) | | 3e-16 | androgenetic alopecia | | 6 | 9677162 | 9677163 | Human |
406994710 | GWAS643686_H | reticulocyte measurement QTL GWAS643686 (human) | | 5e-32 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16290617 | 16290620 | Human |
406994708 | GWAS643684_H | reticulocyte measurement QTL GWAS643684 (human) | | 2e-35 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16282287 | 16282288 | Human |
406994709 | GWAS643685_H | reticulocyte measurement QTL GWAS643685 (human) | | 1e-35 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16285830 | 16285831 | Human |
407101211 | GWAS750187_H | eosinophil count QTL GWAS750187 (human) | | 3e-55 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 577820 | 577821 | Human |
407027483 | GWAS676459_H | coronary artery disease QTL GWAS676459 (human) | | 6e-08 | coronary artery disease | | 6 | 12888772 | 12888773 | Human |
597320903 | GWAS1416977_H | metabolite measurement QTL GWAS1416977 (human) | | 2e-22 | metabolite measurement | | 6 | 14131013 | 14131014 | Human |
597296324 | GWAS1392398_H | BMI-adjusted hip circumference QTL GWAS1392398 (human) | | 2e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7708819 | 7708820 | Human |
597296325 | GWAS1392399_H | BMI-adjusted hip circumference QTL GWAS1392399 (human) | | 7e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7786378 | 7786379 | Human |
596952304 | GWAS1071823_H | mean platelet volume QTL GWAS1071823 (human) | | 2e-09 | mean platelet volume | | 6 | 3446029 | 3446030 | Human |
597435643 | GWAS1531717_H | gut microbiome measurement QTL GWAS1531717 (human) | | 3e-08 | gut microbiome measurement | | 6 | 4752912 | 4752913 | Human |
597345526 | GWAS1441600_H | color vision disorder QTL GWAS1441600 (human) | | 0.0000007 | color vision disorder | | 6 | 1685766 | 1685767 | Human |
597091576 | GWAS1187650_H | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism QTL GWAS1187650 (human) | | 0.0000004 | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | | 6 | 11615072 | 11615073 | Human |
597427432 | GWAS1523506_H | gout QTL GWAS1523506 (human) | | 4e-08 | gout | | 6 | 2050557 | 2050558 | Human |
597165292 | GWAS1261366_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1261366 (human) | | 7e-09 | low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 16134016 | 16134017 | Human |
597427434 | GWAS1523508_H | gout QTL GWAS1523508 (human) | | 3e-58 | gout | | 6 | 7099796 | 7099797 | Human |
597140713 | GWAS1236787_H | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement QTL GWAS1236787 (human) | | 3e-16 | glycerophosphocholine amount (VT:0011004) | | 6 | 10996933 | 10996934 | Human |
597140502 | GWAS1236576_H | 1-pentadecanoyl-2-docosahexaenoyl-GPC (15:0/22:6) measurement QTL GWAS1236576 (human) | | 2e-11 | glycerophosphocholine amount (VT:0011004) | | 6 | 10985097 | 10985098 | Human |
597345311 | GWAS1441385_H | color vision disorder QTL GWAS1441385 (human) | | 0.0000002 | color vision disorder | | 6 | 12798509 | 12798510 | Human |
597189663 | GWAS1285737_H | free androgen index QTL GWAS1285737 (human) | | 4e-08 | free androgen index | | 6 | 7231610 | 7231611 | Human |
597124102 | GWAS1220176_H | bone morphogenetic protein 7 measurement QTL GWAS1220176 (human) | | 6e-13 | bone morphogenetic protein 7 measurement | | 6 | 7700755 | 7700756 | Human |
597206027 | GWAS1302101_H | grip strength measurement QTL GWAS1302101 (human) | | 2e-08 | grip strength measurement | | 6 | 12944861 | 12944862 | Human |
597115907 | GWAS1211981_H | pulse pressure measurement QTL GWAS1211981 (human) | | 7e-14 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12295754 | 12295755 | Human |
597115906 | GWAS1211980_H | pulse pressure measurement QTL GWAS1211980 (human) | | 4e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7211585 | 7211586 | Human |
597459978 | GWAS1556052_H | phospholipids in large LDL measurement QTL GWAS1556052 (human) | | 8e-16 | phospholipids in large LDL measurement | blood low density lipoprotein phospholipid level (CMO:0001568) | 6 | 16113090 | 16113091 | Human |
597017602 | GWAS1113676_H | basophil count QTL GWAS1113676 (human) | | 1e-11 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 7058283 | 7058284 | Human |
597591046 | GWAS1647906_H | phototoxic dermatitis QTL GWAS1647906 (human) | | 3e-44 | phototoxic dermatitis | | 6 | 396321 | 396322 | Human |
597099533 | GWAS1195607_H | prostate carcinoma QTL GWAS1195607 (human) | | 4e-13 | prostate carcinoma | | 6 | 11217664 | 11217665 | Human |
597615620 | GWAS1672480_H | prostate specific antigen amount QTL GWAS1672480 (human) | | 8e-24 | prostate specific antigen amount | | 6 | 15502592 | 15502593 | Human |
597615621 | GWAS1672481_H | prostate specific antigen amount QTL GWAS1672481 (human) | | 3e-20 | prostate specific antigen amount | | 6 | 16512112 | 16512113 | Human |
597099531 | GWAS1195605_H | prostate carcinoma QTL GWAS1195605 (human) | | 2e-09 | prostate carcinoma | | 6 | 1670751 | 1670752 | Human |
597345286 | GWAS1441360_H | FEV/FVC ratio QTL GWAS1441360 (human) | | 4e-09 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7958232 | 7958233 | Human |
597476412 | GWAS1572486_H | blood protein measurement QTL GWAS1572486 (human) | | 3e-21 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 7883235 | 7883236 | Human |
597279801 | GWAS1375875_H | N,N,N-trimethyl-5-aminovalerate measurement QTL GWAS1375875 (human) | | 1e-18 | N,N,N-trimethyl-5-aminovalerate measurement | | 6 | 14131013 | 14131014 | Human |
597591102 | GWAS1647962_H | atrial fibrillation QTL GWAS1647962 (human) | | 3e-57 | atrial fibrillation | | 6 | 16414322 | 16414323 | Human |
597296191 | GWAS1392265_H | lymphocyte count QTL GWAS1392265 (human) | | 2e-08 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 2904557 | 2904558 | Human |
597394494 | GWAS1490568_H | high density lipoprotein cholesterol measurement QTL GWAS1490568 (human) | | 4e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 16824906 | 16824907 | Human |
597328936 | GWAS1425010_H | carnitine measurement QTL GWAS1425010 (human) | | 1e-11 | blood carnitine amount (VT:0003977) | | 6 | 14131013 | 14131014 | Human |
597017633 | GWAS1113707_H | basophil count QTL GWAS1113707 (human) | | 5e-09 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 6 | 7058283 | 7058284 | Human |
406921206 | GWAS570182_H | pulse pressure measurement QTL GWAS570182 (human) | | 0.000003 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12445615 | 12445616 | Human |
597599268 | GWAS1656128_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1656128 (human) | | 1e-19 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 13525133 | 13525134 | Human |
597443623 | GWAS1539697_H | arginine measurement QTL GWAS1539697 (human) | | 0.000007 | arginine measurement | | 6 | 1143874 | 1143875 | Human |
407126010 | GWAS774986_H | smoking initiation QTL GWAS774986 (human) | | 0.0000003 | smoking initiation | | 6 | 4874525 | 4874526 | Human |
597107752 | GWAS1203826_H | Red cell distribution width QTL GWAS1203826 (human) | | 4e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16290617 | 16290620 | Human |
597124180 | GWAS1220254_H | blood protein measurement QTL GWAS1220254 (human) | | 2e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 7240344 | 7240345 | Human |
407043978 | GWAS692954_H | testosterone measurement QTL GWAS692954 (human) | | 0.000009 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1918028 | 1918029 | Human |
597066846 | GWAS1162920_H | susceptibility to vaginal yeast infection measurement QTL GWAS1162920 (human) | | 0.000005 | susceptibility to vaginal yeast infection measurement | | 6 | 13780285 | 13780286 | Human |
597156957 | GWAS1253031_H | testosterone measurement QTL GWAS1253031 (human) | | 6e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 7841888 | 7841889 | Human |
597402704 | GWAS1498778_H | Erythema nodosum QTL GWAS1498778 (human) | | 0.000008 | Erythema nodosum | | 6 | 1168812 | 1168813 | Human |
597378132 | GWAS1474206_H | Red cell distribution width QTL GWAS1474206 (human) | | 4e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 4717639 | 4717640 | Human |
597058628 | GWAS1154702_H | adolescent idiopathic scoliosis QTL GWAS1154702 (human) | | 0.0000003 | adolescent idiopathic scoliosis | | 6 | 10924759 | 10924760 | Human |
597099589 | GWAS1195663_H | gut microbiome measurement QTL GWAS1195663 (human) | | 0.000004 | gut microbiome measurement | | 6 | 18385658 | 18385659 | Human |
597058626 | GWAS1154700_H | adolescent idiopathic scoliosis QTL GWAS1154700 (human) | | 0.0000002 | adolescent idiopathic scoliosis | | 6 | 4700910 | 4700911 | Human |
597148738 | GWAS1244812_H | prostate carcinoma QTL GWAS1244812 (human) | | 0.0000001 | prostate carcinoma | | 6 | 11289515 | 11289516 | Human |
597591115 | GWAS1647975_H | atrial fibrillation QTL GWAS1647975 (human) | | 2e-56 | atrial fibrillation | | 6 | 16414322 | 16414323 | Human |
597148737 | GWAS1244811_H | prostate carcinoma QTL GWAS1244811 (human) | | 1e-16 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
597148736 | GWAS1244810_H | prostate carcinoma QTL GWAS1244810 (human) | | 1e-10 | prostate carcinoma | | 6 | 1670751 | 1670752 | Human |
597263438 | GWAS1359512_H | mean corpuscular hemoglobin concentration QTL GWAS1359512 (human) | | 2e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597255232 | GWAS1351306_H | calcium measurement QTL GWAS1351306 (human) | | 4e-13 | calcium measurement | blood calcium level (CMO:0000502) | 6 | 10877164 | 10877165 | Human |
597296192 | GWAS1392266_H | lymphocyte count QTL GWAS1392266 (human) | | 2e-25 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 410417 | 410418 | Human |
597591108 | GWAS1647968_H | atrial fibrillation QTL GWAS1647968 (human) | | 2e-19 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597615680 | GWAS1672540_H | prostate specific antigen amount QTL GWAS1672540 (human) | | 4e-25 | prostate specific antigen amount | | 6 | 15502592 | 15502593 | Human |
597607546 | GWAS1664406_H | family history, coronary artery disease QTL GWAS1664406 (human) | | 1e-12 | migraine without aura | | 6 | 12903725 | 12903726 | Human |
597460089 | GWAS1556163_H | intraocular pressure measurement QTL GWAS1556163 (human) | | 7e-20 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597599355 | GWAS1656215_H | basophil measurement QTL GWAS1656215 (human) | | 7e-18 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597517424 | GWAS1613498_H | neuroimaging measurement QTL GWAS1613498 (human) | | 0.000001 | neuroimaging measurement | | 6 | 9176428 | 9176429 | Human |
597181545 | GWAS1277619_H | hemoglobin measurement QTL GWAS1277619 (human) | | 0.000001 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16278159 | 16278160 | Human |
597107822 | GWAS1203896_H | cortical surface area change measurement, age at assessment QTL GWAS1203896 (human) | | 0.000004 | cortical surface area change measurement, age at assessment | | 6 | 12897317 | 12897318 | Human |
597116010 | GWAS1212084_H | intraocular pressure measurement QTL GWAS1212084 (human) | | 7e-17 | intraocular pressure measurement | | 6 | 2053443 | 2053444 | Human |
597388187 | GWAS1484261_H | intelligence QTL GWAS1484261 (human) | | 1e-09 | intelligence | | 6 | 11508438 | 11508439 | Human |
597494687 | GWAS1590761_H | S-7-hydroxywarfarin measurement QTL GWAS1590761 (human) | | 0.000007 | S-7-hydroxywarfarin measurement | | 6 | 2352199 | 2352200 | Human |
597388189 | GWAS1484263_H | intelligence QTL GWAS1484263 (human) | | 3e-09 | intelligence | | 6 | 16952668 | 16952669 | Human |
597388188 | GWAS1484262_H | intelligence QTL GWAS1484262 (human) | | 5e-09 | intelligence | | 6 | 16972744 | 16972745 | Human |
597363603 | GWAS1459677_H | acute myeloid leukemia QTL GWAS1459677 (human) | | 0.0000007 | leukocyte integrity trait (VT:0010898) | | 6 | 10129325 | 10129326 | Human |
597363602 | GWAS1459676_H | acute myeloid leukemia QTL GWAS1459676 (human) | | 0.0000006 | leukocyte integrity trait (VT:0010898) | | 6 | 8112971 | 8112972 | Human |
597363601 | GWAS1459675_H | acute myeloid leukemia QTL GWAS1459675 (human) | | 0.000008 | leukocyte integrity trait (VT:0010898) | | 6 | 18003257 | 18003258 | Human |
597363600 | GWAS1459674_H | acute myeloid leukemia QTL GWAS1459674 (human) | | 0.0000006 | leukocyte integrity trait (VT:0010898) | | 6 | 17699091 | 17699092 | Human |
597232527 | GWAS1328601_H | coronary artery disease QTL GWAS1328601 (human) | | 0.000008 | coronary artery disease | | 6 | 6197255 | 6197256 | Human |
597461899 | GWAS1557973_H | rheumatoid arthritis QTL GWAS1557973 (human) | | 0.000007 | rheumatoid arthritis | | 6 | 14102981 | 14102982 | Human |
597044104 | GWAS1140178_H | Corneal astigmatism QTL GWAS1140178 (human) | | 0.000003 | Corneal astigmatism | | 6 | 15681477 | 15681478 | Human |
597035958 | GWAS1132032_H | glaucoma QTL GWAS1132032 (human) | | 4e-21 | glaucoma | | 6 | 1983206 | 1983207 | Human |
597019571 | GWAS1115645_H | idiopathic dilated cardiomyopathy QTL GWAS1115645 (human) | | 0.000009 | idiopathic dilated cardiomyopathy | | 6 | 12928618 | 12928619 | Human |
597330877 | GWAS1426951_H | basal cell carcinoma QTL GWAS1426951 (human) | | 2e-09 | basal cell carcinoma | | 6 | 402905 | 402906 | Human |
596962237 | GWAS1081756_H | multiple myeloma QTL GWAS1081756 (human) | | 7e-08 | multiple myeloma | | 6 | 15216294 | 15216295 | Human |
597380016 | GWAS1476090_H | quinolinic acid measurement QTL GWAS1476090 (human) | | 0.000003 | quinolinic acid measurement | | 6 | 18554137 | 18554138 | Human |
596978617 | GWAS1098136_H | Red cell distribution width QTL GWAS1098136 (human) | | 6e-24 | Red cell distribution width | | 6 | 16290617 | 16290620 | Human |
596978616 | GWAS1098135_H | Red cell distribution width QTL GWAS1098135 (human) | | 5e-15 | Red cell distribution width | | 6 | 16285830 | 16285831 | Human |
597355447 | GWAS1451521_H | information processing speed QTL GWAS1451521 (human) | | 0.0000005 | information processing speed | | 6 | 18991328 | 18991329 | Human |
596962235 | GWAS1081754_H | multiple myeloma QTL GWAS1081754 (human) | | 2e-08 | multiple myeloma | | 6 | 408079 | 408080 | Human |
597019578 | GWAS1115652_H | smoking status measurement, diastolic blood pressure QTL GWAS1115652 (human) | | 3e-08 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 9445767 | 9445768 | Human |
407007341 | GWAS656317_H | intelligence QTL GWAS656317 (human) | | 0.0000008 | intelligence | | 6 | 13942600 | 13942601 | Human |
597199787 | GWAS1295861_H | pregnancy disorder QTL GWAS1295861 (human) | | 0.000007 | pregnancy disorder | | 6 | 16284917 | 16284918 | Human |
597330862 | GWAS1426936_H | basal cell carcinoma QTL GWAS1426936 (human) | | 1e-10 | basal cell carcinoma | | 6 | 386636 | 386637 | Human |
597076898 | GWAS1172972_H | prostate carcinoma QTL GWAS1172972 (human) | | 0.000009 | prostate carcinoma | | 6 | 4905041 | 4905042 | Human |
597257133 | GWAS1353207_H | blood protein measurement QTL GWAS1353207 (human) | | 5e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 16700602 | 16700603 | Human |
597257132 | GWAS1353206_H | blood protein measurement QTL GWAS1353206 (human) | | 3e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 228345 | 228346 | Human |
406958083 | GWAS607059_H | cup-to-disc ratio measurement QTL GWAS607059 (human) | | 2e-08 | calcium measurement | blood calcium level (CMO:0000502) | 6 | 7205563 | 7205564 | Human |
406958084 | GWAS607060_H | cup-to-disc ratio measurement QTL GWAS607060 (human) | | 2e-10 | cup-to-disc ratio measurement | | 6 | 7205563 | 7205564 | Human |
597240799 | GWAS1336873_H | left atrial function QTL GWAS1336873 (human) | | 4e-08 | left atrial function | | 6 | 7573222 | 7573223 | Human |
597330896 | GWAS1426970_H | Tinnitus QTL GWAS1426970 (human) | | 0.0000001 | Tinnitus | | 6 | 12995269 | 12995270 | Human |
597371862 | GWAS1467936_H | coronary artery disease QTL GWAS1467936 (human) | | 6e-12 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597371861 | GWAS1467935_H | coronary artery disease QTL GWAS1467935 (human) | | 0.0000004 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597371860 | GWAS1467934_H | coronary artery disease QTL GWAS1467934 (human) | | 8e-10 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597240776 | GWAS1336850_H | type 2 diabetes mellitus QTL GWAS1336850 (human) | | 7e-14 | type 2 diabetes mellitus | | 6 | 7240344 | 7240345 | Human |
407384091 | GWAS1033067_H | lymphocyte count QTL GWAS1033067 (human) | | 1e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 10534578 | 10534579 | Human |
597027777 | GWAS1123851_H | waist-hip ratio QTL GWAS1123851 (human) | | 3e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 15230512 | 15230513 | Human |
597609416 | GWAS1666276_H | monocyte count QTL GWAS1666276 (human) | | 4e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7127843 | 7127844 | Human |
597609417 | GWAS1666277_H | monocyte count QTL GWAS1666277 (human) | | 2e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10535358 | 10535359 | Human |
597453761 | GWAS1549835_H | cataract QTL GWAS1549835 (human) | | 1e-08 | cataract | | 6 | 14471294 | 14471295 | Human |
597134280 | GWAS1230354_H | memory performance, sex interaction measurement QTL GWAS1230354 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 529104 | 529105 | Human |
597085129 | GWAS1181203_H | type 2 diabetes mellitus QTL GWAS1181203 (human) | | 5e-31 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597609471 | GWAS1666331_H | magnesium measurement QTL GWAS1666331 (human) | | 3e-12 | magnesium measurement | serum magnesium level (CMO:0000541) | 6 | 7085279 | 7085280 | Human |
597068787 | GWAS1164861_H | susceptibility to rubella infection measurement QTL GWAS1164861 (human) | | 0.000006 | susceptibility to rubella infection measurement | | 6 | 18117375 | 18117376 | Human |
597224446 | GWAS1320520_H | aspartate aminotransferase measurement QTL GWAS1320520 (human) | | 3e-09 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 6 | 16758194 | 16758195 | Human |
597224432 | GWAS1320506_H | BMI-adjusted waist circumference QTL GWAS1320506 (human) | | 5e-10 | body size trait (VT:0100005) | | 6 | 1775480 | 1775481 | Human |
597224433 | GWAS1320507_H | BMI-adjusted waist circumference QTL GWAS1320507 (human) | | 6e-13 | body size trait (VT:0100005) | | 6 | 7727979 | 7727980 | Human |
597224434 | GWAS1320508_H | BMI-adjusted waist circumference QTL GWAS1320508 (human) | | 7e-13 | body size trait (VT:0100005) | | 6 | 7695565 | 7695566 | Human |
597363702 | GWAS1459776_H | acute myeloid leukemia QTL GWAS1459776 (human) | | 6e-18 | leukocyte integrity trait (VT:0010898) | | 6 | 10316748 | 10316749 | Human |
597289975 | GWAS1386049_H | phospholipids in small LDL measurement QTL GWAS1386049 (human) | | 1e-12 | blood LDL phospholipid amount (VT:0010505) | | 6 | 16126442 | 16126443 | Human |
406966320 | GWAS615296_H | mitochondrial DNA measurement QTL GWAS615296 (human) | | 0.000002 | mitochondrial DNA measurement | | 6 | 17422305 | 17422306 | Human |
406974517 | GWAS623493_H | neutrophil count QTL GWAS623493 (human) | | 2e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16744456 | 16744457 | Human |
406974516 | GWAS623492_H | neutrophil count QTL GWAS623492 (human) | | 3e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7211518 | 7211519 | Human |
597511142 | GWAS1607216_H | COVID-19 QTL GWAS1607216 (human) | | 0.000007 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
597363481 | GWAS1459555_H | acute myeloid leukemia QTL GWAS1459555 (human) | | 8e-08 | leukocyte integrity trait (VT:0010898) | | 6 | 6994155 | 6994156 | Human |
597363480 | GWAS1459554_H | acute myeloid leukemia QTL GWAS1459554 (human) | | 1e-09 | leukocyte integrity trait (VT:0010898) | | 6 | 6994155 | 6994156 | Human |
596978449 | GWAS1097968_H | ulcerative colitis QTL GWAS1097968 (human) | | 6e-09 | ulcerative colitis | | 6 | 14719265 | 14719266 | Human |
597191454 | GWAS1287528_H | anthropometric measurement QTL GWAS1287528 (human) | | 1e-08 | anthropometric measurement | body morphological measurement (CMO:0000021) | 6 | 2130540 | 2130541 | Human |
597101340 | GWAS1197414_H | low density lipoprotein cholesterol measurement QTL GWAS1197414 (human) | | 5e-18 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11868281 | 11868282 | Human |
597363479 | GWAS1459553_H | acute myeloid leukemia QTL GWAS1459553 (human) | | 7e-12 | leukocyte integrity trait (VT:0010898) | | 6 | 12951808 | 12951809 | Human |
597437203 | GWAS1533277_H | systemic lupus erythematosus QTL GWAS1533277 (human) | | 8e-08 | systemic lupus erythematosus | | 6 | 14715651 | 14715652 | Human |
597297935 | GWAS1394009_H | phosphatidylethanolamine measurement QTL GWAS1394009 (human) | | 9e-12 | phosphatidylethanolamine measurement | | 6 | 11038278 | 11038279 | Human |
597093133 | GWAS1189207_H | circadian rhythm QTL GWAS1189207 (human) | | 2e-08 | circadian rhythm | | 6 | 13170402 | 13170403 | Human |
597125943 | GWAS1222017_H | diacylglycerol 38:5 measurement QTL GWAS1222017 (human) | | 2e-11 | diacylglycerol 38:5 measurement | | 6 | 10982126 | 10982127 | Human |
597396285 | GWAS1492359_H | memory performance QTL GWAS1492359 (human) | | 0.000008 | memory performance | | 6 | 2297549 | 2297550 | Human |
407302383 | GWAS951359_H | unipolar depression QTL GWAS951359 (human) | | 0.000003 | unipolar depression | | 6 | 2518145 | 2518146 | Human |
407179503 | GWAS828479_H | cognitive function measurement QTL GWAS828479 (human) | | 0.000005 | cognitive behavior trait (VT:0010450) | | 6 | 11825215 | 11825216 | Human |
597592885 | GWAS1649745_H | platelet count QTL GWAS1649745 (human) | | 2e-23 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597404470 | GWAS1500544_H | coronary artery disease QTL GWAS1500544 (human) | | 2e-42 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597125945 | GWAS1222019_H | diacylglycerol 38:5 measurement QTL GWAS1222019 (human) | | 3e-11 | diacylglycerol 38:5 measurement | | 6 | 11042676 | 11042677 | Human |
597297973 | GWAS1394047_H | phosphatidylcholine measurement QTL GWAS1394047 (human) | | 2e-10 | phosphatidylcholine measurement | | 6 | 11005453 | 11005454 | Human |
597125944 | GWAS1222018_H | diacylglycerol 38:5 measurement QTL GWAS1222018 (human) | | 6e-11 | diacylglycerol 38:5 measurement | | 6 | 11040190 | 11040191 | Human |
597478191 | GWAS1574265_H | Strabismus QTL GWAS1574265 (human) | | 7e-08 | Strabismus | | 6 | 18594472 | 18594473 | Human |
407302384 | GWAS951360_H | unipolar depression QTL GWAS951360 (human) | | 0.000003 | unipolar depression | | 6 | 2518745 | 2518746 | Human |
597027618 | GWAS1123692_H | systolic blood pressure QTL GWAS1123692 (human) | | 0.000008 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 5108885 | 5108886 | Human |
597601065 | GWAS1657925_H | body mass index QTL GWAS1657925 (human) | | 9e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12100869 | 12100870 | Human |
597592908 | GWAS1649768_H | platelet count QTL GWAS1649768 (human) | | 2e-30 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597240651 | GWAS1336725_H | aging QTL GWAS1336725 (human) | | 7e-23 | aging | | 6 | 18123999 | 18124000 | Human |
407277717 | GWAS926693_H | hair color QTL GWAS926693 (human) | | 8e-22 | hair color | | 6 | 485078 | 485079 | Human |
597322572 | GWAS1418646_H | cup-to-disc ratio measurement QTL GWAS1418646 (human) | | 2e-22 | cup-to-disc ratio measurement | | 6 | 1983206 | 1983207 | Human |
597347139 | GWAS1443213_H | drug use measurement QTL GWAS1443213 (human) | | 3e-08 | drug use measurement | | 6 | 7238342 | 7238343 | Human |
597166913 | GWAS1262987_H | aspartate aminotransferase measurement QTL GWAS1262987 (human) | | 2e-10 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 6 | 16755537 | 16755538 | Human |
407163038 | GWAS812014_H | urate measurement QTL GWAS812014 (human) | | 0.000006 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 6592816 | 6592817 | Human |
597420865 | GWAS1516939_H | cognitive function measurement QTL GWAS1516939 (human) | | 4e-09 | cognitive behavior trait (VT:0010450) | | 6 | 11481764 | 11481765 | Human |
597273411 | GWAS1369485_H | high density lipoprotein cholesterol measurement QTL GWAS1369485 (human) | | 5e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 16818574 | 16818575 | Human |
597371712 | GWAS1467786_H | calcium measurement QTL GWAS1467786 (human) | | 0.000007 | calcium measurement | blood calcium level (CMO:0000502) | 6 | 10163735 | 10163736 | Human |
597035848 | GWAS1131922_H | low density lipoprotein cholesterol measurement QTL GWAS1131922 (human) | | 5e-25 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597437251 | GWAS1533325_H | aortic measurement QTL GWAS1533325 (human) | | 6e-09 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12544440 | 12544441 | Human |
597494655 | GWAS1590729_H | R-warfarin measurement QTL GWAS1590729 (human) | | 0.0000001 | R-warfarin measurement | | 6 | 2278148 | 2278149 | Human |
597109619 | GWAS1205693_H | central nervous system non-hodgkin lymphoma QTL GWAS1205693 (human) | | 2e-13 | central nervous system non-hodgkin lymphoma | | 6 | 484453 | 484454 | Human |
597068656 | GWAS1164730_H | lung adenocarcinoma QTL GWAS1164730 (human) | | 0.0000001 | lung adenocarcinoma | | 6 | 410848 | 410849 | Human |
597609334 | GWAS1666194_H | monocyte count QTL GWAS1666194 (human) | | 4e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 12052033 | 12052034 | Human |
597363568 | GWAS1459642_H | BMI-adjusted waist-hip ratio QTL GWAS1459642 (human) | | 1e-68 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597609330 | GWAS1666190_H | family history of cancer QTL GWAS1666190 (human) | | 3e-31 | family history of cancer | | 6 | 396321 | 396322 | Human |
597519217 | GWAS1615291_H | intelligence QTL GWAS1615291 (human) | | 4e-08 | intelligence | | 6 | 11589317 | 11589318 | Human |
597093218 | GWAS1189292_H | inflammatory bowel disease QTL GWAS1189292 (human) | | 6e-09 | inflammatory bowel disease | | 6 | 382559 | 382560 | Human |
597044064 | GWAS1140138_H | Corneal astigmatism QTL GWAS1140138 (human) | | 0.000004 | Corneal astigmatism | | 6 | 15681477 | 15681478 | Human |
597494629 | GWAS1590703_H | smoking initiation QTL GWAS1590703 (human) | | 4e-13 | smoking initiation | | 6 | 8631618 | 8631619 | Human |
597494628 | GWAS1590702_H | smoking initiation QTL GWAS1590702 (human) | | 1e-11 | smoking initiation | | 6 | 4340570 | 4340571 | Human |
597494631 | GWAS1590705_H | smoking initiation QTL GWAS1590705 (human) | | 6e-12 | smoking initiation | | 6 | 19167765 | 19167766 | Human |
597494630 | GWAS1590704_H | smoking initiation QTL GWAS1590704 (human) | | 3e-09 | smoking initiation | | 6 | 17264750 | 17264751 | Human |
406900927 | GWAS549903_H | lumbar disc degeneration QTL GWAS549903 (human) | | 0.000006 | lumbar disc degeneration | | 6 | 11943293 | 11943294 | Human |
597404315 | GWAS1500389_H | alopecia QTL GWAS1500389 (human) | | 3e-08 | alopecia | | 6 | 9389079 | 9389080 | Human |
597248667 | GWAS1344741_H | serum alanine aminotransferase measurement QTL GWAS1344741 (human) | | 3e-09 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 15502840 | 15502841 | Human |
597453470 | GWAS1549544_H | total cholesterol measurement QTL GWAS1549544 (human) | | 1e-25 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597076629 | GWAS1172703_H | FEV change measurement, response to bronchodilator QTL GWAS1172703 (human) | | 0.0000005 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 6 | 10980406 | 10980407 | Human |
597617307 | GWAS1674167_H | stomach disease QTL GWAS1674167 (human) | | 2e-12 | stomach disease | | 6 | 16761550 | 16761551 | Human |
597404317 | GWAS1500391_H | alopecia QTL GWAS1500391 (human) | | 4e-08 | alopecia | | 6 | 9000190 | 9000191 | Human |
597240469 | GWAS1336543_H | aging QTL GWAS1336543 (human) | | 5e-32 | aging | | 6 | 18122275 | 18122276 | Human |
597396118 | GWAS1492192_H | retinal vasculature measurement QTL GWAS1492192 (human) | | 1e-27 | retina blood vessel morphology trait (VT:0002792) | | 6 | 1385579 | 1385580 | Human |
597240468 | GWAS1336542_H | aging QTL GWAS1336542 (human) | | 4e-54 | aging | | 6 | 18120798 | 18120799 | Human |
597518995 | GWAS1615069_H | apolipoprotein C measurement QTL GWAS1615069 (human) | | 0.0000008 | apolipoprotein C measurement | | 6 | 12367989 | 12367990 | Human |
597076633 | GWAS1172707_H | FEV change measurement, response to bronchodilator QTL GWAS1172707 (human) | | 0.0000005 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 6 | 10961221 | 10961222 | Human |
597060230 | GWAS1156304_H | FEV/FVC ratio QTL GWAS1156304 (human) | | 2e-13 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7958232 | 7958233 | Human |
597166728 | GWAS1262802_H | body mass index QTL GWAS1262802 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 10554377 | 10554378 | Human |
597060231 | GWAS1156305_H | FEV/FVC ratio QTL GWAS1156305 (human) | | 2e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 17912846 | 17912847 | Human |
597060228 | GWAS1156302_H | FEV/FVC ratio QTL GWAS1156302 (human) | | 5e-41 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7146117 | 7146118 | Human |
597060229 | GWAS1156303_H | FEV/FVC ratio QTL GWAS1156303 (human) | | 1e-23 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7562999 | 7563000 | Human |
597166731 | GWAS1262805_H | body mass index QTL GWAS1262805 (human) | | 5e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12086593 | 12086594 | Human |
597060226 | GWAS1156300_H | FEV/FVC ratio QTL GWAS1156300 (human) | | 1e-09 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 684034 | 684035 | Human |
597060227 | GWAS1156301_H | FEV/FVC ratio QTL GWAS1156301 (human) | | 3e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 1771278 | 1771279 | Human |
597207693 | GWAS1303767_H | Diuretic use measurement QTL GWAS1303767 (human) | | 4e-08 | Diuretic use measurement | | 6 | 1901153 | 1901154 | Human |
597420686 | GWAS1516760_H | neuroticism measurement QTL GWAS1516760 (human) | | 3e-09 | neuroticism measurement | | 6 | 3961054 | 3961055 | Human |
597379726 | GWAS1475800_H | phosphatidylcholine 38:4 measurement QTL GWAS1475800 (human) | | 0.000003 | glycerophosphocholine amount (VT:0011004) | | 6 | 16954373 | 16954374 | Human |
597076620 | GWAS1172694_H | FEV change measurement, response to bronchodilator QTL GWAS1172694 (human) | | 0.0000003 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 6 | 10971653 | 10971654 | Human |
597338753 | GWAS1434827_H | puberty onset measurement QTL GWAS1434827 (human) | | 5e-29 | puberty onset measurement | | 6 | 396321 | 396322 | Human |
597461633 | GWAS1557707_H | rheumatoid arthritis QTL GWAS1557707 (human) | | 0.0000002 | rheumatoid arthritis | | 6 | 14102981 | 14102982 | Human |
597355194 | GWAS1451268_H | microsatellite instability measurement, colorectal cancer, overall survival QTL GWAS1451268 (human) | | 0.000005 | microsatellite instability measurement, colorectal cancer, overall survival | | 6 | 6786192 | 6786193 | Human |
597035703 | GWAS1131777_H | glaucoma QTL GWAS1131777 (human) | | 1e-09 | glaucoma | | 6 | 606263 | 606264 | Human |
597371578 | GWAS1467652_H | intelligence QTL GWAS1467652 (human) | | 9e-08 | intelligence | | 6 | 11484900 | 11484901 | Human |
407384428 | GWAS1033404_H | chronic obstructive pulmonary disease QTL GWAS1033404 (human) | | 0.000006 | lung integrity trait (VT:0010906) | | 6 | 7718832 | 7718833 | Human |
597027507 | GWAS1123581_H | mean arterial pressure QTL GWAS1123581 (human) | | 2e-08 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 6 | 1620807 | 1620808 | Human |
597609145 | GWAS1666005_H | hearing loss QTL GWAS1666005 (human) | | 6e-18 | hearing loss | | 6 | 7109200 | 7109201 | Human |
597035708 | GWAS1131782_H | intraocular pressure measurement QTL GWAS1131782 (human) | | 5e-11 | intraocular pressure measurement | | 6 | 606263 | 606264 | Human |
406966635 | GWAS615611_H | hepcidin:ferritin ratio QTL GWAS615611 (human) | | 0.000008 | hepcidin:ferritin ratio | | 6 | 1457494 | 1457495 | Human |
597068477 | GWAS1164551_H | antiphospholipid syndrome QTL GWAS1164551 (human) | | 0.000002 | antiphospholipid syndrome | | 6 | 10924010 | 10924011 | Human |
596978361 | GWAS1097880_H | Red cell distribution width QTL GWAS1097880 (human) | | 2e-08 | Red cell distribution width | | 6 | 3369739 | 3369740 | Human |
597469868 | GWAS1565942_H | ovarian carcinoma QTL GWAS1565942 (human) | | 9e-09 | ovarian carcinoma | | 6 | 3580855 | 3580856 | Human |
597363371 | GWAS1459445_H | acute myeloid leukemia QTL GWAS1459445 (human) | | 0.000008 | leukocyte integrity trait (VT:0010898) | | 6 | 4626063 | 4626064 | Human |
597363370 | GWAS1459444_H | acute myeloid leukemia QTL GWAS1459444 (human) | | 8e-17 | leukocyte integrity trait (VT:0010898) | | 6 | 2855958 | 2855959 | Human |
597469869 | GWAS1565943_H | ovarian carcinoma QTL GWAS1565943 (human) | | 4e-08 | ovarian carcinoma | | 6 | 3580855 | 3580856 | Human |
597117606 | GWAS1213680_H | uric acid measurement QTL GWAS1213680 (human) | | 6e-24 | uric acid measurement | blood uric acid level (CMO:0000501) | 6 | 7101851 | 7101852 | Human |
597363369 | GWAS1459443_H | acute myeloid leukemia QTL GWAS1459443 (human) | | 8e-19 | leukocyte integrity trait (VT:0010898) | | 6 | 2855958 | 2855959 | Human |
597052068 | GWAS1148142_H | hematocrit QTL GWAS1148142 (human) | | 1e-13 | hematocrit | hematocrit (CMO:0000037) | 6 | 13918230 | 13918231 | Human |
597363368 | GWAS1459442_H | acute myeloid leukemia QTL GWAS1459442 (human) | | 7e-13 | leukocyte integrity trait (VT:0010898) | | 6 | 1028554 | 1028555 | Human |
597052067 | GWAS1148141_H | hematocrit QTL GWAS1148141 (human) | | 1e-44 | hematocrit | hematocrit (CMO:0000037) | 6 | 2050557 | 2050558 | Human |
407384447 | GWAS1033423_H | forced expiratory volume QTL GWAS1033423 (human) | | 1e-19 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 6 | 7719826 | 7719827 | Human |
597363367 | GWAS1459441_H | acute myeloid leukemia QTL GWAS1459441 (human) | | 1e-25 | leukocyte integrity trait (VT:0010898) | | 6 | 1028554 | 1028555 | Human |
597068458 | GWAS1164532_H | antiphospholipid syndrome QTL GWAS1164532 (human) | | 0.000001 | antiphospholipid syndrome | | 6 | 10918280 | 10918281 | Human |
597363366 | GWAS1459440_H | acute myeloid leukemia QTL GWAS1459440 (human) | | 2e-12 | leukocyte integrity trait (VT:0010898) | | 6 | 12951808 | 12951809 | Human |
597158568 | GWAS1254642_H | apolipoprotein B measurement QTL GWAS1254642 (human) | | 4e-09 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16134016 | 16134017 | Human |
406917387 | GWAS566363_H | balding measurement QTL GWAS566363 (human) | | 8e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 1408532 | 1408533 | Human |
597166803 | GWAS1262877_H | Periodontal Pocket QTL GWAS1262877 (human) | | 0.000001 | Periodontal Pocket | | 6 | 7452276 | 7452279 | Human |
597494483 | GWAS1590557_H | level of serpin B6 in blood serum QTL GWAS1590557 (human) | | 1e-16 | level of serpin B6 in blood serum | | 6 | 2973872 | 2973873 | Human |
597355208 | GWAS1451282_H | waist-hip ratio QTL GWAS1451282 (human) | | 8e-13 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
597404366 | GWAS1500440_H | vital capacity QTL GWAS1500440 (human) | | 2e-12 | vital capacity | | 6 | 2500586 | 2500587 | Human |
597355203 | GWAS1451277_H | disease free survival, rectum cancer QTL GWAS1451277 (human) | | 0.000005 | disease free survival, rectum cancer | | 6 | 3294794 | 3294795 | Human |
597289664 | GWAS1385738_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1385738 (human) | | 9e-15 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597355200 | GWAS1451274_H | rectum cancer, overall survival QTL GWAS1451274 (human) | | 0.000004 | rectum cancer, overall survival | | 6 | 6786192 | 6786193 | Human |
597256898 | GWAS1352972_H | urate measurement QTL GWAS1352972 (human) | | 2e-16 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7167790 | 7167791 | Human |
597297862 | GWAS1393936_H | waist-hip ratio QTL GWAS1393936 (human) | | 7e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
596978377 | GWAS1097896_H | body height QTL GWAS1097896 (human) | | 6e-11 | body height | | 6 | 7881698 | 7881699 | Human |
597027529 | GWAS1123603_H | low density lipoprotein cholesterol measurement QTL GWAS1123603 (human) | | 1e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597289668 | GWAS1385742_H | Crohn's disease QTL GWAS1385742 (human) | | 0.000004 | intestine integrity trait (VT:0010554) | | 6 | 3433084 | 3433085 | Human |
597609155 | GWAS1666015_H | heart disease QTL GWAS1666015 (human) | | 5e-73 | heart disease | | 6 | 12903725 | 12903726 | Human |
597076681 | GWAS1172755_H | FEV change measurement, response to bronchodilator QTL GWAS1172755 (human) | | 0.0000008 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 6 | 10980406 | 10980407 | Human |
597527293 | GWAS1623367_H | non-alcoholic fatty liver disease, type 2 diabetes mellitus QTL GWAS1623367 (human) | | 6e-10 | non-alcoholic fatty liver disease, type 2 diabetes mellitus | | 6 | 11403257 | 11403258 | Human |
597437179 | GWAS1533253_H | glaucoma QTL GWAS1533253 (human) | | 4e-19 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597215984 | GWAS1312058_H | pulse pressure measurement QTL GWAS1312058 (human) | | 0.000005 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7967713 | 7967714 | Human |
597215985 | GWAS1312059_H | pulse pressure measurement QTL GWAS1312059 (human) | | 3e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7993744 | 7993745 | Human |
597584631 | GWAS1641491_H | mean corpuscular hemoglobin concentration QTL GWAS1641491 (human) | | 7e-71 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597584628 | GWAS1641488_H | mean corpuscular hemoglobin concentration QTL GWAS1641488 (human) | | 4e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 10723216 | 10723217 | Human |
597215986 | GWAS1312060_H | pulse pressure measurement QTL GWAS1312060 (human) | | 2e-13 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12295754 | 12295755 | Human |
407048489 | GWAS697465_H | xanthosine measurement QTL GWAS697465 (human) | | 3e-14 | xanthosine measurement | | 6 | 16269132 | 16269133 | Human |
597215987 | GWAS1312061_H | pulse pressure measurement QTL GWAS1312061 (human) | | 0.0000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12445615 | 12445616 | Human |
597584629 | GWAS1641489_H | mean corpuscular hemoglobin concentration QTL GWAS1641489 (human) | | 3e-23 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 15099354 | 15099355 | Human |
597215988 | GWAS1312062_H | pulse pressure measurement QTL GWAS1312062 (human) | | 2e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 19028392 | 19028393 | Human |
597322484 | GWAS1418558_H | level of thioredoxin domain-containing protein 5 in blood serum QTL GWAS1418558 (human) | | 3e-12 | level of thioredoxin domain-containing protein 5 in blood serum | | 6 | 7881919 | 7881920 | Human |
597502701 | GWAS1598775_H | information processing speed, response to cranial radiation therapy QTL GWAS1598775 (human) | | 0.0000004 | information processing speed, response to cranial radiation therapy | | 6 | 5095798 | 5095799 | Human |
597388011 | GWAS1484085_H | congenital left-sided heart lesions QTL GWAS1484085 (human) | | 2e-08 | congenital left-sided heart lesions | | 6 | 9291650 | 9291651 | Human |
597215979 | GWAS1312053_H | pulse pressure measurement QTL GWAS1312053 (human) | | 5e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 1648798 | 1648799 | Human |
597215980 | GWAS1312054_H | pulse pressure measurement QTL GWAS1312054 (human) | | 7e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 2003456 | 2003457 | Human |
597215981 | GWAS1312055_H | pulse pressure measurement QTL GWAS1312055 (human) | | 4e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 6996928 | 6996929 | Human |
597215982 | GWAS1312056_H | pulse pressure measurement QTL GWAS1312056 (human) | | 8e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7247111 | 7247112 | Human |
597027555 | GWAS1123629_H | low density lipoprotein cholesterol measurement QTL GWAS1123629 (human) | | 4e-15 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597396204 | GWAS1492278_H | cup-to-disc ratio measurement QTL GWAS1492278 (human) | | 2e-13 | cup-to-disc ratio measurement | | 6 | 1548134 | 1548135 | Human |
597215983 | GWAS1312057_H | pulse pressure measurement QTL GWAS1312057 (human) | | 3e-21 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7723729 | 7723730 | Human |
597355234 | GWAS1451308_H | cervical artery dissection QTL GWAS1451308 (human) | | 1e-11 | alcohol consumption measurement | | 6 | 12903725 | 12903726 | Human |
597510880 | GWAS1606954_H | level of thioredoxin domain-containing protein 5 in blood serum QTL GWAS1606954 (human) | | 8e-20 | level of thioredoxin domain-containing protein 5 in blood serum | | 6 | 7883235 | 7883236 | Human |
597330660 | GWAS1426734_H | Tinnitus QTL GWAS1426734 (human) | | 2e-08 | Tinnitus | | 6 | 6595791 | 6595792 | Human |
597240550 | GWAS1336624_H | retinal vasculature measurement QTL GWAS1336624 (human) | | 3e-08 | retina blood vessel morphology trait (VT:0002792) | | 6 | 396321 | 396322 | Human |
597043741 | GWAS1139815_H | Lewy body dementia QTL GWAS1139815 (human) | | 0.000003 | Lewy body dementia | | 6 | 5377247 | 5377248 | Human |
597043738 | GWAS1139812_H | idiopathic pulmonary fibrosis QTL GWAS1139812 (human) | | 3e-30 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597068314 | GWAS1164388_H | age at menopause QTL GWAS1164388 (human) | | 4e-13 | age at menopause | | 6 | 10951504 | 10951505 | Human |
597068313 | GWAS1164387_H | age at menopause QTL GWAS1164387 (human) | | 2e-19 | age at menopause | | 6 | 10895027 | 10895028 | Human |
597494285 | GWAS1590359_H | R-warfarin measurement QTL GWAS1590359 (human) | | 0.0000009 | R-warfarin measurement | | 6 | 16924493 | 16924494 | Human |
597371402 | GWAS1467476_H | HVA measurement, MHPG measurement QTL GWAS1467476 (human) | | 0.000002 | HVA measurement, MHPG measurement | | 6 | 14597751 | 14597752 | Human |
597371401 | GWAS1467475_H | HVA measurement, MHPG measurement QTL GWAS1467475 (human) | | 0.000008 | HVA measurement, MHPG measurement | | 6 | 1524335 | 1524336 | Human |
597494287 | GWAS1590361_H | R-warfarin measurement QTL GWAS1590361 (human) | | 4e-08 | R-warfarin measurement | | 6 | 2380057 | 2380058 | Human |
407400916 | GWAS1049892_H | unipolar depression QTL GWAS1049892 (human) | | 7e-12 | unipolar depression | | 6 | 17028442 | 17028443 | Human |
597027336 | GWAS1123410_H | diabetic retinopathy QTL GWAS1123410 (human) | | 0.0000001 | diabetic retinopathy | | 6 | 9368285 | 9368286 | Human |
597486081 | GWAS1582155_H | lysophosphatidylcholine 22:5 measurement QTL GWAS1582155 (human) | | 3e-13 | lysophosphatidylcholine 22:5 measurement | | 6 | 11061917 | 11061918 | Human |
597600828 | GWAS1657688_H | pyruvate measurement QTL GWAS1657688 (human) | | 0.000007 | pyruvate measurement | blood pyruvate level (CMO:0002422) | 6 | 4040114 | 4040115 | Human |
597428791 | GWAS1524865_H | protein measurement QTL GWAS1524865 (human) | | 2e-32 | protein measurement | | 6 | 3009869 | 3009870 | Human |
597289524 | GWAS1385598_H | sphingomyelin measurement QTL GWAS1385598 (human) | | 3e-10 | sphingomyelin measurement | | 6 | 16130925 | 16130926 | Human |
597092921 | GWAS1188995_H | inflammatory bowel disease QTL GWAS1188995 (human) | | 0.000001 | inflammatory bowel disease | | 6 | 3420172 | 3420173 | Human |
597494317 | GWAS1590391_H | S-7-hydroxywarfarin measurement QTL GWAS1590391 (human) | | 0.000001 | S-7-hydroxywarfarin measurement | | 6 | 2416795 | 2416796 | Human |
597469741 | GWAS1565815_H | fish consumption measurement QTL GWAS1565815 (human) | | 0.000004 | fish consumption measurement | | 6 | 2437997 | 2437998 | Human |
597436971 | GWAS1533045_H | aortic measurement QTL GWAS1533045 (human) | | 3e-08 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12544440 | 12544441 | Human |
597142063 | GWAS1238137_H | HbA1c measurement QTL GWAS1238137 (human) | | 5e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
406942202 | GWAS591178_H | forced expiratory volume QTL GWAS591178 (human) | | 2e-24 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 6 | 7797607 | 7797608 | Human |
597477927 | GWAS1574001_H | protein measurement QTL GWAS1574001 (human) | | 3e-08 | protein measurement | | 6 | 8714082 | 8714083 | Human |
597510751 | GWAS1606825_H | BMI-adjusted hip circumference QTL GWAS1606825 (human) | | 2e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6738801 | 6738802 | Human |
596953687 | GWAS1073206_H | bone density QTL GWAS1073206 (human) | | 7e-09 | bone density | | 6 | 2492879 | 2492880 | Human |
407015809 | GWAS664785_H | unipolar depression QTL GWAS664785 (human) | | 0.000006 | unipolar depression | | 6 | 10175803 | 10175804 | Human |
596953692 | GWAS1073211_H | bone density QTL GWAS1073211 (human) | | 1e-09 | bone density | | 6 | 7058624 | 7058625 | Human |
597076574 | GWAS1172648_H | FEV change measurement, response to bronchodilator QTL GWAS1172648 (human) | | 0.0000001 | FEV change measurement, response to bronchodilator | respiratory system measurement (CMO:0000094) | 6 | 10961221 | 10961222 | Human |
597150302 | GWAS1246376_H | total cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1246376 (human) | | 4e-08 | total cholesterol measurement, low density lipoprotein cholesterol measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 6 | 16134016 | 16134017 | Human |
406942095 | GWAS591071_H | vital capacity QTL GWAS591071 (human) | | 8e-31 | vital capacity | | 6 | 7797607 | 7797608 | Human |
406942094 | GWAS591070_H | vital capacity QTL GWAS591070 (human) | | 2e-08 | vital capacity | | 6 | 7562999 | 7563000 | Human |
597404233 | GWAS1500307_H | sunburn QTL GWAS1500307 (human) | | 2e-08 | sunburn | | 6 | 1023608 | 1023609 | Human |
597584460 | GWAS1641320_H | mean corpuscular hemoglobin concentration QTL GWAS1641320 (human) | | 5e-23 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 15176027 | 15176028 | Human |
597207626 | GWAS1303700_H | grip strength measurement QTL GWAS1303700 (human) | | 8e-10 | grip strength measurement | | 6 | 15411834 | 15411835 | Human |
597404232 | GWAS1500306_H | sunburn QTL GWAS1500306 (human) | | 2e-09 | sunburn | | 6 | 720465 | 720466 | Human |
597363272 | GWAS1459346_H | Takotsubo cardiomyopathy QTL GWAS1459346 (human) | | 0.000005 | Takotsubo cardiomyopathy | | 6 | 6405398 | 6405399 | Human |
597584461 | GWAS1641321_H | mean corpuscular hemoglobin concentration QTL GWAS1641321 (human) | | 7e-80 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597510728 | GWAS1606802_H | small vessel stroke QTL GWAS1606802 (human) | | 7e-11 | small vessel stroke | | 6 | 1364631 | 1364632 | Human |
407024021 | GWAS672997_H | chronic lymphocytic leukemia QTL GWAS672997 (human) | | 2e-20 | leukocyte integrity trait (VT:0010898) | | 6 | 411064 | 411065 | Human |
597510727 | GWAS1606801_H | small vessel stroke QTL GWAS1606801 (human) | | 0.0000002 | small vessel stroke | | 6 | 1364631 | 1364632 | Human |
407146906 | GWAS795882_H | rheumatoid arthritis QTL GWAS795882 (human) | | 2e-10 | rheumatoid arthritis | | 6 | 426155 | 426156 | Human |
407146907 | GWAS795883_H | rheumatoid arthritis QTL GWAS795883 (human) | | 0.0000001 | rheumatoid arthritis | | 6 | 426155 | 426156 | Human |
597617278 | GWAS1674138_H | erythrocyte count QTL GWAS1674138 (human) | | 3e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16292483 | 16292484 | Human |
597617276 | GWAS1674136_H | erythrocyte count QTL GWAS1674136 (human) | | 5e-14 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7195451 | 7195452 | Human |
597617277 | GWAS1674137_H | erythrocyte count QTL GWAS1674137 (human) | | 5e-18 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176027 | 15176028 | Human |
597346942 | GWAS1443016_H | peak expiratory flow QTL GWAS1443016 (human) | | 2e-24 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 1775202 | 1775203 | Human |
597322366 | GWAS1418440_H | cup-to-disc ratio measurement QTL GWAS1418440 (human) | | 4e-24 | cup-to-disc ratio measurement | | 6 | 7205563 | 7205564 | Human |
597387902 | GWAS1483976_H | smoking status measurement, diastolic blood pressure QTL GWAS1483976 (human) | | 0.000006 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 11495815 | 11495816 | Human |
597305981 | GWAS1402055_H | vaginal microbiome measurement QTL GWAS1402055 (human) | | 0.000001 | vaginal microbiome measurement | | 6 | 11639102 | 11639103 | Human |
597338749 | GWAS1434823_H | puberty onset measurement QTL GWAS1434823 (human) | | 3e-11 | puberty onset measurement | | 6 | 19078043 | 19078044 | Human |
597322354 | GWAS1418428_H | cup-to-disc ratio measurement QTL GWAS1418428 (human) | | 8e-17 | cup-to-disc ratio measurement | | 6 | 619600 | 619601 | Human |
597248625 | GWAS1344699_H | neutrophil-to-lymphocyte ratio QTL GWAS1344699 (human) | | 5e-08 | neutrophil-to-lymphocyte ratio | | 6 | 12159466 | 12159467 | Human |
597502580 | GWAS1598654_H | diet measurement QTL GWAS1598654 (human) | | 8e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 4478244 | 4478245 | Human |
597510772 | GWAS1606846_H | COVID-19 QTL GWAS1606846 (human) | | 0.000009 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
597469809 | GWAS1565883_H | cognitive function measurement QTL GWAS1565883 (human) | | 3e-08 | cognitive behavior trait (VT:0010450) | | 6 | 11493601 | 11493602 | Human |
597076600 | GWAS1172674_H | multiple myeloma QTL GWAS1172674 (human) | | 1e-08 | multiple myeloma | | 6 | 15243787 | 15243788 | Human |
597060198 | GWAS1156272_H | vital capacity QTL GWAS1156272 (human) | | 5e-14 | vital capacity | | 6 | 7127843 | 7127844 | Human |
597060199 | GWAS1156273_H | vital capacity QTL GWAS1156273 (human) | | 5e-39 | vital capacity | | 6 | 7797607 | 7797608 | Human |
597060197 | GWAS1156271_H | vital capacity QTL GWAS1156271 (human) | | 1e-09 | vital capacity | | 6 | 2195682 | 2195683 | Human |
597142115 | GWAS1238189_H | Drugs used in diabetes use measurement QTL GWAS1238189 (human) | | 3e-16 | Drugs used in diabetes use measurement | | 6 | 7231610 | 7231611 | Human |
407024055 | GWAS673031_H | hair color QTL GWAS673031 (human) | | 7e-127 | hair color | | 6 | 396321 | 396322 | Human |
597052001 | GWAS1148075_H | intelligence QTL GWAS1148075 (human) | | 0.000002 | intelligence | | 6 | 15696206 | 15696207 | Human |
407024057 | GWAS673033_H | hair color QTL GWAS673033 (human) | | 6e-08 | hair color | | 6 | 542159 | 542160 | Human |
597510753 | GWAS1606827_H | BMI-adjusted hip circumference QTL GWAS1606827 (human) | | 2e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6782065 | 6782066 | Human |
407024063 | GWAS673039_H | hair color QTL GWAS673039 (human) | | 9e-28 | hair color | | 6 | 396321 | 396322 | Human |
597510752 | GWAS1606826_H | BMI-adjusted hip circumference QTL GWAS1606826 (human) | | 6e-14 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6740400 | 6740401 | Human |
597019240 | GWAS1115314_H | smoking status measurement, diastolic blood pressure QTL GWAS1115314 (human) | | 2e-11 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 9445767 | 9445768 | Human |
597281380 | GWAS1377454_H | QT interval QTL GWAS1377454 (human) | | 2e-39 | QT interval | QT interval (CMO:0000235) | 6 | 18209878 | 18209879 | Human |
407024060 | GWAS673036_H | hair color QTL GWAS673036 (human) | | 0.0000005 | hair color | | 6 | 542159 | 542160 | Human |
597437027 | GWAS1533101_H | myocardial infarction QTL GWAS1533101 (human) | | 4e-33 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597019029 | GWAS1115103_H | BMI-adjusted hip circumference QTL GWAS1115103 (human) | | 9e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 1775629 | 1775630 | Human |
597150102 | GWAS1246176_H | skin sensitivity to sun QTL GWAS1246176 (human) | | 8e-11 | skin sensitivity to sun | | 6 | 396321 | 396322 | Human |
597445019 | GWAS1541093_H | thioredoxin domain-containing protein 5 measurement QTL GWAS1541093 (human) | | 5e-27 | thioredoxin domain-containing protein 5 measurement | | 6 | 7883235 | 7883236 | Human |
597076358 | GWAS1172432_H | thiopurine methyltransferase activity measurement QTL GWAS1172432 (human) | | 1e-72 | thiopurine methyltransferase activity measurement | | 6 | 18102797 | 18102798 | Human |
406983251 | GWAS632227_H | hemoglobin measurement QTL GWAS632227 (human) | | 1e-33 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2050557 | 2050558 | Human |
597076359 | GWAS1172433_H | thiopurine methyltransferase activity measurement QTL GWAS1172433 (human) | | 5e-34 | thiopurine methyltransferase activity measurement | | 6 | 18267505 | 18267506 | Human |
597035396 | GWAS1131470_H | triglyceride measurement QTL GWAS1131470 (human) | | 4e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 18747474 | 18747475 | Human |
597076357 | GWAS1172431_H | thiopurine methyltransferase activity measurement QTL GWAS1172431 (human) | | 4e-12 | thiopurine methyltransferase activity measurement | | 6 | 17745784 | 17745785 | Human |
597404045 | GWAS1500119_H | alopecia QTL GWAS1500119 (human) | | 3e-08 | alopecia | | 6 | 9673728 | 9673729 | Human |
596978061 | GWAS1097580_H | body height QTL GWAS1097580 (human) | | 2e-10 | body height | | 6 | 6763213 | 6763214 | Human |
597608836 | GWAS1665696_H | Sensorineural hearing impairment QTL GWAS1665696 (human) | | 3e-16 | Sensorineural hearing impairment | | 6 | 7109200 | 7109201 | Human |
597199234 | GWAS1295308_H | memory performance QTL GWAS1295308 (human) | | 0.000004 | memory performance | | 6 | 11737176 | 11737177 | Human |
597371265 | GWAS1467339_H | spontaneous coronary artery dissection QTL GWAS1467339 (human) | | 5e-14 | coronary artery integrity trait (VT:0010746) | | 6 | 12903725 | 12903726 | Human |
407368284 | GWAS1017260_H | reticulocyte count QTL GWAS1017260 (human) | | 2e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6679939 | 6679944 | Human |
597150090 | GWAS1246164_H | skin sensitivity to sun QTL GWAS1246164 (human) | | 1e-08 | skin sensitivity to sun | | 6 | 385735 | 385736 | Human |
597076360 | GWAS1172434_H | thiopurine methyltransferase activity measurement QTL GWAS1172434 (human) | | 1e-10 | thiopurine methyltransferase activity measurement | | 6 | 18460505 | 18460506 | Human |
597223815 | GWAS1319889_H | BMI-adjusted waist circumference QTL GWAS1319889 (human) | | 4e-10 | body size trait (VT:0100005) | | 6 | 7801378 | 7801379 | Human |
597395891 | GWAS1491965_H | educational attainment QTL GWAS1491965 (human) | | 4e-10 | educational attainment | | 6 | 14913756 | 14913757 | Human |
597395889 | GWAS1491963_H | educational attainment QTL GWAS1491963 (human) | | 1e-13 | educational attainment | | 6 | 14612641 | 14612642 | Human |
597395888 | GWAS1491962_H | educational attainment QTL GWAS1491962 (human) | | 9e-14 | educational attainment | | 6 | 11972279 | 11972280 | Human |
597395893 | GWAS1491967_H | educational attainment QTL GWAS1491967 (human) | | 6e-28 | educational attainment | | 6 | 14719763 | 14719764 | Human |
597338549 | GWAS1434623_H | puberty onset measurement QTL GWAS1434623 (human) | | 1e-15 | puberty onset measurement | | 6 | 396321 | 396322 | Human |
597395892 | GWAS1491966_H | educational attainment QTL GWAS1491966 (human) | | 1e-08 | educational attainment | | 6 | 14166351 | 14166352 | Human |
597395887 | GWAS1491961_H | educational attainment QTL GWAS1491961 (human) | | 2e-09 | educational attainment | | 6 | 6555557 | 6555558 | Human |
597395886 | GWAS1491960_H | educational attainment QTL GWAS1491960 (human) | | 3e-09 | educational attainment | | 6 | 4361944 | 4361945 | Human |
596953517 | GWAS1073036_H | size QTL GWAS1073036 (human) | | 5e-29 | size | | 6 | 7718832 | 7718833 | Human |
597027246 | GWAS1123320_H | systolic blood pressure QTL GWAS1123320 (human) | | 0.000004 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1620807 | 1620808 | Human |
597371302 | GWAS1467376_H | Crohn's disease QTL GWAS1467376 (human) | | 0.000004 | intestine integrity trait (VT:0010554) | | 6 | 2957593 | 2957594 | Human |
406950524 | GWAS599500_H | body mass index QTL GWAS599500 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597264857 | GWAS1360931_H | low density lipoprotein cholesterol measurement QTL GWAS1360931 (human) | | 4e-99 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597264856 | GWAS1360930_H | low density lipoprotein cholesterol measurement QTL GWAS1360930 (human) | | 2e-14 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11842591 | 11842592 | Human |
597371353 | GWAS1467427_H | attention deficit hyperactivity disorder QTL GWAS1467427 (human) | | 0.000004 | attention deficit hyperactivity disorder | | 6 | 9030103 | 9030104 | Human |
597469663 | GWAS1565737_H | alkaline phosphatase measurement QTL GWAS1565737 (human) | | 6e-09 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 7215308 | 7215309 | Human |
597264858 | GWAS1360932_H | low density lipoprotein cholesterol measurement QTL GWAS1360932 (human) | | 5e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 18757574 | 18757575 | Human |
597346783 | GWAS1442857_H | diverticular disease QTL GWAS1442857 (human) | | 2e-08 | diverticular disease | | 6 | 7242372 | 7242373 | Human |
597379550 | GWAS1475624_H | docosapentaenoic acid measurement QTL GWAS1475624 (human) | | 1e-38 | docosapentaenoic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 11075793 | 11075794 | Human |
597199326 | GWAS1295400_H | body mass index QTL GWAS1295400 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12086593 | 12086594 | Human |
597354962 | GWAS1451036_H | BMI-adjusted waist-hip ratio QTL GWAS1451036 (human) | | 2e-18 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597354963 | GWAS1451037_H | BMI-adjusted waist-hip ratio QTL GWAS1451037 (human) | | 0.0000003 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
406917642 | GWAS566618_H | intraocular pressure measurement QTL GWAS566618 (human) | | 2e-14 | intraocular pressure measurement | | 6 | 1983206 | 1983207 | Human |
597354961 | GWAS1451035_H | BMI-adjusted waist-hip ratio QTL GWAS1451035 (human) | | 0.000001 | body size trait (VT:0100005) | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6738519 | 6738520 | Human |
597158363 | GWAS1254437_H | open-angle glaucoma QTL GWAS1254437 (human) | | 2e-31 | open-angle glaucoma | | 6 | 1963520 | 1963521 | Human |
597379543 | GWAS1475617_H | docosahexaenoic acid measurement QTL GWAS1475617 (human) | | 5e-13 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11074114 | 11074115 | Human |
597158362 | GWAS1254436_H | open-angle glaucoma QTL GWAS1254436 (human) | | 6e-20 | open-angle glaucoma | | 6 | 1771278 | 1771279 | Human |
597158361 | GWAS1254435_H | open-angle glaucoma QTL GWAS1254435 (human) | | 2e-30 | open-angle glaucoma | | 6 | 602983 | 602984 | Human |
597354964 | GWAS1451038_H | BMI-adjusted waist-hip ratio QTL GWAS1451038 (human) | | 6e-16 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597469650 | GWAS1565724_H | age at menopause QTL GWAS1565724 (human) | | 4e-112 | age at menopause | | 6 | 10887043 | 10887044 | Human |
597354965 | GWAS1451039_H | BMI-adjusted waist-hip ratio QTL GWAS1451039 (human) | | 8e-20 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597453261 | GWAS1549335_H | alkaline phosphatase measurement QTL GWAS1549335 (human) | | 1e-18 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 7215308 | 7215309 | Human |
597404106 | GWAS1500180_H | motion sickness QTL GWAS1500180 (human) | | 3e-18 | motion sickness | | 6 | 8369446 | 8369447 | Human |
406917653 | GWAS566629_H | intraocular pressure measurement QTL GWAS566629 (human) | | 7e-12 | intraocular pressure measurement | | 6 | 1775629 | 1775630 | Human |
406917661 | GWAS566637_H | cup-to-disc ratio measurement QTL GWAS566637 (human) | | 6e-13 | cup-to-disc ratio measurement | | 6 | 1979974 | 1979975 | Human |
406917660 | GWAS566636_H | cup-to-disc ratio measurement QTL GWAS566636 (human) | | 6e-11 | cup-to-disc ratio measurement | | 6 | 625071 | 625072 | Human |
597617091 | GWAS1673951_H | Inguinal hernia QTL GWAS1673951 (human) | | 3e-13 | Inguinal hernia | | 6 | 7120224 | 7120225 | Human |
597215686 | GWAS1311760_H | prostate carcinoma QTL GWAS1311760 (human) | | 0.00001 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
406917662 | GWAS566638_H | cup-to-disc ratio measurement QTL GWAS566638 (human) | | 2e-19 | cup-to-disc ratio measurement | | 6 | 7205563 | 7205564 | Human |
597461443 | GWAS1557517_H | urate measurement QTL GWAS1557517 (human) | | 1e-09 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 10505673 | 10505674 | Human |
597428675 | GWAS1524749_H | depressive symptom measurement QTL GWAS1524749 (human) | | 3e-09 | depressive symptom measurement | | 6 | 12008029 | 12008030 | Human |
597404153 | GWAS1500227_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1500227 (human) | | 0.0000001 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 6 | 6911218 | 6911219 | Human |
597363185 | GWAS1459259_H | acute myeloid leukemia QTL GWAS1459259 (human) | | 0.000005 | leukocyte integrity trait (VT:0010898) | | 6 | 442206 | 442207 | Human |
596953598 | GWAS1073117_H | pulse pressure measurement QTL GWAS1073117 (human) | | 2e-20 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597363184 | GWAS1459258_H | acute myeloid leukemia QTL GWAS1459258 (human) | | 0.0000001 | leukocyte integrity trait (VT:0010898) | | 6 | 204909 | 204910 | Human |
597338614 | GWAS1434688_H | pulse pressure measurement QTL GWAS1434688 (human) | | 5e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 16306520 | 16306521 | Human |
597338612 | GWAS1434686_H | pulse pressure measurement QTL GWAS1434686 (human) | | 4e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7211585 | 7211586 | Human |
597338613 | GWAS1434687_H | pulse pressure measurement QTL GWAS1434687 (human) | | 1e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12296022 | 12296023 | Human |
597510638 | GWAS1606712_H | aortic measurement QTL GWAS1606712 (human) | | 2e-08 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12544440 | 12544441 | Human |
597264877 | GWAS1360951_H | triglyceride measurement QTL GWAS1360951 (human) | | 7e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 18747474 | 18747475 | Human |
597477865 | GWAS1573939_H | comparative body size at age 10, self-reported QTL GWAS1573939 (human) | | 9e-13 | comparative body size at age 10, self-reported | | 6 | 10015675 | 10015676 | Human |
597207534 | GWAS1303608_H | urate measurement QTL GWAS1303608 (human) | | 5e-51 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7109432 | 7109433 | Human |
597428708 | GWAS1524782_H | testosterone measurement QTL GWAS1524782 (human) | | 1e-14 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1376813 | 1376814 | Human |
597371367 | GWAS1467441_H | pancreatic carcinoma QTL GWAS1467441 (human) | | 0.0000003 | pancreatic carcinoma | | 6 | 1339954 | 1339955 | Human |
597092630 | GWAS1188704_H | Crohn's disease QTL GWAS1188704 (human) | | 1e-09 | intestine integrity trait (VT:0010554) | | 6 | 382559 | 382560 | Human |
597043473 | GWAS1139547_H | hemoglobin measurement QTL GWAS1139547 (human) | | 2e-22 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2050557 | 2050558 | Human |
597371164 | GWAS1467238_H | FEV/FVC ratio QTL GWAS1467238 (human) | | 4e-39 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6741699 | 6741700 | Human |
597141776 | GWAS1237850_H | carnitine measurement QTL GWAS1237850 (human) | | 6e-16 | blood carnitine amount (VT:0003977) | | 6 | 14133342 | 14133343 | Human |
597526805 | GWAS1622879_H | pulse pressure measurement QTL GWAS1622879 (human) | | 2e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12578627 | 12578628 | Human |
597526804 | GWAS1622878_H | pulse pressure measurement QTL GWAS1622878 (human) | | 3e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 8224415 | 8224416 | Human |
597485846 | GWAS1581920_H | angina pectoris QTL GWAS1581920 (human) | | 2e-26 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597526806 | GWAS1622880_H | pulse pressure measurement QTL GWAS1622880 (human) | | 2e-44 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597526801 | GWAS1622875_H | pulse pressure measurement QTL GWAS1622875 (human) | | 0.0000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 1619912 | 1619913 | Human |
597526803 | GWAS1622877_H | pulse pressure measurement QTL GWAS1622877 (human) | | 4e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7518950 | 7518951 | Human |
597526802 | GWAS1622876_H | pulse pressure measurement QTL GWAS1622876 (human) | | 0.000006 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 2355441 | 2355442 | Human |
597428492 | GWAS1524566_H | depressive symptom measurement, stressful life event measurement QTL GWAS1524566 (human) | | 0.000008 | depressive symptom measurement, stressful life event measurement | | 6 | 3114713 | 3114714 | Human |
597362954 | GWAS1459028_H | total cholesterol measurement QTL GWAS1459028 (human) | | 8e-13 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597321995 | GWAS1418069_H | drug allergy, trait in response to platinum QTL GWAS1418069 (human) | | 0.000008 | drug allergy, trait in response to platinum | | 6 | 19208394 | 19208395 | Human |
597412104 | GWAS1508178_H | limited scleroderma QTL GWAS1508178 (human) | | 0.000009 | limited scleroderma | | 6 | 457748 | 457749 | Human |
597256449 | GWAS1352523_H | cancer QTL GWAS1352523 (human) | | 1e-49 | cancer | | 6 | 396321 | 396322 | Human |
597248259 | GWAS1344333_H | neuroblastoma QTL GWAS1344333 (human) | | 0.000009 | neuroblastoma | | 6 | 17534788 | 17534789 | Human |
407147224 | GWAS796200_H | age at menopause QTL GWAS796200 (human) | | 8e-12 | age at menopause | | 6 | 10897255 | 10897256 | Human |
597371140 | GWAS1467214_H | orthostatic hypotension QTL GWAS1467214 (human) | | 0.000009 | orthostatic hypotension | | 6 | 2500586 | 2500587 | Human |
597494073 | GWAS1590147_H | neuroimaging measurement QTL GWAS1590147 (human) | | 7e-10 | neuroimaging measurement | | 6 | 793765 | 793766 | Human |
597027122 | GWAS1123196_H | diastolic blood pressure QTL GWAS1123196 (human) | | 6e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 1620807 | 1620808 | Human |
597100848 | GWAS1196922_H | COVID-19, mortality QTL GWAS1196922 (human) | | 0.00001 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 13942600 | 13942601 | Human |
597469495 | GWAS1565569_H | Myopia QTL GWAS1565569 (human) | | 0.000002 | Myopia | | 6 | 4724729 | 4724730 | Human |
597362998 | GWAS1459072_H | acute myeloid leukemia QTL GWAS1459072 (human) | | 0.000007 | leukocyte integrity trait (VT:0010898) | | 6 | 12772692 | 12772693 | Human |
597256489 | GWAS1352563_H | atrial fibrillation QTL GWAS1352563 (human) | | 2e-18 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597256488 | GWAS1352562_H | atrial fibrillation QTL GWAS1352562 (human) | | 2e-24 | atrial fibrillation | | 6 | 16415520 | 16415521 | Human |
597485860 | GWAS1581934_H | skin neoplasm QTL GWAS1581934 (human) | | 3e-09 | skin neoplasm | | 6 | 4050024 | 4050025 | Human |
407032570 | GWAS681546_H | unipolar depression QTL GWAS681546 (human) | | 5e-09 | unipolar depression | | 6 | 17016169 | 17016170 | Human |
597264678 | GWAS1360752_H | X-12063 measurement QTL GWAS1360752 (human) | | 3e-08 | X-12063 measurement | | 6 | 7780609 | 7780610 | Human |
597182805 | GWAS1278879_H | citrate measurement QTL GWAS1278879 (human) | | 5e-13 | citrate measurement | | 6 | 18399519 | 18399520 | Human |
597502285 | GWAS1598359_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1598359 (human) | | 0.000005 | severe acute respiratory syndrome, COVID-19 | | 6 | 15248337 | 15248338 | Human |
597125445 | GWAS1221519_H | electrocardiography QTL GWAS1221519 (human) | | 2e-09 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
596969799 | GWAS1089318_H | major depressive disorder QTL GWAS1089318 (human) | | 7e-12 | major depressive disorder | | 6 | 17028442 | 17028443 | Human |
406983318 | GWAS632294_H | hemoglobin measurement QTL GWAS632294 (human) | | 4e-19 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7229386 | 7229387 | Human |
597485896 | GWAS1581970_H | radiation-induced disorder QTL GWAS1581970 (human) | | 5e-08 | radiation-induced disorder | | 6 | 8837005 | 8837006 | Human |
407384733 | GWAS1033709_H | eosinophil count QTL GWAS1033709 (human) | | 1e-47 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 245096 | 245097 | Human |
407384734 | GWAS1033710_H | eosinophil count QTL GWAS1033710 (human) | | 6e-24 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 390658 | 390659 | Human |
406983317 | GWAS632293_H | hemoglobin measurement QTL GWAS632293 (human) | | 7e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7221860 | 7221861 | Human |
597207360 | GWAS1303434_H | glucose-dependent insulinotropic peptide measurement QTL GWAS1303434 (human) | | 6e-09 | glucose-dependent insulinotropic peptide measurement | | 6 | 865369 | 865370 | Human |
597363014 | GWAS1459088_H | QRS amplitude, QRS complex QTL GWAS1459088 (human) | | 2e-08 | QRS amplitude, QRS complex | QRS amplitude (CMO:0000268) | 6 | 7502516 | 7502517 | Human |
597141878 | GWAS1237952_H | Inguinal hernia QTL GWAS1237952 (human) | | 4e-10 | Inguinal hernia | | 6 | 7132823 | 7132824 | Human |
597412216 | GWAS1508290_H | C-reactive protein measurement QTL GWAS1508290 (human) | | 6e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 7099796 | 7099797 | Human |
407024295 | GWAS673271_H | pit and fissure surface dental caries QTL GWAS673271 (human) | | 0.000006 | pit and fissure surface dental caries | | 6 | 577820 | 577821 | Human |
597092723 | GWAS1188797_H | Crohn's disease QTL GWAS1188797 (human) | | 3e-08 | intestine integrity trait (VT:0010554) | | 6 | 3420172 | 3420173 | Human |
597617017 | GWAS1673877_H | gastrointestinal disease, complication QTL GWAS1673877 (human) | | 4e-12 | gastrointestinal disease, complication | | 6 | 13522702 | 13522703 | Human |
597289331 | GWAS1385405_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1385405 (human) | | 2e-13 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126442 | 16126443 | Human |
597526902 | GWAS1622976_H | protein measurement QTL GWAS1622976 (human) | | 2e-273 | protein measurement | | 6 | 2993201 | 2993202 | Human |
407147177 | GWAS796153_H | allergic rhinitis QTL GWAS796153 (human) | | 0.0000006 | allergic rhinitis | | 6 | 10906023 | 10906024 | Human |
597363060 | GWAS1459134_H | mean corpuscular hemoglobin QTL GWAS1459134 (human) | | 2e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16167286 | 16167287 | Human |
597133668 | GWAS1229742_H | memory performance QTL GWAS1229742 (human) | | 0.000004 | memory performance | | 6 | 4995574 | 4995575 | Human |
597412207 | GWAS1508281_H | refractive error, age at onset, Myopia QTL GWAS1508281 (human) | | 1e-09 | refractive error, age at onset, Myopia | | 6 | 7317250 | 7317251 | Human |
407138993 | GWAS787969_H | diffuse large B-cell lymphoma QTL GWAS787969 (human) | | 2e-21 | diffuse large B-cell lymphoma | | 6 | 484453 | 484454 | Human |
597412206 | GWAS1508280_H | refractive error, age at onset, Myopia QTL GWAS1508280 (human) | | 1e-09 | refractive error, age at onset, Myopia | | 6 | 2429509 | 2429510 | Human |
597608809 | GWAS1665669_H | plasma protein metabolism disease QTL GWAS1665669 (human) | | 2e-15 | plasma protein metabolism disease | | 6 | 484453 | 484454 | Human |
407024312 | GWAS673288_H | response to olanzapine QTL GWAS673288 (human) | | 0.000002 | response to olanzapine | | 6 | 12196980 | 12196981 | Human |
597461350 | GWAS1557424_H | body mass index QTL GWAS1557424 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12716327 | 12716328 | Human |
597461351 | GWAS1557425_H | body mass index QTL GWAS1557425 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13183291 | 13183292 | Human |
597362842 | GWAS1458916_H | body mass index, visceral:subcutaneous adipose tissue ratio QTL GWAS1458916 (human) | | 2e-09 | body mass index, visceral:subcutaneous adipose tissue ratio | body mass index (BMI) (CMO:0000105) | 6 | 6735964 | 6735965 | Human |
597092501 | GWAS1188575_H | Alzheimer disease, age at onset QTL GWAS1188575 (human) | | 5e-08 | Alzheimer disease, age at onset | | 6 | 6316080 | 6316081 | Human |
597379224 | GWAS1475298_H | eicosapentaenoic acid measurement QTL GWAS1475298 (human) | | 5e-11 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11075793 | 11075794 | Human |
597403806 | GWAS1499880_H | inflammatory bowel disease QTL GWAS1499880 (human) | | 2e-11 | inflammatory bowel disease | | 6 | 14719265 | 14719266 | Human |
596977821 | GWAS1097340_H | Ischemic stroke QTL GWAS1097340 (human) | | 2e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
597502101 | GWAS1598175_H | chronic obstructive pulmonary disease QTL GWAS1598175 (human) | | 1e-18 | lung integrity trait (VT:0010906) | | 6 | 6734789 | 6734790 | Human |
597436565 | GWAS1532639_H | lipid measurement QTL GWAS1532639 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 11200924 | 11200925 | Human |
597207186 | GWAS1303260_H | urate measurement QTL GWAS1303260 (human) | | 0.0000003 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 1997631 | 1997632 | Human |
597526673 | GWAS1622747_H | (2 or 3)-decenoate (10:1n7 or n8) measurement QTL GWAS1622747 (human) | | 1e-22 | (2 or 3)-decenoate (10:1n7 or n8) measurement | | 6 | 4125421 | 4125422 | Human |
597371031 | GWAS1467105_H | waist-hip ratio QTL GWAS1467105 (human) | | 2e-10 | Inguinal hernia | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
406917965 | GWAS566941_H | behavior QTL GWAS566941 (human) | | 0.000001 | behavior | | 6 | 18791492 | 18791493 | Human |
597502092 | GWAS1598166_H | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n3) measurement QTL GWAS1598166 (human) | | 2e-27 | glycerophosphocholine amount (VT:0011004) | | 6 | 11044425 | 11044426 | Human |
597026948 | GWAS1123022_H | body mass index QTL GWAS1123022 (human) | | 5e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597362820 | GWAS1458894_H | chronic kidney disease, diabetic nephropathy QTL GWAS1458894 (human) | | 0.000004 | kidney integrity trait (VT:0010580) | | 6 | 8226764 | 8226765 | Human |
597387451 | GWAS1483525_H | smoking status measurement, diastolic blood pressure QTL GWAS1483525 (human) | | 2e-08 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 11495815 | 11495816 | Human |
597076151 | GWAS1172225_H | heel bone mineral density QTL GWAS1172225 (human) | | 0.0000004 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
407057250 | GWAS706226_H | gut microbiome measurement QTL GWAS706226 (human) | | 0.000007 | gut microbiome measurement | | 6 | 12236858 | 12236859 | Human |
597190841 | GWAS1286915_H | cesarean section, anxiety QTL GWAS1286915 (human) | | 4e-08 | cesarean section, anxiety | | 6 | 16616950 | 16616951 | Human |
597469374 | GWAS1565448_H | protein measurement QTL GWAS1565448 (human) | | 4e-10 | protein measurement | | 6 | 8871655 | 8871656 | Human |
597051573 | GWAS1147647_H | low density lipoprotein cholesterol measurement, physical activity QTL GWAS1147647 (human) | | 2e-27 | low density lipoprotein cholesterol measurement, physical activity | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597313713 | GWAS1409787_H | cortical thickness QTL GWAS1409787 (human) | | 2e-16 | cortical thickness | | 6 | 7109432 | 7109433 | Human |
597108901 | GWAS1204975_H | mathematical ability QTL GWAS1204975 (human) | | 3e-09 | mathematical ability | | 6 | 19028557 | 19028558 | Human |
597117091 | GWAS1213165_H | hemoglobin measurement QTL GWAS1213165 (human) | | 2e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16290617 | 16290620 | Human |
596953249 | GWAS1072768_H | employment status, environmental factor QTL GWAS1072768 (human) | | 8e-10 | employment status, environmental factor | | 6 | 16965821 | 16965822 | Human |
597289134 | GWAS1385208_H | apolipoprotein B measurement QTL GWAS1385208 (human) | | 5e-12 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16126442 | 16126443 | Human |
597387431 | GWAS1483505_H | forced expiratory volume, response to bronchodilator QTL GWAS1483505 (human) | | 0.000001 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 8383251 | 8383252 | Human |
597313703 | GWAS1409777_H | total cholesterol measurement QTL GWAS1409777 (human) | | 1e-17 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16128841 | 16128842 | Human |
406950783 | GWAS599759_H | mean corpuscular hemoglobin concentration QTL GWAS599759 (human) | | 4e-27 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16287961 | 16287962 | Human |
597231782 | GWAS1327856_H | smoking cessation QTL GWAS1327856 (human) | | 9e-09 | smoking cessation | | 6 | 396321 | 396322 | Human |
597469347 | GWAS1565421_H | protein measurement QTL GWAS1565421 (human) | | 1e-08 | protein measurement | | 6 | 1105564 | 1105565 | Human |
597117139 | GWAS1213213_H | mathematical ability QTL GWAS1213213 (human) | | 4e-12 | mathematical ability | | 6 | 19028557 | 19028558 | Human |
597321949 | GWAS1418023_H | systolic blood pressure QTL GWAS1418023 (human) | | 5e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1616538 | 1616542 | Human |
597600466 | GWAS1657326_H | basophil measurement QTL GWAS1657326 (human) | | 2e-21 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597600460 | GWAS1657320_H | basophil measurement QTL GWAS1657320 (human) | | 3e-14 | basophil measurement | | 6 | 7156791 | 7156792 | Human |
597051588 | GWAS1147662_H | response to antidepressant QTL GWAS1147662 (human) | | 0.000002 | response to antidepressant | | 6 | 11776838 | 11776839 | Human |
597117125 | GWAS1213199_H | self reported educational attainment QTL GWAS1213199 (human) | | 1e-09 | self reported educational attainment | | 6 | 19184603 | 19184604 | Human |
597379272 | GWAS1475346_H | neuropsychological test QTL GWAS1475346 (human) | | 0.000002 | neuropsychological test | | 6 | 14596134 | 14596135 | Human |
597117124 | GWAS1213198_H | self reported educational attainment QTL GWAS1213198 (human) | | 8e-23 | self reported educational attainment | | 6 | 19035804 | 19035805 | Human |
597117123 | GWAS1213197_H | self reported educational attainment QTL GWAS1213197 (human) | | 3e-10 | educational attainment | | 6 | 17127475 | 17127476 | Human |
597117122 | GWAS1213196_H | self reported educational attainment QTL GWAS1213196 (human) | | 1e-09 | self reported educational attainment | | 6 | 16662870 | 16662871 | Human |
597231808 | GWAS1327882_H | BMI-adjusted waist-hip ratio QTL GWAS1327882 (human) | | 4e-13 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
406950687 | GWAS599663_H | neuroticism measurement QTL GWAS599663 (human) | | 0.000004 | neuroticism measurement | | 6 | 6313151 | 6313152 | Human |
597608703 | GWAS1665563_H | benign neoplasm of eye QTL GWAS1665563 (human) | | 9e-74 | benign neoplasm of eye | | 6 | 396321 | 396322 | Human |
406999843 | GWAS648819_H | BMI-adjusted waist circumference QTL GWAS648819 (human) | | 2e-14 | body size trait (VT:0100005) | | 6 | 7789710 | 7789711 | Human |
597248248 | GWAS1344322_H | blood phosphate measurement QTL GWAS1344322 (human) | | 2e-11 | blood phosphate amount (VT:0001565) | blood phosphate level (CMO:0000504) | 6 | 18913980 | 18913981 | Human |
597600509 | GWAS1657369_H | body mass index QTL GWAS1657369 (human) | | 4e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12117111 | 12117112 | Human |
597108979 | GWAS1205053_H | urate measurement QTL GWAS1205053 (human) | | 2e-21 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7109432 | 7109433 | Human |
597371123 | GWAS1467197_H | migraine disorder QTL GWAS1467197 (human) | | 3e-08 | heart failure | | 6 | 12903725 | 12903726 | Human |
597403890 | GWAS1499964_H | pelvic organ prolapse QTL GWAS1499964 (human) | | 0.000003 | pelvic organ prolapse | | 6 | 6722724 | 6722725 | Human |
597256425 | GWAS1352499_H | urate measurement QTL GWAS1352499 (human) | | 1e-09 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7247111 | 7247112 | Human |
597158118 | GWAS1254192_H | IGA glomerulonephritis QTL GWAS1254192 (human) | | 3e-11 | IGA glomerulonephritis | | 6 | 249571 | 249572 | Human |
597190891 | GWAS1286965_H | testosterone measurement QTL GWAS1286965 (human) | | 1e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 17416027 | 17416028 | Human |
597207278 | GWAS1303352_H | Waldenstrom macroglobulinemia QTL GWAS1303352 (human) | | 1e-54 | Waldenstrom macroglobulinemia | | 6 | 484453 | 484454 | Human |
597149933 | GWAS1246007_H | skin sensitivity to sun QTL GWAS1246007 (human) | | 8e-20 | skin sensitivity to sun | | 6 | 396321 | 396322 | Human |
597608676 | GWAS1665536_H | basophil measurement QTL GWAS1665536 (human) | | 1e-11 | basophil measurement | | 6 | 17602639 | 17602640 | Human |
597158124 | GWAS1254198_H | IGA glomerulonephritis QTL GWAS1254198 (human) | | 0.000003 | IGA glomerulonephritis | | 6 | 5675612 | 5675613 | Human |
407057208 | GWAS706184_H | central corneal thickness QTL GWAS706184 (human) | | 3e-09 | central corneal thickness | | 6 | 16522376 | 16522377 | Human |
597412070 | GWAS1508144_H | diet measurement QTL GWAS1508144 (human) | | 4e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 16753147 | 16753148 | Human |
597231641 | GWAS1327715_H | gout QTL GWAS1327715 (human) | | 9e-15 | gout | | 6 | 7118757 | 7118758 | Human |
597592090 | GWAS1648950_H | skin disease QTL GWAS1648950 (human) | | 4e-12 | skin disease | | 6 | 396321 | 396322 | Human |
597608474 | GWAS1665334_H | gout QTL GWAS1665334 (human) | | 5e-27 | gout | | 6 | 7109432 | 7109433 | Human |
597362718 | GWAS1458792_H | visceral:subcutaneous adipose tissue ratio QTL GWAS1458792 (human) | | 3e-09 | visceral:subcutaneous adipose tissue ratio | | 6 | 6735964 | 6735965 | Human |
597592088 | GWAS1648948_H | pigmentation disease QTL GWAS1648948 (human) | | 3e-59 | pigmentation disease | | 6 | 396321 | 396322 | Human |
597075997 | GWAS1172071_H | heel bone mineral density QTL GWAS1172071 (human) | | 6e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7231610 | 7231611 | Human |
597084186 | GWAS1180260_H | monocyte count QTL GWAS1180260 (human) | | 2e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 12044743 | 12044744 | Human |
597084187 | GWAS1180261_H | monocyte count QTL GWAS1180261 (human) | | 3e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 16716616 | 16716617 | Human |
597084184 | GWAS1180258_H | monocyte count QTL GWAS1180258 (human) | | 2e-40 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7144958 | 7144959 | Human |
597084185 | GWAS1180259_H | monocyte count QTL GWAS1180259 (human) | | 1e-24 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7156526 | 7156527 | Human |
597329941 | GWAS1426015_H | sexual dimorphism measurement QTL GWAS1426015 (human) | | 5e-09 | sexual dimorphism measurement | | 6 | 7800912 | 7800913 | Human |
597428236 | GWAS1524310_H | gout QTL GWAS1524310 (human) | | 9e-63 | gout | | 6 | 7099796 | 7099797 | Human |
597592079 | GWAS1648939_H | Vitiligo QTL GWAS1648939 (human) | | 3e-52 | Vitiligo | | 6 | 396321 | 396322 | Human |
597493774 | GWAS1589848_H | neuroticism measurement, cognitive function measurement QTL GWAS1589848 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 6 | 16965821 | 16965822 | Human |
597092355 | GWAS1188429_H | circadian rhythm QTL GWAS1188429 (human) | | 0.000003 | circadian rhythm | | 6 | 13170402 | 13170403 | Human |
597616648 | GWAS1673508_H | gastric ulcer, hemorrhage QTL GWAS1673508 (human) | | 5e-12 | gastric ulcer, hemorrhage | | 6 | 445634 | 445635 | Human |
597592071 | GWAS1648931_H | seborrheic dermatitis QTL GWAS1648931 (human) | | 5e-13 | macular degeneration | | 6 | 17602639 | 17602640 | Human |
597428231 | GWAS1524305_H | gout QTL GWAS1524305 (human) | | 2e-08 | gout | | 6 | 13510547 | 13510548 | Human |
597583877 | GWAS1640737_H | mean corpuscular hemoglobin concentration QTL GWAS1640737 (human) | | 4e-56 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597592064 | GWAS1648924_H | skin disease QTL GWAS1648924 (human) | | 3e-12 | leukocyte integrity trait (VT:0010898) | | 6 | 396321 | 396322 | Human |
597182521 | GWAS1278595_H | hemoglobin measurement QTL GWAS1278595 (human) | | 0.000003 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2198093 | 2198094 | Human |
407385066 | GWAS1034042_H | intelligence QTL GWAS1034042 (human) | | 4e-09 | intelligence | | 6 | 19082432 | 19082433 | Human |
597076018 | GWAS1172092_H | Vitiligo QTL GWAS1172092 (human) | | 3e-08 | Vitiligo | | 6 | 2908357 | 2908358 | Human |
597616692 | GWAS1673552_H | mean corpuscular hemoglobin concentration QTL GWAS1673552 (human) | | 4e-52 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16287961 | 16287962 | Human |
597379127 | GWAS1475201_H | neurotic disorder QTL GWAS1475201 (human) | | 4e-09 | neurotic disorder | | 6 | 11994529 | 11994530 | Human |
597444652 | GWAS1540726_H | open-angle glaucoma QTL GWAS1540726 (human) | | 9e-52 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597411882 | GWAS1507956_H | intraocular pressure measurement QTL GWAS1507956 (human) | | 2e-28 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597592105 | GWAS1648965_H | psoriasis QTL GWAS1648965 (human) | | 3e-99 | psoriasis | | 6 | 17602639 | 17602640 | Human |
597436508 | GWAS1532582_H | BMI-adjusted waist-hip ratio QTL GWAS1532582 (human) | | 2e-32 | body size trait (VT:0100005) | | 6 | 6782065 | 6782066 | Human |
407024514 | GWAS673490_H | unipolar depression QTL GWAS673490 (human) | | 0.000001 | unipolar depression | | 6 | 16255812 | 16255813 | Human |
596953173 | GWAS1072692_H | respiratory system disease QTL GWAS1072692 (human) | | 9e-11 | respiratory system disease | | 6 | 7231610 | 7231611 | Human |
597436509 | GWAS1532583_H | BMI-adjusted waist-hip ratio QTL GWAS1532583 (human) | | 3e-09 | body size trait (VT:0100005) | | 6 | 14595642 | 14595643 | Human |
597330008 | GWAS1426082_H | color vision disorder QTL GWAS1426082 (human) | | 0.00001 | color vision disorder | | 6 | 2120179 | 2120180 | Human |
597436504 | GWAS1532578_H | BMI-adjusted waist-hip ratio QTL GWAS1532578 (human) | | 2e-23 | body size trait (VT:0100005) | | 6 | 6757309 | 6757310 | Human |
597379166 | GWAS1475240_H | reticulocyte measurement QTL GWAS1475240 (human) | | 4e-18 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 2503101 | 2503102 | Human |
597428313 | GWAS1524387_H | depressive symptom measurement, stressful life event measurement QTL GWAS1524387 (human) | | 0.000004 | depressive symptom measurement, stressful life event measurement | | 6 | 3114713 | 3114714 | Human |
597436505 | GWAS1532579_H | BMI-adjusted waist-hip ratio QTL GWAS1532579 (human) | | 3e-17 | body size trait (VT:0100005) | | 6 | 6754893 | 6754894 | Human |
597436506 | GWAS1532580_H | BMI-adjusted waist-hip ratio QTL GWAS1532580 (human) | | 1e-10 | body size trait (VT:0100005) | | 6 | 6766471 | 6766472 | Human |
597436507 | GWAS1532581_H | BMI-adjusted waist-hip ratio QTL GWAS1532581 (human) | | 2e-18 | body size trait (VT:0100005) | | 6 | 6760630 | 6760631 | Human |
597436503 | GWAS1532577_H | BMI-adjusted waist-hip ratio QTL GWAS1532577 (human) | | 2e-42 | body size trait (VT:0100005) | | 6 | 6740400 | 6740401 | Human |
597297239 | GWAS1393313_H | phosphatidylethanolamine measurement QTL GWAS1393313 (human) | | 7e-09 | phosphatidylethanolamine measurement | | 6 | 10971715 | 10971716 | Human |
597510220 | GWAS1606294_H | decreased susceptibility to hepatitis C infection QTL GWAS1606294 (human) | | 0.000006 | decreased susceptibility to hepatitis C infection | | 6 | 10177861 | 10177862 | Human |
597510217 | GWAS1606291_H | electrocardiography QTL GWAS1606291 (human) | | 2e-08 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597329998 | GWAS1426072_H | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement QTL GWAS1426072 (human) | | 8e-12 | glycerophosphocholine amount (VT:0011004) | | 6 | 10994782 | 10994783 | Human |
597592139 | GWAS1648999_H | psoriasis vulgaris QTL GWAS1648999 (human) | | 4e-98 | psoriasis vulgaris | | 6 | 17602639 | 17602640 | Human |
597477444 | GWAS1573518_H | blood protein measurement QTL GWAS1573518 (human) | | 3e-18 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6332851 | 6332852 | Human |
407180191 | GWAS829167_H | nicotine dependence symptom count QTL GWAS829167 (human) | | 0.000005 | nicotine dependence symptom count | | 6 | 10886716 | 10886717 | Human |
597321792 | GWAS1417866_H | sensory peripheral neuropathy, trait in response to platinum QTL GWAS1417866 (human) | | 0.000008 | sensory peripheral neuropathy, trait in response to platinum | | 6 | 15731075 | 15731076 | Human |
597256258 | GWAS1352332_H | urate measurement QTL GWAS1352332 (human) | | 2e-17 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7075549 | 7075550 | Human |
597305412 | GWAS1401486_H | coronary artery disease QTL GWAS1401486 (human) | | 3e-11 | coronary artery disease | | 6 | 1616908 | 1616909 | Human |
597321850 | GWAS1417924_H | non-high density lipoprotein cholesterol measurement QTL GWAS1417924 (human) | | 7e-14 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 11865364 | 11865365 | Human |
597321851 | GWAS1417925_H | non-high density lipoprotein cholesterol measurement QTL GWAS1417925 (human) | | 2e-68 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 16130925 | 16130926 | Human |
406950819 | GWAS599795_H | trait in response to escitalopram, unipolar depression, trait in response to citalopram, mood disorder QTL GWAS599795 (human) | | 0.0000009 | trait in response to escitalopram, unipolar depression, trait in response to citalopram, mood disorder | | 6 | 1402915 | 1402916 | Human |
597395576 | GWAS1491650_H | educational attainment QTL GWAS1491650 (human) | | 6e-16 | educational attainment | | 6 | 3463840 | 3463841 | Human |
597403774 | GWAS1499848_H | alopecia QTL GWAS1499848 (human) | | 1e-21 | alopecia | | 6 | 9604955 | 9604956 | Human |
597297279 | GWAS1393353_H | hematocrit QTL GWAS1393353 (human) | | 5e-13 | hematocrit | hematocrit (CMO:0000037) | 6 | 12294025 | 12294026 | Human |
597305458 | GWAS1401532_H | total blood protein measurement QTL GWAS1401532 (human) | | 6e-10 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 16700602 | 16700603 | Human |
406942634 | GWAS591610_H | insomnia measurement QTL GWAS591610 (human) | | 5e-09 | sleep behavior trait (VT:0001501) | | 6 | 7115694 | 7115695 | Human |
597305460 | GWAS1401534_H | total blood protein measurement QTL GWAS1401534 (human) | | 2e-31 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 223039 | 223040 | Human |
597239912 | GWAS1335986_H | Myopia QTL GWAS1335986 (human) | | 0.000004 | Myopia | | 6 | 7345110 | 7345111 | Human |
596977767 | GWAS1097286_H | body height QTL GWAS1097286 (human) | | 4e-24 | body height | | 6 | 2071427 | 2071428 | Human |
597395561 | GWAS1491635_H | cup-to-disc ratio measurement QTL GWAS1491635 (human) | | 9e-09 | cup-to-disc ratio measurement | | 6 | 11411605 | 11411606 | Human |
596977760 | GWAS1097279_H | body height QTL GWAS1097279 (human) | | 8e-55 | body height | | 6 | 7231610 | 7231611 | Human |
597313645 | GWAS1409719_H | memory performance QTL GWAS1409719 (human) | | 0.000001 | memory performance | | 6 | 611232 | 611233 | Human |
597502052 | GWAS1598126_H | QT interval QTL GWAS1598126 (human) | | 6e-10 | QT interval | QT interval (CMO:0000235) | 6 | 6901430 | 6901431 | Human |
597241752 | GWAS1337826_H | educational attainment QTL GWAS1337826 (human) | | 2e-08 | educational attainment | | 6 | 5102140 | 5102141 | Human |
597282715 | GWAS1378789_H | COVID-19 QTL GWAS1378789 (human) | | 0.000007 | COVID-19 | | 6 | 6170992 | 6170993 | Human |
597135253 | GWAS1231327_H | memory performance QTL GWAS1231327 (human) | | 0.0000009 | memory performance | | 6 | 16089836 | 16089837 | Human |
597135251 | GWAS1231325_H | memory performance QTL GWAS1231325 (human) | | 0.0000008 | memory performance | | 6 | 11732434 | 11732435 | Human |
407385152 | GWAS1034128_H | obsolete_red blood cell distribution width QTL GWAS1034128 (human) | | 2e-16 | obsolete_red blood cell distribution width | | 6 | 16261045 | 16261046 | Human |
597266321 | GWAS1362395_H | educational attainment QTL GWAS1362395 (human) | | 2e-13 | educational attainment | | 6 | 18886651 | 18886652 | Human |
597274512 | GWAS1370586_H | physical activity measurement QTL GWAS1370586 (human) | | 5e-10 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 12693222 | 12693223 | Human |
407385153 | GWAS1034129_H | obsolete_red blood cell distribution width QTL GWAS1034129 (human) | | 2e-14 | obsolete_red blood cell distribution width | | 6 | 18747474 | 18747475 | Human |
597462935 | GWAS1559009_H | multiple sclerosis QTL GWAS1559009 (human) | | 1e-10 | multiple sclerosis | | 6 | 14719265 | 14719266 | Human |
597266322 | GWAS1362396_H | educational attainment QTL GWAS1362396 (human) | | 1e-26 | educational attainment | | 6 | 19028557 | 19028558 | Human |
597036954 | GWAS1133028_H | femoral neck bone mineral density QTL GWAS1133028 (human) | | 0.0000001 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 6 | 3263257 | 3263258 | Human |
597372820 | GWAS1468894_H | birth weight QTL GWAS1468894 (human) | | 0.000001 | birth weight | neonatal body weight (CMO:0002079) | 6 | 4379277 | 4379278 | Human |
597241739 | GWAS1337813_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1337813 (human) | | 1e-11 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 12117111 | 12117112 | Human |
597094276 | GWAS1190350_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1190350 (human) | | 0.000002 | 3-hydroxypropylmercapturic acid measurement | | 6 | 19235878 | 19235879 | Human |
597364622 | GWAS1460696_H | intelligence QTL GWAS1460696 (human) | | 1e-08 | intelligence | | 6 | 19025510 | 19025511 | Human |
597159823 | GWAS1255897_H | lipid measurement QTL GWAS1255897 (human) | | 0.000008 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 7432750 | 7432751 | Human |
597430205 | GWAS1526279_H | pneumonia QTL GWAS1526279 (human) | | 0.000003 | pneumonia | | 6 | 11484550 | 11484551 | Human |
597487541 | GWAS1583615_H | esterified cholesterol measurement QTL GWAS1583615 (human) | | 2e-13 | esterified cholesterol measurement | | 6 | 16113090 | 16113091 | Human |
597225395 | GWAS1321469_H | chronotype measurement QTL GWAS1321469 (human) | | 3e-09 | sleep behavior trait (VT:0001501) | | 6 | 19079960 | 19079961 | Human |
407016558 | GWAS665534_H | platelet count QTL GWAS665534 (human) | | 6e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2776761 | 2776762 | Human |
597159866 | GWAS1255940_H | platelet count QTL GWAS1255940 (human) | | 3e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2779706 | 2779707 | Human |
597331893 | GWAS1427967_H | cutaneous squamous cell carcinoma QTL GWAS1427967 (human) | | 1e-234 | cutaneous squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
596979621 | GWAS1099140_H | hypothyroidism QTL GWAS1099140 (human) | | 4e-12 | hypothyroidism | | 6 | 403799 | 403800 | Human |
597413802 | GWAS1509876_H | BMI-adjusted waist-hip ratio QTL GWAS1509876 (human) | | 7e-10 | body size trait (VT:0100005) | | 6 | 7018258 | 7018259 | Human |
597528487 | GWAS1624561_H | pain QTL GWAS1624561 (human) | | 0.0000002 | pain | | 6 | 12903725 | 12903726 | Human |
597036973 | GWAS1133047_H | rheumatoid arthritis QTL GWAS1133047 (human) | | 1e-11 | rheumatoid arthritis | | 6 | 426155 | 426156 | Human |
597307303 | GWAS1403377_H | platelet count QTL GWAS1403377 (human) | | 2e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 7085584 | 7085585 | Human |
597618595 | GWAS1675455_H | heart disease QTL GWAS1675455 (human) | | 2e-48 | heart disease | | 6 | 12903725 | 12903726 | Human |
597372836 | GWAS1468910_H | urinary nitrogen measurement QTL GWAS1468910 (human) | | 0.0000004 | urinary nitrogen measurement | | 6 | 2565518 | 2565519 | Human |
597102504 | GWAS1198578_H | low density lipoprotein cholesterol measurement QTL GWAS1198578 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 6972360 | 6972361 | Human |
597430236 | GWAS1526310_H | Inguinal hernia QTL GWAS1526310 (human) | | 2e-08 | Inguinal hernia | | 6 | 6745222 | 6745223 | Human |
597200856 | GWAS1296930_H | type 1 diabetes mellitus QTL GWAS1296930 (human) | | 0.000006 | type 1 diabetes mellitus | | 6 | 17120009 | 17120010 | Human |
597430237 | GWAS1526311_H | Inguinal hernia QTL GWAS1526311 (human) | | 3e-10 | Inguinal hernia | | 6 | 6745933 | 6745934 | Human |
597430232 | GWAS1526306_H | Inguinal hernia QTL GWAS1526306 (human) | | 5e-09 | Inguinal hernia | | 6 | 6744770 | 6744771 | Human |
597430233 | GWAS1526307_H | Inguinal hernia QTL GWAS1526307 (human) | | 5e-09 | Inguinal hernia | | 6 | 6744794 | 6744795 | Human |
597430234 | GWAS1526308_H | Inguinal hernia QTL GWAS1526308 (human) | | 6e-09 | Inguinal hernia | | 6 | 6744930 | 6744931 | Human |
597430235 | GWAS1526309_H | Inguinal hernia QTL GWAS1526309 (human) | | 5e-09 | Inguinal hernia | | 6 | 6745144 | 6745145 | Human |
597438420 | GWAS1534494_H | Ischemic stroke QTL GWAS1534494 (human) | | 6e-09 | Ischemic stroke | | 6 | 1377366 | 1377367 | Human |
597430228 | GWAS1526302_H | Inguinal hernia QTL GWAS1526302 (human) | | 6e-09 | Inguinal hernia | | 6 | 6744419 | 6744420 | Human |
597045214 | GWAS1141288_H | cutaneous melanoma, hair color QTL GWAS1141288 (human) | | 1e-10 | cutaneous melanoma, hair color | | 6 | 11637250 | 11637251 | Human |
597430229 | GWAS1526303_H | Inguinal hernia QTL GWAS1526303 (human) | | 4e-10 | Inguinal hernia | | 6 | 6744465 | 6744466 | Human |
597430230 | GWAS1526304_H | Inguinal hernia QTL GWAS1526304 (human) | | 1e-08 | Inguinal hernia | | 6 | 6744757 | 6744758 | Human |
597159901 | GWAS1255975_H | citrate measurement QTL GWAS1255975 (human) | | 2e-08 | citrate measurement | | 6 | 18431464 | 18431465 | Human |
597430231 | GWAS1526305_H | Inguinal hernia QTL GWAS1526305 (human) | | 1e-08 | Inguinal hernia | | 6 | 6744760 | 6744762 | Human |
597430226 | GWAS1526300_H | Inguinal hernia QTL GWAS1526300 (human) | | 5e-09 | Inguinal hernia | | 6 | 6744313 | 6744314 | Human |
597430227 | GWAS1526301_H | Inguinal hernia QTL GWAS1526301 (human) | | 6e-09 | Inguinal hernia | | 6 | 6744390 | 6744391 | Human |
597356501 | GWAS1452575_H | alpha wave measurement, electroencephalogram measurement QTL GWAS1452575 (human) | | 0.000004 | alpha wave measurement, electroencephalogram measurement | brain activity measurement (CMO:0001737) | 6 | 9994156 | 9994157 | Human |
597405633 | GWAS1501707_H | bilirubin measurement QTL GWAS1501707 (human) | | 3e-09 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 6 | 6971520 | 6971521 | Human |
407098396 | GWAS747372_H | acute myeloid leukemia QTL GWAS747372 (human) | | 0.0000003 | leukocyte integrity trait (VT:0010898) | | 6 | 17665248 | 17665249 | Human |
597389307 | GWAS1485381_H | body weight QTL GWAS1485381 (human) | | 0.0000007 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 3865792 | 3865793 | Human |
597069812 | GWAS1165886_H | lean body mass QTL GWAS1165886 (human) | | 0.0000008 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 10606778 | 10606779 | Human |
597594105 | GWAS1650965_H | body mass index QTL GWAS1650965 (human) | | 8e-30 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12117111 | 12117112 | Human |
407254062 | GWAS903038_H | genomic measurement QTL GWAS903038 (human) | | 3e-09 | genomic measurement | | 6 | 15313558 | 15313559 | Human |
597110782 | GWAS1206856_H | mathematical ability QTL GWAS1206856 (human) | | 2e-16 | mathematical ability | | 6 | 19028557 | 19028558 | Human |
597323760 | GWAS1419834_H | cup-to-disc ratio measurement QTL GWAS1419834 (human) | | 2e-18 | cup-to-disc ratio measurement | | 6 | 7211585 | 7211586 | Human |
597110781 | GWAS1206855_H | mathematical ability QTL GWAS1206855 (human) | | 6e-09 | mathematical ability | | 6 | 17127475 | 17127476 | Human |
597110780 | GWAS1206854_H | mathematical ability QTL GWAS1206854 (human) | | 2e-08 | mathematical ability | | 6 | 16315427 | 16315428 | Human |
597463024 | GWAS1559098_H | hippocampal volume QTL GWAS1559098 (human) | | 0.0000005 | hippocampal volume | | 6 | 5877202 | 5877203 | Human |
597110779 | GWAS1206853_H | mathematical ability QTL GWAS1206853 (human) | | 2e-08 | mathematical ability | | 6 | 7232156 | 7232157 | Human |
597086182 | GWAS1182256_H | cortical thickness, neuroimaging measurement QTL GWAS1182256 (human) | | 4e-08 | cortical thickness, neuroimaging measurement | | 6 | 7189625 | 7189626 | Human |
407385146 | GWAS1034122_H | obsolete_red blood cell distribution width QTL GWAS1034122 (human) | | 2e-21 | obsolete_red blood cell distribution width | | 6 | 3423353 | 3423354 | Human |
597241835 | GWAS1337909_H | C-reactive protein measurement QTL GWAS1337909 (human) | | 3e-12 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 7112586 | 7112587 | Human |
407385147 | GWAS1034123_H | obsolete_red blood cell distribution width QTL GWAS1034123 (human) | | 4e-18 | obsolete_red blood cell distribution width | | 6 | 4717639 | 4717640 | Human |
407385148 | GWAS1034124_H | obsolete_red blood cell distribution width QTL GWAS1034124 (human) | | 9e-23 | obsolete_red blood cell distribution width | | 6 | 5137468 | 5137469 | Human |
407385149 | GWAS1034125_H | obsolete_red blood cell distribution width QTL GWAS1034125 (human) | | 4e-09 | obsolete_red blood cell distribution width | | 6 | 5262479 | 5262480 | Human |
407385150 | GWAS1034126_H | obsolete_red blood cell distribution width QTL GWAS1034126 (human) | | 4e-08 | obsolete_red blood cell distribution width | | 6 | 6924907 | 6924908 | Human |
597045216 | GWAS1141290_H | cutaneous melanoma, hair color QTL GWAS1141290 (human) | | 8e-10 | cutaneous melanoma, hair color | | 6 | 7189334 | 7189335 | Human |
407385151 | GWAS1034127_H | obsolete_red blood cell distribution width QTL GWAS1034127 (human) | | 3e-10 | obsolete_red blood cell distribution width | | 6 | 7695740 | 7695741 | Human |
597241825 | GWAS1337899_H | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head QTL GWAS1337899 (human) | | 8e-08 | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | | 6 | 7236387 | 7236388 | Human |
597594087 | GWAS1650947_H | blood urea nitrogen measurement QTL GWAS1650947 (human) | | 4e-13 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 6 | 9547303 | 9547304 | Human |
596955112 | GWAS1074631_H | hypertension QTL GWAS1074631 (human) | | 5e-09 | hypertension | | 6 | 1613451 | 1613452 | Human |
596955115 | GWAS1074634_H | hypertension QTL GWAS1074634 (human) | | 4e-09 | hypertension | | 6 | 13475437 | 13475438 | Human |
596954908 | GWAS1074427_H | Red cell distribution width QTL GWAS1074427 (human) | | 1e-23 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3162144 | 3162145 | Human |
597241616 | GWAS1337690_H | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head QTL GWAS1337690 (human) | | 1e-08 | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | | 6 | 7236387 | 7236388 | Human |
597307155 | GWAS1403229_H | amyloid-beta measurement, Alzheimer's disease biomarker measurement QTL GWAS1403229 (human) | | 0.0000009 | amyloid-beta measurement, Alzheimer's disease biomarker measurement | | 6 | 16147118 | 16147119 | Human |
597487383 | GWAS1583457_H | serum alanine aminotransferase measurement QTL GWAS1583457 (human) | | 5e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 7315953 | 7315954 | Human |
597110553 | GWAS1206627_H | Antiglaucoma preparations and miotics use measurement QTL GWAS1206627 (human) | | 8e-10 | Antiglaucoma preparations and miotics use measurement | | 6 | 637465 | 637466 | Human |
597233417 | GWAS1329491_H | appendicular lean mass QTL GWAS1329491 (human) | | 4e-09 | appendicular lean mass | | 6 | 7231610 | 7231611 | Human |
597438222 | GWAS1534296_H | peptide measurement QTL GWAS1534296 (human) | | 0.000002 | peptide metabolism trait (VT:0010634) | | 6 | 8269182 | 8269183 | Human |
597036814 | GWAS1132888_H | white matter volume measurement QTL GWAS1132888 (human) | | 0.000003 | brain size trait (VT:0000771) | | 6 | 3075319 | 3075320 | Human |
406959323 | GWAS608299_H | androgenetic alopecia QTL GWAS608299 (human) | | 4e-11 | androgenetic alopecia | | 6 | 396321 | 396322 | Human |
597167931 | GWAS1264005_H | radiation-induced disorder QTL GWAS1264005 (human) | | 0.0000005 | radiation-induced disorder | | 6 | 8412720 | 8412721 | Human |
597479221 | GWAS1575295_H | platelet crit QTL GWAS1575295 (human) | | 1e-11 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 6 | 2768671 | 2768672 | Human |
406992107 | GWAS641083_H | mean corpuscular hemoglobin concentration QTL GWAS641083 (human) | | 2e-30 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16298740 | 16298741 | Human |
597225266 | GWAS1321340_H | chronotype measurement QTL GWAS1321340 (human) | | 3e-09 | sleep behavior trait (VT:0001501) | | 6 | 19102016 | 19102017 | Human |
597585715 | GWAS1642575_H | eosinophil count QTL GWAS1642575 (human) | | 3e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 246178 | 246179 | Human |
597372726 | GWAS1468800_H | chronic hepatitis C virus infection QTL GWAS1468800 (human) | | 0.000005 | chronic hepatitis C virus infection | | 6 | 1535763 | 1535764 | Human |
597200681 | GWAS1296755_H | memory performance QTL GWAS1296755 (human) | | 0.000009 | memory performance | | 6 | 15471139 | 15471140 | Human |
597323565 | GWAS1419639_H | cup-to-disc ratio measurement QTL GWAS1419639 (human) | | 1e-21 | cup-to-disc ratio measurement | | 6 | 1983206 | 1983207 | Human |
597102378 | GWAS1198452_H | alopecia QTL GWAS1198452 (human) | | 3e-13 | alopecia | | 6 | 9537891 | 9537892 | Human |
597225305 | GWAS1321379_H | BMI-adjusted waist-hip ratio QTL GWAS1321379 (human) | | 1e-11 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597225311 | GWAS1321385_H | chronotype measurement QTL GWAS1321385 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 6 | 12154881 | 12154882 | Human |
596954973 | GWAS1074492_H | coronary artery disease QTL GWAS1074492 (human) | | 9e-26 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597512020 | GWAS1608094_H | body mass index QTL GWAS1608094 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18492119 | 18492120 | Human |
597438294 | GWAS1534368_H | colorectal health QTL GWAS1534368 (human) | | 0.000009 | colorectal health | | 6 | 998578 | 998579 | Human |
597372745 | GWAS1468819_H | major depressive disorder QTL GWAS1468819 (human) | | 0.000006 | major depressive disorder | | 6 | 10175803 | 10175804 | Human |
597053253 | GWAS1149327_H | eosinophil count QTL GWAS1149327 (human) | | 3e-52 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 577820 | 577821 | Human |
597036876 | GWAS1132950_H | grey matter volume measurement QTL GWAS1132950 (human) | | 0.000009 | grey matter volume measurement | | 6 | 15234556 | 15234557 | Human |
597053258 | GWAS1149332_H | household income QTL GWAS1149332 (human) | | 5e-10 | household income | | 6 | 16663232 | 16663233 | Human |
597036875 | GWAS1132949_H | grey matter volume measurement QTL GWAS1132949 (human) | | 0.000001 | grey matter volume measurement | | 6 | 1722059 | 1722060 | Human |
597102409 | GWAS1198483_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1198483 (human) | | 2e-10 | schizophrenia, intelligence, self reported educational attainment | | 6 | 16663232 | 16663233 | Human |
597200760 | GWAS1296834_H | lean body mass QTL GWAS1296834 (human) | | 2e-38 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7699318 | 7699319 | Human |
597512056 | GWAS1608130_H | testosterone measurement QTL GWAS1608130 (human) | | 5e-10 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1373379 | 1373380 | Human |
406942890 | GWAS591866_H | lipid measurement QTL GWAS591866 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 6325809 | 6325810 | Human |
597290866 | GWAS1386940_H | irritable bowel syndrome, vital capacity QTL GWAS1386940 (human) | | 2e-08 | irritable bowel syndrome, vital capacity | | 6 | 7130363 | 7130364 | Human |
597200757 | GWAS1296831_H | lean body mass QTL GWAS1296831 (human) | | 6e-40 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7702426 | 7702427 | Human |
597323618 | GWAS1419692_H | colorectal cancer QTL GWAS1419692 (human) | | 0.000002 | colorectal cancer | | 6 | 18747224 | 18747225 | Human |
597143406 | GWAS1239480_H | anterior thigh muscle volume QTL GWAS1239480 (human) | | 1e-11 | anterior thigh muscle volume | | 6 | 7697379 | 7697380 | Human |
407123133 | GWAS772109_H | obsolete_prostate specific antigen measurement QTL GWAS772109 (human) | | 9e-12 | obsolete_prostate specific antigen measurement | | 6 | 16514923 | 16514924 | Human |
597446498 | GWAS1542572_H | HbA1c measurement QTL GWAS1542572 (human) | | 2e-11 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7218104 | 7218105 | Human |
597438306 | GWAS1534380_H | ulcerative colitis QTL GWAS1534380 (human) | | 0.0000007 | ulcerative colitis | | 6 | 14719265 | 14719266 | Human |
407123131 | GWAS772107_H | obsolete_prostate specific antigen measurement QTL GWAS772107 (human) | | 2e-12 | obsolete_prostate specific antigen measurement | | 6 | 15462908 | 15462909 | Human |
597462684 | GWAS1558758_H | Headache QTL GWAS1558758 (human) | | 4e-15 | Headache | | 6 | 12903725 | 12903726 | Human |
597200536 | GWAS1296610_H | restless legs syndrome QTL GWAS1296610 (human) | | 2e-08 | restless legs syndrome | | 6 | 16430724 | 16430725 | Human |
597511839 | GWAS1607913_H | episodic memory QTL GWAS1607913 (human) | | 0.000002 | episodic memory | | 6 | 14690218 | 14690219 | Human |
597020315 | GWAS1116389_H | forced expiratory volume, response to bronchodilator QTL GWAS1116389 (human) | | 0.000004 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 1315560 | 1315561 | Human |
597601937 | GWAS1658797_H | monocyte count QTL GWAS1658797 (human) | | 2e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 291291 | 291292 | Human |
407024973 | GWAS673949_H | myocardial infarction QTL GWAS673949 (human) | | 1e-09 | coronary artery disease | | 6 | 12927312 | 12927313 | Human |
596987524 | GWAS1107043_H | memory performance, sex interaction measurement QTL GWAS1107043 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 529104 | 529105 | Human |
407385437 | GWAS1034413_H | obsolete_red blood cell distribution width QTL GWAS1034413 (human) | | 1e-10 | obsolete_red blood cell distribution width | | 6 | 13920785 | 13920786 | Human |
597249676 | GWAS1345750_H | corneal resistance factor QTL GWAS1345750 (human) | | 6e-09 | corneal resistance factor | | 6 | 16521098 | 16521099 | Human |
407385438 | GWAS1034414_H | obsolete_red blood cell distribution width QTL GWAS1034414 (human) | | 8e-18 | obsolete_red blood cell distribution width | | 6 | 16267244 | 16267245 | Human |
407385439 | GWAS1034415_H | obsolete_red blood cell distribution width QTL GWAS1034415 (human) | | 1e-15 | obsolete_red blood cell distribution width | | 6 | 18757083 | 18757084 | Human |
597528197 | GWAS1624271_H | FEV/FVC ratio QTL GWAS1624271 (human) | | 1e-10 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7214266 | 7214267 | Human |
597036684 | GWAS1132758_H | respiratory symptom change measurement, response to placebo QTL GWAS1132758 (human) | | 0.000008 | respiratory symptom change measurement, response to placebo | respiratory system measurement (CMO:0000094) | 6 | 5589406 | 5589407 | Human |
597421696 | GWAS1517770_H | neuroticism measurement QTL GWAS1517770 (human) | | 2e-08 | neuroticism measurement | | 6 | 11711582 | 11711583 | Human |
597266105 | GWAS1362179_H | educational attainment QTL GWAS1362179 (human) | | 8e-10 | educational attainment | | 6 | 16814654 | 16814655 | Human |
597266104 | GWAS1362178_H | educational attainment QTL GWAS1362178 (human) | | 4e-08 | educational attainment | | 6 | 16668786 | 16668787 | Human |
597446334 | GWAS1542408_H | free cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1542408 (human) | | 5e-08 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 3920825 | 3920826 | Human |
597266107 | GWAS1362181_H | educational attainment QTL GWAS1362181 (human) | | 2e-13 | educational attainment | | 6 | 16962373 | 16962374 | Human |
597266106 | GWAS1362180_H | educational attainment QTL GWAS1362180 (human) | | 3e-09 | educational attainment | | 6 | 16900907 | 16900908 | Human |
406943079 | GWAS592055_H | aging QTL GWAS592055 (human) | | 0.000009 | aging | | 6 | 858970 | 858971 | Human |
407041386 | GWAS690362_H | sitting height ratio QTL GWAS690362 (human) | | 0.000004 | sitting height ratio | | 6 | 604158 | 604159 | Human |
406992233 | GWAS641209_H | intelligence QTL GWAS641209 (human) | | 8e-09 | intelligence | | 6 | 16296593 | 16296594 | Human |
597266101 | GWAS1362175_H | educational attainment QTL GWAS1362175 (human) | | 3e-08 | educational attainment | | 6 | 16433711 | 16433712 | Human |
597110458 | GWAS1206532_H | chronotype measurement QTL GWAS1206532 (human) | | 8e-10 | sleep behavior trait (VT:0001501) | | 6 | 11574141 | 11574142 | Human |
597266103 | GWAS1362177_H | educational attainment QTL GWAS1362177 (human) | | 9e-26 | educational attainment | | 6 | 16662870 | 16662871 | Human |
597266102 | GWAS1362176_H | educational attainment QTL GWAS1362176 (human) | | 0.000001 | educational attainment | | 6 | 16533665 | 16533666 | Human |
596954789 | GWAS1074308_H | glucose measurement QTL GWAS1074308 (human) | | 2e-12 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597397153 | GWAS1493227_H | pulse pressure measurement QTL GWAS1493227 (human) | | 7e-22 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597044908 | GWAS1140982_H | hemoglobin measurement QTL GWAS1140982 (human) | | 8e-21 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16287961 | 16287962 | Human |
597233317 | GWAS1329391_H | basal cell carcinoma QTL GWAS1329391 (human) | | 4e-08 | basal cell carcinoma | | 6 | 501939 | 501940 | Human |
597397212 | GWAS1493286_H | vaginal microbiome measurement QTL GWAS1493286 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597356240 | GWAS1452314_H | tuberculosis QTL GWAS1452314 (human) | | 0.000004 | tuberculosis | | 6 | 2355441 | 2355442 | Human |
597487318 | GWAS1583392_H | linoleic acid measurement QTL GWAS1583392 (human) | | 1e-09 | linoleic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 16113090 | 16113091 | Human |
597282504 | GWAS1378578_H | COVID-19 QTL GWAS1378578 (human) | | 0.000005 | COVID-19 | | 6 | 12017538 | 12017539 | Human |
597077750 | GWAS1173824_H | blood protein measurement QTL GWAS1173824 (human) | | 0.000004 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 7913450 | 7913451 | Human |
406951204 | GWAS600180_H | JT interval, response to sulfonylurea QTL GWAS600180 (human) | | 0.0000004 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 6 | 5478560 | 5478561 | Human |
597364467 | GWAS1460541_H | hemoglobin measurement QTL GWAS1460541 (human) | | 1e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12288189 | 12288190 | Human |
597044966 | GWAS1141040_H | aging, epigenetic status QTL GWAS1141040 (human) | | 2e-15 | aging, epigenetic status | | 6 | 18104469 | 18104470 | Human |
597044967 | GWAS1141041_H | aging, epigenetic status QTL GWAS1141041 (human) | | 6e-26 | aging, epigenetic status | | 6 | 18140332 | 18140333 | Human |
597585644 | GWAS1642504_H | eosinophil count QTL GWAS1642504 (human) | | 2e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
597339874 | GWAS1435948_H | sexual dimorphism measurement QTL GWAS1435948 (human) | | 3e-19 | sexual dimorphism measurement | | 6 | 7729381 | 7729382 | Human |
597298915 | GWAS1394989_H | type 2 diabetes mellitus QTL GWAS1394989 (human) | | 4e-25 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597593831 | GWAS1650691_H | eosinophil count QTL GWAS1650691 (human) | | 8e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 12099656 | 12099657 | Human |
597339873 | GWAS1435947_H | sexual dimorphism measurement QTL GWAS1435947 (human) | | 1e-08 | sexual dimorphism measurement | | 6 | 7753975 | 7753976 | Human |
596979434 | GWAS1098953_H | body height QTL GWAS1098953 (human) | | 8e-10 | body height | | 6 | 15397210 | 15397211 | Human |
597110294 | GWAS1206368_H | colorectal cancer, breast carcinoma QTL GWAS1206368 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 6 | 14107800 | 14107801 | Human |
597274142 | GWAS1370216_H | BMI-adjusted waist circumference QTL GWAS1370216 (human) | | 4e-08 | body size trait (VT:0100005) | | 6 | 7120224 | 7120225 | Human |
597372435 | GWAS1468509_H | schizophrenia QTL GWAS1468509 (human) | | 0.000004 | schizophrenia | | 6 | 475489 | 475490 | Human |
597462540 | GWAS1558614_H | educational attainment QTL GWAS1558614 (human) | | 2e-12 | educational attainment | | 6 | 14718029 | 14718030 | Human |
597462541 | GWAS1558615_H | educational attainment QTL GWAS1558615 (human) | | 3e-09 | educational attainment | | 6 | 16948220 | 16948221 | Human |
597372431 | GWAS1468505_H | schizophrenia QTL GWAS1468505 (human) | | 0.000003 | schizophrenia | | 6 | 475489 | 475490 | Human |
597429769 | GWAS1525843_H | Red cell distribution width QTL GWAS1525843 (human) | | 6e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 4717531 | 4717532 | Human |
597020162 | GWAS1116236_H | late-onset myasthenia gravis QTL GWAS1116236 (human) | | 0.000002 | late-onset myasthenia gravis | | 6 | 1759646 | 1759647 | Human |
597396994 | GWAS1493068_H | cup-to-disc ratio measurement QTL GWAS1493068 (human) | | 2e-11 | cup-to-disc ratio measurement | | 6 | 11411605 | 11411606 | Human |
597388859 | GWAS1484933_H | susceptibility to plantar warts measurement QTL GWAS1484933 (human) | | 0.000003 | susceptibility to plantar warts measurement | | 6 | 475649 | 475650 | Human |
597044799 | GWAS1140873_H | Abnormality of refraction QTL GWAS1140873 (human) | | 3e-08 | Abnormality of refraction | | 6 | 11719245 | 11719246 | Human |
406992361 | GWAS641337_H | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy QTL GWAS641337 (human) | | 1e-08 | response to viral infection trait (VT:0010439) | | 6 | 221146 | 221147 | Human |
597339702 | GWAS1435776_H | pulse pressure measurement QTL GWAS1435776 (human) | | 3e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 16306520 | 16306521 | Human |
597339700 | GWAS1435774_H | pulse pressure measurement QTL GWAS1435774 (human) | | 2e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7211585 | 7211586 | Human |
597061176 | GWAS1157250_H | adolescent idiopathic scoliosis QTL GWAS1157250 (human) | | 0.0000006 | adolescent idiopathic scoliosis | | 6 | 15754527 | 15754528 | Human |
597339701 | GWAS1435775_H | pulse pressure measurement QTL GWAS1435775 (human) | | 8e-14 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12296022 | 12296023 | Human |
597503533 | GWAS1599607_H | Widow's peak QTL GWAS1599607 (human) | | 1e-49 | Widow's peak | | 6 | 2453236 | 2453237 | Human |
597610027 | GWAS1666887_H | monocyte count QTL GWAS1666887 (human) | | 1e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 291291 | 291292 | Human |
597167662 | GWAS1263736_H | phenylalanine measurement QTL GWAS1263736 (human) | | 5e-09 | phenylalanine measurement | | 6 | 18117724 | 18117725 | Human |
596954659 | GWAS1074178_H | size QTL GWAS1074178 (human) | | 6e-10 | size | | 6 | 18548535 | 18548536 | Human |
597290532 | GWAS1386606_H | asthma, endometriosis QTL GWAS1386606 (human) | | 0.000007 | asthma, endometriosis | | 6 | 5479863 | 5479864 | Human |
407221754 | GWAS870730_H | mean corpuscular hemoglobin QTL GWAS870730 (human) | | 1e-21 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15180275 | 15180276 | Human |
597053013 | GWAS1149087_H | non-melanoma skin carcinoma QTL GWAS1149087 (human) | | 0.000006 | non-melanoma skin carcinoma | | 6 | 615736 | 615737 | Human |
597503577 | GWAS1599651_H | insomnia QTL GWAS1599651 (human) | | 5e-09 | insomnia | | 6 | 7315263 | 7315264 | Human |
597618265 | GWAS1675125_H | trauma complication, cataract QTL GWAS1675125 (human) | | 2e-11 | trauma complication, cataract | | 6 | 6750222 | 6750223 | Human |
597503578 | GWAS1599652_H | insomnia QTL GWAS1599652 (human) | | 2e-10 | insomnia | | 6 | 14915447 | 14915448 | Human |
597151323 | GWAS1247397_H | Dupuytren Contracture QTL GWAS1247397 (human) | | 0.0000004 | Dupuytren Contracture | | 6 | 875559 | 875560 | Human |
597405269 | GWAS1501343_H | systolic blood pressure QTL GWAS1501343 (human) | | 2e-11 | systolic blood pressure | | 6 | 12903725 | 12903726 | Human |
597061191 | GWAS1157265_H | adolescent idiopathic scoliosis QTL GWAS1157265 (human) | | 0.000001 | adolescent idiopathic scoliosis | | 6 | 9427283 | 9427284 | Human |
597028423 | GWAS1124497_H | Red cell distribution width QTL GWAS1124497 (human) | | 2e-08 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3369739 | 3369740 | Human |
597323342 | GWAS1419416_H | 1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPC (P-18:0/22:6) measurement QTL GWAS1419416 (human) | | 1e-15 | 1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPC (P-18:0/22:6) measurement | | 6 | 11088186 | 11088187 | Human |
597323343 | GWAS1419417_H | 1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPE (P-18:0/22:6) measurement QTL GWAS1419417 (human) | | 3e-15 | 1-(1-enyl-stearoyl)-2-docosahexaenoyl-GPE (P-18:0/22:6) measurement | | 6 | 11028421 | 11028422 | Human |
597380686 | GWAS1476760_H | mean corpuscular hemoglobin QTL GWAS1476760 (human) | | 3e-20 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15085682 | 15085683 | Human |
597585481 | GWAS1642341_H | squamous cell carcinoma QTL GWAS1642341 (human) | | 3e-238 | squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597069377 | GWAS1165451_H | susceptibility to childhood ear infection measurement QTL GWAS1165451 (human) | | 0.000005 | response to infection trait (VT:0010434) | | 6 | 1626309 | 1626310 | Human |
406967708 | GWAS616684_H | chronic obstructive pulmonary disease QTL GWAS616684 (human) | | 4e-09 | lung integrity trait (VT:0010906) | | 6 | 7562999 | 7563000 | Human |
597192314 | GWAS1288388_H | free androgen index QTL GWAS1288388 (human) | | 5e-08 | free androgen index | | 6 | 1618731 | 1618732 | Human |
597421695 | GWAS1517769_H | neuroticism measurement QTL GWAS1517769 (human) | | 1e-09 | neuroticism measurement | | 6 | 3961054 | 3961055 | Human |
597167728 | GWAS1263802_H | alkaline phosphatase measurement QTL GWAS1263802 (human) | | 4e-15 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 15645308 | 15645309 | Human |
597470839 | GWAS1566913_H | electrocardiography QTL GWAS1566913 (human) | | 3e-08 | electrocardiography | | 6 | 3463835 | 3463836 | Human |
597143143 | GWAS1239217_H | C-reactive protein measurement QTL GWAS1239217 (human) | | 9e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 7112586 | 7112587 | Human |
597610094 | GWAS1666954_H | monocyte count QTL GWAS1666954 (human) | | 2e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 17602639 | 17602640 | Human |
407049650 | GWAS698626_H | coronary artery calcification QTL GWAS698626 (human) | | 0.000003 | coronary artery calcification | | 6 | 8000884 | 8000885 | Human |
597610092 | GWAS1666952_H | monocyte count QTL GWAS1666952 (human) | | 2e-21 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 291291 | 291292 | Human |
597372521 | GWAS1468595_H | coronary artery calcification QTL GWAS1468595 (human) | | 0.000003 | coronary artery calcification | | 6 | 8228709 | 8228710 | Human |
597610093 | GWAS1666953_H | monocyte count QTL GWAS1666953 (human) | | 3e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10535358 | 10535359 | Human |
407074229 | GWAS723205_H | marginal zone B-cell lymphoma, systemic lupus erythematosus QTL GWAS723205 (human) | | 6e-08 | marginal zone B-cell lymphoma, systemic lupus erythematosus | | 6 | 16970739 | 16970740 | Human |
597093783 | GWAS1189857_H | hair color QTL GWAS1189857 (human) | | 3e-12 | hair color | | 6 | 422631 | 422632 | Human |
597511573 | GWAS1607647_H | DNA methylation QTL GWAS1607647 (human) | | 4e-08 | DNA methylation | | 6 | 18492119 | 18492120 | Human |
597388689 | GWAS1484763_H | squamous cell lung carcinoma QTL GWAS1484763 (human) | | 0.000002 | squamous cell lung carcinoma | | 6 | 10414773 | 10414774 | Human |
597486993 | GWAS1583067_H | docosahexaenoic acid measurement, fatty acid measurement QTL GWAS1583067 (human) | | 6e-39 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11050570 | 11050571 | Human |
597052804 | GWAS1148878_H | BMI-adjusted waist-hip ratio QTL GWAS1148878 (human) | | 2e-08 | body size trait (VT:0100005) | | 6 | 7231537 | 7231538 | Human |
407123542 | GWAS772518_H | unipolar depression, anxiety QTL GWAS772518 (human) | | 0.000008 | unipolar depression, anxiety | | 6 | 11811081 | 11811082 | Human |
597372297 | GWAS1468371_H | mean corpuscular hemoglobin QTL GWAS1468371 (human) | | 1e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16153698 | 16153699 | Human |
597372296 | GWAS1468370_H | mean corpuscular hemoglobin QTL GWAS1468370 (human) | | 2e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 2408436 | 2408437 | Human |
596970881 | GWAS1090400_H | major depressive disorder QTL GWAS1090400 (human) | | 0.000003 | major depressive disorder | | 6 | 2518145 | 2518146 | Human |
597052803 | GWAS1148877_H | BMI-adjusted waist-hip ratio QTL GWAS1148877 (human) | | 5e-19 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597413262 | GWAS1509336_H | coronary artery disease QTL GWAS1509336 (human) | | 0.0000005 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597486987 | GWAS1583061_H | docosahexaenoic acid measurement QTL GWAS1583061 (human) | | 4e-25 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11054512 | 11054513 | Human |
597118348 | GWAS1214422_H | erythrocyte count QTL GWAS1214422 (human) | | 2e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16290617 | 16290620 | Human |
597290372 | GWAS1386446_H | total lipids in very small VLDL measurement QTL GWAS1386446 (human) | | 5e-10 | total lipids in very small VLDL measurement | | 6 | 16126442 | 16126443 | Human |
596970933 | GWAS1090452_H | pulse pressure measurement QTL GWAS1090452 (human) | | 2e-08 | pulse pressure measurement | | 6 | 1303610 | 1303611 | Human |
597110196 | GWAS1206270_H | systolic blood pressure QTL GWAS1206270 (human) | | 4e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1613451 | 1613452 | Human |
406984292 | GWAS633268_H | intelligence QTL GWAS633268 (human) | | 8e-10 | intelligence | | 6 | 16320756 | 16320757 | Human |
597175730 | GWAS1271804_H | vital capacity QTL GWAS1271804 (human) | | 1e-15 | vital capacity | | 6 | 7240643 | 7240644 | Human |
597601717 | GWAS1658577_H | monocyte count QTL GWAS1658577 (human) | | 4e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 17602639 | 17602640 | Human |
597413303 | GWAS1509377_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1509377 (human) | | 0.000005 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 6 | 10432392 | 10432393 | Human |
597413302 | GWAS1509376_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1509376 (human) | | 0.000003 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 6 | 960551 | 960552 | Human |
597208502 | GWAS1304576_H | type 2 diabetes mellitus QTL GWAS1304576 (human) | | 3e-11 | type 2 diabetes mellitus | | 6 | 7281421 | 7281422 | Human |
597396907 | GWAS1492981_H | vaginal microbiome measurement QTL GWAS1492981 (human) | | 0.000007 | vaginal microbiome measurement | | 6 | 7025637 | 7025638 | Human |
406967922 | GWAS616898_H | reticulocyte count QTL GWAS616898 (human) | | 1e-10 | reticulocyte quantity (VT:0003135) | red blood cell measurement (CMO:0001356) | 6 | 16285830 | 16285831 | Human |
597110179 | GWAS1206253_H | urate measurement QTL GWAS1206253 (human) | | 2e-11 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 1997631 | 1997632 | Human |
407115377 | GWAS764353_H | cognitive decline measurement QTL GWAS764353 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 6 | 6248834 | 6248835 | Human |
597396899 | GWAS1492973_H | vaginal microbiome measurement QTL GWAS1492973 (human) | | 8e-08 | vaginal microbiome measurement | | 6 | 8859422 | 8859423 | Human |
407025274 | GWAS674250_H | hip geometry QTL GWAS674250 (human) | | 0.000003 | hip geometry | hip circumference (CMO:0000014) | 6 | 13215826 | 13215827 | Human |
597290403 | GWAS1386477_H | size QTL GWAS1386477 (human) | | 8e-09 | size | | 6 | 2670364 | 2670365 | Human |
597298599 | GWAS1394673_H | cholesteryl ester 16:2 measurement QTL GWAS1394673 (human) | | 4e-08 | cholesteryl ester 16:2 measurement | | 6 | 12969824 | 12969825 | Human |
597061072 | GWAS1157146_H | colorectal mucinous adenocarcinoma QTL GWAS1157146 (human) | | 0.000006 | colorectal mucinous adenocarcinoma | | 6 | 1294916 | 1294917 | Human |
597306834 | GWAS1402908_H | coronary artery disease QTL GWAS1402908 (human) | | 3e-11 | coronary artery disease | | 6 | 1617092 | 1617093 | Human |
596954590 | GWAS1074109_H | Chronic pain QTL GWAS1074109 (human) | | 1e-18 | Chronic pain | | 6 | 12903725 | 12903726 | Human |
597470673 | GWAS1566747_H | eye colour measurement QTL GWAS1566747 (human) | | 0.000003 | eye colour measurement | eye morphological measurement (CMO:0003080) | 6 | 4371835 | 4371836 | Human |
596962758 | GWAS1082277_H | forced expiratory volume, inflammatory bowel disease QTL GWAS1082277 (human) | | 4e-08 | forced expiratory volume, inflammatory bowel disease | | 6 | 7694497 | 7694498 | Human |
596979136 | GWAS1098655_H | body height QTL GWAS1098655 (human) | | 3e-13 | body height | | 6 | 7726808 | 7726809 | Human |
597593547 | GWAS1650407_H | retinopathy QTL GWAS1650407 (human) | | 5e-24 | retinopathy | | 6 | 10185180 | 10185181 | Human |
407008799 | GWAS657775_H | neutrophil count QTL GWAS657775 (human) | | 1e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16757771 | 16757772 | Human |
407000604 | GWAS649580_H | BMI-adjusted waist circumference QTL GWAS649580 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 16728463 | 16728464 | Human |
597388740 | GWAS1484814_H | body weight QTL GWAS1484814 (human) | | 0.000005 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 11995574 | 11995575 | Human |
407377449 | GWAS1026425_H | obsolete_red blood cell distribution width QTL GWAS1026425 (human) | | 1e-12 | obsolete_red blood cell distribution width | | 6 | 3166734 | 3166735 | Human |
597388794 | GWAS1484868_H | glucose-dependent insulinotropic peptide measurement, glucose tolerance test QTL GWAS1484868 (human) | | 4e-08 | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | | 6 | 6331640 | 6331641 | Human |
597421561 | GWAS1517635_H | blood protein measurement QTL GWAS1517635 (human) | | 9e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 255796 | 255797 | Human |
597413362 | GWAS1509436_H | heel bone mineral density QTL GWAS1509436 (human) | | 5e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7058624 | 7058625 | Human |
597069308 | GWAS1165382_H | lung carcinoma QTL GWAS1165382 (human) | | 0.000003 | lung carcinoma | | 6 | 422631 | 422632 | Human |
597413361 | GWAS1509435_H | heel bone mineral density QTL GWAS1509435 (human) | | 5e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2500586 | 2500587 | Human |
597052922 | GWAS1148996_H | non-melanoma skin carcinoma QTL GWAS1148996 (human) | | 8e-13 | non-melanoma skin carcinoma | | 6 | 392364 | 392365 | Human |
597618163 | GWAS1675023_H | body weight QTL GWAS1675023 (human) | | 6e-14 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12100869 | 12100870 | Human |
597347828 | GWAS1443902_H | urinary albumin to creatinine ratio QTL GWAS1443902 (human) | | 0.0000007 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 6 | 7820120 | 7820121 | Human |
597487085 | GWAS1583159_H | coronary artery disease, plasminogen activator inhibitor 1 measurement QTL GWAS1583159 (human) | | 4e-29 | coronary artery disease, plasminogen activator inhibitor 1 measurement | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 6 | 12903203 | 12903204 | Human |
597478888 | GWAS1574962_H | waist-hip ratio QTL GWAS1574962 (human) | | 1e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
597134831 | GWAS1230905_H | memory performance QTL GWAS1230905 (human) | | 0.000008 | memory performance | | 6 | 16209404 | 16209405 | Human |
597528036 | GWAS1624110_H | basal cell carcinoma QTL GWAS1624110 (human) | | 9e-77 | basal cell carcinoma | | 6 | 463479 | 463480 | Human |
597126638 | GWAS1222712_H | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide QTL GWAS1222712 (human) | | 2e-08 | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | | 6 | 8427876 | 8427877 | Human |
597175777 | GWAS1271851_H | Alzheimer disease, dementia QTL GWAS1271851 (human) | | 0.0000002 | Alzheimer disease, dementia | | 6 | 10358244 | 10358245 | Human |
597102061 | GWAS1198135_H | alkaline phosphatase measurement QTL GWAS1198135 (human) | | 3e-12 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 15540793 | 15540794 | Human |
597527837 | GWAS1623911_H | level of pterin in blood QTL GWAS1623911 (human) | | 9e-36 | level of pterin in blood | | 6 | 3021464 | 3021465 | Human |
597093655 | GWAS1189729_H | hair color QTL GWAS1189729 (human) | | 5e-08 | hair color | | 6 | 422631 | 422632 | Human |
597495068 | GWAS1591142_H | COVID-19 QTL GWAS1591142 (human) | | 0.0000003 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
597093649 | GWAS1189723_H | hair color QTL GWAS1189723 (human) | | 1e-13 | hair color | | 6 | 422631 | 422632 | Human |
2289320 | BW390_H | Body weight QTL 390 (human) | 2.13 | | Body weight | BMI | 6 | 1 | 19321359 | Human |
597191954 | GWAS1288028_H | systemic lupus erythematosus QTL GWAS1288028 (human) | | 1e-08 | systemic lupus erythematosus | | 6 | 14096427 | 14096428 | Human |
597363977 | GWAS1460051_H | self reported educational attainment QTL GWAS1460051 (human) | | 3e-09 | self reported educational attainment | | 6 | 16950400 | 16950401 | Human |
597363976 | GWAS1460050_H | self reported educational attainment QTL GWAS1460050 (human) | | 3e-12 | self reported educational attainment | | 6 | 14723377 | 14723378 | Human |
597609741 | GWAS1666601_H | basophil measurement QTL GWAS1666601 (human) | | 7e-14 | basophil measurement | | 6 | 17602639 | 17602640 | Human |
406968020 | GWAS616996_H | neutrophil count, basophil count QTL GWAS616996 (human) | | 4e-09 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 6 | 7211518 | 7211519 | Human |
597167374 | GWAS1263448_H | body mass index QTL GWAS1263448 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13180222 | 13180223 | Human |
406968025 | GWAS617001_H | neutrophil count, basophil count QTL GWAS617001 (human) | | 3e-13 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 6 | 16744456 | 16744457 | Human |
597421318 | GWAS1517392_H | bilirubin measurement QTL GWAS1517392 (human) | | 2e-11 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 6 | 6971520 | 6971521 | Human |
597339396 | GWAS1435470_H | sexual dimorphism measurement QTL GWAS1435470 (human) | | 2e-08 | sexual dimorphism measurement | | 6 | 2071923 | 2071924 | Human |
597323066 | GWAS1419140_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419140 (human) | | 3e-12 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 11847152 | 11847153 | Human |
597429564 | GWAS1525638_H | protein measurement QTL GWAS1525638 (human) | | 5e-16 | protein measurement | | 6 | 14117803 | 14117804 | Human |
597421370 | GWAS1517444_H | neuroticism measurement QTL GWAS1517444 (human) | | 2e-09 | neuroticism measurement | | 6 | 3961054 | 3961055 | Human |
597323067 | GWAS1419141_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419141 (human) | | 2e-52 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 16130925 | 16130926 | Human |
597314873 | GWAS1410947_H | cortical thickness QTL GWAS1410947 (human) | | 5e-09 | cortical thickness | | 6 | 17885814 | 17885815 | Human |
597306686 | GWAS1402760_H | uric acid measurement QTL GWAS1402760 (human) | | 2e-23 | uric acid measurement | blood uric acid level (CMO:0000501) | 6 | 2038810 | 2038811 | Human |
597593400 | GWAS1650260_H | prostate specific antigen amount QTL GWAS1650260 (human) | | 4e-24 | prostate specific antigen amount | | 6 | 16512112 | 16512113 | Human |
597323069 | GWAS1419143_H | non-high density lipoprotein cholesterol measurement QTL GWAS1419143 (human) | | 2e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 6 | 18771579 | 18771580 | Human |
407099119 | GWAS748095_H | total cholesterol measurement QTL GWAS748095 (human) | | 0.000005 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 17632830 | 17632831 | Human |
407099116 | GWAS748092_H | low density lipoprotein cholesterol measurement QTL GWAS748092 (human) | | 0.000003 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 17632830 | 17632831 | Human |
597208360 | GWAS1304434_H | childhood onset asthma QTL GWAS1304434 (human) | | 7e-11 | childhood onset asthma | | 6 | 409119 | 409120 | Human |
597069088 | GWAS1165162_H | susceptibility to hepatitis B infection measurement QTL GWAS1165162 (human) | | 0.000008 | susceptibility to hepatitis B infection measurement | | 6 | 1931664 | 1931665 | Human |
597347617 | GWAS1443691_H | urinary albumin to creatinine ratio QTL GWAS1443691 (human) | | 4e-08 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 6 | 7820120 | 7820121 | Human |
597519651 | GWAS1615725_H | electrocardiography QTL GWAS1615725 (human) | | 7e-09 | electrocardiography | | 6 | 7532188 | 7532189 | Human |
597364057 | GWAS1460131_H | reticulocyte count QTL GWAS1460131 (human) | | 6e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2504388 | 2504390 | Human |
597511518 | GWAS1607592_H | COVID-19 QTL GWAS1607592 (human) | | 0.0000004 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
597503321 | GWAS1599395_H | colorectal cancer QTL GWAS1599395 (human) | | 1e-08 | colorectal cancer | | 6 | 6749556 | 6749557 | Human |
596987217 | GWAS1106736_H | memory performance, sex interaction measurement QTL GWAS1106736 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 7534921 | 7534922 | Human |
596987216 | GWAS1106735_H | memory performance, sex interaction measurement QTL GWAS1106735 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 7534896 | 7534897 | Human |
596954460 | GWAS1073979_H | coronary artery disease QTL GWAS1073979 (human) | | 6e-19 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597290320 | GWAS1386394_H | free cholesterol in small LDL measurement QTL GWAS1386394 (human) | | 4e-14 | blood LDL cholesterol amount (VT:0000181) | | 6 | 16130925 | 16130926 | Human |
597052765 | GWAS1148839_H | BMI-adjusted waist-hip ratio QTL GWAS1148839 (human) | | 4e-08 | body size trait (VT:0100005) | | 6 | 6631763 | 6631764 | Human |
597454160 | GWAS1550234_H | BMI-adjusted hip circumference QTL GWAS1550234 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6782065 | 6782066 | Human |
597036378 | GWAS1132452_H | type 2 diabetes mellitus QTL GWAS1132452 (human) | | 0.0000004 | type 2 diabetes mellitus | | 6 | 7035501 | 7035502 | Human |
597265749 | GWAS1361823_H | total cholesterol measurement QTL GWAS1361823 (human) | | 1e-57 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16130925 | 16130926 | Human |
406976141 | GWAS625117_H | mean corpuscular hemoglobin QTL GWAS625117 (human) | | 2e-59 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16287961 | 16287962 | Human |
597036379 | GWAS1132453_H | type 2 diabetes mellitus QTL GWAS1132453 (human) | | 3e-21 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597265748 | GWAS1361822_H | total cholesterol measurement QTL GWAS1361822 (human) | | 9e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 11868449 | 11868450 | Human |
406976140 | GWAS625116_H | mean corpuscular hemoglobin QTL GWAS625116 (human) | | 2e-12 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16285830 | 16285831 | Human |
597265750 | GWAS1361824_H | total cholesterol measurement QTL GWAS1361824 (human) | | 1e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 18765683 | 18765684 | Human |
597454158 | GWAS1550232_H | BMI-adjusted hip circumference QTL GWAS1550232 (human) | | 8e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6739621 | 6739622 | Human |
597347656 | GWAS1443730_H | urate measurement QTL GWAS1443730 (human) | | 3e-76 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7118901 | 7118902 | Human |
597454159 | GWAS1550233_H | BMI-adjusted hip circumference QTL GWAS1550233 (human) | | 2e-14 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6734789 | 6734790 | Human |
597347657 | GWAS1443731_H | urate measurement QTL GWAS1443731 (human) | | 7e-09 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 10523142 | 10523143 | Human |
597208384 | GWAS1304458_H | mathematical ability QTL GWAS1304458 (human) | | 3e-08 | mathematical ability | | 6 | 16315427 | 16315428 | Human |
597208385 | GWAS1304459_H | mathematical ability QTL GWAS1304459 (human) | | 1e-11 | mathematical ability | | 6 | 17127475 | 17127476 | Human |
597208386 | GWAS1304460_H | mathematical ability QTL GWAS1304460 (human) | | 1e-22 | mathematical ability | | 6 | 19028557 | 19028558 | Human |
597306689 | GWAS1402763_H | uric acid measurement QTL GWAS1402763 (human) | | 5e-63 | uric acid measurement | blood uric acid level (CMO:0000501) | 6 | 7120224 | 7120225 | Human |
597609797 | GWAS1666657_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1666657 (human) | | 5e-22 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 13525133 | 13525134 | Human |
597347655 | GWAS1443729_H | urate measurement QTL GWAS1443729 (human) | | 3e-20 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2050557 | 2050558 | Human |
596987253 | GWAS1106772_H | memory performance, sex interaction measurement QTL GWAS1106772 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12858010 | 12858011 | Human |
597290360 | GWAS1386434_H | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1386434 (human) | | 2e-10 | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 6 | 261343 | 261344 | Human |
597396858 | GWAS1492932_H | vaginal microbiome measurement QTL GWAS1492932 (human) | | 0.00001 | vaginal microbiome measurement | | 6 | 6873309 | 6873310 | Human |
596987252 | GWAS1106771_H | memory performance, sex interaction measurement QTL GWAS1106771 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12854730 | 12854731 | Human |
597200249 | GWAS1296323_H | lean body mass QTL GWAS1296323 (human) | | 1e-15 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 19128135 | 19128136 | Human |
596987255 | GWAS1106774_H | memory performance, sex interaction measurement QTL GWAS1106774 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12849390 | 12849391 | Human |
596987249 | GWAS1106768_H | memory performance, sex interaction measurement QTL GWAS1106768 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12851393 | 12851394 | Human |
597216637 | GWAS1312711_H | Orofacial cleft QTL GWAS1312711 (human) | | 0.000002 | Orofacial cleft | | 6 | 1631837 | 1631838 | Human |
407008935 | GWAS657911_H | unipolar depression QTL GWAS657911 (human) | | 0.000007 | unipolar depression | | 6 | 6612234 | 6612235 | Human |
596987260 | GWAS1106779_H | memory performance, sex interaction measurement QTL GWAS1106779 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12844543 | 12844544 | Human |
596987257 | GWAS1106776_H | memory performance, sex interaction measurement QTL GWAS1106776 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12860755 | 12860756 | Human |
596987256 | GWAS1106775_H | memory performance, sex interaction measurement QTL GWAS1106775 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12858672 | 12858673 | Human |
596987259 | GWAS1106778_H | memory performance, sex interaction measurement QTL GWAS1106778 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12862012 | 12862013 | Human |
596987258 | GWAS1106777_H | memory performance, sex interaction measurement QTL GWAS1106777 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12861968 | 12861969 | Human |
406959796 | GWAS608772_H | neutrophil count, eosinophil count QTL GWAS608772 (human) | | 6e-13 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 6 | 16744456 | 16744457 | Human |
597585257 | GWAS1642117_H | diabetes mellitus, Drugs used in diabetes use measurement QTL GWAS1642117 (human) | | 6e-13 | pancreas integrity trait (VT:0010560) | | 6 | 7245225 | 7245226 | Human |
597486749 | GWAS1582823_H | total cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1582823 (human) | | 7e-17 | total cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16113090 | 16113091 | Human |
597437592 | GWAS1533666_H | angina pectoris QTL GWAS1533666 (human) | | 1e-09 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597609616 | GWAS1666476_H | benign neoplasm of eye QTL GWAS1666476 (human) | | 2e-79 | benign neoplasm of eye | | 6 | 396321 | 396322 | Human |
406984531 | GWAS633507_H | hemoglobin measurement QTL GWAS633507 (human) | | 7e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 13508211 | 13508212 | Human |
406984532 | GWAS633508_H | hemoglobin measurement QTL GWAS633508 (human) | | 1e-20 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16289677 | 16289680 | Human |
597331073 | GWAS1427147_H | Tinnitus QTL GWAS1427147 (human) | | 4e-08 | Tinnitus | | 6 | 13633840 | 13633841 | Human |
597216388 | GWAS1312462_H | galanin peptides measurement QTL GWAS1312462 (human) | | 9e-19 | galanin peptides measurement | | 6 | 1690107 | 1690108 | Human |
597019786 | GWAS1115860_H | body mass index QTL GWAS1115860 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597609662 | GWAS1666522_H | magnesium measurement QTL GWAS1666522 (human) | | 3e-12 | magnesium measurement | serum magnesium level (CMO:0000541) | 6 | 7057950 | 7057951 | Human |
2289408 | BW324_H | Body weight QTL 324 (human) | 3.15 | 0.0001 | Body fat amount | | 6 | 1 | 20803913 | Human |
597028018 | GWAS1124092_H | waist-hip ratio QTL GWAS1124092 (human) | | 2e-12 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 14572832 | 14572833 | Human |
597396663 | GWAS1492737_H | cognitive function measurement QTL GWAS1492737 (human) | | 0.000005 | cognitive behavior trait (VT:0010450) | | 6 | 2960808 | 2960809 | Human |
407123829 | GWAS772805_H | prostate carcinoma QTL GWAS772805 (human) | | 3e-09 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
597388458 | GWAS1484532_H | low density lipoprotein cholesterol measurement QTL GWAS1484532 (human) | | 3e-14 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597388457 | GWAS1484531_H | low density lipoprotein cholesterol measurement QTL GWAS1484531 (human) | | 2e-14 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597470382 | GWAS1566456_H | major depressive disorder QTL GWAS1566456 (human) | | 4e-08 | major depressive disorder | | 6 | 17016169 | 17016170 | Human |
597388456 | GWAS1484530_H | low density lipoprotein cholesterol measurement QTL GWAS1484530 (human) | | 2e-18 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16124329 | 16124330 | Human |
597478569 | GWAS1574643_H | waist-hip ratio QTL GWAS1574643 (human) | | 4e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6738519 | 6738520 | Human |
597052590 | GWAS1148664_H | coronary artery disease QTL GWAS1148664 (human) | | 0.000006 | coronary artery disease | | 6 | 12722755 | 12722756 | Human |
2289435 | BMD4_H | Bone mineral density QTL 4 (human) | 3.15 | 0.0001 | Bone mineral density | | 6 | 1 | 20803913 | Human |
596962477 | GWAS1081996_H | age at menarche QTL GWAS1081996 (human) | | 1e-08 | age at menarche | | 6 | 5041236 | 5041237 | Human |
597036204 | GWAS1132278_H | gut microbiome measurement QTL GWAS1132278 (human) | | 0.000002 | gut microbiome measurement | | 6 | 311938 | 311939 | Human |
597388455 | GWAS1484529_H | low density lipoprotein cholesterol measurement QTL GWAS1484529 (human) | | 4e-18 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16124329 | 16124330 | Human |
597478563 | GWAS1574637_H | waist-hip ratio QTL GWAS1574637 (human) | | 0.000003 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6742916 | 6742917 | Human |
597363928 | GWAS1460002_H | lymphocyte count QTL GWAS1460002 (human) | | 1e-11 | lymphocyte count | | 6 | 6901426 | 6901427 | Human |
597249247 | GWAS1345321_H | cancer QTL GWAS1345321 (human) | | 8e-47 | cancer | | 6 | 396321 | 396322 | Human |
597044433 | GWAS1140507_H | nevus count, cutaneous melanoma QTL GWAS1140507 (human) | | 5e-09 | nevus count, cutaneous melanoma | | 6 | 15503465 | 15503466 | Human |
597044447 | GWAS1140521_H | nevus count, cutaneous melanoma QTL GWAS1140521 (human) | | 4e-08 | nevus count, cutaneous melanoma | | 6 | 1142496 | 1142497 | Human |
596970718 | GWAS1090237_H | major depressive disorder QTL GWAS1090237 (human) | | 0.000003 | major depressive disorder | | 6 | 2518745 | 2518746 | Human |
596962501 | GWAS1082020_H | irritable bowel syndrome, vital capacity QTL GWAS1082020 (human) | | 2e-08 | irritable bowel syndrome, vital capacity | | 6 | 7130363 | 7130364 | Human |
597109960 | GWAS1206034_H | pseudotumor cerebri QTL GWAS1206034 (human) | | 0.0000002 | pseudotumor cerebri | | 6 | 17605974 | 17605975 | Human |
597052663 | GWAS1148737_H | Red cell distribution width QTL GWAS1148737 (human) | | 2e-21 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423353 | 3423354 | Human |
597298430 | GWAS1394504_H | revision of total knee arthroplasty QTL GWAS1394504 (human) | | 3e-08 | revision of total knee arthroplasty | | 6 | 3086255 | 3086256 | Human |
597601530 | GWAS1658390_H | body mass index QTL GWAS1658390 (human) | | 5e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12117111 | 12117112 | Human |
597257457 | GWAS1353531_H | multiple myeloma QTL GWAS1353531 (human) | | 7e-08 | multiple myeloma | | 6 | 15216294 | 15216295 | Human |
597142782 | GWAS1238856_H | Antihypertensive use measurement QTL GWAS1238856 (human) | | 2e-09 | Antihypertensive use measurement | | 6 | 1614132 | 1614133 | Human |
597052668 | GWAS1148742_H | Red cell distribution width QTL GWAS1148742 (human) | | 2e-16 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16261045 | 16261046 | Human |
597052669 | GWAS1148743_H | Red cell distribution width QTL GWAS1148743 (human) | | 2e-14 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 18747474 | 18747475 | Human |
597052666 | GWAS1148740_H | Red cell distribution width QTL GWAS1148740 (human) | | 4e-08 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 6924907 | 6924908 | Human |
597052667 | GWAS1148741_H | Red cell distribution width QTL GWAS1148741 (human) | | 3e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 7695740 | 7695741 | Human |
407369514 | GWAS1018490_H | Cleft palate, cleft lip QTL GWAS1018490 (human) | | 3e-09 | Cleft palate, cleft lip | | 6 | 9469005 | 9469006 | Human |
597052664 | GWAS1148738_H | Red cell distribution width QTL GWAS1148738 (human) | | 9e-23 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5137468 | 5137469 | Human |
597052665 | GWAS1148739_H | Red cell distribution width QTL GWAS1148739 (human) | | 4e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5262479 | 5262480 | Human |
597232876 | GWAS1328950_H | gut microbiome measurement QTL GWAS1328950 (human) | | 0.000009 | gut microbiome measurement | | 6 | 888821 | 888822 | Human |
597257455 | GWAS1353529_H | multiple myeloma QTL GWAS1353529 (human) | | 2e-08 | multiple myeloma | | 6 | 408079 | 408080 | Human |
596954338 | GWAS1073857_H | body mass index QTL GWAS1073857 (human) | | 1e-09 | body mass index | | 6 | 7705771 | 7705772 | Human |
597372131 | GWAS1468205_H | fatty acid measurement QTL GWAS1468205 (human) | | 0.000004 | fatty acid measurement | | 6 | 14199916 | 14199917 | Human |
597404896 | GWAS1500970_H | metabolite measurement QTL GWAS1500970 (human) | | 6e-76 | metabolite measurement | | 6 | 2996087 | 2996088 | Human |
407041852 | GWAS690828_H | dental caries QTL GWAS690828 (human) | | 0.000003 | dental caries | | 6 | 566741 | 566742 | Human |
597388319 | GWAS1484393_H | pursuit maintenance gain measurement QTL GWAS1484393 (human) | | 0.0000005 | pursuit maintenance gain measurement | | 6 | 8520673 | 8520674 | Human |
597183517 | GWAS1279591_H | protein measurement QTL GWAS1279591 (human) | | 2e-50 | protein measurement | | 6 | 3271554 | 3271555 | Human |
597257247 | GWAS1353321_H | urate measurement QTL GWAS1353321 (human) | | 1e-11 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7269065 | 7269066 | Human |
597519381 | GWAS1615455_H | migraine disorder QTL GWAS1615455 (human) | | 3e-18 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
596986908 | GWAS1106427_H | memory performance QTL GWAS1106427 (human) | | 0.000004 | memory performance | | 6 | 4995574 | 4995575 | Human |
597077018 | GWAS1173092_H | intelligence QTL GWAS1173092 (human) | | 1e-11 | intelligence | | 6 | 3446029 | 3446030 | Human |
597077019 | GWAS1173093_H | intelligence QTL GWAS1173093 (human) | | 3e-08 | intelligence | | 6 | 19035804 | 19035805 | Human |
597421066 | GWAS1517140_H | non-melanoma skin carcinoma QTL GWAS1517140 (human) | | 0.0000002 | non-melanoma skin carcinoma | | 6 | 693473 | 693474 | Human |
597494795 | GWAS1590869_H | insomnia QTL GWAS1590869 (human) | | 1e-08 | insomnia | | 6 | 14927144 | 14927145 | Human |
597494794 | GWAS1590868_H | insomnia QTL GWAS1590868 (human) | | 2e-09 | insomnia | | 6 | 14915447 | 14915448 | Human |
597363715 | GWAS1459789_H | chronic lymphocytic leukemia QTL GWAS1459789 (human) | | 1e-28 | leukocyte integrity trait (VT:0010898) | | 6 | 412802 | 412803 | Human |
597322755 | GWAS1418829_H | 1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPE (P-16:0/22:6) measurement QTL GWAS1418829 (human) | | 1e-17 | 1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPE (P-16:0/22:6) measurement | | 6 | 11028421 | 11028422 | Human |
407123928 | GWAS772904_H | prostate carcinoma QTL GWAS772904 (human) | | 4e-08 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
597339140 | GWAS1435214_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1435214 (human) | | 9e-18 | severe acute respiratory syndrome, COVID-19 | | 6 | 5281216 | 5281217 | Human |
407369688 | GWAS1018664_H | eosinophil percentage of leukocytes QTL GWAS1018664 (human) | | 3e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 209159 | 209160 | Human |
597363770 | GWAS1459844_H | waist-hip ratio QTL GWAS1459844 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 14595642 | 14595643 | Human |
597437503 | GWAS1533577_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1533577 (human) | | 0.000004 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6736698 | 6736699 | Human |
597462079 | GWAS1558153_H | ankle injury QTL GWAS1558153 (human) | | 0.0000001 | ankle injury | | 6 | 11825631 | 11825632 | Human |
597240890 | GWAS1336964_H | educational attainment QTL GWAS1336964 (human) | | 8e-16 | educational attainment | | 6 | 19023495 | 19023496 | Human |
597306430 | GWAS1402504_H | breast cancer, ovarian carcinoma QTL GWAS1402504 (human) | | 2e-12 | breast cancer, ovarian carcinoma | | 6 | 13716491 | 13716492 | Human |
597429305 | GWAS1525379_H | neuroticism measurement QTL GWAS1525379 (human) | | 1e-10 | neuroticism measurement | | 6 | 11712110 | 11712111 | Human |
597429306 | GWAS1525380_H | neuroticism measurement QTL GWAS1525380 (human) | | 1e-09 | neuroticism measurement | | 6 | 12008029 | 12008030 | Human |
597240881 | GWAS1336955_H | aging QTL GWAS1336955 (human) | | 1e-17 | aging | | 6 | 18105845 | 18105846 | Human |
407025643 | GWAS674619_H | cardiovascular disease QTL GWAS674619 (human) | | 0.000007 | cardiovascular disease | | 6 | 13332235 | 13332236 | Human |
597036092 | GWAS1132166_H | triglyceride measurement QTL GWAS1132166 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 7249227 | 7249228 | Human |
597240882 | GWAS1336956_H | aging QTL GWAS1336956 (human) | | 1e-21 | aging | | 6 | 18120062 | 18120063 | Human |
597191720 | GWAS1287794_H | sexual dimorphism measurement QTL GWAS1287794 (human) | | 2e-10 | sexual dimorphism measurement | | 6 | 7719115 | 7719116 | Human |
597330986 | GWAS1427060_H | basal cell carcinoma QTL GWAS1427060 (human) | | 4e-08 | basal cell carcinoma | | 6 | 15388046 | 15388047 | Human |
596954150 | GWAS1073669_H | body mass index QTL GWAS1073669 (human) | | 7e-10 | body mass index | | 6 | 12084212 | 12084213 | Human |
597290028 | GWAS1386102_H | remnant cholesterol measurement QTL GWAS1386102 (human) | | 1e-10 | remnant cholesterol measurement | | 6 | 16126442 | 16126443 | Human |
597527595 | GWAS1623669_H | gallstones QTL GWAS1623669 (human) | | 5e-10 | gallstones | | 6 | 2302966 | 2302967 | Human |
597503013 | GWAS1599087_H | diastolic blood pressure, systolic blood pressure QTL GWAS1599087 (human) | | 3e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 19143913 | 19143914 | Human |
597503012 | GWAS1599086_H | diastolic blood pressure, systolic blood pressure QTL GWAS1599086 (human) | | 2e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7332612 | 7332613 | Human |
597388320 | GWAS1484394_H | pursuit maintenance gain measurement QTL GWAS1484394 (human) | | 0.000001 | pursuit maintenance gain measurement | | 6 | 17335171 | 17335172 | Human |
597388327 | GWAS1484401_H | pursuit maintenance gain measurement QTL GWAS1484401 (human) | | 0.000004 | pursuit maintenance gain measurement | | 6 | 8520673 | 8520674 | Human |
406943742 | GWAS592718_H | hematocrit QTL GWAS592718 (human) | | 4e-43 | hematocrit | hematocrit (CMO:0000037) | 6 | 2093889 | 2093890 | Human |
597249115 | GWAS1345189_H | cervical cancer QTL GWAS1345189 (human) | | 0.000004 | cervical cancer | | 6 | 15376763 | 15376764 | Human |
597027922 | GWAS1123996_H | body mass index QTL GWAS1123996 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13189709 | 13189710 | Human |
597036127 | GWAS1132201_H | low density lipoprotein cholesterol measurement QTL GWAS1132201 (human) | | 0.0000001 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 11838809 | 11838810 | Human |
596986972 | GWAS1106491_H | memory performance, sex interaction measurement QTL GWAS1106491 (human) | | 0.000006 | memory performance, sex interaction measurement | | 6 | 12860468 | 12860469 | Human |
597617748 | GWAS1674608_H | prostate specific antigen amount QTL GWAS1674608 (human) | | 1e-11 | prostate specific antigen amount | | 6 | 15532669 | 15532670 | Human |
597380176 | GWAS1476250_H | white matter hyperintensity measurement QTL GWAS1476250 (human) | | 0.000002 | white matter hyperintensity measurement | | 6 | 1366620 | 1366621 | Human |
596986969 | GWAS1106488_H | memory performance, sex interaction measurement QTL GWAS1106488 (human) | | 0.000006 | memory performance, sex interaction measurement | | 6 | 12857161 | 12857162 | Human |
597412948 | GWAS1509022_H | coronary artery disease QTL GWAS1509022 (human) | | 4e-08 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597519439 | GWAS1615513_H | open-angle glaucoma QTL GWAS1615513 (human) | | 8e-25 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597609548 | GWAS1666408_H | body weight QTL GWAS1666408 (human) | | 1e-36 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12117111 | 12117112 | Human |
597380168 | GWAS1476242_H | white matter hyperintensity measurement QTL GWAS1476242 (human) | | 0.000008 | white matter hyperintensity measurement | | 6 | 1366620 | 1366621 | Human |
597101634 | GWAS1197708_H | type 2 diabetes mellitus QTL GWAS1197708 (human) | | 3e-08 | type 2 diabetes mellitus | | 6 | 7226726 | 7226727 | Human |
597085251 | GWAS1181325_H | type 2 diabetes mellitus QTL GWAS1181325 (human) | | 7e-11 | type 2 diabetes mellitus | | 6 | 15474820 | 15474821 | Human |
597306439 | GWAS1402513_H | bilirubin measurement QTL GWAS1402513 (human) | | 9e-09 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 6 | 12811723 | 12811724 | Human |
597290104 | GWAS1386178_H | total cholesterol in small LDL QTL GWAS1386178 (human) | | 2e-16 | total cholesterol in small LDL | | 6 | 16114017 | 16114018 | Human |
597027959 | GWAS1124033_H | body mass index QTL GWAS1124033 (human) | | 7e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13180222 | 13180223 | Human |
597429368 | GWAS1525442_H | wellbeing measurement QTL GWAS1525442 (human) | | 5e-09 | wellness/fitness trait (VT:1000152) | | 6 | 11972509 | 11972510 | Human |
597486714 | GWAS1582788_H | gut microbiome measurement QTL GWAS1582788 (human) | | 3e-09 | gut microbiome measurement | | 6 | 4388635 | 4388636 | Human |
597486715 | GWAS1582789_H | gut microbiome measurement QTL GWAS1582789 (human) | | 8e-10 | gut microbiome measurement | | 6 | 4388635 | 4388636 | Human |
597585012 | GWAS1641872_H | diabetes mellitus QTL GWAS1641872 (human) | | 6e-12 | pancreas integrity trait (VT:0010560) | | 6 | 7245225 | 7245226 | Human |
597199987 | GWAS1296061_H | neuroticism measurement QTL GWAS1296061 (human) | | 0.000006 | neuroticism measurement | | 6 | 396321 | 396322 | Human |
597118055 | GWAS1214129_H | cerebral amyloid deposition measurement QTL GWAS1214129 (human) | | 0.000001 | cerebral cortex integrity trait (VT:0010923) | | 6 | 16661527 | 16661528 | Human |
406992819 | GWAS641795_H | body mass index QTL GWAS641795 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12509895 | 12509896 | Human |
597593196 | GWAS1650056_H | platelet count QTL GWAS1650056 (human) | | 1e-22 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597429358 | GWAS1525432_H | wellbeing measurement QTL GWAS1525432 (human) | | 6e-10 | wellness/fitness trait (VT:1000152) | | 6 | 11712110 | 11712111 | Human |
597380201 | GWAS1476275_H | lymphocyte count QTL GWAS1476275 (human) | | 2e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 14715979 | 14715980 | Human |
596954215 | GWAS1073734_H | Vitiligo QTL GWAS1073734 (human) | | 3e-10 | Vitiligo | | 6 | 396321 | 396322 | Human |
597380200 | GWAS1476274_H | lymphocyte count QTL GWAS1476274 (human) | | 2e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6902706 | 6902707 | Human |
597609574 | GWAS1666434_H | monocyte count QTL GWAS1666434 (human) | | 1e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 12052033 | 12052034 | Human |
597609572 | GWAS1666432_H | monocyte count QTL GWAS1666432 (human) | | 6e-21 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7137130 | 7137131 | Human |
597609573 | GWAS1666433_H | monocyte count QTL GWAS1666433 (human) | | 4e-22 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10535358 | 10535359 | Human |
597380199 | GWAS1476273_H | lymphocyte count QTL GWAS1476273 (human) | | 8e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901349 | 6901350 | Human |
597380198 | GWAS1476272_H | lymphocyte count QTL GWAS1476272 (human) | | 6e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 231878 | 231879 | Human |
597423002 | GWAS1519076_H | cortical thickness QTL GWAS1519076 (human) | | 2e-13 | cortical thickness | | 6 | 793060 | 793061 | Human |
407259207 | GWAS908183_H | genomic measurement QTL GWAS908183 (human) | | 6e-10 | genomic measurement | | 6 | 15313558 | 15313559 | Human |
597365657 | GWAS1461731_H | balding measurement QTL GWAS1461731 (human) | | 6e-75 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9690610 | 9690611 | Human |
596956048 | GWAS1075567_H | intraocular pressure measurement QTL GWAS1075567 (human) | | 1e-10 | intraocular pressure measurement | | 6 | 2052577 | 2052578 | Human |
597316510 | GWAS1412584_H | 1-eicosapentaenoyl-GPC (20:5) measurement QTL GWAS1412584 (human) | | 4e-20 | 1-eicosapentaenoyl-GPC (20:5) measurement | | 6 | 11005793 | 11005794 | Human |
597324703 | GWAS1420777_H | actinic keratosis QTL GWAS1420777 (human) | | 8e-33 | actinic keratosis | | 6 | 396321 | 396322 | Human |
597169053 | GWAS1265127_H | hypothyroidism QTL GWAS1265127 (human) | | 4e-08 | hypothyroidism | | 6 | 11309595 | 11309596 | Human |
596972435 | GWAS1091954_H | radiation-induced disorder QTL GWAS1091954 (human) | | 5e-08 | radiation-induced disorder | | 6 | 8837005 | 8837006 | Human |
597029778 | GWAS1125852_H | waist-hip ratio QTL GWAS1125852 (human) | | 2e-19 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7211585 | 7211586 | Human |
596972434 | GWAS1091953_H | radiation-induced disorder QTL GWAS1091953 (human) | | 0.0000005 | radiation-induced disorder | | 6 | 8412720 | 8412721 | Human |
597144479 | GWAS1240553_H | chronic obstructive pulmonary disease QTL GWAS1240553 (human) | | 6e-10 | lung integrity trait (VT:0010906) | | 6 | 7727929 | 7727930 | Human |
1298458 | BW9_H | Body weight QTL 9 (human) | 2.7 | 0.0002 | Body fat amount | | 6 | 6911960 | 32911960 | Human |
597226390 | GWAS1322464_H | childhood onset asthma QTL GWAS1322464 (human) | | 4e-12 | childhood onset asthma | | 6 | 409119 | 409120 | Human |
597357461 | GWAS1453535_H | gastritis QTL GWAS1453535 (human) | | 0.000009 | stomach integrity trait (VT:0010603) | | 6 | 6476045 | 6476046 | Human |
597439372 | GWAS1535446_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1535446 (human) | | 4e-14 | body size trait (VT:0100005) | | 6 | 6734789 | 6734790 | Human |
597398412 | GWAS1494486_H | cortical thickness QTL GWAS1494486 (human) | | 2e-14 | cortical thickness | | 6 | 796416 | 796417 | Human |
597283726 | GWAS1379800_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1379800 (human) | | 2e-13 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597578630 | GWAS1635490_H | hematocrit QTL GWAS1635490 (human) | | 4e-15 | hematocrit | hematocrit (CMO:0000037) | 6 | 7214266 | 7214267 | Human |
597439362 | GWAS1535436_H | coronary artery calcification QTL GWAS1535436 (human) | | 0.000007 | coronary artery calcification | | 6 | 17031825 | 17031826 | Human |
597463997 | GWAS1560071_H | acylcarnitine measurement QTL GWAS1560071 (human) | | 0.000003 | acylcarnitine measurement | | 6 | 3593722 | 3593723 | Human |
597373880 | GWAS1469954_H | waist-hip ratio QTL GWAS1469954 (human) | | 3e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 14595642 | 14595643 | Human |
406997094 | GWAS646070_H | mean corpuscular hemoglobin concentration QTL GWAS646070 (human) | | 4e-76 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597414846 | GWAS1510920_H | BMI-adjusted waist-hip ratio QTL GWAS1510920 (human) | | 5e-40 | body size trait (VT:0100005) | | 6 | 6748836 | 6748837 | Human |
597029810 | GWAS1125884_H | squamous cell carcinoma QTL GWAS1125884 (human) | | 1e-08 | squamous cell carcinoma | | 6 | 15535090 | 15535091 | Human |
597021630 | GWAS1117704_H | growth-regulated alpha protein measurement QTL GWAS1117704 (human) | | 0.0000001 | growth-regulated alpha protein measurement | | 6 | 16494752 | 16494753 | Human |
597119907 | GWAS1215981_H | cholesteryl ester 22:6 measurement QTL GWAS1215981 (human) | | 2e-13 | blood lipid amount (VT:0003949) | | 6 | 11042676 | 11042677 | Human |
597119906 | GWAS1215980_H | cholesteryl ester 22:6 measurement QTL GWAS1215980 (human) | | 5e-12 | blood lipid amount (VT:0003949) | | 6 | 11040190 | 11040191 | Human |
597119905 | GWAS1215979_H | cholesteryl ester 22:6 measurement QTL GWAS1215979 (human) | | 2e-13 | blood lipid amount (VT:0003949) | | 6 | 10982126 | 10982127 | Human |
597250977 | GWAS1347051_H | central corneal thickness QTL GWAS1347051 (human) | | 1e-13 | central corneal thickness | | 6 | 16522376 | 16522377 | Human |
597316515 | GWAS1412589_H | 1-eicosapentaenoyl-GPE (20:5) measurement QTL GWAS1412589 (human) | | 4e-15 | 1-eicosapentaenoyl-GPE (20:5) measurement | | 6 | 10966308 | 10966309 | Human |
597586848 | GWAS1643708_H | eosinophil count QTL GWAS1643708 (human) | | 1e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
597316517 | GWAS1412591_H | 1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) measurement QTL GWAS1412591 (human) | | 3e-17 | glycerophosphocholine amount (VT:0011004) | | 6 | 11088186 | 11088187 | Human |
597586849 | GWAS1643709_H | eosinophil count QTL GWAS1643709 (human) | | 2e-19 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
597251035 | GWAS1347109_H | mean arterial pressure QTL GWAS1347109 (human) | | 0.000003 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 6 | 12595043 | 12595044 | Human |
597218271 | GWAS1314345_H | Ewing sarcoma QTL GWAS1314345 (human) | | 1e-18 | Ewing sarcoma | | 6 | 6854256 | 6854257 | Human |
597210066 | GWAS1306140_H | blood protein measurement QTL GWAS1306140 (human) | | 5e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 14091451 | 14091452 | Human |
597079002 | GWAS1175076_H | platelet count QTL GWAS1175076 (human) | | 2e-13 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 7085584 | 7085585 | Human |
597210068 | GWAS1306142_H | blood protein measurement QTL GWAS1306142 (human) | | 3e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15914118 | 15914119 | Human |
597079003 | GWAS1175077_H | platelet count QTL GWAS1175077 (human) | | 3e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 11593752 | 11593753 | Human |
597079001 | GWAS1175075_H | platelet count QTL GWAS1175075 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2769404 | 2769405 | Human |
407095319 | GWAS744295_H | chromatid-type aberration frequency QTL GWAS744295 (human) | | 0.0000003 | chromatid-type aberration frequency | | 6 | 7973684 | 7973685 | Human |
597210062 | GWAS1306136_H | blood protein measurement QTL GWAS1306136 (human) | | 1e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15898653 | 15898654 | Human |
597488587 | GWAS1584661_H | phosphatidylethanolamine measurement QTL GWAS1584661 (human) | | 6e-09 | phosphatidylethanolamine measurement | | 6 | 10975563 | 10975564 | Human |
407095316 | GWAS744292_H | low density lipoprotein cholesterol measurement, alcohol drinking QTL GWAS744292 (human) | | 3e-26 | low density lipoprotein cholesterol measurement, alcohol drinking | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597414851 | GWAS1510925_H | BMI-adjusted waist-hip ratio QTL GWAS1510925 (human) | | 4e-30 | body size trait (VT:0100005) | | 6 | 6783907 | 6783908 | Human |
597152717 | GWAS1248791_H | low density lipoprotein cholesterol measurement QTL GWAS1248791 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16134016 | 16134017 | Human |
597414855 | GWAS1510929_H | BMI-adjusted waist-hip ratio QTL GWAS1510929 (human) | | 4e-20 | body size trait (VT:0100005) | | 6 | 6727130 | 6727131 | Human |
597382087 | GWAS1478161_H | mammographic density measurement QTL GWAS1478161 (human) | | 8e-10 | mammographic density measurement | | 6 | 6742316 | 6742317 | Human |
597365701 | GWAS1461775_H | peak expiratory flow QTL GWAS1461775 (human) | | 0.000001 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 6741699 | 6741700 | Human |
597414852 | GWAS1510926_H | BMI-adjusted waist-hip ratio QTL GWAS1510926 (human) | | 3e-28 | body size trait (VT:0100005) | | 6 | 6758872 | 6758873 | Human |
597160904 | GWAS1256978_H | monocyte count QTL GWAS1256978 (human) | | 2e-08 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7227813 | 7227814 | Human |
597079025 | GWAS1175099_H | mean corpuscular hemoglobin QTL GWAS1175099 (human) | | 3e-38 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15176868 | 15176869 | Human |
597513210 | GWAS1609284_H | colorectal cancer QTL GWAS1609284 (human) | | 0.0000008 | colorectal cancer | | 6 | 19211046 | 19211047 | Human |
597603317 | GWAS1660177_H | neutrophil count QTL GWAS1660177 (human) | | 1e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 17602639 | 17602640 | Human |
597431280 | GWAS1527354_H | protein measurement QTL GWAS1527354 (human) | | 4e-45 | protein measurement | | 6 | 2898066 | 2898067 | Human |
597595122 | GWAS1651982_H | hematocrit QTL GWAS1651982 (human) | | 2e-37 | hematocrit | hematocrit (CMO:0000037) | 6 | 7203762 | 7203763 | Human |
597119992 | GWAS1216066_H | blood protein measurement QTL GWAS1216066 (human) | | 8e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 483593 | 483594 | Human |
596956128 | GWAS1075647_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075647 (human) | | 7e-09 | lymphocyte measurement, neutrophil measurement | | 6 | 16744456 | 16744457 | Human |
406997047 | GWAS646023_H | mean corpuscular hemoglobin concentration QTL GWAS646023 (human) | | 2e-22 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 13930123 | 13930124 | Human |
597439462 | GWAS1535536_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1535536 (human) | | 1e-15 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
596964331 | GWAS1083850_H | major depressive disorder QTL GWAS1083850 (human) | | 0.000003 | major depressive disorder | | 6 | 10818696 | 10818697 | Human |
597046249 | GWAS1142323_H | QT interval QTL GWAS1142323 (human) | | 0.000003 | QT interval | QT interval (CMO:0000235) | 6 | 16290530 | 16290531 | Human |
597193497 | GWAS1289571_H | visuospatial function measurement QTL GWAS1289571 (human) | | 0.000003 | visuospatial function measurement | | 6 | 5466422 | 5466423 | Human |
407251140 | GWAS900116_H | asthma QTL GWAS900116 (human) | | 5e-09 | asthma | | 6 | 12159466 | 12159467 | Human |
407070919 | GWAS719895_H | disease recurrence, malaria QTL GWAS719895 (human) | | 5e-08 | disease recurrence, malaria | | 6 | 2666821 | 2666822 | Human |
596964113 | GWAS1083632_H | trait in response to escitalopram, trait in response to citalopram, mood disorder, major depressive disorder QTL GWAS1083632 (human) | | 0.0000009 | trait in response to escitalopram, trait in response to citalopram, mood disorder, major depressive disorder | | 6 | 1402915 | 1402916 | Human |
597103388 | GWAS1199462_H | platelet crit QTL GWAS1199462 (human) | | 2e-11 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 6 | 7705771 | 7705772 | Human |
597381911 | GWAS1477985_H | autoimmune disease QTL GWAS1477985 (human) | | 1e-10 | autoimmune disease | | 6 | 412802 | 412803 | Human |
597103387 | GWAS1199461_H | platelet crit QTL GWAS1199461 (human) | | 1e-14 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 6 | 7066248 | 7066249 | Human |
597103386 | GWAS1199460_H | platelet crit QTL GWAS1199460 (human) | | 8e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 6 | 2904557 | 2904558 | Human |
597193494 | GWAS1289568_H | language measurement QTL GWAS1289568 (human) | | 0.000009 | language measurement | | 6 | 1781636 | 1781637 | Human |
407070925 | GWAS719901_H | serum alanine aminotransferase measurement QTL GWAS719901 (human) | | 0.0000006 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 6669940 | 6669941 | Human |
597037848 | GWAS1133922_H | dental caries QTL GWAS1133922 (human) | | 2e-08 | dental caries | | 6 | 11241555 | 11241556 | Human |
407144661 | GWAS793637_H | Ischemic stroke QTL GWAS793637 (human) | | 2e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
597611276 | GWAS1668136_H | body weight QTL GWAS1668136 (human) | | 1e-35 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12117111 | 12117112 | Human |
597373709 | GWAS1469783_H | reticulocyte measurement QTL GWAS1469783 (human) | | 5e-10 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 6923601 | 6923602 | Human |
597373708 | GWAS1469782_H | reticulocyte measurement QTL GWAS1469782 (human) | | 2e-22 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 6682429 | 6682430 | Human |
597021454 | GWAS1117528_H | eotaxin measurement QTL GWAS1117528 (human) | | 0.000005 | eotaxin measurement | | 6 | 7223333 | 7223334 | Human |
597275441 | GWAS1371515_H | diet measurement QTL GWAS1371515 (human) | | 2e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 5473731 | 5473732 | Human |
597226288 | GWAS1322362_H | self reported educational attainment QTL GWAS1322362 (human) | | 2e-10 | self reported educational attainment | | 6 | 16662697 | 16662698 | Human |
597226289 | GWAS1322363_H | self reported educational attainment QTL GWAS1322363 (human) | | 1e-19 | self reported educational attainment | | 6 | 19035804 | 19035805 | Human |
597070652 | GWAS1166726_H | body weight QTL GWAS1166726 (human) | | 0.0000004 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 4790301 | 4790302 | Human |
597226290 | GWAS1322364_H | self reported educational attainment QTL GWAS1322364 (human) | | 2e-08 | self reported educational attainment | | 6 | 19205227 | 19205228 | Human |
597422891 | GWAS1518965_H | cognitive function measurement QTL GWAS1518965 (human) | | 1e-09 | cognitive behavior trait (VT:0010450) | | 6 | 11497103 | 11497104 | Human |
597250858 | GWAS1346932_H | corneal resistance factor QTL GWAS1346932 (human) | | 2e-09 | corneal resistance factor | | 6 | 16521098 | 16521099 | Human |
597226287 | GWAS1322361_H | self reported educational attainment QTL GWAS1322361 (human) | | 3e-09 | self reported educational attainment | | 6 | 6069355 | 6069356 | Human |
596955939 | GWAS1075458_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075458 (human) | | 2e-09 | lymphocyte measurement, neutrophil measurement | | 6 | 13530168 | 13530169 | Human |
597365539 | GWAS1461613_H | hematocrit QTL GWAS1461613 (human) | | 1e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12288189 | 12288190 | Human |
597291809 | GWAS1387883_H | size QTL GWAS1387883 (human) | | 8e-13 | size | | 6 | 15432886 | 15432887 | Human |
597365538 | GWAS1461612_H | hematocrit QTL GWAS1461612 (human) | | 2e-48 | hematocrit | hematocrit (CMO:0000037) | 6 | 7255417 | 7255418 | Human |
597619549 | GWAS1676409_H | paralytic strabismus QTL GWAS1676409 (human) | | 2e-12 | paralytic strabismus | | 6 | 11377969 | 11377970 | Human |
597177180 | GWAS1273254_H | hemoglobin measurement QTL GWAS1273254 (human) | | 0.000001 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2036941 | 2036942 | Human |
596980563 | GWAS1100082_H | memory performance QTL GWAS1100082 (human) | | 0.000006 | memory performance | | 6 | 11729184 | 11729185 | Human |
407079051 | GWAS728027_H | psoriasis QTL GWAS728027 (human) | | 6e-08 | psoriasis | | 6 | 549390 | 549391 | Human |
597496660 | GWAS1592734_H | hip geometry QTL GWAS1592734 (human) | | 5e-14 | hip geometry | hip circumference (CMO:0000014) | 6 | 1775960 | 1775961 | Human |
407087242 | GWAS736218_H | low density lipoprotein cholesterol measurement QTL GWAS736218 (human) | | 6e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597095257 | GWAS1191331_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1191331 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 10213427 | 10213428 | Human |
597177160 | GWAS1273234_H | protein measurement QTL GWAS1273234 (human) | | 9e-234 | protein measurement | | 6 | 16288384 | 16288385 | Human |
597119811 | GWAS1215885_H | chronic obstructive pulmonary disease QTL GWAS1215885 (human) | | 9e-10 | lung integrity trait (VT:0010906) | | 6 | 7211585 | 7211586 | Human |
597529412 | GWAS1625486_H | Varicose veins QTL GWAS1625486 (human) | | 4e-08 | Varicose veins | | 6 | 6740133 | 6740134 | Human |
597111629 | GWAS1207703_H | pulse pressure measurement QTL GWAS1207703 (human) | | 2e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 19028392 | 19028393 | Human |
597414725 | GWAS1510799_H | adolescent idiopathic scoliosis QTL GWAS1510799 (human) | | 0.000007 | adolescent idiopathic scoliosis | | 6 | 4501106 | 4501107 | Human |
597177158 | GWAS1273232_H | protein measurement QTL GWAS1273232 (human) | | 5e-5404 | protein measurement | | 6 | 16288384 | 16288385 | Human |
597316469 | GWAS1412543_H | cutaneous melanoma QTL GWAS1412543 (human) | | 0.000001 | cutaneous melanoma | | 6 | 1145030 | 1145031 | Human |
597439341 | GWAS1535415_H | forced expiratory volume, response to bronchodilator QTL GWAS1535415 (human) | | 0.000005 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 3894081 | 3894082 | Human |
597463915 | GWAS1559989_H | Barrett's esophagus QTL GWAS1559989 (human) | | 0.0000002 | Barrett's esophagus | | 6 | 9509797 | 9509798 | Human |
596956003 | GWAS1075522_H | information processing speed, cognitive function measurement QTL GWAS1075522 (human) | | 5e-08 | information processing speed, cognitive function measurement | | 6 | 11480702 | 11480703 | Human |
597439132 | GWAS1535206_H | BMI-adjusted hip circumference QTL GWAS1535206 (human) | | 0.000005 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 4473853 | 4473854 | Human |
597209753 | GWAS1305827_H | blood protein measurement QTL GWAS1305827 (human) | | 1e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 14091451 | 14091452 | Human |
597209755 | GWAS1305829_H | blood protein measurement QTL GWAS1305829 (human) | | 3e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15880309 | 15880310 | Human |
597209757 | GWAS1305831_H | blood protein measurement QTL GWAS1305831 (human) | | 6e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15880309 | 15880310 | Human |
597160593 | GWAS1256667_H | lipid measurement QTL GWAS1256667 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 6246028 | 6246029 | Human |
597414556 | GWAS1510630_H | blood protein measurement QTL GWAS1510630 (human) | | 0.0000009 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 4144968 | 4144969 | Human |
597594772 | GWAS1651632_H | eosinophil count QTL GWAS1651632 (human) | | 7e-39 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
597160603 | GWAS1256677_H | lipid measurement QTL GWAS1256677 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 10555056 | 10555057 | Human |
407365961 | GWAS1014937_H | reticulocyte count QTL GWAS1014937 (human) | | 1e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6679939 | 6679944 | Human |
597209751 | GWAS1305825_H | blood protein measurement QTL GWAS1305825 (human) | | 2e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15898653 | 15898654 | Human |
597258890 | GWAS1354964_H | open-angle glaucoma QTL GWAS1354964 (human) | | 6e-21 | open-angle glaucoma | | 6 | 1775960 | 1775961 | Human |
597136004 | GWAS1232078_H | intelligence, response to cranial radiation therapy QTL GWAS1232078 (human) | | 0.00001 | intelligence, response to cranial radiation therapy | | 6 | 9399261 | 9399262 | Human |
597357198 | GWAS1453272_H | Alzheimer disease QTL GWAS1453272 (human) | | 0.000006 | Alzheimer disease | | 6 | 10101984 | 10101985 | Human |
597275277 | GWAS1371351_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1371351 (human) | | 3e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 14106966 | 14106967 | Human |
597439115 | GWAS1535189_H | forced expiratory volume, response to bronchodilator QTL GWAS1535189 (human) | | 0.000001 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 8536139 | 8536140 | Human |
597414531 | GWAS1510605_H | BMI-adjusted waist-hip ratio QTL GWAS1510605 (human) | | 5e-10 | body size trait (VT:0100005) | | 6 | 7062365 | 7062366 | Human |
597512837 | GWAS1608911_H | vital capacity QTL GWAS1608911 (human) | | 6e-09 | vital capacity | | 6 | 18673480 | 18673481 | Human |
597275267 | GWAS1371341_H | rheumatoid arthritis QTL GWAS1371341 (human) | | 5e-09 | rheumatoid arthritis | | 6 | 14106966 | 14106967 | Human |
597136012 | GWAS1232086_H | 1-palmitoyl-2-eicosapentaenoyl-GPC (16:0/20:5) measurement QTL GWAS1232086 (human) | | 4e-18 | glycerophosphocholine amount (VT:0011004) | | 6 | 10966787 | 10966788 | Human |
597521025 | GWAS1617099_H | myocardial infarction QTL GWAS1617099 (human) | | 2e-55 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
596963978 | GWAS1083497_H | major depressive disorder QTL GWAS1083497 (human) | | 0.000006 | major depressive disorder | | 6 | 10175803 | 10175804 | Human |
597488317 | GWAS1584391_H | phosphatidylcholine 39:5 measurement QTL GWAS1584391 (human) | | 3e-08 | phosphatidylcholine 39:5 measurement | | 6 | 11072089 | 11072090 | Human |
597439166 | GWAS1535240_H | BMI-adjusted waist-hip ratio QTL GWAS1535240 (human) | | 3e-11 | body size trait (VT:0100005) | | 6 | 6736698 | 6736699 | Human |
597439160 | GWAS1535234_H | mosquito bite reaction size measurement QTL GWAS1535234 (human) | | 0.000003 | mosquito bite reaction size measurement | | 6 | 1161657 | 1161658 | Human |
597209778 | GWAS1305852_H | eye color QTL GWAS1305852 (human) | | 5e-13 | eye color | | 6 | 396321 | 396322 | Human |
597390001 | GWAS1486075_H | glaucoma QTL GWAS1486075 (human) | | 1e-30 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597209780 | GWAS1305854_H | eye color QTL GWAS1305854 (human) | | 7e-10 | alcohol consumption measurement | | 6 | 396321 | 396322 | Human |
407128424 | GWAS777400_H | platelet crit QTL GWAS777400 (human) | | 3e-09 | neutrophil count | | 6 | 7085584 | 7085585 | Human |
597209783 | GWAS1305857_H | eye color QTL GWAS1305857 (human) | | 2e-11 | balding measurement | | 6 | 396321 | 396322 | Human |
597602993 | GWAS1659853_H | drug use measurement, coronary artery disease QTL GWAS1659853 (human) | | 1e-33 | drug use measurement, coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597594801 | GWAS1651661_H | eosinophil count QTL GWAS1651661 (human) | | 5e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
597488300 | GWAS1584374_H | phosphatidylcholine 38:5 measurement QTL GWAS1584374 (human) | | 6e-11 | glycerophosphocholine amount (VT:0011004) | | 6 | 11072089 | 11072090 | Human |
406964596 | GWAS613572_H | chronic lymphocytic leukemia QTL GWAS613572 (human) | | 3e-16 | leukocyte integrity trait (VT:0010898) | | 6 | 411064 | 411065 | Human |
597406381 | GWAS1502455_H | stroke QTL GWAS1502455 (human) | | 1e-09 | stroke | | 6 | 1356681 | 1356682 | Human |
597160609 | GWAS1256683_H | lipid measurement QTL GWAS1256683 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 16226037 | 16226038 | Human |
597414608 | GWAS1510682_H | type 2 diabetes mellitus QTL GWAS1510682 (human) | | 9e-10 | type 2 diabetes mellitus | | 6 | 7255417 | 7255418 | Human |
597308113 | GWAS1404187_H | phosphatidylcholine measurement QTL GWAS1404187 (human) | | 5e-10 | phosphatidylcholine measurement | | 6 | 11018579 | 11018580 | Human |
597144282 | GWAS1240356_H | COVID-19 QTL GWAS1240356 (human) | | 0.0000006 | COVID-19 | | 6 | 1785684 | 1785685 | Human |
407095569 | GWAS744545_H | cognitive function measurement QTL GWAS744545 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 6 | 7579179 | 7579180 | Human |
597594828 | GWAS1651688_H | eosinophil count QTL GWAS1651688 (human) | | 2e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
596964039 | GWAS1083558_H | anxiety, major depressive disorder QTL GWAS1083558 (human) | | 0.000008 | anxiety, major depressive disorder | | 6 | 11811081 | 11811082 | Human |
597455567 | GWAS1551641_H | coronary artery disease QTL GWAS1551641 (human) | | 6e-19 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597390024 | GWAS1486098_H | gut microbiome measurement QTL GWAS1486098 (human) | | 0.000003 | gut microbiome measurement | | 6 | 15707198 | 15707199 | Human |
407095573 | GWAS744549_H | cognitive function measurement QTL GWAS744549 (human) | | 0.000001 | cognitive behavior trait (VT:0010450) | | 6 | 12121869 | 12121870 | Human |
597439172 | GWAS1535246_H | coronary artery calcification QTL GWAS1535246 (human) | | 0.000005 | coronary artery calcification | | 6 | 16108703 | 16108704 | Human |
597324480 | GWAS1420554_H | colorectal cancer QTL GWAS1420554 (human) | | 4e-15 | colorectal cancer | | 6 | 12292539 | 12292540 | Human |
597316289 | GWAS1412363_H | BMI-adjusted waist circumference QTL GWAS1412363 (human) | | 6e-09 | body size trait (VT:0100005) | | 6 | 16710829 | 16710830 | Human |
597521088 | GWAS1617162_H | open-angle glaucoma QTL GWAS1617162 (human) | | 3e-32 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597160693 | GWAS1256767_H | lipid measurement QTL GWAS1256767 (human) | | 0.000003 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 18403028 | 18403029 | Human |
597160692 | GWAS1256766_H | lipid measurement QTL GWAS1256766 (human) | | 0.000001 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 18224942 | 18224943 | Human |
406948132 | GWAS597108_H | PR interval QTL GWAS597108 (human) | | 5e-10 | PR interval | PR interval (CMO:0000233) | 6 | 18227315 | 18227316 | Human |
597324534 | GWAS1420608_H | actinic keratosis QTL GWAS1420608 (human) | | 8e-184 | actinic keratosis | | 6 | 396321 | 396322 | Human |
597349109 | GWAS1445183_H | cholelithiasis QTL GWAS1445183 (human) | | 4e-08 | cholelithiasis | | 6 | 17675015 | 17675016 | Human |
597267179 | GWAS1363253_H | eosinophil count QTL GWAS1363253 (human) | | 4e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 246178 | 246179 | Human |
597316328 | GWAS1412402_H | 1-docosapentaenoyl-GPC (22:5n3) measurement QTL GWAS1412402 (human) | | 4e-31 | glycerophosphocholine amount (VT:0011004) | | 6 | 10996933 | 10996934 | Human |
597267178 | GWAS1363252_H | eosinophil count QTL GWAS1363252 (human) | | 3e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 517095 | 517096 | Human |
597398254 | GWAS1494328_H | X-13435 measurement QTL GWAS1494328 (human) | | 3e-08 | X-13435 measurement | | 6 | 4114554 | 4114555 | Human |
597316333 | GWAS1412407_H | 1-docosapentaenoyl-GPC (22:5n6) measurement QTL GWAS1412407 (human) | | 2e-20 | 1-docosapentaenoyl-GPC (22:5n6) measurement | | 6 | 11040534 | 11040535 | Human |
597316320 | GWAS1412394_H | 1-docosahexaenoyl-GPC (22:6) measurement QTL GWAS1412394 (human) | | 8e-18 | glycerophosphocholine amount (VT:0011004) | | 6 | 10985995 | 10985996 | Human |
597045997 | GWAS1142071_H | intraocular pressure measurement QTL GWAS1142071 (human) | | 8e-17 | intraocular pressure measurement | | 6 | 1988690 | 1988691 | Human |
597316324 | GWAS1412398_H | 1-docosahexaenoyl-GPE (22:6) measurement QTL GWAS1412398 (human) | | 1e-14 | 1-docosahexaenoyl-GPE (22:6) measurement | | 6 | 10985995 | 10985996 | Human |
597152488 | GWAS1248562_H | low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1248562 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood cholesterol level (CMO:0002280) | 6 | 16134016 | 16134017 | Human |
597176849 | GWAS1272923_H | trypsin-3 measurement QTL GWAS1272923 (human) | | 1e-14 | trypsin-3 measurement | | 6 | 7106083 | 7106084 | Human |
597266965 | GWAS1363039_H | eosinophil count QTL GWAS1363039 (human) | | 5e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 403799 | 403800 | Human |
597414411 | GWAS1510485_H | metabolic syndrome QTL GWAS1510485 (human) | | 5e-13 | metabolic syndrome | | 6 | 7255417 | 7255418 | Human |
597176844 | GWAS1272918_H | thioredoxin domain-containing protein 5 measurement QTL GWAS1272918 (human) | | 1e-45 | thioredoxin domain-containing protein 5 measurement | | 6 | 7887106 | 7887111 | Human |
596988417 | GWAS1107936_H | body mass index QTL GWAS1107936 (human) | | 1e-09 | body mass index | | 6 | 18497117 | 18497118 | Human |
597479945 | GWAS1576019_H | complement factor D measurement QTL GWAS1576019 (human) | | 5e-08 | complement protein amount (VT:0010033) | | 6 | 2914711 | 2914712 | Human |
596988416 | GWAS1107935_H | body mass index QTL GWAS1107935 (human) | | 1e-09 | body mass index | | 6 | 13189043 | 13189044 | Human |
597438986 | GWAS1535060_H | BMI-adjusted waist-hip ratio QTL GWAS1535060 (human) | | 9e-15 | body size trait (VT:0100005) | | 6 | 6734789 | 6734790 | Human |
597438987 | GWAS1535061_H | BMI-adjusted waist-hip ratio QTL GWAS1535061 (human) | | 1e-16 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597611008 | GWAS1667868_H | neutrophil count QTL GWAS1667868 (human) | | 8e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7137130 | 7137131 | Human |
597611009 | GWAS1667869_H | neutrophil count QTL GWAS1667869 (human) | | 8e-15 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16752633 | 16752634 | Human |
597307961 | GWAS1404035_H | monocyte count QTL GWAS1404035 (human) | | 7e-31 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7140598 | 7140599 | Human |
597365311 | GWAS1461385_H | bipolar disorder QTL GWAS1461385 (human) | | 0.000002 | bipolar disorder | | 6 | 10167324 | 10167325 | Human |
597471803 | GWAS1567877_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1567877 (human) | | 7e-13 | schizophrenia, intelligence, self reported educational attainment | | 6 | 14717284 | 14717285 | Human |
597414451 | GWAS1510525_H | open-angle glaucoma QTL GWAS1510525 (human) | | 0.0000005 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597611063 | GWAS1667923_H | neutrophil count QTL GWAS1667923 (human) | | 1e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7136539 | 7136540 | Human |
597307958 | GWAS1404032_H | monocyte count QTL GWAS1404032 (human) | | 1e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 16711971 | 16711976 | Human |
597512749 | GWAS1608823_H | systemic lupus erythematosus QTL GWAS1608823 (human) | | 1e-09 | systemic lupus erythematosus | | 6 | 256281 | 256282 | Human |
597242408 | GWAS1338482_H | sodium measurement QTL GWAS1338482 (human) | | 6e-24 | sodium measurement | blood sodium level (CMO:0000499) | 6 | 556497 | 556498 | Human |
597373486 | GWAS1469560_H | response to camptothecin, response to antineoplastic agent QTL GWAS1469560 (human) | | 0.000001 | response to camptothecin, response to antineoplastic agent | | 6 | 3836964 | 3836965 | Human |
597439017 | GWAS1535091_H | forced expiratory volume, response to bronchodilator QTL GWAS1535091 (human) | | 0.0000008 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 8816262 | 8816263 | Human |
597430820 | GWAS1526894_H | femoral neck bone mineral density QTL GWAS1526894 (human) | | 0.000009 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 6 | 15936059 | 15936060 | Human |
597144107 | GWAS1240181_H | X-12627 measurement QTL GWAS1240181 (human) | | 3e-14 | X-12627 measurement | | 6 | 11084321 | 11084322 | Human |
597340710 | GWAS1436784_H | neuroticism measurement, cognitive function measurement QTL GWAS1436784 (human) | | 4e-16 | cognitive behavior trait (VT:0010450) | | 6 | 19118366 | 19118367 | Human |
597258790 | GWAS1354864_H | open-angle glaucoma QTL GWAS1354864 (human) | | 5e-29 | open-angle glaucoma | | 6 | 602983 | 602984 | Human |
597430819 | GWAS1526893_H | femoral neck bone mineral density QTL GWAS1526893 (human) | | 0.000006 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 6 | 15852376 | 15852377 | Human |
597135958 | GWAS1232032_H | trait in response to apixaban QTL GWAS1232032 (human) | | 5e-10 | trait in response to apixaban | | 6 | 6323137 | 6323138 | Human |
596963925 | GWAS1083444_H | major depressive disorder QTL GWAS1083444 (human) | | 0.000007 | major depressive disorder | | 6 | 6612234 | 6612235 | Human |
597348955 | GWAS1445029_H | restless legs syndrome QTL GWAS1445029 (human) | | 6e-12 | restless legs syndrome | | 6 | 12803560 | 12803561 | Human |
597586522 | GWAS1643382_H | eosinophil count QTL GWAS1643382 (human) | | 1e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
596955728 | GWAS1075247_H | intraocular pressure measurement QTL GWAS1075247 (human) | | 7e-20 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597586523 | GWAS1643383_H | eosinophil count QTL GWAS1643383 (human) | | 3e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
597504596 | GWAS1600670_H | (2 or 3)-decenoate (10:1n7 or n8) measurement QTL GWAS1600670 (human) | | 5e-17 | (2 or 3)-decenoate (10:1n7 or n8) measurement | | 6 | 4109359 | 4109360 | Human |
597062239 | GWAS1158313_H | body mass index QTL GWAS1158313 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 4790301 | 4790302 | Human |
597480016 | GWAS1576090_H | protein measurement QTL GWAS1576090 (human) | | 3e-09 | protein measurement | | 6 | 2981538 | 2981539 | Human |
597504595 | GWAS1600669_H | 3-decenoylcarnitine measurement QTL GWAS1600669 (human) | | 3e-32 | 3-decenoylcarnitine measurement | | 6 | 4106136 | 4106137 | Human |
597611088 | GWAS1667948_H | neutrophil count QTL GWAS1667948 (human) | | 5e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16752633 | 16752634 | Human |
596963908 | GWAS1083427_H | mean corpuscular volume QTL GWAS1083427 (human) | | 1e-11 | Red cell distribution width | | 6 | 18757083 | 18757084 | Human |
597529161 | GWAS1625235_H | coronary artery calcification QTL GWAS1625235 (human) | | 6e-29 | coronary artery calcification | | 6 | 12903725 | 12903726 | Human |
597242434 | GWAS1338508_H | urate measurement QTL GWAS1338508 (human) | | 5e-10 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2097452 | 2097453 | Human |
596955751 | GWAS1075270_H | wellbeing measurement, employment status QTL GWAS1075270 (human) | | 1e-09 | wellbeing measurement, employment status | | 6 | 19078043 | 19078044 | Human |
596963939 | GWAS1083458_H | major depressive disorder QTL GWAS1083458 (human) | | 0.000001 | major depressive disorder | | 6 | 16255812 | 16255813 | Human |
597594526 | GWAS1651386_H | eosinophil count QTL GWAS1651386 (human) | | 1e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
596980117 | GWAS1099636_H | memory performance QTL GWAS1099636 (human) | | 0.000003 | memory performance | | 6 | 16244593 | 16244594 | Human |
597193115 | GWAS1289189_H | testosterone measurement QTL GWAS1289189 (human) | | 1e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1618731 | 1618732 | Human |
597594522 | GWAS1651382_H | drug use measurement, myocardial infarction QTL GWAS1651382 (human) | | 1e-32 | drug use measurement, myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597471640 | GWAS1567714_H | self reported educational attainment QTL GWAS1567714 (human) | | 2e-08 | self reported educational attainment | | 6 | 16954137 | 16954138 | Human |
597471641 | GWAS1567715_H | self reported educational attainment QTL GWAS1567715 (human) | | 2e-19 | self reported educational attainment | | 6 | 16965821 | 16965822 | Human |
597471636 | GWAS1567710_H | self reported educational attainment QTL GWAS1567710 (human) | | 5e-13 | self reported educational attainment | | 6 | 3463840 | 3463841 | Human |
597471637 | GWAS1567711_H | self reported educational attainment QTL GWAS1567711 (human) | | 2e-08 | self reported educational attainment | | 6 | 14618917 | 14618918 | Human |
597471638 | GWAS1567712_H | self reported educational attainment QTL GWAS1567712 (human) | | 5e-18 | self reported educational attainment | | 6 | 14718029 | 14718030 | Human |
597471639 | GWAS1567713_H | self reported educational attainment QTL GWAS1567713 (human) | | 2e-08 | self reported educational attainment | | 6 | 14886746 | 14886747 | Human |
406940238 | GWAS589214_H | gut microbiome measurement QTL GWAS589214 (human) | | 2e-08 | gut microbiome measurement | | 6 | 16612992 | 16612993 | Human |
597397902 | GWAS1493976_H | vaginal microbiome measurement QTL GWAS1493976 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 905972 | 905973 | Human |
597438857 | GWAS1534931_H | BMI-adjusted waist-hip ratio QTL GWAS1534931 (human) | | 2e-09 | body size trait (VT:0100005) | | 6 | 6734789 | 6734790 | Human |
597135746 | GWAS1231820_H | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement QTL GWAS1231820 (human) | | 2e-21 | glycerophosphocholine amount (VT:0011004) | | 6 | 10985995 | 10985996 | Human |
597422467 | GWAS1518541_H | BMI-adjusted waist-hip ratio QTL GWAS1518541 (human) | | 7e-19 | body size trait (VT:0100005) | | 6 | 6760630 | 6760631 | Human |
597422466 | GWAS1518540_H | BMI-adjusted waist-hip ratio QTL GWAS1518540 (human) | | 1e-17 | body size trait (VT:0100005) | | 6 | 6754893 | 6754894 | Human |
597348736 | GWAS1444810_H | apolipoprotein C measurement QTL GWAS1444810 (human) | | 7e-08 | apolipoprotein C measurement | | 6 | 3316628 | 3316629 | Human |
597422465 | GWAS1518539_H | BMI-adjusted waist-hip ratio QTL GWAS1518539 (human) | | 7e-24 | body size trait (VT:0100005) | | 6 | 6757309 | 6757310 | Human |
597422464 | GWAS1518538_H | BMI-adjusted waist-hip ratio QTL GWAS1518538 (human) | | 1e-42 | body size trait (VT:0100005) | | 6 | 6740400 | 6740401 | Human |
597422469 | GWAS1518543_H | BMI-adjusted waist-hip ratio QTL GWAS1518543 (human) | | 2e-31 | body size trait (VT:0100005) | | 6 | 6782065 | 6782066 | Human |
597422468 | GWAS1518542_H | BMI-adjusted waist-hip ratio QTL GWAS1518542 (human) | | 6e-11 | body size trait (VT:0100005) | | 6 | 6777218 | 6777219 | Human |
597397950 | GWAS1494024_H | oleoylcarnitine measurement QTL GWAS1494024 (human) | | 0.0000007 | oleoylcarnitine measurement | | 6 | 9974640 | 9974641 | Human |
597045692 | GWAS1141766_H | membranous glomerulonephritis QTL GWAS1141766 (human) | | 1e-14 | membranous glomerulonephritis | | 6 | 382537 | 382538 | Human |
597430710 | GWAS1526784_H | erythrocyte count QTL GWAS1526784 (human) | | 3e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2522574 | 2522575 | Human |
597242290 | GWAS1338364_H | serum metabolite measurement QTL GWAS1338364 (human) | | 8e-12 | serum metabolite measurement | | 6 | 16705420 | 16705421 | Human |
597291446 | GWAS1387520_H | body mass index QTL GWAS1387520 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 7705771 | 7705772 | Human |
597619121 | GWAS1675981_H | body weight QTL GWAS1675981 (human) | | 3e-13 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12117111 | 12117112 | Human |
597135783 | GWAS1231857_H | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement QTL GWAS1231857 (human) | | 1e-22 | glycerophosphocholine amount (VT:0011004) | | 6 | 11088186 | 11088187 | Human |
597299626 | GWAS1395700_H | body mass index QTL GWAS1395700 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18497117 | 18497118 | Human |
597602735 | GWAS1659595_H | drug use measurement, myocardial infarction QTL GWAS1659595 (human) | | 7e-30 | drug use measurement, myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597299624 | GWAS1395698_H | body mass index QTL GWAS1395698 (human) | | 2e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597299625 | GWAS1395699_H | body mass index QTL GWAS1395699 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13189043 | 13189044 | Human |
597275055 | GWAS1371129_H | rheumatoid arthritis QTL GWAS1371129 (human) | | 0.0000002 | rheumatoid arthritis | | 6 | 426268 | 426269 | Human |
597291439 | GWAS1387513_H | body mass index QTL GWAS1387513 (human) | | 7e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12084212 | 12084213 | Human |
597488036 | GWAS1584110_H | Cleft palate, cleft lip QTL GWAS1584110 (human) | | 0.000007 | Cleft palate, cleft lip | | 6 | 3002503 | 3002504 | Human |
597406115 | GWAS1502189_H | alkaline phosphatase measurement QTL GWAS1502189 (human) | | 1e-09 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 7215946 | 7215947 | Human |
597430695 | GWAS1526769_H | cognitive function measurement QTL GWAS1526769 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 6 | 791124 | 791125 | Human |
597406112 | GWAS1502186_H | alkaline phosphatase measurement QTL GWAS1502186 (human) | | 2e-09 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 2680498 | 2680499 | Human |
597258661 | GWAS1354735_H | open-angle glaucoma QTL GWAS1354735 (human) | | 1e-09 | open-angle glaucoma | | 6 | 2106189 | 2106190 | Human |
597258660 | GWAS1354734_H | open-angle glaucoma QTL GWAS1354734 (human) | | 3e-39 | open-angle glaucoma | | 6 | 1974640 | 1974641 | Human |
597414361 | GWAS1510435_H | adolescent idiopathic scoliosis QTL GWAS1510435 (human) | | 0.000005 | adolescent idiopathic scoliosis | | 6 | 1208775 | 1208776 | Human |
597201371 | GWAS1297445_H | systolic blood pressure QTL GWAS1297445 (human) | | 0.0000006 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 19028392 | 19028393 | Human |
597045712 | GWAS1141786_H | membranous glomerulonephritis QTL GWAS1141786 (human) | | 9e-14 | membranous glomerulonephritis | | 6 | 382537 | 382538 | Human |
597504475 | GWAS1600549_H | chronic obstructive pulmonary disease QTL GWAS1600549 (human) | | 4e-08 | lung integrity trait (VT:0010906) | | 6 | 4579464 | 4579465 | Human |
597414365 | GWAS1510439_H | adolescent idiopathic scoliosis QTL GWAS1510439 (human) | | 6e-09 | adolescent idiopathic scoliosis | | 6 | 11815276 | 11815277 | Human |
597340626 | GWAS1436700_H | serum gamma-glutamyl transferase measurement QTL GWAS1436700 (human) | | 2e-08 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 6 | 15503344 | 15503345 | Human |
597078493 | GWAS1174567_H | serum metabolite measurement QTL GWAS1174567 (human) | | 2e-13 | serum metabolite measurement | | 6 | 11028421 | 11028422 | Human |
597029339 | GWAS1125413_H | sensory perception of sweet taste QTL GWAS1125413 (human) | | 0.000009 | sensory perception of sweet taste | | 6 | 13570054 | 13570055 | Human |
597103046 | GWAS1199120_H | neutrophil count QTL GWAS1199120 (human) | | 3e-29 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16744456 | 16744457 | Human |
597103045 | GWAS1199119_H | neutrophil count QTL GWAS1199119 (human) | | 8e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 12159466 | 12159467 | Human |
597103044 | GWAS1199118_H | neutrophil count QTL GWAS1199118 (human) | | 4e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7154957 | 7154958 | Human |
597103043 | GWAS1199117_H | neutrophil count QTL GWAS1199117 (human) | | 3e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7140598 | 7140599 | Human |
597103042 | GWAS1199116_H | neutrophil count QTL GWAS1199116 (human) | | 3e-09 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 6 | 7085584 | 7085585 | Human |
407276062 | GWAS925038_H | hair color QTL GWAS925038 (human) | | 9e-21 | hair color | | 6 | 421196 | 421197 | Human |
597406145 | GWAS1502219_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS1502219 (human) | | 6e-10 | omega-6 polyunsaturated fatty acid measurement | | 6 | 16113090 | 16113091 | Human |
407276059 | GWAS925035_H | hair color QTL GWAS925035 (human) | | 2e-66 | hair color | | 6 | 433066 | 433067 | Human |
406989343 | GWAS638319_H | open-angle glaucoma QTL GWAS638319 (human) | | 0.0000009 | open-angle glaucoma | | 6 | 5475252 | 5475253 | Human |
597389819 | GWAS1485893_H | hematocrit QTL GWAS1485893 (human) | | 7e-16 | hematocrit | hematocrit (CMO:0000037) | 6 | 12288189 | 12288190 | Human |
597389818 | GWAS1485892_H | hematocrit QTL GWAS1485892 (human) | | 1e-50 | hematocrit | hematocrit (CMO:0000037) | 6 | 7255417 | 7255418 | Human |
596988415 | GWAS1107934_H | body mass index QTL GWAS1107934 (human) | | 2e-17 | body mass index | | 6 | 12124622 | 12124623 | Human |
597414384 | GWAS1510458_H | reaction time measurement QTL GWAS1510458 (human) | | 0.000007 | cognitive behavior trait (VT:0010450) | | 6 | 4160061 | 4160062 | Human |
597414383 | GWAS1510457_H | Cannabis use, age at onset QTL GWAS1510457 (human) | | 0.000002 | Cannabis use, age at onset | | 6 | 1594981 | 1594982 | Human |
407079477 | GWAS728453_H | gut microbiome measurement QTL GWAS728453 (human) | | 4e-08 | gut microbiome measurement | | 6 | 487567 | 487568 | Human |
597045728 | GWAS1141802_H | hemoglobin measurement QTL GWAS1141802 (human) | | 3e-21 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7247111 | 7247112 | Human |
597422563 | GWAS1518637_H | cognitive function measurement QTL GWAS1518637 (human) | | 1e-09 | cognitive behavior trait (VT:0010450) | | 6 | 19161644 | 19161645 | Human |
407112253 | GWAS761229_H | waist-hip ratio QTL GWAS761229 (human) | | 6e-22 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7109432 | 7109433 | Human |
407112251 | GWAS761227_H | waist-hip ratio QTL GWAS761227 (human) | | 9e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 1613451 | 1613452 | Human |
597438749 | GWAS1534823_H | BMI-adjusted waist-hip ratio QTL GWAS1534823 (human) | | 0.000003 | body size trait (VT:0100005) | | 6 | 6734789 | 6734790 | Human |
597127445 | GWAS1223519_H | osteoarthritis, hand QTL GWAS1223519 (human) | | 9e-11 | osteoarthritis, hand | | 6 | 18403902 | 18403903 | Human |
597430552 | GWAS1526626_H | Inguinal hernia QTL GWAS1526626 (human) | | 2e-08 | Inguinal hernia | | 6 | 6734789 | 6734790 | Human |
597430553 | GWAS1526627_H | Inguinal hernia QTL GWAS1526627 (human) | | 4e-10 | Inguinal hernia | | 6 | 6735964 | 6735965 | Human |
597405971 | GWAS1502045_H | BMI-adjusted hip circumference QTL GWAS1502045 (human) | | 4e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6761885 | 6761886 | Human |
597045534 | GWAS1141608_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1141608 (human) | | 0.000002 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 6 | 10810295 | 10810296 | Human |
597405970 | GWAS1502044_H | BMI-adjusted hip circumference QTL GWAS1502044 (human) | | 2e-14 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6754893 | 6754894 | Human |
597405969 | GWAS1502043_H | BMI-adjusted hip circumference QTL GWAS1502043 (human) | | 1e-17 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6754858 | 6754859 | Human |
597201171 | GWAS1297245_H | memory performance, sex interaction measurement QTL GWAS1297245 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 1146110 | 1146111 | Human |
597430551 | GWAS1526625_H | Inguinal hernia QTL GWAS1526625 (human) | | 3e-08 | Inguinal hernia | | 6 | 6733307 | 6733308 | Human |
597405968 | GWAS1502042_H | BMI-adjusted hip circumference QTL GWAS1502042 (human) | | 1e-32 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6735964 | 6735965 | Human |
597405974 | GWAS1502048_H | BMI-adjusted hip circumference QTL GWAS1502048 (human) | | 1e-17 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6782065 | 6782066 | Human |
597405973 | GWAS1502047_H | BMI-adjusted hip circumference QTL GWAS1502047 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6767190 | 6767191 | Human |
597209366 | GWAS1305440_H | birth weight, parental genotype effect measurement QTL GWAS1305440 (human) | | 1e-16 | birth weight, parental genotype effect measurement | neonatal body weight (CMO:0002079) | 6 | 7231610 | 7231611 | Human |
597405972 | GWAS1502046_H | BMI-adjusted hip circumference QTL GWAS1502046 (human) | | 8e-18 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6778441 | 6778442 | Human |
597053703 | GWAS1149777_H | sunburn QTL GWAS1149777 (human) | | 1e-300 | sunburn | | 6 | 396321 | 396322 | Human |
597405967 | GWAS1502041_H | BMI-adjusted hip circumference QTL GWAS1502041 (human) | | 2e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6737358 | 6737359 | Human |
597594378 | GWAS1651238_H | body mass index QTL GWAS1651238 (human) | | 1e-27 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12117111 | 12117112 | Human |
597405966 | GWAS1502040_H | BMI-adjusted hip circumference QTL GWAS1502040 (human) | | 5e-17 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6727130 | 6727131 | Human |
597373198 | GWAS1469272_H | response to vaccine QTL GWAS1469272 (human) | | 0.0000006 | response to vaccine | | 6 | 17240923 | 17240924 | Human |
597479690 | GWAS1575764_H | heel bone mineral density QTL GWAS1575764 (human) | | 6e-39 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2500586 | 2500587 | Human |
597405965 | GWAS1502039_H | BMI-adjusted hip circumference QTL GWAS1502039 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6685569 | 6685570 | Human |
407022292 | GWAS671268_H | low density lipoprotein cholesterol measurement QTL GWAS671268 (human) | | 2e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16196963 | 16196964 | Human |
597332230 | GWAS1428304_H | R-6-hydroxywarfarin measurement QTL GWAS1428304 (human) | | 0.000009 | R-6-hydroxywarfarin measurement | | 6 | 12561153 | 12561154 | Human |
597053704 | GWAS1149778_H | sunburn QTL GWAS1149778 (human) | | 1e-11 | sunburn | | 6 | 495636 | 495637 | Human |
597053705 | GWAS1149779_H | sunburn QTL GWAS1149779 (human) | | 6e-15 | sunburn | | 6 | 599042 | 599043 | Human |
597045554 | GWAS1141628_H | intraocular pressure measurement QTL GWAS1141628 (human) | | 3e-13 | intraocular pressure measurement | | 6 | 1777530 | 1777531 | Human |
406964965 | GWAS613941_H | reticulocyte count QTL GWAS613941 (human) | | 4e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 7157433 | 7157434 | Human |
597332274 | GWAS1428348_H | S-6-hydroxywarfarin measurement QTL GWAS1428348 (human) | | 0.000006 | S-6-hydroxywarfarin measurement | | 6 | 17394158 | 17394159 | Human |
597618994 | GWAS1675854_H | glaucoma QTL GWAS1675854 (human) | | 5e-17 | glaucoma | | 6 | 602983 | 602984 | Human |
597365047 | GWAS1461121_H | response to cisplatin, platinum measurement QTL GWAS1461121 (human) | | 0.000009 | response to cisplatin, platinum measurement | | 6 | 16951395 | 16951396 | Human |
597061926 | GWAS1158000_H | small cell lung carcinoma QTL GWAS1158000 (human) | | 0.000001 | small cell lung carcinoma | | 6 | 7770278 | 7770279 | Human |
597094692 | GWAS1190766_H | diabetic nephropathy QTL GWAS1190766 (human) | | 0.000009 | kidney integrity trait (VT:0010580) | | 6 | 11101685 | 11101686 | Human |
597348652 | GWAS1444726_H | myocardial infarction QTL GWAS1444726 (human) | | 5e-09 | myocardial infarction | | 6 | 13098070 | 13098071 | Human |
597602654 | GWAS1659514_H | monocyte count QTL GWAS1659514 (human) | | 2e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 17602639 | 17602640 | Human |
597291353 | GWAS1387427_H | wellbeing measurement, employment status QTL GWAS1387427 (human) | | 1e-09 | wellness/fitness trait (VT:1000152) | | 6 | 19078043 | 19078044 | Human |
597586269 | GWAS1643129_H | family history of cancer QTL GWAS1643129 (human) | | 4e-29 | family history of cancer | | 6 | 396321 | 396322 | Human |
597135697 | GWAS1231771_H | diastolic blood pressure, systolic blood pressure QTL GWAS1231771 (human) | | 2e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 13664623 | 13664624 | Human |
597619032 | GWAS1675892_H | atrial fibrillation QTL GWAS1675892 (human) | | 7e-13 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597061969 | GWAS1158043_H | small cell lung carcinoma QTL GWAS1158043 (human) | | 0.000004 | small cell lung carcinoma | | 6 | 11322557 | 11322558 | Human |
597135696 | GWAS1231770_H | diastolic blood pressure, systolic blood pressure QTL GWAS1231770 (human) | | 4e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12470371 | 12470372 | Human |
597340498 | GWAS1436572_H | neuroticism measurement, cognitive function measurement QTL GWAS1436572 (human) | | 1e-10 | cognitive behavior trait (VT:0010450) | | 6 | 3450580 | 3450581 | Human |
597619031 | GWAS1675891_H | atrial fibrillation QTL GWAS1675891 (human) | | 2e-36 | atrial fibrillation | | 6 | 16415625 | 16415626 | Human |
597119324 | GWAS1215398_H | cholesteryl ester 22:6 measurement QTL GWAS1215398 (human) | | 1e-12 | blood lipid amount (VT:0003949) | | 6 | 11088670 | 11088671 | Human |
597463377 | GWAS1559451_H | stroke QTL GWAS1559451 (human) | | 3e-09 | stroke | | 6 | 1336945 | 1336946 | Human |
407145099 | GWAS794075_H | cholesteryl ester 20:5 measurement QTL GWAS794075 (human) | | 0.000004 | blood lipid amount (VT:0003949) | | 6 | 10908636 | 10908637 | Human |
597340491 | GWAS1436565_H | idiopathic pulmonary fibrosis QTL GWAS1436565 (human) | | 1e-18 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
596980034 | GWAS1099553_H | memory performance QTL GWAS1099553 (human) | | 0.000003 | memory performance | | 6 | 13335517 | 13335518 | Human |
597135695 | GWAS1231769_H | diastolic blood pressure, systolic blood pressure QTL GWAS1231769 (human) | | 0.0000007 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 2005235 | 2005236 | Human |
597111112 | GWAS1207186_H | body mass index QTL GWAS1207186 (human) | | 0.0000007 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 2840082 | 2840083 | Human |
597397828 | GWAS1493902_H | Vasodilators used in cardiac diseases use measurement QTL GWAS1493902 (human) | | 7e-16 | Vasodilators used in cardiac diseases use measurement | | 6 | 12903725 | 12903726 | Human |
597348730 | GWAS1444804_H | lean body mass QTL GWAS1444804 (human) | | 2e-16 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 19078043 | 19078044 | Human |
597406073 | GWAS1502147_H | Ischemic stroke QTL GWAS1502147 (human) | | 3e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
597422463 | GWAS1518537_H | BMI-adjusted waist-hip ratio QTL GWAS1518537 (human) | | 2e-25 | body size trait (VT:0100005) | | 6 | 6739621 | 6739622 | Human |
597422462 | GWAS1518536_H | BMI-adjusted waist-hip ratio QTL GWAS1518536 (human) | | 2e-15 | body size trait (VT:0100005) | | 6 | 6727130 | 6727131 | Human |
596980089 | GWAS1099608_H | memory performance QTL GWAS1099608 (human) | | 0.000007 | memory performance | | 6 | 11737176 | 11737177 | Human |
597447025 | GWAS1543099_H | IGF-1 measurement QTL GWAS1543099 (human) | | 1e-10 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 6 | 6971520 | 6971521 | Human |
597619056 | GWAS1675916_H | atrial fibrillation QTL GWAS1675916 (human) | | 2e-38 | atrial fibrillation | | 6 | 16415390 | 16415391 | Human |
597119352 | GWAS1215426_H | blood protein measurement QTL GWAS1215426 (human) | | 2e-37 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 3012544 | 3012545 | Human |
597504370 | GWAS1600444_H | juvenile idiopathic arthritis QTL GWAS1600444 (human) | | 9e-08 | juvenile idiopathic arthritis | | 6 | 3570127 | 3570128 | Human |
597406068 | GWAS1502142_H | low density lipoprotein cholesterol measurement QTL GWAS1502142 (human) | | 1e-15 | low density lipoprotein cholesterol measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 6 | 16113090 | 16113091 | Human |
597619057 | GWAS1675917_H | atrial fibrillation QTL GWAS1675917 (human) | | 4e-12 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
407145140 | GWAS794116_H | unipolar depression QTL GWAS794116 (human) | | 0.000003 | unipolar depression | | 6 | 10818696 | 10818697 | Human |
597340520 | GWAS1436594_H | sexual dimorphism measurement QTL GWAS1436594 (human) | | 2e-09 | sexual dimorphism measurement | | 6 | 7729381 | 7729382 | Human |
597070179 | GWAS1166253_H | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement QTL GWAS1166253 (human) | | 0.0000003 | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | | 6 | 10725043 | 10725044 | Human |
597594475 | GWAS1651335_H | myocardial infarction QTL GWAS1651335 (human) | | 1e-37 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597193069 | GWAS1289143_H | memory performance QTL GWAS1289143 (human) | | 0.000008 | memory performance | | 6 | 16776095 | 16776096 | Human |
597021039 | GWAS1117113_H | ferritin measurement QTL GWAS1117113 (human) | | 0.0000003 | ferritin measurement | | 6 | 10233702 | 10233703 | Human |
597283171 | GWAS1379245_H | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio QTL GWAS1379245 (human) | | 2e-15 | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597414245 | GWAS1510319_H | Abnormality of refraction QTL GWAS1510319 (human) | | 1e-21 | Abnormality of refraction | | 6 | 6901623 | 6901624 | Human |
597381275 | GWAS1477349_H | cardiovascular disease QTL GWAS1477349 (human) | | 8e-09 | cardiovascular disease | | 6 | 1619912 | 1619913 | Human |
597045397 | GWAS1141471_H | cutaneous melanoma QTL GWAS1141471 (human) | | 8e-09 | cutaneous melanoma | | 6 | 1145030 | 1145031 | Human |
406973250 | GWAS622226_H | daytime rest measurement QTL GWAS622226 (human) | | 4e-08 | sleep behavior trait (VT:0001501) | | 6 | 1903356 | 1903357 | Human |
597053589 | GWAS1149663_H | neuroticism measurement QTL GWAS1149663 (human) | | 3e-10 | neuroticism measurement | | 6 | 11959603 | 11959604 | Human |
597414045 | GWAS1510119_H | metabolic syndrome QTL GWAS1510119 (human) | | 2e-09 | metabolic syndrome | | 6 | 18559456 | 18559457 | Human |
597610644 | GWAS1667504_H | monocyte count QTL GWAS1667504 (human) | | 2e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7136539 | 7136540 | Human |
597364880 | GWAS1460954_H | hair color QTL GWAS1460954 (human) | | 1e-18 | hair color | | 6 | 412802 | 412803 | Human |
407104328 | GWAS753304_H | FEV/FVC ratio QTL GWAS753304 (human) | | 7e-23 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7562999 | 7563000 | Human |
597610645 | GWAS1667505_H | monocyte count QTL GWAS1667505 (human) | | 3e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10539056 | 10539057 | Human |
597504144 | GWAS1600218_H | age of onset of childhood onset asthma QTL GWAS1600218 (human) | | 2e-09 | age of onset of childhood onset asthma | | 6 | 412802 | 412803 | Human |
597323927 | GWAS1420001_H | 1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6) measurement QTL GWAS1420001 (human) | | 8e-18 | glycerophosphocholine amount (VT:0011004) | | 6 | 11033392 | 11033393 | Human |
596955268 | GWAS1074787_H | Progressive visual loss QTL GWAS1074787 (human) | | 1e-09 | Progressive visual loss | | 6 | 10035850 | 10035851 | Human |
597282957 | GWAS1379031_H | esterified cholesterol measurement, intermediate density lipoprotein measurement QTL GWAS1379031 (human) | | 2e-15 | esterified cholesterol measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 6 | 16131066 | 16131067 | Human |
597348486 | GWAS1444560_H | body mass index QTL GWAS1444560 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12142584 | 12142585 | Human |
597405884 | GWAS1501958_H | erythrocyte count QTL GWAS1501958 (human) | | 4e-25 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7255417 | 7255418 | Human |
597438644 | GWAS1534718_H | forced expiratory volume, response to bronchodilator QTL GWAS1534718 (human) | | 1e-08 | forced expiratory volume, response to bronchodilator | forced expiratory volume (CMO:0000254) | 6 | 1340507 | 1340508 | Human |
597479605 | GWAS1575679_H | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine QTL GWAS1575679 (human) | | 0.0000005 | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | | 6 | 15024446 | 15024447 | Human |
597250227 | GWAS1346301_H | stimulant use measurement QTL GWAS1346301 (human) | | 0.00001 | response to addictive substance trait (VT:0010488) | | 6 | 11597426 | 11597427 | Human |
406973292 | GWAS622268_H | daytime rest measurement QTL GWAS622268 (human) | | 0.000002 | sleep behavior trait (VT:0001501) | | 6 | 1658988 | 1658989 | Human |
597029050 | GWAS1125124_H | BMI-adjusted waist-hip ratio QTL GWAS1125124 (human) | | 3e-21 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597414059 | GWAS1510133_H | adolescent idiopathic scoliosis QTL GWAS1510133 (human) | | 0.000003 | adolescent idiopathic scoliosis | | 6 | 5013107 | 5013108 | Human |
597438637 | GWAS1534711_H | P wave terminal force measurement QTL GWAS1534711 (human) | | 8e-09 | heart excitatory physiology trait (VT:0000231) | | 6 | 2507667 | 2507668 | Human |
597414058 | GWAS1510132_H | adolescent idiopathic scoliosis QTL GWAS1510132 (human) | | 0.000003 | adolescent idiopathic scoliosis | | 6 | 4255406 | 4255407 | Human |
597438634 | GWAS1534708_H | P wave terminal force measurement QTL GWAS1534708 (human) | | 2e-08 | heart excitatory physiology trait (VT:0000231) | | 6 | 2507667 | 2507668 | Human |
597291168 | GWAS1387242_H | forced expiratory volume, inflammatory bowel disease QTL GWAS1387242 (human) | | 4e-08 | forced expiratory volume, inflammatory bowel disease | forced expiratory volume (CMO:0000254) | 6 | 7694497 | 7694498 | Human |
597291225 | GWAS1387299_H | hypertension QTL GWAS1387299 (human) | | 5e-09 | hypertension | | 6 | 1613451 | 1613452 | Human |
597471453 | GWAS1567527_H | health study participation QTL GWAS1567527 (human) | | 2e-08 | health study participation | | 6 | 3465696 | 3465697 | Human |
597291224 | GWAS1387298_H | hypertension QTL GWAS1387298 (human) | | 4e-09 | hypertension | | 6 | 13475437 | 13475438 | Human |
597299419 | GWAS1395493_H | apolipoprotein A 1 measurement, apolipoprotein B measurement QTL GWAS1395493 (human) | | 2e-10 | apolipoprotein A 1 measurement, apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16134016 | 16134017 | Human |
597151958 | GWAS1248032_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1248032 (human) | | 0.0000001 | lifestyle measurement, maximum cigarettes per day measurement | | 6 | 18420134 | 18420135 | Human |
407390987 | GWAS1039963_H | obsolete_red blood cell distribution width QTL GWAS1039963 (human) | | 5e-15 | obsolete_red blood cell distribution width | | 6 | 16285830 | 16285831 | Human |
407390988 | GWAS1039964_H | obsolete_red blood cell distribution width QTL GWAS1039964 (human) | | 6e-24 | obsolete_red blood cell distribution width | | 6 | 16290617 | 16290620 | Human |
597414096 | GWAS1510170_H | BMI-adjusted waist-hip ratio QTL GWAS1510170 (human) | | 2e-14 | body size trait (VT:0100005) | | 6 | 14595642 | 14595643 | Human |
597618897 | GWAS1675757_H | angina pectoris QTL GWAS1675757 (human) | | 9e-24 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597414095 | GWAS1510169_H | BMI-adjusted waist-hip ratio QTL GWAS1510169 (human) | | 3e-15 | body size trait (VT:0100005) | | 6 | 6769697 | 6769698 | Human |
597151938 | GWAS1248012_H | fatty acid measurement, linoleic acid measurement QTL GWAS1248012 (human) | | 2e-08 | fatty acid measurement, linoleic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 11025187 | 11025188 | Human |
597504203 | GWAS1600277_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1600277 (human) | | 8e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 6 | 11591562 | 11591563 | Human |
597414092 | GWAS1510166_H | BMI-adjusted waist-hip ratio QTL GWAS1510166 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 6767190 | 6767191 | Human |
597307587 | GWAS1403661_H | pulse pressure measurement QTL GWAS1403661 (human) | | 1e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7723729 | 7723730 | Human |
597020872 | GWAS1116946_H | response to lithium ion QTL GWAS1116946 (human) | | 0.0000003 | response to lithium ion | | 6 | 17160887 | 17160888 | Human |
597479678 | GWAS1575752_H | glaucoma QTL GWAS1575752 (human) | | 1e-13 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597528825 | GWAS1624899_H | color vision disorder QTL GWAS1624899 (human) | | 0.0000001 | color vision disorder | | 6 | 14753013 | 14753014 | Human |
597430521 | GWAS1526595_H | urate measurement QTL GWAS1526595 (human) | | 1e-11 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 6727130 | 6727131 | Human |
597618939 | GWAS1675799_H | coronary atherosclerosis QTL GWAS1675799 (human) | | 5e-59 | coronary atherosclerosis | | 6 | 12903725 | 12903726 | Human |
597340413 | GWAS1436487_H | serum gamma-glutamyl transferase measurement QTL GWAS1436487 (human) | | 2e-18 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 6 | 7242372 | 7242373 | Human |
1643377 | BW325_H | Body weight QTL 325 (human) | 2.32 | 0.0005 | Body fat amount | | 6 | 6911960 | 32911960 | Human |
597266676 | GWAS1362750_H | diastolic blood pressure QTL GWAS1362750 (human) | | 6e-11 | brain measurement | diastolic blood pressure (CMO:0000005) | 6 | 1618731 | 1618732 | Human |
597242103 | GWAS1338177_H | body fat percentage QTL GWAS1338177 (human) | | 1e-12 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 6 | 12117111 | 12117112 | Human |
406948654 | GWAS597630_H | BMI-adjusted hip circumference QTL GWAS597630 (human) | | 3e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7789710 | 7789711 | Human |
597135608 | GWAS1231682_H | memory performance QTL GWAS1231682 (human) | | 0.000003 | memory performance | | 6 | 13335517 | 13335518 | Human |
597586156 | GWAS1643016_H | basal cell carcinoma QTL GWAS1643016 (human) | | 3e-233 | basal cell carcinoma | | 6 | 396321 | 396322 | Human |
597250283 | GWAS1346357_H | dementia QTL GWAS1346357 (human) | | 0.000002 | dementia | | 6 | 15519654 | 15519655 | Human |
597528814 | GWAS1624888_H | opioid use disorder QTL GWAS1624888 (human) | | 8e-09 | conditioned place preference behavior trait (VT:0010723) | | 6 | 11506670 | 11506671 | Human |
596955362 | GWAS1074881_H | size QTL GWAS1074881 (human) | | 1e-26 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597037281 | GWAS1133355_H | hippocampal volume QTL GWAS1133355 (human) | | 0.000003 | hippocampal volume | | 6 | 9393479 | 9393480 | Human |
597053678 | GWAS1149752_H | sunburn QTL GWAS1149752 (human) | | 2e-11 | sunburn | | 6 | 242312 | 242313 | Human |
596963561 | GWAS1083080_H | orofacial cleft QTL GWAS1083080 (human) | | 0.000005 | orofacial cleft | | 6 | 7736510 | 7736511 | Human |
597209317 | GWAS1305391_H | Facial wrinkling QTL GWAS1305391 (human) | | 0.000003 | Facial wrinkling | | 6 | 7870804 | 7870805 | Human |
597602529 | GWAS1659389_H | monocyte count QTL GWAS1659389 (human) | | 5e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 291291 | 291292 | Human |
597405722 | GWAS1501796_H | total lipids in small LDL QTL GWAS1501796 (human) | | 9e-16 | total lipids in small LDL | | 6 | 16113090 | 16113091 | Human |
1643418 | BW282_H | Body Weight QTL 282 (human) | 2.07 | 0.001 | Body weight | | 6 | 1 | 19321359 | Human |
597028883 | GWAS1124957_H | rheumatoid arthritis QTL GWAS1124957 (human) | | 0.0000002 | rheumatoid arthritis | | 6 | 426155 | 426156 | Human |
597250066 | GWAS1346140_H | stimulant use measurement QTL GWAS1346140 (human) | | 0.000002 | response to addictive substance trait (VT:0010488) | | 6 | 12273914 | 12273915 | Human |
597307412 | GWAS1403486_H | retinal vasculature measurement QTL GWAS1403486 (human) | | 3e-22 | retina blood vessel morphology trait (VT:0002792) | | 6 | 12476464 | 12476465 | Human |
597135361 | GWAS1231435_H | memory performance QTL GWAS1231435 (human) | | 0.000003 | memory performance | | 6 | 16209404 | 16209405 | Human |
597233665 | GWAS1329739_H | appendicular lean mass QTL GWAS1329739 (human) | | 3e-13 | appendicular lean mass | | 6 | 7231610 | 7231611 | Human |
597159949 | GWAS1256023_H | IGA glomerulonephritis QTL GWAS1256023 (human) | | 2e-10 | IGA glomerulonephritis | | 6 | 249571 | 249572 | Human |
1643399 | BMD5_H | Bone mineral density QTL 5 (human) | 2.32 | 0.0005 | Bone mineral density | | 6 | 6911960 | 32911960 | Human |
597233670 | GWAS1329744_H | gut microbiome measurement QTL GWAS1329744 (human) | | 0.000002 | gut microbiome measurement | | 6 | 888821 | 888822 | Human |
597463096 | GWAS1559170_H | coronary artery disease QTL GWAS1559170 (human) | | 2e-08 | coronary artery disease | | 6 | 13098070 | 13098071 | Human |
597471288 | GWAS1567362_H | chronotype measurement QTL GWAS1567362 (human) | | 1e-09 | sleep behavior trait (VT:0001501) | | 6 | 14877829 | 14877830 | Human |
597585977 | GWAS1642837_H | skin neoplasm QTL GWAS1642837 (human) | | 3e-236 | skin neoplasm | | 6 | 396321 | 396322 | Human |
597463094 | GWAS1559168_H | coronary artery disease QTL GWAS1559168 (human) | | 1e-47 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597463095 | GWAS1559169_H | coronary artery disease QTL GWAS1559169 (human) | | 2e-08 | coronary artery disease | | 6 | 13022496 | 13022497 | Human |
597323831 | GWAS1419905_H | colorectal cancer, inflammatory bowel disease QTL GWAS1419905 (human) | | 0.000001 | colorectal cancer, inflammatory bowel disease | | 6 | 18745227 | 18745228 | Human |
596971559 | GWAS1091078_H | bipolar disorder, seasonality measurement, major depressive disorder QTL GWAS1091078 (human) | | 0.000001 | bipolar disorder, seasonality measurement, major depressive disorder | | 6 | 1128802 | 1128803 | Human |
407079920 | GWAS728896_H | psoriasis QTL GWAS728896 (human) | | 0.0000003 | psoriasis | | 6 | 577820 | 577821 | Human |
596963362 | GWAS1082881_H | type 2 diabetes mellitus QTL GWAS1082881 (human) | | 0.0000007 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597332002 | GWAS1428076_H | S-6-hydroxywarfarin measurement QTL GWAS1428076 (human) | | 0.000006 | S-6-hydroxywarfarin measurement | | 6 | 11239288 | 11239289 | Human |
597315623 | GWAS1411697_H | X-17676 measurement QTL GWAS1411697 (human) | | 3e-49 | X-17676 measurement | | 6 | 3149626 | 3149627 | Human |
597160021 | GWAS1256095_H | lipid measurement QTL GWAS1256095 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 6080203 | 6080204 | Human |
597373021 | GWAS1469095_H | reticulocyte measurement QTL GWAS1469095 (human) | | 5e-21 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 2503101 | 2503102 | Human |
596979804 | GWAS1099323_H | myocardial infarction QTL GWAS1099323 (human) | | 2e-20 | myocardial infarction | | 6 | 12891069 | 12891070 | Human |
597028941 | GWAS1125015_H | Red cell distribution width QTL GWAS1125015 (human) | | 1e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3166734 | 3166735 | Human |
597397571 | GWAS1493645_H | vaginal microbiome measurement QTL GWAS1493645 (human) | | 0.000004 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597413952 | GWAS1510026_H | Abnormality of refraction QTL GWAS1510026 (human) | | 2e-20 | Abnormality of refraction | | 6 | 2437997 | 2437998 | Human |
597389376 | GWAS1485450_H | macrophage colony stimulating factor measurement QTL GWAS1485450 (human) | | 0.000006 | cytokine amount (VT:0008713) | | 6 | 4592455 | 4592456 | Human |
407071646 | GWAS720622_H | balding measurement QTL GWAS720622 (human) | | 8e-177 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9329346 | 9329347 | Human |
597389381 | GWAS1485455_H | monokine induced by gamma interferon measurement QTL GWAS1485455 (human) | | 0.000007 | chemokine amount (VT:0008721) | | 6 | 9017279 | 9017280 | Human |
597389380 | GWAS1485454_H | monokine induced by gamma interferon measurement QTL GWAS1485454 (human) | | 0.000004 | chemokine amount (VT:0008721) | | 6 | 8904959 | 8904960 | Human |
407038883 | GWAS687859_H | QT interval QTL GWAS687859 (human) | | 3e-10 | QT interval | QT interval (CMO:0000235) | 6 | 16294491 | 16294492 | Human |
596963446 | GWAS1082965_H | type 2 diabetes mellitus QTL GWAS1082965 (human) | | 4e-25 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597241968 | GWAS1338042_H | calcium measurement QTL GWAS1338042 (human) | | 3e-25 | calcium measurement | blood calcium level (CMO:0000502) | 6 | 556497 | 556498 | Human |
597422194 | GWAS1518268_H | atrial fibrillation QTL GWAS1518268 (human) | | 2e-17 | atrial fibrillation | | 6 | 18361432 | 18361433 | Human |
597422193 | GWAS1518267_H | atrial fibrillation QTL GWAS1518267 (human) | | 1e-24 | atrial fibrillation | | 6 | 16415520 | 16415521 | Human |
407178167 | GWAS827143_H | hair color QTL GWAS827143 (human) | | 2e-308 | hair color | | 6 | 421281 | 421282 | Human |
597340265 | GWAS1436339_H | cartilage thickness measurement QTL GWAS1436339 (human) | | 5e-09 | cartilage morphology trait (VT:0000163) | | 6 | 7729381 | 7729382 | Human |
597463145 | GWAS1559219_H | C-reactive protein measurement QTL GWAS1559219 (human) | | 1e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 18492119 | 18492120 | Human |
407038900 | GWAS687876_H | vital capacity QTL GWAS687876 (human) | | 6e-13 | vital capacity | | 6 | 7800879 | 7800880 | Human |
597487716 | GWAS1583790_H | carnitine measurement QTL GWAS1583790 (human) | | 3e-10 | blood carnitine amount (VT:0003977) | | 6 | 4106136 | 4106137 | Human |
597282912 | GWAS1378986_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1378986 (human) | | 8e-14 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597225569 | GWAS1321643_H | ovarian carcinoma QTL GWAS1321643 (human) | | 0.000003 | ovarian carcinoma | | 6 | 17689625 | 17689626 | Human |
407178168 | GWAS827144_H | hair color QTL GWAS827144 (human) | | 6e-76 | hair color | | 6 | 433066 | 433067 | Human |
1643495 | BW291_H | Body Weight QTL 291 (human) | 2.13 | | Body weight | BMI | 6 | 1 | 19321359 | Human |
406965315 | GWAS614291_H | Child Behaviour Checklist assessment QTL GWAS614291 (human) | | 0.0000005 | Child Behaviour Checklist assessment | | 6 | 3076907 | 3076908 | Human |
596989853 | GWAS1109372_H | memory performance QTL GWAS1109372 (human) | | 0.000009 | memory performance | | 6 | 14371188 | 14371189 | Human |
597071770 | GWAS1167844_H | thiopurine methyltransferase activity measurement, trait in response to mercaptopurine QTL GWAS1167844 (human) | | 9e-61 | thiopurine methyltransferase activity measurement, trait in response to mercaptopurine | | 6 | 18130687 | 18130688 | Human |
597489549 | GWAS1585623_H | COVID-19 QTL GWAS1585623 (human) | | 0.0000005 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
597055365 | GWAS1151439_H | BMI-adjusted waist circumference QTL GWAS1151439 (human) | | 5e-11 | body size trait (VT:0100005) | | 6 | 1775480 | 1775481 | Human |
597325705 | GWAS1421779_H | docosapentaenoate n3 DPA; 22:5n3 measurement QTL GWAS1421779 (human) | | 2e-14 | docosapentaenoate n3 DPA; 22:5n3 measurement | | 6 | 10982740 | 10982741 | Human |
597587843 | GWAS1644703_H | lymphoid leukemia QTL GWAS1644703 (human) | | 9e-22 | lymphoid leukemia | | 6 | 421281 | 421282 | Human |
597309372 | GWAS1405446_H | vaginal microbiome measurement QTL GWAS1405446 (human) | | 0.000004 | vaginal microbiome measurement | | 6 | 1906694 | 1906695 | Human |
1643569 | GLUCO21_H | Glucose level QTL 21 (human) | | 0.021 | Glucose level | non-insulin-dependent | 6 | 6911960 | 32911960 | Human |
597325751 | GWAS1421825_H | vital capacity QTL GWAS1421825 (human) | | 3e-23 | vital capacity | | 6 | 7710819 | 7710820 | Human |
597399468 | GWAS1495542_H | vaginal microbiome measurement QTL GWAS1495542 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 5083368 | 5083369 | Human |
597407651 | GWAS1503725_H | phospholipids in VLDL measurement QTL GWAS1503725 (human) | | 1e-12 | blood VLDL phospholipid amount (VT:0010507) | | 6 | 16113090 | 16113091 | Human |
597227428 | GWAS1323502_H | eye colour measurement QTL GWAS1323502 (human) | | 0.000004 | eye colour measurement | eye morphological measurement (CMO:0003080) | 6 | 2187322 | 2187323 | Human |
597399463 | GWAS1495537_H | vaginal microbiome measurement QTL GWAS1495537 (human) | | 0.000007 | vaginal microbiome measurement | | 6 | 15066900 | 15066901 | Human |
597464994 | GWAS1561068_H | BMI-adjusted waist-hip ratio QTL GWAS1561068 (human) | | 9e-48 | body size trait (VT:0100005) | | 6 | 6745933 | 6745934 | Human |
596989909 | GWAS1109428_H | memory performance, sex interaction measurement QTL GWAS1109428 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12854649 | 12854650 | Human |
596989908 | GWAS1109427_H | memory performance, sex interaction measurement QTL GWAS1109427 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12853747 | 12853748 | Human |
596989911 | GWAS1109430_H | memory performance, sex interaction measurement QTL GWAS1109430 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12864077 | 12864078 | Human |
597366749 | GWAS1462823_H | memory performance QTL GWAS1462823 (human) | | 0.0000003 | memory performance | | 6 | 14201743 | 14201744 | Human |
597481435 | GWAS1577509_H | monocyte count QTL GWAS1577509 (human) | | 3e-28 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10519657 | 10519658 | Human |
596989906 | GWAS1109425_H | memory performance, sex interaction measurement QTL GWAS1109425 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12863018 | 12863019 | Human |
597088209 | GWAS1184283_H | type 2 diabetes mellitus QTL GWAS1184283 (human) | | 3e-08 | type 2 diabetes mellitus | | 6 | 15474820 | 15474821 | Human |
596989919 | GWAS1109438_H | memory performance, sex interaction measurement QTL GWAS1109438 (human) | | 0.000009 | memory performance, sex interaction measurement | | 6 | 12855772 | 12855773 | Human |
596989912 | GWAS1109431_H | memory performance, sex interaction measurement QTL GWAS1109431 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12856255 | 12856256 | Human |
596989915 | GWAS1109434_H | memory performance, sex interaction measurement QTL GWAS1109434 (human) | | 0.000009 | memory performance, sex interaction measurement | | 6 | 12860530 | 12860531 | Human |
596989914 | GWAS1109433_H | memory performance, sex interaction measurement QTL GWAS1109433 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12850372 | 12850373 | Human |
597489608 | GWAS1585682_H | X-02249 measurement QTL GWAS1585682 (human) | | 0.000002 | X-02249 measurement | | 6 | 6567175 | 6567176 | Human |
597497800 | GWAS1593874_H | perivascular space measurement QTL GWAS1593874 (human) | | 4e-08 | perivascular space measurement | | 6 | 1364456 | 1364457 | Human |
597342156 | GWAS1438230_H | complex trait QTL GWAS1438230 (human) | | 1e-09 | complex trait | | 6 | 7727979 | 7727980 | Human |
597293006 | GWAS1389080_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389080 (human) | | 7e-09 | lymphocyte measurement, neutrophil measurement | | 6 | 16744456 | 16744457 | Human |
597497797 | GWAS1593871_H | perivascular space measurement QTL GWAS1593871 (human) | | 3e-09 | perivascular space measurement | | 6 | 2616888 | 2616889 | Human |
597096394 | GWAS1192468_H | sex hormone-binding globulin measurement QTL GWAS1192468 (human) | | 0.000003 | sex hormone-binding globulin measurement | | 6 | 15398100 | 15398101 | Human |
597080054 | GWAS1176128_H | Red cell distribution width QTL GWAS1176128 (human) | | 1e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 18747474 | 18747475 | Human |
597481470 | GWAS1577544_H | open-angle glaucoma QTL GWAS1577544 (human) | | 1e-12 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597080052 | GWAS1176126_H | Red cell distribution width QTL GWAS1176126 (human) | | 3e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 13930123 | 13930124 | Human |
597080053 | GWAS1176127_H | Red cell distribution width QTL GWAS1176127 (human) | | 2e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16288384 | 16288385 | Human |
597080050 | GWAS1176124_H | Red cell distribution width QTL GWAS1176124 (human) | | 2e-22 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597399551 | GWAS1495625_H | vaginal microbiome measurement QTL GWAS1495625 (human) | | 0.0000009 | vaginal microbiome measurement | | 6 | 12286605 | 12286606 | Human |
597080051 | GWAS1176125_H | Red cell distribution width QTL GWAS1176125 (human) | | 2e-22 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5260461 | 5260462 | Human |
597522416 | GWAS1618490_H | asthma QTL GWAS1618490 (human) | | 4e-08 | asthma | | 6 | 253272 | 253273 | Human |
597587952 | GWAS1644812_H | eosinophil count QTL GWAS1644812 (human) | | 9e-25 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 246178 | 246179 | Human |
597137382 | GWAS1233456_H | docosahexaenoate DHA; 22:6n3 measurement QTL GWAS1233456 (human) | | 8e-12 | docosahexaenoate DHA; 22:6n3 measurement | | 6 | 10985995 | 10985996 | Human |
597522412 | GWAS1618486_H | diastolic blood pressure QTL GWAS1618486 (human) | | 0.0000003 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 11472612 | 11472613 | Human |
597120998 | GWAS1217072_H | verbal-numerical reasoning measurement QTL GWAS1217072 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 6 | 16313800 | 16313801 | Human |
597456879 | GWAS1552953_H | employment status, environmental factor QTL GWAS1552953 (human) | | 8e-10 | employment status, environmental factor | | 6 | 16965821 | 16965822 | Human |
597522411 | GWAS1618485_H | diastolic blood pressure QTL GWAS1618485 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 10034219 | 10034220 | Human |
597522410 | GWAS1618484_H | diastolic blood pressure QTL GWAS1618484 (human) | | 3e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 6 | 1619912 | 1619913 | Human |
597260257 | GWAS1356331_H | phosphatidylinositol measurement QTL GWAS1356331 (human) | | 4e-10 | phosphatidylinositol measurement | | 6 | 11013987 | 11013988 | Human |
597243872 | GWAS1339946_H | urgency urinary incontinence QTL GWAS1339946 (human) | | 2e-09 | urgency urinary incontinence | | 6 | 12532834 | 12532835 | Human |
597432294 | GWAS1528368_H | protein measurement QTL GWAS1528368 (human) | | 2e-15 | protein measurement | | 6 | 7883235 | 7883236 | Human |
597260259 | GWAS1356333_H | phosphatidylinositol measurement QTL GWAS1356333 (human) | | 7e-10 | phosphatidylinositol measurement | | 6 | 10984097 | 10984098 | Human |
597260258 | GWAS1356332_H | phosphatidylinositol measurement QTL GWAS1356332 (human) | | 6e-10 | phosphatidylinositol measurement | | 6 | 11010567 | 11010568 | Human |
597374951 | GWAS1471025_H | response to trauma exposure QTL GWAS1471025 (human) | | 0.000007 | response to trauma exposure | | 6 | 8806815 | 8806816 | Human |
597260261 | GWAS1356335_H | phosphatidylinositol measurement QTL GWAS1356335 (human) | | 7e-10 | phosphatidylinositol measurement | | 6 | 11012626 | 11012627 | Human |
597260260 | GWAS1356334_H | phosphatidylinositol measurement QTL GWAS1356334 (human) | | 7e-10 | phosphatidylinositol measurement | | 6 | 11010841 | 11010842 | Human |
597489432 | GWAS1585506_H | pulse pressure measurement QTL GWAS1585506 (human) | | 5e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 2355441 | 2355442 | Human |
597260060 | GWAS1356134_H | acute myeloid leukemia, myelodysplastic syndrome QTL GWAS1356134 (human) | | 3e-12 | acute myeloid leukemia, myelodysplastic syndrome | | 6 | 396321 | 396322 | Human |
597251871 | GWAS1347945_H | escherichia seropositivity QTL GWAS1347945 (human) | | 6e-10 | escherichia seropositivity | | 6 | 11520817 | 11520818 | Human |
597415708 | GWAS1511782_H | cognitive function measurement QTL GWAS1511782 (human) | | 3e-10 | cognitive behavior trait (VT:0010450) | | 6 | 11508438 | 11508439 | Human |
407129293 | GWAS778269_H | multiple sclerosis QTL GWAS778269 (human) | | 0.000003 | multiple sclerosis | | 6 | 7118757 | 7118758 | Human |
597325584 | GWAS1421658_H | color vision disorder QTL GWAS1421658 (human) | | 0.0000001 | color vision disorder | | 6 | 7351652 | 7351653 | Human |
597284626 | GWAS1380700_H | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS1380700 (human) | | 1e-12 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597481224 | GWAS1577298_H | open-angle glaucoma QTL GWAS1577298 (human) | | 9e-20 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597489416 | GWAS1585490_H | response to diuretic QTL GWAS1585490 (human) | | 0.000002 | response to diuretic | | 6 | 13531161 | 13531162 | Human |
597325583 | GWAS1421657_H | color vision disorder QTL GWAS1421657 (human) | | 6e-08 | color vision disorder | | 6 | 5482195 | 5482196 | Human |
597260089 | GWAS1356163_H | dementia QTL GWAS1356163 (human) | | 0.000008 | dementia | | 6 | 12455913 | 12455914 | Human |
597161780 | GWAS1257854_H | gamma-glutamylglutamate measurement QTL GWAS1257854 (human) | | 0.000004 | gamma-glutamylglutamate measurement | | 6 | 18750709 | 18750710 | Human |
597595963 | GWAS1652823_H | skin disease QTL GWAS1652823 (human) | | 5e-22 | skin disease | | 6 | 17602639 | 17602640 | Human |
597620537 | GWAS1677397_H | open-angle glaucoma QTL GWAS1677397 (human) | | 2e-26 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597104446 | GWAS1200520_H | alopecia QTL GWAS1200520 (human) | | 6e-09 | alopecia | | 6 | 9304416 | 9304417 | Human |
597161790 | GWAS1257864_H | Immunosuppressant use measurement QTL GWAS1257864 (human) | | 7e-09 | Immunosuppressant use measurement | | 6 | 14091451 | 14091452 | Human |
597317431 | GWAS1413505_H | JT interval QTL GWAS1413505 (human) | | 6e-39 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 6 | 18209878 | 18209879 | Human |
407055598 | GWAS704574_H | insomnia measurement QTL GWAS704574 (human) | | 1e-08 | sleep behavior trait (VT:0001501) | | 6 | 18843579 | 18843580 | Human |
597104441 | GWAS1200515_H | alopecia QTL GWAS1200515 (human) | | 3e-35 | alopecia | | 6 | 9327323 | 9327324 | Human |
597309236 | GWAS1405310_H | body mass index QTL GWAS1405310 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13180222 | 13180223 | Human |
597399336 | GWAS1495410_H | schizophrenia QTL GWAS1495410 (human) | | 0.000001 | schizophrenia | | 6 | 16327837 | 16327838 | Human |
597366573 | GWAS1462647_H | balding measurement QTL GWAS1462647 (human) | | 4e-34 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 456143 | 456144 | Human |
597530410 | GWAS1626484_H | hippocampal CA3 volume QTL GWAS1626484 (human) | | 5e-08 | hippocampal CA3 volume | | 6 | 3642632 | 3642633 | Human |
597104424 | GWAS1200498_H | coronary artery disease QTL GWAS1200498 (human) | | 3e-08 | coronary artery disease | | 6 | 13022496 | 13022497 | Human |
597440348 | GWAS1536422_H | lipid measurement QTL GWAS1536422 (human) | | 0.000006 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 8227141 | 8227142 | Human |
597415771 | GWAS1511845_H | self reported educational attainment QTL GWAS1511845 (human) | | 5e-11 | self reported educational attainment | | 6 | 14895448 | 14895449 | Human |
597415770 | GWAS1511844_H | self reported educational attainment QTL GWAS1511844 (human) | | 2e-17 | self reported educational attainment | | 6 | 14718029 | 14718030 | Human |
597604188 | GWAS1661048_H | Red cell distribution width QTL GWAS1661048 (human) | | 3e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597415769 | GWAS1511843_H | self reported educational attainment QTL GWAS1511843 (human) | | 2e-08 | self reported educational attainment | | 6 | 14169900 | 14169901 | Human |
597415772 | GWAS1511846_H | self reported educational attainment QTL GWAS1511846 (human) | | 1e-20 | self reported educational attainment | | 6 | 16965821 | 16965822 | Human |
596957021 | GWAS1076540_H | behavioural disinhibition measurement QTL GWAS1076540 (human) | | 0.0000002 | behavioural disinhibition measurement | | 6 | 1106224 | 1106225 | Human |
597251923 | GWAS1347997_H | thrombin generation potential measurement QTL GWAS1347997 (human) | | 0.0000006 | thrombin generation potential measurement | | 6 | 10923619 | 10923620 | Human |
597415767 | GWAS1511841_H | urate measurement QTL GWAS1511841 (human) | | 1e-47 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7214443 | 7214444 | Human |
597145435 | GWAS1241509_H | self reported educational attainment QTL GWAS1241509 (human) | | 6e-10 | self reported educational attainment | | 6 | 19037901 | 19037902 | Human |
597153607 | GWAS1249681_H | psoriasis QTL GWAS1249681 (human) | | 0.000002 | psoriasis | | 6 | 18139165 | 18139166 | Human |
597587791 | GWAS1644651_H | benign neoplasm of eye QTL GWAS1644651 (human) | | 7e-72 | benign neoplasm of eye | | 6 | 396321 | 396322 | Human |
597489485 | GWAS1585559_H | metabolic disease, COVID-19 QTL GWAS1585559 (human) | | 0.000001 | metabolic disease, COVID-19 | | 6 | 1059594 | 1059595 | Human |
597153606 | GWAS1249680_H | psoriasis QTL GWAS1249680 (human) | | 0.000001 | psoriasis | | 6 | 18121442 | 18121443 | Human |
597366601 | GWAS1462675_H | gut microbiome measurement QTL GWAS1462675 (human) | | 0.000003 | gut microbiome measurement | | 6 | 4394672 | 4394673 | Human |
597440334 | GWAS1536408_H | lipid measurement QTL GWAS1536408 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 6495289 | 6495290 | Human |
597153605 | GWAS1249679_H | psoriasis QTL GWAS1249679 (human) | | 0.000007 | psoriasis | | 6 | 17888267 | 17888268 | Human |
597489487 | GWAS1585561_H | metabolic disease, COVID-19 QTL GWAS1585561 (human) | | 0.000002 | metabolic disease, COVID-19 | | 6 | 1059594 | 1059595 | Human |
597153604 | GWAS1249678_H | psoriasis QTL GWAS1249678 (human) | | 0.000002 | psoriasis | | 6 | 17729143 | 17729144 | Human |
406965396 | GWAS614372_H | chronic lymphocytic leukemia QTL GWAS614372 (human) | | 6e-20 | leukocyte integrity trait (VT:0010898) | | 6 | 411064 | 411065 | Human |
597595977 | GWAS1652837_H | drug use measurement, skin disease QTL GWAS1652837 (human) | | 2e-15 | drug use measurement, skin disease | | 6 | 17602639 | 17602640 | Human |
597620550 | GWAS1677410_H | open-angle glaucoma QTL GWAS1677410 (human) | | 3e-19 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597620549 | GWAS1677409_H | open-angle glaucoma QTL GWAS1677409 (human) | | 6e-16 | open-angle glaucoma | | 6 | 602983 | 602984 | Human |
597178179 | GWAS1274253_H | cancer QTL GWAS1274253 (human) | | 9e-09 | cancer | | 6 | 7231610 | 7231611 | Human |
597153610 | GWAS1249684_H | total cholesterol measurement, diet measurement QTL GWAS1249684 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 654075 | 654076 | Human |
597587833 | GWAS1644693_H | benign neoplasm of eye QTL GWAS1644693 (human) | | 1e-75 | benign neoplasm of eye | | 6 | 396321 | 396322 | Human |
597407601 | GWAS1503675_H | vaginal microbiome measurement QTL GWAS1503675 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597251958 | GWAS1348032_H | HbA1c measurement QTL GWAS1348032 (human) | | 4e-09 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7247111 | 7247112 | Human |
597456748 | GWAS1552822_H | Crohn's disease QTL GWAS1552822 (human) | | 0.0000002 | intestine integrity trait (VT:0010554) | | 6 | 246629 | 246630 | Human |
597145443 | GWAS1241517_H | prostate carcinoma QTL GWAS1241517 (human) | | 4e-10 | prostate carcinoma | | 6 | 11289515 | 11289516 | Human |
597145442 | GWAS1241516_H | prostate carcinoma QTL GWAS1241516 (human) | | 2e-16 | prostate carcinoma | | 6 | 11218797 | 11218798 | Human |
597432169 | GWAS1528243_H | coronary artery disease QTL GWAS1528243 (human) | | 3e-11 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
596965218 | GWAS1084737_H | total cholesterol measurement, diet measurement QTL GWAS1084737 (human) | | 0.000002 | total cholesterol measurement, diet measurement | | 6 | 654075 | 654076 | Human |
597145441 | GWAS1241515_H | prostate carcinoma QTL GWAS1241515 (human) | | 4e-15 | prostate carcinoma | | 6 | 1670751 | 1670752 | Human |
407137465 | GWAS786441_H | response to selective serotonin reuptake inhibitor QTL GWAS786441 (human) | | 0.000001 | response to selective serotonin reuptake inhibitor | | 6 | 13070841 | 13070842 | Human |
407137467 | GWAS786443_H | response to selective serotonin reuptake inhibitor QTL GWAS786443 (human) | | 0.000002 | response to selective serotonin reuptake inhibitor | | 6 | 17505713 | 17505714 | Human |
597276317 | GWAS1372391_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1372391 (human) | | 1e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 6 | 3450814 | 3450815 | Human |
407039303 | GWAS688279_H | psoriasis QTL GWAS688279 (human) | | 0.000006 | psoriasis | | 6 | 542416 | 542417 | Human |
597399196 | GWAS1495270_H | vaginal microbiome measurement QTL GWAS1495270 (human) | | 0.0000003 | vaginal microbiome measurement | | 6 | 6873309 | 6873310 | Human |
597145247 | GWAS1241321_H | systolic blood pressure QTL GWAS1241321 (human) | | 0.000004 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 6894715 | 6894716 | Human |
597530262 | GWAS1626336_H | coronary artery disease QTL GWAS1626336 (human) | | 1e-08 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597071514 | GWAS1167588_H | psoriasis QTL GWAS1167588 (human) | | 2e-11 | psoriasis | | 6 | 577820 | 577821 | Human |
597325463 | GWAS1421537_H | FEV/FVC ratio QTL GWAS1421537 (human) | | 1e-09 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 688741 | 688742 | Human |
407268694 | GWAS917670_H | coronary artery disease QTL GWAS917670 (human) | | 6e-19 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597472905 | GWAS1568979_H | basal cell carcinoma QTL GWAS1568979 (human) | | 4e-21 | basal cell carcinoma | | 6 | 461906 | 461907 | Human |
597399180 | GWAS1495254_H | vaginal microbiome measurement QTL GWAS1495254 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597055118 | GWAS1151192_H | systolic blood pressure QTL GWAS1151192 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16324091 | 16324092 | Human |
406973784 | GWAS622760_H | QRS amplitude, QRS complex QTL GWAS622760 (human) | | 3e-08 | QRS amplitude, QRS complex | QRS amplitude (CMO:0000268) | 6 | 12159466 | 12159467 | Human |
597055116 | GWAS1151190_H | systolic blood pressure QTL GWAS1151190 (human) | | 4e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7725527 | 7725528 | Human |
597055117 | GWAS1151191_H | systolic blood pressure QTL GWAS1151191 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12295754 | 12295755 | Human |
597350022 | GWAS1446096_H | myocardial infarction QTL GWAS1446096 (human) | | 0.0000003 | myocardial infarction | | 6 | 1617092 | 1617093 | Human |
597587587 | GWAS1644447_H | cutaneous melanoma QTL GWAS1644447 (human) | | 2e-41 | cutaneous melanoma | | 6 | 396321 | 396322 | Human |
597350023 | GWAS1446097_H | myocardial infarction QTL GWAS1446097 (human) | | 5e-23 | myocardial infarction | | 6 | 12801735 | 12801736 | Human |
597358250 | GWAS1454324_H | coronary artery disease QTL GWAS1454324 (human) | | 9e-26 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597186218 | GWAS1282292_H | renal cell carcinoma QTL GWAS1282292 (human) | | 6e-08 | renal cell carcinoma | | 6 | 914591 | 914592 | Human |
597218987 | GWAS1315061_H | cystatin C measurement QTL GWAS1315061 (human) | | 8e-11 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 6 | 2097452 | 2097453 | Human |
597620397 | GWAS1677257_H | hearing loss QTL GWAS1677257 (human) | | 5e-15 | hearing loss | | 6 | 7106083 | 7106084 | Human |
597472932 | GWAS1569006_H | heel bone mineral density QTL GWAS1569006 (human) | | 2e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2442947 | 2442948 | Human |
597472933 | GWAS1569007_H | heel bone mineral density QTL GWAS1569007 (human) | | 5e-39 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2495812 | 2495813 | Human |
597579431 | GWAS1636291_H | hemoglobin measurement QTL GWAS1636291 (human) | | 1e-18 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7195451 | 7195452 | Human |
597489317 | GWAS1585391_H | aspartate aminotransferase measurement QTL GWAS1585391 (human) | | 2e-31 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 6 | 13512277 | 13512278 | Human |
597210785 | GWAS1306859_H | blood protein measurement QTL GWAS1306859 (human) | | 6e-19 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15896776 | 15896777 | Human |
597472934 | GWAS1569008_H | heel bone mineral density QTL GWAS1569008 (human) | | 6e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2580493 | 2580494 | Human |
597472935 | GWAS1569009_H | heel bone mineral density QTL GWAS1569009 (human) | | 1e-41 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7058624 | 7058625 | Human |
597612193 | GWAS1669053_H | platelet count QTL GWAS1669053 (human) | | 3e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597481180 | GWAS1577254_H | mathematical ability QTL GWAS1577254 (human) | | 2e-11 | mathematical ability | | 6 | 3463840 | 3463841 | Human |
597071575 | GWAS1167649_H | blood protein measurement QTL GWAS1167649 (human) | | 3e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 231579 | 231580 | Human |
597210841 | GWAS1306915_H | IGA glomerulonephritis QTL GWAS1306915 (human) | | 3e-11 | IGA glomerulonephritis | | 6 | 249714 | 249715 | Human |
597481181 | GWAS1577255_H | mathematical ability QTL GWAS1577255 (human) | | 5e-08 | mathematical ability | | 6 | 13270713 | 13270714 | Human |
597481182 | GWAS1577256_H | mathematical ability QTL GWAS1577256 (human) | | 3e-08 | mathematical ability | | 6 | 14618917 | 14618918 | Human |
597481183 | GWAS1577257_H | mathematical ability QTL GWAS1577257 (human) | | 2e-11 | mathematical ability | | 6 | 14895448 | 14895449 | Human |
597276381 | GWAS1372455_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372455 (human) | | 2e-08 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 15195451 | 15195452 | Human |
597513947 | GWAS1610021_H | peak expiratory flow QTL GWAS1610021 (human) | | 2e-25 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 2507667 | 2507668 | Human |
597079760 | GWAS1175834_H | mean corpuscular hemoglobin concentration QTL GWAS1175834 (human) | | 7e-13 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290617 | 16290620 | Human |
597202643 | GWAS1298717_H | memory performance QTL GWAS1298717 (human) | | 0.000009 | memory performance | | 6 | 17799535 | 17799536 | Human |
406916367 | GWAS565343_H | obsolete Mendelian syndromes with cleft lip/palate, alcohol consumption measurement, cleft lip QTL GWAS565343 (human) | | 4e-08 | obsolete Mendelian syndromes with cleft lip/palate, alcohol consumption measurement, cleft lip | | 6 | 11729849 | 11729850 | Human |
407039249 | GWAS688225_H | gamma-linolenic acid measurement QTL GWAS688225 (human) | | 0.000007 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 2837612 | 2837613 | Human |
597481160 | GWAS1577234_H | open-angle glaucoma QTL GWAS1577234 (human) | | 4e-13 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597079758 | GWAS1175832_H | mean corpuscular hemoglobin concentration QTL GWAS1175832 (human) | | 3e-56 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597079759 | GWAS1175833_H | mean corpuscular hemoglobin concentration QTL GWAS1175833 (human) | | 1e-19 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16285830 | 16285831 | Human |
407055647 | GWAS704623_H | trauma exposure measurement QTL GWAS704623 (human) | | 0.000009 | trauma exposure measurement | | 6 | 18319476 | 18319477 | Human |
597169861 | GWAS1265935_H | Periodontal Pocket QTL GWAS1265935 (human) | | 0.000002 | Periodontal Pocket | | 6 | 7452276 | 7452279 | Human |
597473018 | GWAS1569092_H | protein measurement QTL GWAS1569092 (human) | | 2e-08 | protein measurement | | 6 | 3906043 | 3906044 | Human |
597317363 | GWAS1413437_H | age at onset, major depressive disorder QTL GWAS1413437 (human) | | 0.000002 | age at onset, major depressive disorder | | 6 | 5367040 | 5367041 | Human |
597112574 | GWAS1208648_H | ovarian carcinoma QTL GWAS1208648 (human) | | 0.000006 | ovarian carcinoma | | 6 | 10403963 | 10403964 | Human |
597227252 | GWAS1323326_H | atrial fibrillation QTL GWAS1323326 (human) | | 2e-25 | atrial fibrillation | | 6 | 16415520 | 16415521 | Human |
597227253 | GWAS1323327_H | atrial fibrillation QTL GWAS1323327 (human) | | 2e-19 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597620462 | GWAS1677322_H | Sensorineural hearing impairment QTL GWAS1677322 (human) | | 2e-12 | Sensorineural hearing impairment | | 6 | 7109200 | 7109201 | Human |
406908209 | GWAS557185_H | systemic lupus erythematosus QTL GWAS557185 (human) | | 3e-08 | systemic lupus erythematosus | | 6 | 16630667 | 16630668 | Human |
597374697 | GWAS1470771_H | body mass index QTL GWAS1470771 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18492119 | 18492120 | Human |
597104352 | GWAS1200426_H | alopecia QTL GWAS1200426 (human) | | 2e-15 | alopecia | | 6 | 9419866 | 9419867 | Human |
597456612 | GWAS1552686_H | intermediate density lipoprotein measurement QTL GWAS1552686 (human) | | 3e-15 | intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 6 | 16113090 | 16113091 | Human |
407113157 | GWAS762133_H | mean corpuscular hemoglobin QTL GWAS762133 (human) | | 2e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 3162144 | 3162145 | Human |
407113158 | GWAS762134_H | mean corpuscular hemoglobin QTL GWAS762134 (human) | | 2e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 3365499 | 3365500 | Human |
407113159 | GWAS762135_H | mean corpuscular hemoglobin QTL GWAS762135 (human) | | 1e-08 | body height | mean corpuscular hemoglobin (CMO:0000290) | 6 | 7729381 | 7729382 | Human |
597169691 | GWAS1265765_H | Varicose veins QTL GWAS1265765 (human) | | 2e-10 | Varicose veins | | 6 | 12463340 | 12463341 | Human |
596973075 | GWAS1092594_H | age at onset, major depressive disorder QTL GWAS1092594 (human) | | 0.000009 | age at onset, major depressive disorder | | 6 | 5389170 | 5389171 | Human |
407113155 | GWAS762131_H | mean corpuscular hemoglobin QTL GWAS762131 (human) | | 5e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 530476 | 530477 | Human |
596973086 | GWAS1092605_H | age at onset, major depressive disorder QTL GWAS1092605 (human) | | 0.000002 | age at onset, major depressive disorder | | 6 | 5367040 | 5367041 | Human |
597177876 | GWAS1273950_H | bone morphogenetic protein 7 measurement QTL GWAS1273950 (human) | | 4e-13 | bone morphogenetic protein 7 measurement | | 6 | 7708398 | 7708399 | Human |
407113160 | GWAS762136_H | mean corpuscular hemoglobin QTL GWAS762136 (human) | | 1e-13 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 7963699 | 7963700 | Human |
597472786 | GWAS1568860_H | protein measurement QTL GWAS1568860 (human) | | 1e-12 | protein measurement | | 6 | 2990961 | 2990962 | Human |
597374475 | GWAS1470549_H | anxiety, major depressive disorder QTL GWAS1470549 (human) | | 0.000008 | anxiety, major depressive disorder | | 6 | 11811081 | 11811082 | Human |
407145940 | GWAS794916_H | QT interval QTL GWAS794916 (human) | | 0.000004 | QT interval | QT interval (CMO:0000235) | 6 | 13225739 | 13225740 | Human |
597251594 | GWAS1347668_H | worry measurement QTL GWAS1347668 (human) | | 0.0000009 | worry measurement | | 6 | 11959603 | 11959604 | Human |
597431818 | GWAS1527892_H | protein measurement QTL GWAS1527892 (human) | | 4e-14 | protein measurement | | 6 | 2990139 | 2990140 | Human |
597202447 | GWAS1298521_H | memory performance QTL GWAS1298521 (human) | | 0.000004 | memory performance | | 6 | 11732434 | 11732435 | Human |
597366273 | GWAS1462347_H | balding measurement QTL GWAS1462347 (human) | | 5e-21 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9116124 | 9116125 | Human |
597505542 | GWAS1601616_H | cervical artery dissection QTL GWAS1601616 (human) | | 8e-17 | cervical artery dissection | | 6 | 12903725 | 12903726 | Human |
597292549 | GWAS1388623_H | respiratory system disease QTL GWAS1388623 (human) | | 9e-11 | respiratory system disease | | 6 | 7231610 | 7231611 | Human |
407055839 | GWAS704815_H | trauma exposure measurement QTL GWAS704815 (human) | | 8e-08 | trauma exposure measurement | | 6 | 17012781 | 17012782 | Human |
597210629 | GWAS1306703_H | blood protein measurement QTL GWAS1306703 (human) | | 3e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15896772 | 15896773 | Human |
597276167 | GWAS1372241_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1372241 (human) | | 3e-09 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 426268 | 426269 | Human |
407145947 | GWAS794923_H | ejection fraction measurement QTL GWAS794923 (human) | | 0.000003 | ejection fraction measurement | ejection fraction (CMO:0000180) | 6 | 16699829 | 16699830 | Human |
597407293 | GWAS1503367_H | vaginal microbiome measurement QTL GWAS1503367 (human) | | 0.000007 | vaginal microbiome measurement | | 6 | 5083368 | 5083369 | Human |
406916583 | GWAS565559_H | pulse pressure measurement QTL GWAS565559 (human) | | 4e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 7727929 | 7727930 | Human |
407055850 | GWAS704826_H | mean corpuscular hemoglobin concentration QTL GWAS704826 (human) | | 1e-10 | mean corpuscular volume | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 18757083 | 18757084 | Human |
407047656 | GWAS696632_H | triacylglycerol 56:6 measurement QTL GWAS696632 (human) | | 0.000008 | blood triglyceride amount (VT:0002644) | | 6 | 7555002 | 7555003 | Human |
407047660 | GWAS696636_H | response to quetiapine QTL GWAS696636 (human) | | 0.0000002 | response to quetiapine | | 6 | 3359103 | 3359104 | Human |
596964898 | GWAS1084417_H | diet measurement, apolipoprotein B measurement QTL GWAS1084417 (human) | | 0.000008 | diet measurement, apolipoprotein B measurement | | 6 | 8369079 | 8369080 | Human |
597145135 | GWAS1241209_H | systolic blood pressure QTL GWAS1241209 (human) | | 0.000004 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 13162099 | 13162100 | Human |
597169699 | GWAS1265773_H | serum alanine aminotransferase measurement QTL GWAS1265773 (human) | | 1e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 15389015 | 15389016 | Human |
407154060 | GWAS803036_H | apolipoprotein B measurement QTL GWAS803036 (human) | | 1e-08 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 11838809 | 11838810 | Human |
597440086 | GWAS1536160_H | BMI-adjusted hip circumference QTL GWAS1536160 (human) | | 0.000002 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 796747 | 796748 | Human |
597497424 | GWAS1593498_H | hair color QTL GWAS1593498 (human) | | 6e-14 | hair color | | 6 | 475489 | 475490 | Human |
597522002 | GWAS1618076_H | neuroticism measurement QTL GWAS1618076 (human) | | 6e-08 | neuroticism measurement | | 6 | 11993783 | 11993784 | Human |
406908304 | GWAS557280_H | albumin:globulin ratio measurement QTL GWAS557280 (human) | | 0.000004 | albumin:globulin ratio measurement | | 6 | 252145 | 252146 | Human |
596973124 | GWAS1092643_H | major depressive disorder QTL GWAS1092643 (human) | | 5e-09 | major depressive disorder | | 6 | 17016169 | 17016170 | Human |
597497423 | GWAS1593497_H | hair color QTL GWAS1593497 (human) | | 1e-08 | hair color | | 6 | 471136 | 471137 | Human |
407055760 | GWAS704736_H | chronic obstructive pulmonary disease QTL GWAS704736 (human) | | 1e-08 | lung integrity trait (VT:0010906) | | 6 | 7211585 | 7211586 | Human |
406949271 | GWAS598247_H | total trans-18:1 fatty acid measurement, trans fatty acid measurement, trans-16:1n-7 fatty acid measurement QTL GWAS598247 (human) | | 0.000003 | total trans-18:1 fatty acid measurement, trans fatty acid measurement, trans-16:1n-7 fatty acid measurement | milk trans fatty acid measurement (CMO:0000824) | 6 | 1785684 | 1785685 | Human |
597497412 | GWAS1593486_H | freckles QTL GWAS1593486 (human) | | 2e-09 | freckles | | 6 | 453415 | 453416 | Human |
597104204 | GWAS1200278_H | alopecia QTL GWAS1200278 (human) | | 3e-49 | alopecia | | 6 | 396321 | 396322 | Human |
597161546 | GWAS1257620_H | neutrophil count QTL GWAS1257620 (human) | | 4e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16758194 | 16758195 | Human |
597243463 | GWAS1339537_H | blood protein measurement QTL GWAS1339537 (human) | | 2e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 403604 | 403605 | Human |
407367065 | GWAS1016041_H | beta-amyloid 1-42 measurement QTL GWAS1016041 (human) | | 2e-08 | beta-amyloid 1-42 measurement | | 6 | 2838014 | 2838015 | Human |
597497410 | GWAS1593484_H | freckles QTL GWAS1593484 (human) | | 2e-09 | freckles | | 6 | 475489 | 475490 | Human |
597292614 | GWAS1388688_H | lymphocyte count QTL GWAS1388688 (human) | | 8e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 11770472 | 11770473 | Human |
597612158 | GWAS1669018_H | erythrocyte count QTL GWAS1669018 (human) | | 4e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16292483 | 16292484 | Human |
406998435 | GWAS647411_H | urinary bladder carcinoma QTL GWAS647411 (human) | | 0.000003 | urinary bladder carcinoma | | 6 | 1402302 | 1402303 | Human |
597603964 | GWAS1660824_H | neuroendocrine neoplasm QTL GWAS1660824 (human) | | 3e-11 | neuroendocrine neoplasm | | 6 | 10599162 | 10599163 | Human |
597022326 | GWAS1118400_H | macrophage inflammatory protein 1a measurement QTL GWAS1118400 (human) | | 0.000003 | chemokine amount (VT:0008721) | | 6 | 380341 | 380342 | Human |
597472895 | GWAS1568969_H | basal cell carcinoma QTL GWAS1568969 (human) | | 1e-23 | basal cell carcinoma | | 6 | 453415 | 453416 | Human |
407039393 | GWAS688369_H | coronary artery calcification QTL GWAS688369 (human) | | 4e-09 | coronary artery calcification | | 6 | 11040190 | 11040191 | Human |
597382775 | GWAS1478849_H | monocyte count QTL GWAS1478849 (human) | | 3e-44 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10519657 | 10519658 | Human |
597382774 | GWAS1478848_H | monocyte count QTL GWAS1478848 (human) | | 2e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 6708615 | 6708616 | Human |
597382773 | GWAS1478847_H | monocyte count QTL GWAS1478847 (human) | | 4e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 2877446 | 2877447 | Human |
597382772 | GWAS1478846_H | Red cell distribution width QTL GWAS1478846 (human) | | 3e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 2501301 | 2501302 | Human |
597456492 | GWAS1552566_H | C-reactive protein measurement QTL GWAS1552566 (human) | | 1e-10 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 7004628 | 7004629 | Human |
597374570 | GWAS1470644_H | hemoglobin measurement QTL GWAS1470644 (human) | | 1e-13 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2522574 | 2522575 | Human |
407227830 | GWAS876806_H | urate measurement QTL GWAS876806 (human) | | 0.000008 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 10963614 | 10963615 | Human |
407055802 | GWAS704778_H | body mass index QTL GWAS704778 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18862209 | 18862210 | Human |
597317223 | GWAS1413297_H | age at onset, major depressive disorder QTL GWAS1413297 (human) | | 0.000009 | age at onset, major depressive disorder | | 6 | 5389170 | 5389171 | Human |
597022314 | GWAS1118388_H | interleukin 5 measurement QTL GWAS1118388 (human) | | 0.000002 | blood interleukin-5 amount (VT:0008625) | | 6 | 16092129 | 16092130 | Human |
597153384 | GWAS1249458_H | low density lipoprotein cholesterol measurement QTL GWAS1249458 (human) | | 3e-09 | low density lipoprotein cholesterol measurement | blood cholesterol level (CMO:0002280) | 6 | 16134016 | 16134017 | Human |
597431709 | GWAS1527783_H | protein measurement QTL GWAS1527783 (human) | | 8e-319 | protein measurement | | 6 | 3010156 | 3010157 | Human |
597587355 | GWAS1644215_H | eosinophil count QTL GWAS1644215 (human) | | 3e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 561527 | 561528 | Human |
597218704 | GWAS1314778_H | BMI-adjusted waist-hip ratio QTL GWAS1314778 (human) | | 2e-09 | body size trait (VT:0100005) | | 6 | 7159781 | 7159782 | Human |
597218705 | GWAS1314779_H | BMI-adjusted waist-hip ratio QTL GWAS1314779 (human) | | 6e-09 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597218706 | GWAS1314780_H | BMI-adjusted waist-hip ratio QTL GWAS1314780 (human) | | 2e-08 | body size trait (VT:0100005) | | 6 | 7237836 | 7237837 | Human |
407227982 | GWAS876958_H | Hodgkins lymphoma, multiple myeloma, chronic lymphocytic leukemia QTL GWAS876958 (human) | | 6e-09 | leukocyte integrity trait (VT:0010898) | | 6 | 442357 | 442358 | Human |
597218707 | GWAS1314781_H | BMI-adjusted waist-hip ratio QTL GWAS1314781 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 7258290 | 7258291 | Human |
597579148 | GWAS1636008_H | glaucoma QTL GWAS1636008 (human) | | 1e-24 | glaucoma | | 6 | 1548134 | 1548135 | Human |
596981126 | GWAS1100645_H | memory performance QTL GWAS1100645 (human) | | 0.000004 | memory performance | | 6 | 11737176 | 11737177 | Human |
597226892 | GWAS1322966_H | asthma, age at onset QTL GWAS1322966 (human) | | 0.0000002 | asthma, age at onset | | 6 | 409119 | 409120 | Human |
597218701 | GWAS1314775_H | BMI-adjusted waist-hip ratio QTL GWAS1314775 (human) | | 3e-09 | body size trait (VT:0100005) | | 6 | 7066248 | 7066249 | Human |
597218702 | GWAS1314776_H | BMI-adjusted waist-hip ratio QTL GWAS1314776 (human) | | 6e-09 | body size trait (VT:0100005) | | 6 | 7076458 | 7076459 | Human |
597218703 | GWAS1314777_H | BMI-adjusted waist-hip ratio QTL GWAS1314777 (human) | | 1e-13 | body size trait (VT:0100005) | | 6 | 7109432 | 7109433 | Human |
597472651 | GWAS1568725_H | chronotype measurement QTL GWAS1568725 (human) | | 1e-33 | sleep behavior trait (VT:0001501) | | 6 | 13183766 | 13183767 | Human |
597431684 | GWAS1527758_H | Inguinal hernia QTL GWAS1527758 (human) | | 3e-10 | Inguinal hernia | | 6 | 6743562 | 6743563 | Human |
597136783 | GWAS1232857_H | neuroimaging measurement QTL GWAS1232857 (human) | | 3e-12 | neuroimaging measurement | | 6 | 7736184 | 7736185 | Human |
407146076 | GWAS795052_H | amyotrophic lateral sclerosis QTL GWAS795052 (human) | | 0.000004 | amyotrophic lateral sclerosis | | 6 | 16741802 | 16741803 | Human |
597431685 | GWAS1527759_H | Inguinal hernia QTL GWAS1527759 (human) | | 3e-10 | Inguinal hernia | | 6 | 6743902 | 6743903 | Human |
597439877 | GWAS1535951_H | lobe attachment QTL GWAS1535951 (human) | | 2e-10 | lobe attachment | ear measurement (CMO:0002667) | 6 | 14752078 | 14752079 | Human |
597431686 | GWAS1527760_H | Inguinal hernia QTL GWAS1527760 (human) | | 6e-09 | Inguinal hernia | | 6 | 6744059 | 6744060 | Human |
597431687 | GWAS1527761_H | Inguinal hernia QTL GWAS1527761 (human) | | 3e-10 | Inguinal hernia | | 6 | 6744244 | 6744245 | Human |
597431680 | GWAS1527754_H | Inguinal hernia QTL GWAS1527754 (human) | | 2e-10 | Inguinal hernia | | 6 | 6742316 | 6742317 | Human |
597603714 | GWAS1660574_H | monocyte count QTL GWAS1660574 (human) | | 9e-21 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10535358 | 10535359 | Human |
597431681 | GWAS1527755_H | Inguinal hernia QTL GWAS1527755 (human) | | 5e-09 | Inguinal hernia | | 6 | 6742519 | 6742520 | Human |
597423494 | GWAS1519568_H | BMI-adjusted waist circumference QTL GWAS1519568 (human) | | 5e-14 | body size trait (VT:0100005) | | 6 | 6782065 | 6782066 | Human |
597063051 | GWAS1159125_H | wellbeing measurement QTL GWAS1159125 (human) | | 3e-08 | wellness/fitness trait (VT:1000152) | | 6 | 11750897 | 11750898 | Human |
597431682 | GWAS1527756_H | Inguinal hernia QTL GWAS1527756 (human) | | 3e-10 | Inguinal hernia | | 6 | 6743086 | 6743087 | Human |
597423493 | GWAS1519567_H | BMI-adjusted waist circumference QTL GWAS1519567 (human) | | 7e-09 | body size trait (VT:0100005) | | 6 | 6761934 | 6761935 | Human |
597431683 | GWAS1527757_H | Inguinal hernia QTL GWAS1527757 (human) | | 1e-08 | Inguinal hernia | | 6 | 6743272 | 6743273 | Human |
597161399 | GWAS1257473_H | gamma-glutamylleucine measurement QTL GWAS1257473 (human) | | 0.000002 | gamma-glutamylleucine measurement | | 6 | 5335864 | 5335865 | Human |
597603775 | GWAS1660635_H | neutrophil count QTL GWAS1660635 (human) | | 8e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 17602639 | 17602640 | Human |
597030327 | GWAS1126401_H | balding measurement QTL GWAS1126401 (human) | | 7e-105 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 396321 | 396322 | Human |
597030332 | GWAS1126406_H | balding measurement QTL GWAS1126406 (human) | | 6e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 16752633 | 16752634 | Human |
596964797 | GWAS1084316_H | psoriasis QTL GWAS1084316 (human) | | 0.000007 | psoriasis | | 6 | 17888267 | 17888268 | Human |
596964798 | GWAS1084317_H | psoriasis QTL GWAS1084317 (human) | | 0.000001 | psoriasis | | 6 | 18121442 | 18121443 | Human |
597030329 | GWAS1126403_H | balding measurement QTL GWAS1126403 (human) | | 1e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 7250727 | 7250728 | Human |
597030328 | GWAS1126402_H | balding measurement QTL GWAS1126402 (human) | | 2e-14 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 7109432 | 7109433 | Human |
597349815 | GWAS1445889_H | obsessive-compulsive symptom measurement QTL GWAS1445889 (human) | | 0.000006 | anxiety-related behavior trait (VT:0010716) | | 6 | 18498116 | 18498117 | Human |
597587376 | GWAS1644236_H | examination for neoplasm QTL GWAS1644236 (human) | | 3e-15 | examination for neoplasm | | 6 | 396321 | 396322 | Human |
597030331 | GWAS1126405_H | balding measurement QTL GWAS1126405 (human) | | 4e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 11637250 | 11637251 | Human |
597030330 | GWAS1126404_H | balding measurement QTL GWAS1126404 (human) | | 4e-61 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9321075 | 9321076 | Human |
597587374 | GWAS1644234_H | HPV seropositivity, common wart QTL GWAS1644234 (human) | | 2e-11 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 396321 | 396322 | Human |
597226968 | GWAS1323042_H | self reported educational attainment QTL GWAS1323042 (human) | | 7e-09 | self reported educational attainment | | 6 | 19227436 | 19227437 | Human |
597407192 | GWAS1503266_H | total blood protein measurement QTL GWAS1503266 (human) | | 4e-09 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 15086386 | 15086387 | Human |
597439961 | GWAS1536035_H | susceptibility to vaginal yeast infection measurement QTL GWAS1536035 (human) | | 0.0000002 | susceptibility to vaginal yeast infection measurement | | 6 | 10009979 | 10009980 | Human |
597439963 | GWAS1536037_H | susceptibility to vaginal yeast infection measurement QTL GWAS1536037 (human) | | 0.000002 | susceptibility to vaginal yeast infection measurement | | 6 | 9880470 | 9880471 | Human |
597333458 | GWAS1429532_H | S-6-hydroxywarfarin measurement QTL GWAS1429532 (human) | | 0.000002 | S-6-hydroxywarfarin measurement | | 6 | 629612 | 629613 | Human |
407383555 | GWAS1032531_H | obsolete_red blood cell distribution width QTL GWAS1032531 (human) | | 2e-22 | obsolete_red blood cell distribution width | | 6 | 3423313 | 3423314 | Human |
407383556 | GWAS1032532_H | obsolete_red blood cell distribution width QTL GWAS1032532 (human) | | 2e-22 | obsolete_red blood cell distribution width | | 6 | 5260461 | 5260462 | Human |
597374423 | GWAS1470497_H | short-term memory QTL GWAS1470497 (human) | | 0.000001 | short-term memory | | 6 | 14598589 | 14598590 | Human |
407383557 | GWAS1032533_H | obsolete_red blood cell distribution width QTL GWAS1032533 (human) | | 3e-12 | obsolete_red blood cell distribution width | | 6 | 13930123 | 13930124 | Human |
407383558 | GWAS1032534_H | obsolete_red blood cell distribution width QTL GWAS1032534 (human) | | 2e-18 | obsolete_red blood cell distribution width | | 6 | 16288384 | 16288385 | Human |
597595601 | GWAS1652461_H | drug use measurement, coronary artery disease QTL GWAS1652461 (human) | | 7e-42 | drug use measurement, coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597489107 | GWAS1585181_H | revision of total joint arthroplasty QTL GWAS1585181 (human) | | 0.000002 | revision of total joint arthroplasty | | 6 | 17099535 | 17099536 | Human |
407383559 | GWAS1032535_H | obsolete_red blood cell distribution width QTL GWAS1032535 (human) | | 1e-15 | obsolete_red blood cell distribution width | | 6 | 18747474 | 18747475 | Human |
596964803 | GWAS1084322_H | psoriasis QTL GWAS1084322 (human) | | 0.000002 | psoriasis | | 6 | 18139165 | 18139166 | Human |
597210565 | GWAS1306639_H | protein measurement QTL GWAS1306639 (human) | | 5e-12 | protein measurement | | 6 | 3002004 | 3002005 | Human |
597587450 | GWAS1644310_H | hypothyroidism QTL GWAS1644310 (human) | | 2e-12 | hypothyroidism | | 6 | 410417 | 410418 | Human |
597210623 | GWAS1306697_H | blood protein measurement QTL GWAS1306697 (human) | | 2e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15898140 | 15898141 | Human |
597579243 | GWAS1636103_H | eosinophil count QTL GWAS1636103 (human) | | 4e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 277101 | 277102 | Human |
597308898 | GWAS1404972_H | vaginal microbiome measurement QTL GWAS1404972 (human) | | 0.00001 | vaginal microbiome measurement | | 6 | 16517726 | 16517727 | Human |
597530084 | GWAS1626158_H | otosclerosis QTL GWAS1626158 (human) | | 0.0000004 | otosclerosis | | 6 | 10819154 | 10819155 | Human |
597226981 | GWAS1323055_H | smoking cessation QTL GWAS1323055 (human) | | 1e-08 | smoking cessation | | 6 | 396321 | 396322 | Human |
597251355 | GWAS1347429_H | corneal resistance factor QTL GWAS1347429 (human) | | 2e-14 | corneal resistance factor | | 6 | 16522173 | 16522174 | Human |
597415192 | GWAS1511266_H | wellbeing measurement QTL GWAS1511266 (human) | | 2e-09 | wellness/fitness trait (VT:1000152) | | 6 | 12008029 | 12008030 | Human |
597587226 | GWAS1644086_H | skin cancer QTL GWAS1644086 (human) | | 8e-12 | skin cancer | | 6 | 396321 | 396322 | Human |
407383747 | GWAS1032723_H | mean corpuscular hemoglobin concentration QTL GWAS1032723 (human) | | 2e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 6924844 | 6924845 | Human |
597415191 | GWAS1511265_H | wellbeing measurement QTL GWAS1511265 (human) | | 2e-10 | wellness/fitness trait (VT:1000152) | | 6 | 11712110 | 11712111 | Human |
597185814 | GWAS1281888_H | migraine disorder, Headache QTL GWAS1281888 (human) | | 2e-09 | migraine disorder, Headache | | 6 | 12880931 | 12880932 | Human |
597185815 | GWAS1281889_H | migraine disorder, Headache QTL GWAS1281889 (human) | | 1e-15 | migraine disorder, Headache | | 6 | 12901209 | 12901210 | Human |
597587215 | GWAS1644075_H | skin disease QTL GWAS1644075 (human) | | 4e-20 | skin disease | | 6 | 17602639 | 17602640 | Human |
597488905 | GWAS1584979_H | phosphatidylcholine measurement QTL GWAS1584979 (human) | | 7e-11 | phosphatidylcholine measurement | | 6 | 11072089 | 11072090 | Human |
597456139 | GWAS1552213_H | total cholesterol in medium LDL QTL GWAS1552213 (human) | | 8e-17 | total cholesterol in large LDL | | 6 | 16113090 | 16113091 | Human |
597177600 | GWAS1273674_H | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma QTL GWAS1273674 (human) | | 2e-10 | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | | 6 | 483593 | 483594 | Human |
597210371 | GWAS1306445_H | protein measurement QTL GWAS1306445 (human) | | 5e-10 | protein measurement | | 6 | 1426818 | 1426819 | Human |
597611779 | GWAS1668639_H | esophageal ulcer QTL GWAS1668639 (human) | | 5e-12 | esophageal ulcer | | 6 | 1548612 | 1548613 | Human |
597087497 | GWAS1183571_H | PR interval QTL GWAS1183571 (human) | | 1e-10 | PR interval | PR interval (CMO:0000233) | 6 | 18227315 | 18227316 | Human |
597366075 | GWAS1462149_H | chronotype measurement QTL GWAS1462149 (human) | | 2e-18 | sleep behavior trait (VT:0001501) | | 6 | 13183291 | 13183292 | Human |
597579069 | GWAS1635929_H | drug use measurement, glaucoma QTL GWAS1635929 (human) | | 9e-19 | drug use measurement, glaucoma | | 6 | 1548134 | 1548135 | Human |
597595450 | GWAS1652310_H | drug use measurement, skin cancer QTL GWAS1652310 (human) | | 2e-53 | drug use measurement, skin cancer | | 6 | 396321 | 396322 | Human |
597439800 | GWAS1535874_H | Crohn's disease QTL GWAS1535874 (human) | | 0.0000002 | intestine integrity trait (VT:0010554) | | 6 | 14719265 | 14719266 | Human |
407047911 | GWAS696887_H | indoxyl sulfate measurement QTL GWAS696887 (human) | | 0.0000001 | indoxyl sulfate measurement | | 6 | 18319318 | 18319319 | Human |
407056101 | GWAS705077_H | chronic obstructive pulmonary disease QTL GWAS705077 (human) | | 0.0000002 | lung integrity trait (VT:0010906) | | 6 | 7562999 | 7563000 | Human |
597169448 | GWAS1265522_H | type 2 diabetes mellitus QTL GWAS1265522 (human) | | 1e-10 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597275941 | GWAS1372015_H | nisinate (24:6n3) measurement QTL GWAS1372015 (human) | | 1e-19 | nisinate (24:6n3) measurement | | 6 | 10991434 | 10991436 | Human |
597316902 | GWAS1412976_H | vaginal microbiome measurement QTL GWAS1412976 (human) | | 0.000009 | vaginal microbiome measurement | | 6 | 11639102 | 11639103 | Human |
597325093 | GWAS1421167_H | vital capacity QTL GWAS1421167 (human) | | 2e-40 | vital capacity | | 6 | 7792087 | 7792088 | Human |
597382491 | GWAS1478565_H | FEV/FVC ratio QTL GWAS1478565 (human) | | 2e-10 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 4571425 | 4571426 | Human |
597374299 | GWAS1470373_H | reticulocyte count QTL GWAS1470373 (human) | | 6e-18 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 7217431 | 7217432 | Human |
597374298 | GWAS1470372_H | reticulocyte count QTL GWAS1470372 (human) | | 5e-11 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6923601 | 6923602 | Human |
597374297 | GWAS1470371_H | reticulocyte count QTL GWAS1470371 (human) | | 1e-21 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6682429 | 6682430 | Human |
597341528 | GWAS1437602_H | thiopurine methyltransferase activity measurement QTL GWAS1437602 (human) | | 4e-16 | thiopurine methyltransferase activity measurement | | 6 | 18130687 | 18130688 | Human |
597374296 | GWAS1470370_H | reticulocyte count QTL GWAS1470370 (human) | | 2e-20 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2485234 | 2485235 | Human |
597382494 | GWAS1478568_H | FEV/FVC ratio QTL GWAS1478568 (human) | | 1e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 8115159 | 8115160 | Human |
597382493 | GWAS1478567_H | FEV/FVC ratio QTL GWAS1478567 (human) | | 6e-19 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6857407 | 6857408 | Human |
597382492 | GWAS1478566_H | FEV/FVC ratio QTL GWAS1478566 (human) | | 3e-50 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6738801 | 6738802 | Human |
597095761 | GWAS1191835_H | sex hormone-binding globulin measurement QTL GWAS1191835 (human) | | 5e-26 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597054813 | GWAS1150887_H | household income QTL GWAS1150887 (human) | | 3e-08 | household income | | 6 | 3445302 | 3445303 | Human |
597210440 | GWAS1306514_H | blood protein measurement QTL GWAS1306514 (human) | | 7e-11 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 14091451 | 14091452 | Human |
597210441 | GWAS1306515_H | blood protein measurement QTL GWAS1306515 (human) | | 2e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15880309 | 15880310 | Human |
407367315 | GWAS1016291_H | gastroesophageal reflux disease QTL GWAS1016291 (human) | | 0.000004 | gastroesophageal reflux disease | | 6 | 6805938 | 6805939 | Human |
597497158 | GWAS1593232_H | protein measurement QTL GWAS1593232 (human) | | 2e-51 | protein measurement | | 6 | 3138265 | 3138266 | Human |
406965916 | GWAS614892_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS614892 (human) | | 0.0000007 | omega-6 polyunsaturated fatty acid measurement | | 6 | 10994782 | 10994783 | Human |
597210437 | GWAS1306511_H | blood protein measurement QTL GWAS1306511 (human) | | 1e-25 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15880309 | 15880310 | Human |
597431676 | GWAS1527750_H | Inguinal hernia QTL GWAS1527750 (human) | | 3e-09 | Inguinal hernia | | 6 | 6741094 | 6741095 | Human |
597431678 | GWAS1527752_H | Inguinal hernia QTL GWAS1527752 (human) | | 2e-09 | Inguinal hernia | | 6 | 6741699 | 6741700 | Human |
597431679 | GWAS1527753_H | Inguinal hernia QTL GWAS1527753 (human) | | 2e-10 | Inguinal hernia | | 6 | 6741952 | 6741953 | Human |
597071221 | GWAS1167295_H | mean corpuscular hemoglobin QTL GWAS1167295 (human) | | 4e-18 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16269132 | 16269133 | Human |
406916772 | GWAS565748_H | obsolete Mendelian syndromes with cleft lip/palate QTL GWAS565748 (human) | | 0.000005 | obsolete Mendelian syndromes with cleft lip/palate | | 6 | 7736510 | 7736511 | Human |
597390718 | GWAS1486792_H | obesity QTL GWAS1486792 (human) | | 0.000009 | obesity | | 6 | 16940230 | 16940231 | Human |
597431674 | GWAS1527748_H | Inguinal hernia QTL GWAS1527748 (human) | | 6e-10 | Inguinal hernia | | 6 | 6740133 | 6740134 | Human |
597431675 | GWAS1527749_H | Inguinal hernia QTL GWAS1527749 (human) | | 5e-10 | Inguinal hernia | | 6 | 6740400 | 6740401 | Human |
597521782 | GWAS1617856_H | basal cell carcinoma QTL GWAS1617856 (human) | | 1e-12 | basal cell carcinoma | | 6 | 413389 | 413390 | Human |
597521778 | GWAS1617852_H | basal cell carcinoma QTL GWAS1617852 (human) | | 2e-08 | basal cell carcinoma | | 6 | 432505 | 432506 | Human |
597202280 | GWAS1298354_H | lean body mass QTL GWAS1298354 (human) | | 8e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 18993033 | 18993034 | Human |
597079396 | GWAS1175470_H | mean corpuscular hemoglobin QTL GWAS1175470 (human) | | 6e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 3162144 | 3162145 | Human |
597079397 | GWAS1175471_H | mean corpuscular hemoglobin QTL GWAS1175471 (human) | | 1e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 7746999 | 7747000 | Human |
406908596 | GWAS557572_H | systemic lupus erythematosus QTL GWAS557572 (human) | | 3e-12 | systemic lupus erythematosus | | 6 | 16630667 | 16630668 | Human |
597333346 | GWAS1429420_H | smoking initiation QTL GWAS1429420 (human) | | 2e-21 | smoking initiation | | 6 | 13030118 | 13030119 | Human |
407113404 | GWAS762380_H | mean corpuscular hemoglobin QTL GWAS762380 (human) | | 2e-160 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16294491 | 16294492 | Human |
597415266 | GWAS1511340_H | monocyte count QTL GWAS1511340 (human) | | 1e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10519657 | 10519658 | Human |
597333347 | GWAS1429421_H | smoking initiation QTL GWAS1429421 (human) | | 3e-15 | smoking initiation | | 6 | 15445568 | 15445569 | Human |
597333344 | GWAS1429418_H | smoking initiation QTL GWAS1429418 (human) | | 2e-09 | smoking initiation | | 6 | 11975017 | 11975018 | Human |
597333345 | GWAS1429419_H | smoking initiation QTL GWAS1429419 (human) | | 8e-14 | smoking initiation | | 6 | 12750701 | 12750702 | Human |
597488999 | GWAS1585073_H | cholesterol esters in large LDL measurement QTL GWAS1585073 (human) | | 1e-16 | cholesterol esters in large LDL measurement | | 6 | 16113090 | 16113091 | Human |
597333348 | GWAS1429422_H | smoking initiation QTL GWAS1429422 (human) | | 3e-09 | smoking initiation | | 6 | 17013198 | 17013199 | Human |
597333349 | GWAS1429423_H | smoking initiation QTL GWAS1429423 (human) | | 9e-20 | smoking initiation | | 6 | 18950900 | 18950901 | Human |
406966081 | GWAS615057_H | open-angle glaucoma QTL GWAS615057 (human) | | 8e-10 | open-angle glaucoma | | 6 | 1922673 | 1922674 | Human |
597308574 | GWAS1404648_H | platelet count QTL GWAS1404648 (human) | | 2e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 11593752 | 11593753 | Human |
596989087 | GWAS1108606_H | memory performance, sex interaction measurement QTL GWAS1108606 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 1146110 | 1146111 | Human |
597374102 | GWAS1470176_H | basal cell carcinoma QTL GWAS1470176 (human) | | 1e-09 | basal cell carcinoma | | 6 | 475489 | 475490 | Human |
597595278 | GWAS1652138_H | coronary artery disease QTL GWAS1652138 (human) | | 3e-47 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
596989069 | GWAS1108588_H | memory performance QTL GWAS1108588 (human) | | 0.000009 | memory performance | | 6 | 15471139 | 15471140 | Human |
597210242 | GWAS1306316_H | blood protein measurement QTL GWAS1306316 (human) | | 3e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15898653 | 15898654 | Human |
597243013 | GWAS1339087_H | cardioembolic stroke QTL GWAS1339087 (human) | | 0.0000004 | cardioembolic stroke | | 6 | 5992819 | 5992820 | Human |
597210246 | GWAS1306320_H | blood protein measurement QTL GWAS1306320 (human) | | 2e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 14091451 | 14091452 | Human |
597111991 | GWAS1208065_H | intraocular pressure measurement QTL GWAS1208065 (human) | | 4e-11 | intraocular pressure measurement | | 6 | 597164 | 597165 | Human |
597431484 | GWAS1527558_H | reticulocyte count QTL GWAS1527558 (human) | | 4e-19 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6923601 | 6923602 | Human |
597431485 | GWAS1527559_H | reticulocyte count QTL GWAS1527559 (human) | | 3e-14 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 7216820 | 7216821 | Human |
597431481 | GWAS1527555_H | reticulocyte count QTL GWAS1527555 (human) | | 2e-13 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2485234 | 2485235 | Human |
597431482 | GWAS1527556_H | reticulocyte count QTL GWAS1527556 (human) | | 5e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2885696 | 2885697 | Human |
597431483 | GWAS1527557_H | reticulocyte count QTL GWAS1527557 (human) | | 4e-16 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6682429 | 6682430 | Human |
407023467 | GWAS672443_H | interstitial lung disease QTL GWAS672443 (human) | | 1e-19 | interstitial lung disease | | 6 | 7562999 | 7563000 | Human |
597021886 | GWAS1117960_H | idiopathic osteonecrosis of the femoral head QTL GWAS1117960 (human) | | 0.000005 | idiopathic osteonecrosis of the femoral head | | 6 | 3114223 | 3114224 | Human |
597292213 | GWAS1388287_H | cholesteryl ester 24:5 measurement QTL GWAS1388287 (human) | | 0.0000001 | cholesteryl ester 24:5 measurement | | 6 | 10963614 | 10963615 | Human |
597292212 | GWAS1388286_H | cholesteryl ester 24:5 measurement QTL GWAS1388286 (human) | | 5e-20 | cholesteryl ester 24:5 measurement | | 6 | 10933145 | 10933146 | Human |
597292214 | GWAS1388288_H | cholesteryl ester 24:5 measurement QTL GWAS1388288 (human) | | 2e-42 | cholesteryl ester 24:5 measurement | | 6 | 11011172 | 11011173 | Human |
597472430 | GWAS1568504_H | hemorrhoid QTL GWAS1568504 (human) | | 2e-12 | hemorrhoid | | 6 | 17387307 | 17387308 | Human |
597488810 | GWAS1584884_H | phosphatidylcholine measurement QTL GWAS1584884 (human) | | 7e-09 | phosphatidylcholine measurement | | 6 | 10975563 | 10975564 | Human |
597365923 | GWAS1461997_H | intraocular pressure measurement QTL GWAS1461997 (human) | | 4e-22 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597210332 | GWAS1306406_H | body weights and measures QTL GWAS1306406 (human) | | 2e-10 | body weights and measures | body morphological measurement (CMO:0000021) | 6 | 1944111 | 1944112 | Human |
597365971 | GWAS1462045_H | gut microbiome measurement QTL GWAS1462045 (human) | | 0.000001 | gut microbiome measurement | | 6 | 4743999 | 4744000 | Human |
597505237 | GWAS1601311_H | migraine without aura QTL GWAS1601311 (human) | | 1e-12 | migraine without aura | | 6 | 12903725 | 12903726 | Human |
597505236 | GWAS1601310_H | cervical artery dissection QTL GWAS1601310 (human) | | 2e-25 | cervical artery dissection | | 6 | 12903725 | 12903726 | Human |
597439703 | GWAS1535777_H | interleukin 10 measurement QTL GWAS1535777 (human) | | 3e-08 | interleukin 10 measurement | | 6 | 15922795 | 15922796 | Human |
407072526 | GWAS721502_H | lean body mass QTL GWAS721502 (human) | | 4e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7718832 | 7718833 | Human |
597374165 | GWAS1470239_H | ICAM-1 measurement QTL GWAS1470239 (human) | | 0.000001 | ICAM-1 measurement | | 6 | 3294590 | 3294591 | Human |
597505235 | GWAS1601309_H | migraine disorder QTL GWAS1601309 (human) | | 6e-24 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597161176 | GWAS1257250_H | glucose measurement QTL GWAS1257250 (human) | | 3e-10 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7250037 | 7250038 | Human |
407219988 | GWAS868964_H | lymphocyte count QTL GWAS868964 (human) | | 2e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 11770472 | 11770473 | Human |
407219991 | GWAS868967_H | lymphocyte count QTL GWAS868967 (human) | | 3e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 15326571 | 15326572 | Human |
407219985 | GWAS868961_H | lymphocyte count QTL GWAS868961 (human) | | 7e-37 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 410417 | 410418 | Human |
597497030 | GWAS1593104_H | hip geometry QTL GWAS1593104 (human) | | 6e-10 | hip geometry | hip circumference (CMO:0000014) | 6 | 2478852 | 2478853 | Human |
597513409 | GWAS1609483_H | free androgen index QTL GWAS1609483 (human) | | 7e-09 | free androgen index | | 6 | 6968126 | 6968127 | Human |
407342874 | GWAS991850_H | mean corpuscular hemoglobin QTL GWAS991850 (human) | | 3e-43 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15176868 | 15176869 | Human |
597275846 | GWAS1371920_H | opioid use disorder QTL GWAS1371920 (human) | | 2e-09 | conditioned place preference behavior trait (VT:0010723) | | 6 | 19076186 | 19076187 | Human |
597579006 | GWAS1635866_H | crystal arthropathy QTL GWAS1635866 (human) | | 3e-31 | crystal arthropathy | | 6 | 18403902 | 18403903 | Human |
597579007 | GWAS1635867_H | Chondrocalcinosis QTL GWAS1635867 (human) | | 4e-33 | Chondrocalcinosis | | 6 | 18399163 | 18399164 | Human |
597611772 | GWAS1668632_H | erythrocyte count QTL GWAS1668632 (human) | | 2e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7214266 | 7214267 | Human |
597611773 | GWAS1668633_H | erythrocyte count QTL GWAS1668633 (human) | | 5e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176027 | 15176028 | Human |
597316850 | GWAS1412924_H | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement QTL GWAS1412924 (human) | | 1e-19 | phosphatidylcholine (16:0/22:5n3, 18:1/20:4) measurement | | 6 | 10996933 | 10996934 | Human |
597292278 | GWAS1388352_H | intraocular pressure measurement QTL GWAS1388352 (human) | | 1e-10 | intraocular pressure measurement | | 6 | 2052577 | 2052578 | Human |
597128419 | GWAS1224493_H | cortical thickness QTL GWAS1224493 (human) | | 2e-08 | cortical thickness | | 6 | 17885814 | 17885815 | Human |
597128418 | GWAS1224492_H | cortical thickness QTL GWAS1224492 (human) | | 3e-14 | cortical thickness | | 6 | 7736184 | 7736185 | Human |
597587179 | GWAS1644039_H | drug use measurement, skin disease QTL GWAS1644039 (human) | | 8e-15 | drug use measurement, skin disease | | 6 | 17602639 | 17602640 | Human |
597128417 | GWAS1224491_H | cortical thickness QTL GWAS1224491 (human) | | 2e-16 | cortical thickness | | 6 | 7120224 | 7120225 | Human |
597284079 | GWAS1380153_H | cholesterol esters in medium LDL measurement QTL GWAS1380153 (human) | | 7e-17 | cholesterol esters in medium LDL measurement | | 6 | 16114017 | 16114018 | Human |
597480679 | GWAS1576753_H | intraocular pressure measurement QTL GWAS1576753 (human) | | 3e-22 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
596980974 | GWAS1100493_H | memory performance QTL GWAS1100493 (human) | | 0.000004 | memory performance | | 6 | 16775869 | 16775870 | Human |
597472480 | GWAS1568554_H | systolic blood pressure QTL GWAS1568554 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1619912 | 1619913 | Human |
597595362 | GWAS1652222_H | blood urea nitrogen measurement QTL GWAS1652222 (human) | | 7e-15 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 6 | 9547303 | 9547304 | Human |
597267684 | GWAS1363758_H | BMI-adjusted waist-hip ratio QTL GWAS1363758 (human) | | 9e-10 | body size trait (VT:0100005) | | 6 | 7219640 | 7219641 | Human |
597472481 | GWAS1568555_H | systolic blood pressure QTL GWAS1568555 (human) | | 3e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 11472612 | 11472613 | Human |
406957887 | GWAS606863_H | venous thromboembolism QTL GWAS606863 (human) | | 2e-08 | venous thromboembolism | | 6 | 6625471 | 6625472 | Human |
597103849 | GWAS1199923_H | response to simvastatin, myopathy QTL GWAS1199923 (human) | | 0.000009 | response to simvastatin, myopathy | | 6 | 11754825 | 11754826 | Human |
597472482 | GWAS1568556_H | systolic blood pressure QTL GWAS1568556 (human) | | 7e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
407072572 | GWAS721548_H | low density lipoprotein cholesterol measurement, alcohol drinking QTL GWAS721548 (human) | | 1e-30 | low density lipoprotein cholesterol measurement, alcohol drinking | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597431324 | GWAS1527398_H | Inguinal hernia QTL GWAS1527398 (human) | | 7e-10 | Inguinal hernia | | 6 | 6737358 | 6737359 | Human |
597431325 | GWAS1527399_H | Inguinal hernia QTL GWAS1527399 (human) | | 2e-10 | Inguinal hernia | | 6 | 6737504 | 6737505 | Human |
597431326 | GWAS1527400_H | Inguinal hernia QTL GWAS1527400 (human) | | 3e-10 | Inguinal hernia | | 6 | 6737870 | 6737871 | Human |
597431327 | GWAS1527401_H | Inguinal hernia QTL GWAS1527401 (human) | | 4e-10 | Inguinal hernia | | 6 | 6738122 | 6738123 | Human |
597431323 | GWAS1527397_H | Inguinal hernia QTL GWAS1527397 (human) | | 2e-10 | Inguinal hernia | | 6 | 6736698 | 6736699 | Human |
407023562 | GWAS672538_H | vasoactive peptide measurement QTL GWAS672538 (human) | | 1e-27 | vasoactive peptide measurement | | 6 | 12296022 | 12296023 | Human |
597079070 | GWAS1175144_H | mean corpuscular hemoglobin QTL GWAS1175144 (human) | | 4e-26 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16294491 | 16294492 | Human |
597079071 | GWAS1175145_H | mean corpuscular hemoglobin QTL GWAS1175145 (human) | | 4e-53 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16285830 | 16285831 | Human |
597267475 | GWAS1363549_H | rheumatoid arthritis QTL GWAS1363549 (human) | | 0.0000002 | rheumatoid arthritis | | 6 | 382537 | 382538 | Human |
597111837 | GWAS1207911_H | platelet count QTL GWAS1207911 (human) | | 8e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 11593752 | 11593753 | Human |
597062684 | GWAS1158758_H | wellbeing measurement QTL GWAS1158758 (human) | | 2e-09 | wellness/fitness trait (VT:1000152) | | 6 | 11734031 | 11734032 | Human |
597201939 | GWAS1298013_H | memory performance QTL GWAS1298013 (human) | | 0.000007 | memory performance | | 6 | 11737176 | 11737177 | Human |
597079069 | GWAS1175143_H | mean corpuscular hemoglobin QTL GWAS1175143 (human) | | 1e-18 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16280956 | 16280957 | Human |
597029895 | GWAS1125969_H | body mass index QTL GWAS1125969 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
597029894 | GWAS1125968_H | body mass index QTL GWAS1125968 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5978836 | 5978837 | Human |
597160962 | GWAS1257036_H | total blood protein measurement QTL GWAS1257036 (human) | | 1e-11 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 7231610 | 7231611 | Human |
597373965 | GWAS1470039_H | mean corpuscular hemoglobin concentration QTL GWAS1470039 (human) | | 2e-10 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 7212967 | 7212968 | Human |
597029896 | GWAS1125970_H | body mass index QTL GWAS1125970 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12142584 | 12142585 | Human |
597455874 | GWAS1551948_H | Chronic pain QTL GWAS1551948 (human) | | 1e-18 | Chronic pain | | 6 | 12903725 | 12903726 | Human |
597464120 | GWAS1560194_H | neurofibrillary tangles measurement QTL GWAS1560194 (human) | | 0.0000001 | neurofibrillary tangles measurement | | 6 | 1264023 | 1264024 | Human |
597603386 | GWAS1660246_H | neutrophil count QTL GWAS1660246 (human) | | 1e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16752633 | 16752634 | Human |
597283903 | GWAS1379977_H | free cholesterol in medium LDL measurement QTL GWAS1379977 (human) | | 1e-15 | blood LDL cholesterol amount (VT:0000181) | | 6 | 16131066 | 16131067 | Human |
597259326 | GWAS1355400_H | aortic measurement QTL GWAS1355400 (human) | | 2e-12 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12295754 | 12295755 | Human |
597578803 | GWAS1635663_H | hemoglobin measurement QTL GWAS1635663 (human) | | 2e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7214266 | 7214267 | Human |
597021733 | GWAS1117807_H | interleukin 13 measurement QTL GWAS1117807 (human) | | 0.000003 | blood interleukin-13 amount (VT:0008607) | | 6 | 5140622 | 5140623 | Human |
597079072 | GWAS1175146_H | mean corpuscular hemoglobin QTL GWAS1175146 (human) | | 3e-49 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 16290617 | 16290620 | Human |
597431328 | GWAS1527402_H | Inguinal hernia QTL GWAS1527402 (human) | | 5e-10 | Inguinal hernia | | 6 | 6738519 | 6738520 | Human |
597521440 | GWAS1617514_H | basal cell carcinoma QTL GWAS1617514 (human) | | 9e-10 | basal cell carcinoma | | 6 | 461906 | 461907 | Human |
597431329 | GWAS1527403_H | Inguinal hernia QTL GWAS1527403 (human) | | 1e-09 | Inguinal hernia | | 6 | 6738801 | 6738802 | Human |
597136426 | GWAS1232500_H | 1-stearoyl-2-docosapentaenoyl-GPC (18:0/22:5n6) measurement QTL GWAS1232500 (human) | | 1e-26 | glycerophosphocholine amount (VT:0011004) | | 6 | 11085823 | 11085824 | Human |
597431330 | GWAS1527404_H | Inguinal hernia QTL GWAS1527404 (human) | | 1e-09 | Inguinal hernia | | 6 | 6739621 | 6739622 | Human |
597431331 | GWAS1527405_H | Inguinal hernia QTL GWAS1527405 (human) | | 1e-09 | Inguinal hernia | | 6 | 6739691 | 6739692 | Human |
596964436 | GWAS1083955_H | gut microbiome measurement, bone density QTL GWAS1083955 (human) | | 2e-08 | gut microbiome measurement, bone density | | 6 | 15900976 | 15900977 | Human |
596964437 | GWAS1083956_H | gut microbiome measurement, bone density QTL GWAS1083956 (human) | | 2e-08 | gut microbiome measurement, bone density | | 6 | 15900980 | 15900981 | Human |
597029968 | GWAS1126042_H | self reported educational attainment QTL GWAS1126042 (human) | | 2e-15 | self reported educational attainment | | 6 | 19035804 | 19035805 | Human |
597128282 | GWAS1224356_H | phosphatidylcholine measurement QTL GWAS1224356 (human) | | 9e-11 | phosphatidylcholine measurement | | 6 | 11042676 | 11042677 | Human |
597128281 | GWAS1224355_H | phosphatidylcholine measurement QTL GWAS1224355 (human) | | 1e-10 | phosphatidylcholine measurement | | 6 | 10982126 | 10982127 | Human |
597505107 | GWAS1601181_H | diastolic blood pressure, systolic blood pressure QTL GWAS1601181 (human) | | 6e-11 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12418998 | 12418999 | Human |
597324884 | GWAS1420958_H | diastolic blood pressure, systolic blood pressure QTL GWAS1420958 (human) | | 0.0000002 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12470371 | 12470372 | Human |
597505106 | GWAS1601180_H | diastolic blood pressure, systolic blood pressure QTL GWAS1601180 (human) | | 0.0000005 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7487883 | 7487884 | Human |
597324885 | GWAS1420959_H | diastolic blood pressure, systolic blood pressure QTL GWAS1420959 (human) | | 0.000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 13664623 | 13664624 | Human |
406966167 | GWAS615143_H | type 2 diabetes mellitus QTL GWAS615143 (human) | | 1e-09 | type 2 diabetes mellitus | | 6 | 7258384 | 7258385 | Human |
596964418 | GWAS1083937_H | gut microbiome measurement, bone density QTL GWAS1083937 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15886888 | 15886889 | Human |
596964419 | GWAS1083938_H | gut microbiome measurement, bone density QTL GWAS1083938 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15887058 | 15887059 | Human |
597210177 | GWAS1306251_H | protein measurement QTL GWAS1306251 (human) | | 8e-25 | protein measurement | | 6 | 3149037 | 3149038 | Human |
597029967 | GWAS1126041_H | self reported educational attainment QTL GWAS1126041 (human) | | 3e-09 | educational attainment | | 6 | 3452011 | 3452012 | Human |
596964430 | GWAS1083949_H | gut microbiome measurement, bone density QTL GWAS1083949 (human) | | 3e-08 | gut microbiome measurement, bone density | | 6 | 15889100 | 15889101 | Human |
597136460 | GWAS1232534_H | information processing speed, response to cranial radiation therapy QTL GWAS1232534 (human) | | 0.000003 | information processing speed, response to cranial radiation therapy | | 6 | 10999511 | 10999512 | Human |
597578819 | GWAS1635679_H | hematocrit QTL GWAS1635679 (human) | | 8e-20 | hematocrit | hematocrit (CMO:0000037) | 6 | 7214266 | 7214267 | Human |
597308539 | GWAS1404613_H | erythrocyte count QTL GWAS1404613 (human) | | 2e-27 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 2050557 | 2050558 | Human |
597308536 | GWAS1404610_H | erythrocyte count QTL GWAS1404610 (human) | | 6e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16294491 | 16294492 | Human |
597423224 | GWAS1519298_H | drug dependence QTL GWAS1519298 (human) | | 0.000002 | drug dependence | | 6 | 10013095 | 10013096 | Human |
597054578 | GWAS1150652_H | household income QTL GWAS1150652 (human) | | 3e-11 | household income | | 6 | 3446029 | 3446030 | Human |
597578872 | GWAS1635732_H | hemoglobin measurement QTL GWAS1635732 (human) | | 2e-16 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7214266 | 7214267 | Human |
597087345 | GWAS1183419_H | type 2 diabetes mellitus QTL GWAS1183419 (human) | | 4e-22 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597431409 | GWAS1527483_H | wellbeing measurement QTL GWAS1527483 (human) | | 5e-10 | wellness/fitness trait (VT:1000152) | | 6 | 11991006 | 11991007 | Human |
597185653 | GWAS1281727_H | migraine disorder, Headache QTL GWAS1281727 (human) | | 8e-13 | migraine disorder, Headache | | 6 | 12801735 | 12801736 | Human |
597185654 | GWAS1281728_H | migraine disorder, Headache QTL GWAS1281728 (human) | | 1e-13 | migraine disorder, Headache | | 6 | 12878869 | 12878870 | Human |
597029988 | GWAS1126062_H | keratinocyte carcinoma QTL GWAS1126062 (human) | | 2e-302 | keratinocyte carcinoma | | 6 | 396321 | 396322 | Human |
597292141 | GWAS1388215_H | body mass index QTL GWAS1388215 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 19082432 | 19082433 | Human |
597521509 | GWAS1617583_H | urate measurement QTL GWAS1617583 (human) | | 1e-08 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2560044 | 2560045 | Human |
597310363 | GWAS1406437_H | vaginal microbiome measurement QTL GWAS1406437 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9569990 | 9569991 | Human |
597310366 | GWAS1406440_H | vaginal microbiome measurement QTL GWAS1406440 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9572200 | 9572201 | Human |
597310367 | GWAS1406441_H | vaginal microbiome measurement QTL GWAS1406441 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9573047 | 9573048 | Human |
597384094 | GWAS1480168_H | Red cell distribution width QTL GWAS1480168 (human) | | 1e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 13920785 | 13920786 | Human |
406929476 | GWAS578452_H | uric acid measurement QTL GWAS578452 (human) | | 0.000008 | uric acid measurement | blood uric acid level (CMO:0000501) | 6 | 14582213 | 14582214 | Human |
597310364 | GWAS1406438_H | vaginal microbiome measurement QTL GWAS1406438 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9570926 | 9570927 | Human |
597310365 | GWAS1406439_H | vaginal microbiome measurement QTL GWAS1406439 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9571055 | 9571056 | Human |
597433239 | GWAS1529313_H | erythrocyte count QTL GWAS1529313 (human) | | 5e-28 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7255417 | 7255418 | Human |
597416855 | GWAS1512929_H | major depressive disorder QTL GWAS1512929 (human) | | 0.000003 | major depressive disorder | | 6 | 2518145 | 2518146 | Human |
597203863 | GWAS1299937_H | Oral ulcer QTL GWAS1299937 (human) | | 3e-09 | Oral ulcer | | 6 | 7196090 | 7196091 | Human |
597310346 | GWAS1406420_H | vaginal microbiome measurement QTL GWAS1406420 (human) | | 0.00001 | vaginal microbiome measurement | | 6 | 11639102 | 11639103 | Human |
597392265 | GWAS1488339_H | balding measurement QTL GWAS1488339 (human) | | 1e-17 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 4383098 | 4383099 | Human |
597334920 | GWAS1430994_H | colorectal cancer, hormone replacement therapy QTL GWAS1430994 (human) | | 0.0000007 | colorectal cancer, hormone replacement therapy | | 6 | 12027402 | 12027403 | Human |
407126103 | GWAS775079_H | chronic lymphocytic leukemia QTL GWAS775079 (human) | | 0.000002 | leukocyte integrity trait (VT:0010898) | | 6 | 417727 | 417728 | Human |
597613450 | GWAS1670310_H | rosacea QTL GWAS1670310 (human) | | 2e-19 | rosacea | | 6 | 396321 | 396322 | Human |
407101527 | GWAS750503_H | eosinophil count QTL GWAS750503 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 670871 | 670872 | Human |
597506952 | GWAS1603026_H | systolic blood pressure QTL GWAS1603026 (human) | | 7e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
407052377 | GWAS701353_H | fatty acid measurement, docosapentaenoic acid measurement QTL GWAS701353 (human) | | 4e-09 | fatty acid measurement, docosapentaenoic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 10980820 | 10980821 | Human |
407101529 | GWAS750505_H | eosinophil count QTL GWAS750505 (human) | | 6e-08 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 12141986 | 12141987 | Human |
407101528 | GWAS750504_H | eosinophil count QTL GWAS750504 (human) | | 2e-08 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 11720988 | 11720989 | Human |
597138316 | GWAS1234390_H | Premature atrial contractions QTL GWAS1234390 (human) | | 0.000006 | Premature atrial contractions | | 6 | 19178357 | 19178358 | Human |
597236612 | GWAS1332686_H | lymphocyte count QTL GWAS1332686 (human) | | 3e-20 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 403799 | 403800 | Human |
597588864 | GWAS1645724_H | migraine disorder QTL GWAS1645724 (human) | | 3e-12 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597277624 | GWAS1373698_H | insomnia QTL GWAS1373698 (human) | | 3e-08 | insomnia | | 6 | 7229386 | 7229387 | Human |
597277627 | GWAS1373701_H | insomnia QTL GWAS1373701 (human) | | 3e-08 | insomnia | | 6 | 7305413 | 7305414 | Human |
406970467 | GWAS619443_H | sporadic amyotrophic lateral sclerosis QTL GWAS619443 (human) | | 0.000003 | sporadic amyotrophic lateral sclerosis | | 6 | 10403417 | 10403418 | Human |
597580731 | GWAS1637591_H | lymphocyte count QTL GWAS1637591 (human) | | 7e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901426 | 6901427 | Human |
597392316 | GWAS1488390_H | Buruli ulcer disease, age at onset QTL GWAS1488390 (human) | | 0.0000001 | Buruli ulcer disease, age at onset | | 6 | 984961 | 984962 | Human |
597400508 | GWAS1496582_H | Takayasu arteritis QTL GWAS1496582 (human) | | 0.000005 | Takayasu arteritis | | 6 | 11938439 | 11938440 | Human |
597244862 | GWAS1340936_H | aortic measurement QTL GWAS1340936 (human) | | 5e-13 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12295754 | 12295755 | Human |
597408690 | GWAS1504764_H | vaginal microbiome measurement QTL GWAS1504764 (human) | | 0.000007 | vaginal microbiome measurement | | 6 | 9921792 | 9921793 | Human |
597269426 | GWAS1365500_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement QTL GWAS1365500 (human) | | 0.000002 | aspartate aminotransferase measurement, serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 18130687 | 18130688 | Human |
597375927 | GWAS1472001_H | freckles QTL GWAS1472001 (human) | | 4e-18 | freckles | | 6 | 466033 | 466034 | Human |
407101551 | GWAS750527_H | eosinophil count QTL GWAS750527 (human) | | 9e-08 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 16658900 | 16658901 | Human |
597203894 | GWAS1299968_H | systemic lupus erythematosus QTL GWAS1299968 (human) | | 3e-10 | systemic lupus erythematosus | | 6 | 252145 | 252146 | Human |
597277622 | GWAS1373696_H | insomnia QTL GWAS1373696 (human) | | 4e-08 | insomnia | | 6 | 13192527 | 13192528 | Human |
597302186 | GWAS1398260_H | systemic lupus erythematosus QTL GWAS1398260 (human) | | 2e-08 | systemic lupus erythematosus | | 6 | 16968557 | 16968558 | Human |
597466029 | GWAS1562103_H | squamous cell carcinoma QTL GWAS1562103 (human) | | 2e-14 | squamous cell carcinoma | | 6 | 4979722 | 4979723 | Human |
597277610 | GWAS1373684_H | diet measurement QTL GWAS1373684 (human) | | 6e-11 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 19028557 | 19028558 | Human |
597466026 | GWAS1562100_H | basal cell carcinoma QTL GWAS1562100 (human) | | 5e-26 | basal cell carcinoma | | 6 | 4979722 | 4979723 | Human |
597261230 | GWAS1357304_H | dementia QTL GWAS1357304 (human) | | 0.000004 | dementia | | 6 | 17738146 | 17738147 | Human |
597253026 | GWAS1349100_H | apolipoprotein B measurement QTL GWAS1349100 (human) | | 3e-11 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16190155 | 16190156 | Human |
597318566 | GWAS1414640_H | waist-hip ratio QTL GWAS1414640 (human) | | 1e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7220727 | 7220728 | Human |
597507039 | GWAS1603113_H | C-reactive protein measurement QTL GWAS1603113 (human) | | 9e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 6 | 18492119 | 18492120 | Human |
597228508 | GWAS1324582_H | Facial wrinkling QTL GWAS1324582 (human) | | 3e-08 | Facial wrinkling | | 6 | 11184634 | 11184635 | Human |
597105618 | GWAS1201692_H | Thyroid preparation use measurement QTL GWAS1201692 (human) | | 7e-16 | Thyroid preparation use measurement | | 6 | 409119 | 409120 | Human |
597367763 | GWAS1463837_H | waist-hip ratio QTL GWAS1463837 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6738519 | 6738520 | Human |
597400533 | GWAS1496607_H | chronic lymphocytic leukemia QTL GWAS1496607 (human) | | 2e-08 | leukocyte integrity trait (VT:0010898) | | 6 | 2969044 | 2969045 | Human |
597613516 | GWAS1670376_H | Red cell distribution width QTL GWAS1670376 (human) | | 2e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 18791560 | 18791561 | Human |
597613515 | GWAS1670375_H | Red cell distribution width QTL GWAS1670375 (human) | | 3e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597408706 | GWAS1504780_H | coronary artery disease QTL GWAS1504780 (human) | | 4e-114 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597597125 | GWAS1653985_H | basophil measurement QTL GWAS1653985 (human) | | 1e-21 | basophil measurement | | 6 | 7143371 | 7143372 | Human |
597277634 | GWAS1373708_H | insomnia QTL GWAS1373708 (human) | | 2e-08 | insomnia | | 6 | 12954872 | 12954873 | Human |
597261253 | GWAS1357327_H | electrocardiography QTL GWAS1357327 (human) | | 7e-13 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597261255 | GWAS1357329_H | electrocardiography QTL GWAS1357329 (human) | | 7e-10 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597261254 | GWAS1357328_H | electrocardiography QTL GWAS1357328 (human) | | 7e-11 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597580796 | GWAS1637656_H | mean corpuscular hemoglobin concentration QTL GWAS1637656 (human) | | 9e-50 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597605370 | GWAS1662230_H | neutrophil count QTL GWAS1662230 (human) | | 4e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7134168 | 7134169 | Human |
597613560 | GWAS1670420_H | drug use measurement, gout QTL GWAS1670420 (human) | | 2e-16 | drug use measurement, gout | | 6 | 7118901 | 7118902 | Human |
597310461 | GWAS1406535_H | body mass index QTL GWAS1406535 (human) | | 5e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12086593 | 12086594 | Human |
597580789 | GWAS1637649_H | lymphocyte count QTL GWAS1637649 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 12099656 | 12099657 | Human |
597408758 | GWAS1504832_H | metabolite measurement QTL GWAS1504832 (human) | | 1e-161 | metabolite measurement | | 6 | 2996087 | 2996088 | Human |
597023736 | GWAS1119810_H | breast carcinoma QTL GWAS1119810 (human) | | 2e-08 | mammary gland integrity trait (VT:0010552) | | 6 | 16399326 | 16399327 | Human |
597294057 | GWAS1390131_H | phosphatidylcholine measurement QTL GWAS1390131 (human) | | 4e-11 | phosphatidylcholine measurement | | 6 | 11040190 | 11040191 | Human |
597089254 | GWAS1185328_H | mean reticulocyte volume QTL GWAS1185328 (human) | | 1e-09 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 6 | 15173989 | 15173990 | Human |
597294056 | GWAS1390130_H | phosphatidylcholine measurement QTL GWAS1390130 (human) | | 8e-15 | phosphatidylcholine measurement | | 6 | 11005453 | 11005454 | Human |
597089253 | GWAS1185327_H | mean reticulocyte volume QTL GWAS1185327 (human) | | 1e-16 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 6 | 15136809 | 15136810 | Human |
597400556 | GWAS1496630_H | HIV viral set point measurement QTL GWAS1496630 (human) | | 0.000004 | HIV viral set point measurement | | 6 | 13267979 | 13267980 | Human |
597416935 | GWAS1513009_H | gout QTL GWAS1513009 (human) | | 7e-14 | gout | | 6 | 6749556 | 6749557 | Human |
597400549 | GWAS1496623_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1496623 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 11785127 | 11785128 | Human |
597294054 | GWAS1390128_H | phosphatidylcholine measurement QTL GWAS1390128 (human) | | 4e-12 | phosphatidylcholine measurement | | 6 | 10982126 | 10982127 | Human |
597490462 | GWAS1586536_H | response to calcium channel blocker QTL GWAS1586536 (human) | | 0.000007 | response to calcium channel blocker | | 6 | 6444282 | 6444283 | Human |
597170964 | GWAS1267038_H | body mass index QTL GWAS1267038 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
597457682 | GWAS1553756_H | attempted suicide QTL GWAS1553756 (human) | | 2e-09 | attempted suicide | | 6 | 19306883 | 19306884 | Human |
597269270 | GWAS1365344_H | aortic measurement QTL GWAS1365344 (human) | | 0.0000002 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12295754 | 12295755 | Human |
597228296 | GWAS1324370_H | chronotype measurement QTL GWAS1324370 (human) | | 2e-15 | sleep behavior trait (VT:0001501) | | 6 | 13064164 | 13064165 | Human |
597375753 | GWAS1471827_H | migraine disorder QTL GWAS1471827 (human) | | 3e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597613322 | GWAS1670182_H | erythematosquamous dermatosis QTL GWAS1670182 (human) | | 6e-57 | erythematosquamous dermatosis | | 6 | 396321 | 396322 | Human |
597375759 | GWAS1471833_H | migraine disorder QTL GWAS1471833 (human) | | 5e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597613320 | GWAS1670180_H | pigmentation disease QTL GWAS1670180 (human) | | 8e-61 | pigmentation disease | | 6 | 396321 | 396322 | Human |
597465861 | GWAS1561935_H | breast carcinoma QTL GWAS1561935 (human) | | 0.000002 | mammary gland integrity trait (VT:0010552) | | 6 | 4445100 | 4445101 | Human |
597105421 | GWAS1201495_H | cytokine measurement QTL GWAS1201495 (human) | | 0.000004 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 14147737 | 14147738 | Human |
597089035 | GWAS1185109_H | mean reticulocyte volume QTL GWAS1185109 (human) | | 5e-09 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 6 | 3162237 | 3162240 | Human |
597048072 | GWAS1144146_H | suntan QTL GWAS1144146 (human) | | 9e-20 | suntan | | 6 | 226284 | 226285 | Human |
597367557 | GWAS1463631_H | BMI-adjusted waist-hip ratio QTL GWAS1463631 (human) | | 1e-14 | body size trait (VT:0100005) | | 6 | 14595642 | 14595643 | Human |
597048073 | GWAS1144147_H | suntan QTL GWAS1144147 (human) | | 5e-48 | suntan | | 6 | 553489 | 553490 | Human |
597424955 | GWAS1521029_H | BMI-adjusted waist-hip ratio QTL GWAS1521029 (human) | | 1e-08 | body size trait (VT:0100005) | | 6 | 7018258 | 7018259 | Human |
597424954 | GWAS1521028_H | BMI-adjusted waist-hip ratio QTL GWAS1521028 (human) | | 2e-13 | body size trait (VT:0100005) | | 6 | 6742316 | 6742317 | Human |
597326651 | GWAS1422725_H | FEV/FVC ratio QTL GWAS1422725 (human) | | 8e-27 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 7562999 | 7563000 | Human |
597588797 | GWAS1645657_H | retinopathy QTL GWAS1645657 (human) | | 1e-21 | retinopathy | | 6 | 10185180 | 10185181 | Human |
597252927 | GWAS1349001_H | non-melanoma skin carcinoma QTL GWAS1349001 (human) | | 2e-11 | non-melanoma skin carcinoma | | 6 | 500956 | 500957 | Human |
596958002 | GWAS1077521_H | BMI-adjusted waist-hip ratio QTL GWAS1077521 (human) | | 4e-08 | BMI-adjusted waist-hip ratio | | 6 | 7220146 | 7220147 | Human |
597179185 | GWAS1275259_H | hemoglobin measurement QTL GWAS1275259 (human) | | 6e-15 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7229386 | 7229387 | Human |
597408567 | GWAS1504641_H | total cholesterol measurement QTL GWAS1504641 (human) | | 7e-14 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16113090 | 16113091 | Human |
597080868 | GWAS1176942_H | monocyte count QTL GWAS1176942 (human) | | 4e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 12044743 | 12044744 | Human |
597080869 | GWAS1176943_H | monocyte count QTL GWAS1176943 (human) | | 3e-19 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 16727229 | 16727230 | Human |
406954229 | GWAS603205_H | hematocrit QTL GWAS603205 (human) | | 1e-17 | hematocrit | hematocrit (CMO:0000037) | 6 | 2050557 | 2050558 | Human |
407093494 | GWAS742470_H | hair color QTL GWAS742470 (human) | | 5e-17 | hair color | | 6 | 385735 | 385736 | Human |
406954230 | GWAS603206_H | hematocrit QTL GWAS603206 (human) | | 6e-14 | hematocrit | hematocrit (CMO:0000037) | 6 | 7232156 | 7232157 | Human |
597490468 | GWAS1586542_H | response to calcium channel blocker QTL GWAS1586542 (human) | | 0.000004 | response to calcium channel blocker | | 6 | 6446375 | 6446376 | Human |
597269280 | GWAS1365354_H | aortic measurement QTL GWAS1365354 (human) | | 1e-08 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12291749 | 12291750 | Human |
597367590 | GWAS1463664_H | balding measurement QTL GWAS1463664 (human) | | 2e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 8892948 | 8892949 | Human |
597367589 | GWAS1463663_H | balding measurement QTL GWAS1463663 (human) | | 9e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 4604113 | 4604114 | Human |
597048105 | GWAS1144179_H | suntan QTL GWAS1144179 (human) | | 1e-17 | suntan | | 6 | 686110 | 686111 | Human |
597162792 | GWAS1258866_H | lipid measurement QTL GWAS1258866 (human) | | 0.000001 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 1444880 | 1444881 | Human |
597187417 | GWAS1283491_H | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement QTL GWAS1283491 (human) | | 2e-23 | glycerophosphocholine amount (VT:0011004) | | 6 | 10991434 | 10991436 | Human |
597211993 | GWAS1308067_H | self reported educational attainment QTL GWAS1308067 (human) | | 2e-20 | self reported educational attainment | | 6 | 19023495 | 19023496 | Human |
597187420 | GWAS1283494_H | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement QTL GWAS1283494 (human) | | 3e-20 | glycerophosphocholine amount (VT:0011004) | | 6 | 10984097 | 10984098 | Human |
597531476 | GWAS1627550_H | 1-margaroyl-2-linoleoyl-GPC (17:0/18:2) measurement QTL GWAS1627550 (human) | | 0.000003 | glycerophosphocholine amount (VT:0011004) | | 6 | 10118032 | 10118033 | Human |
596958047 | GWAS1077566_H | retinal vasculature measurement QTL GWAS1077566 (human) | | 4e-14 | retinal vasculature measurement | | 6 | 396321 | 396322 | Human |
597523282 | GWAS1619356_H | QRS-T angle QTL GWAS1619356 (human) | | 4e-11 | heart excitatory physiology trait (VT:0000231) | | 6 | 7487883 | 7487884 | Human |
597072710 | GWAS1168784_H | breast carcinoma QTL GWAS1168784 (human) | | 4e-10 | mammary gland integrity trait (VT:0010552) | | 6 | 13722291 | 13722292 | Human |
597072709 | GWAS1168783_H | breast carcinoma QTL GWAS1168783 (human) | | 0.0000001 | mammary gland integrity trait (VT:0010552) | | 6 | 1318643 | 1318644 | Human |
597031756 | GWAS1127830_H | sensory perception of sweet taste QTL GWAS1127830 (human) | | 0.000008 | sensory perception of sweet taste | | 6 | 10613224 | 10613225 | Human |
597302080 | GWAS1398154_H | cholesteryl ester 24:5 measurement QTL GWAS1398154 (human) | | 4e-30 | cholesteryl ester 24:5 measurement | | 6 | 11011172 | 11011173 | Human |
597302081 | GWAS1398155_H | cholesteryl ester 24:6 measurement QTL GWAS1398155 (human) | | 5e-13 | cholesteryl ester 24:6 measurement | | 6 | 11011172 | 11011173 | Human |
597416775 | GWAS1512849_H | cognitive function measurement QTL GWAS1512849 (human) | | 3e-09 | cognitive behavior trait (VT:0010450) | | 6 | 14871320 | 14871321 | Human |
597416774 | GWAS1512848_H | cognitive function measurement QTL GWAS1512848 (human) | | 4e-11 | cognitive behavior trait (VT:0010450) | | 6 | 3463840 | 3463841 | Human |
597613376 | GWAS1670236_H | Vitiligo QTL GWAS1670236 (human) | | 5e-54 | Vitiligo | | 6 | 396321 | 396322 | Human |
597056381 | GWAS1152455_H | basophil percentage of leukocytes QTL GWAS1152455 (human) | | 2e-09 | basophil quantity (VT:0002607) | blood basophil count to total leukocyte count ratio (CMO:0000368) | 6 | 13163986 | 13163987 | Human |
597588851 | GWAS1645711_H | glucose measurement QTL GWAS1645711 (human) | | 2e-11 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7249227 | 7249228 | Human |
597293940 | GWAS1390014_H | lysophosphatidylcholine 22:5 measurement QTL GWAS1390014 (human) | | 4e-08 | lysophosphatidylcholine 22:5 measurement | | 6 | 11036592 | 11036593 | Human |
597613419 | GWAS1670279_H | platelet count QTL GWAS1670279 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 2904557 | 2904558 | Human |
597162849 | GWAS1258923_H | Nasal Cavity Polyp QTL GWAS1258923 (human) | | 5e-12 | Nasal Cavity Polyp | | 6 | 410417 | 410418 | Human |
406986933 | GWAS635909_H | intelligence QTL GWAS635909 (human) | | 3e-08 | executive function measurement | | 6 | 3450580 | 3450581 | Human |
597310304 | GWAS1406378_H | Thyroid preparation use measurement QTL GWAS1406378 (human) | | 1e-14 | Thyroid preparation use measurement | | 6 | 409119 | 409120 | Human |
597080940 | GWAS1177014_H | neutrophil count QTL GWAS1177014 (human) | | 5e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 12159466 | 12159467 | Human |
597588837 | GWAS1645697_H | glucose measurement QTL GWAS1645697 (human) | | 1e-19 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7231610 | 7231611 | Human |
597080941 | GWAS1177015_H | neutrophil count QTL GWAS1177015 (human) | | 2e-36 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16757771 | 16757772 | Human |
597080939 | GWAS1177013_H | neutrophil count QTL GWAS1177013 (human) | | 1e-19 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7201427 | 7201428 | Human |
597179024 | GWAS1275098_H | hemoglobin measurement QTL GWAS1275098 (human) | | 3e-09 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16290530 | 16290531 | Human |
597424785 | GWAS1520859_H | systolic blood pressure QTL GWAS1520859 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 16362461 | 16362462 | Human |
597424784 | GWAS1520858_H | systolic blood pressure QTL GWAS1520858 (human) | | 5e-15 | fibromuscular dysplasia | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
406962509 | GWAS611485_H | rheumatoid arthritis QTL GWAS611485 (human) | | 2e-08 | rheumatoid arthritis | | 6 | 14096427 | 14096428 | Human |
597613201 | GWAS1670061_H | psoriatic arthritis QTL GWAS1670061 (human) | | 2e-11 | psoriatic arthritis | | 6 | 3315857 | 3315858 | Human |
597047943 | GWAS1144017_H | suntan QTL GWAS1144017 (human) | | 1e-581 | suntan | | 6 | 396321 | 396322 | Human |
597400200 | GWAS1496274_H | myocardial infarction QTL GWAS1496274 (human) | | 2e-60 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597424783 | GWAS1520857_H | systolic blood pressure QTL GWAS1520857 (human) | | 1e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7715456 | 7715457 | Human |
596966016 | GWAS1085535_H | body height QTL GWAS1085535 (human) | | 3e-09 | body height | | 6 | 19129432 | 19129433 | Human |
597424782 | GWAS1520856_H | systolic blood pressure QTL GWAS1520856 (human) | | 3e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1613451 | 1613452 | Human |
597613190 | GWAS1670050_H | skin disease QTL GWAS1670050 (human) | | 3e-37 | skin disease | | 6 | 396321 | 396322 | Human |
597277315 | GWAS1373389_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1373389 (human) | | 0.0000001 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 15195451 | 15195452 | Human |
597285508 | GWAS1381582_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1381582 (human) | | 3e-16 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597228166 | GWAS1324240_H | BMI-adjusted waist-hip ratio QTL GWAS1324240 (human) | | 1e-10 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597310138 | GWAS1406212_H | vaginal microbiome measurement QTL GWAS1406212 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9559154 | 9559155 | Human |
597310139 | GWAS1406213_H | vaginal microbiome measurement QTL GWAS1406213 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9560287 | 9560288 | Human |
597310136 | GWAS1406210_H | vaginal microbiome measurement QTL GWAS1406210 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9556163 | 9556164 | Human |
597310137 | GWAS1406211_H | vaginal microbiome measurement QTL GWAS1406211 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9557964 | 9557965 | Human |
597613245 | GWAS1670105_H | psoriatic arthritis QTL GWAS1670105 (human) | | 5e-40 | psoriatic arthritis | | 6 | 17602639 | 17602640 | Human |
597310142 | GWAS1406216_H | vaginal microbiome measurement QTL GWAS1406216 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9564166 | 9564167 | Human |
597310143 | GWAS1406217_H | vaginal microbiome measurement QTL GWAS1406217 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9565250 | 9565251 | Human |
597310140 | GWAS1406214_H | vaginal microbiome measurement QTL GWAS1406214 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9561584 | 9561585 | Human |
597310141 | GWAS1406215_H | vaginal microbiome measurement QTL GWAS1406215 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9563052 | 9563053 | Human |
407134573 | GWAS783549_H | multiple sclerosis, chronic lymphocytic leukemia QTL GWAS783549 (human) | | 1e-08 | leukocyte integrity trait (VT:0010898) | | 6 | 7118757 | 7118758 | Human |
597310134 | GWAS1406208_H | vaginal microbiome measurement QTL GWAS1406208 (human) | | 0.000004 | vaginal microbiome measurement | | 6 | 9552301 | 9552302 | Human |
597310135 | GWAS1406209_H | vaginal microbiome measurement QTL GWAS1406209 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9553004 | 9553005 | Human |
597613235 | GWAS1670095_H | psoriasis vulgaris QTL GWAS1670095 (human) | | 1e-94 | psoriasis vulgaris | | 6 | 17602639 | 17602640 | Human |
597482163 | GWAS1578237_H | Abdominal symptom QTL GWAS1578237 (human) | | 7e-09 | Abdominal symptom | | 6 | 14649122 | 14649123 | Human |
597432994 | GWAS1529068_H | protein measurement QTL GWAS1529068 (human) | | 5e-08 | protein measurement | | 6 | 3149369 | 3149371 | Human |
597588702 | GWAS1645562_H | hematocrit QTL GWAS1645562 (human) | | 1e-21 | hematocrit | hematocrit (CMO:0000037) | 6 | 7203762 | 7203763 | Human |
597416666 | GWAS1512740_H | human papilloma virus infection, oropharynx cancer QTL GWAS1512740 (human) | | 0.000001 | human papilloma virus infection, oropharynx cancer | | 6 | 10415901 | 10415902 | Human |
407060736 | GWAS709712_H | coronary artery disease QTL GWAS709712 (human) | | 3e-11 | coronary artery disease | | 6 | 12901209 | 12901210 | Human |
597416670 | GWAS1512744_H | human papilloma virus infection, oral cavity cancer QTL GWAS1512744 (human) | | 0.000004 | human papilloma virus infection, oral cavity cancer | | 6 | 10415901 | 10415902 | Human |
597424860 | GWAS1520934_H | low density lipoprotein cholesterol measurement QTL GWAS1520934 (human) | | 2e-29 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597211857 | GWAS1307931_H | Strabismus QTL GWAS1307931 (human) | | 0.000006 | Strabismus | | 6 | 891483 | 891484 | Human |
597482193 | GWAS1578267_H | open-angle glaucoma QTL GWAS1578267 (human) | | 3e-13 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597121754 | GWAS1217828_H | cleft lip QTL GWAS1217828 (human) | | 0.000004 | cleft lip | | 6 | 16371313 | 16371314 | Human |
597252808 | GWAS1348882_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1348882 (human) | | 3e-09 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 15499188 | 15499189 | Human |
597621449 | GWAS1678309_H | coronary artery disease QTL GWAS1678309 (human) | | 2e-49 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597310146 | GWAS1406220_H | vaginal microbiome measurement QTL GWAS1406220 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9567108 | 9567109 | Human |
597310147 | GWAS1406221_H | vaginal microbiome measurement QTL GWAS1406221 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9567399 | 9567400 | Human |
597310144 | GWAS1406218_H | vaginal microbiome measurement QTL GWAS1406218 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9566015 | 9566016 | Human |
597433031 | GWAS1529105_H | protein measurement QTL GWAS1529105 (human) | | 2e-53 | protein measurement | | 6 | 2841905 | 2841906 | Human |
597310145 | GWAS1406219_H | vaginal microbiome measurement QTL GWAS1406219 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9566881 | 9566882 | Human |
597383879 | GWAS1479953_H | total cholesterol measurement QTL GWAS1479953 (human) | | 4e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597383878 | GWAS1479952_H | total cholesterol measurement QTL GWAS1479952 (human) | | 7e-12 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16127176 | 16127177 | Human |
597310148 | GWAS1406222_H | vaginal microbiome measurement QTL GWAS1406222 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9567839 | 9567840 | Human |
597293767 | GWAS1389841_H | phosphatidylethanolamine measurement QTL GWAS1389841 (human) | | 8e-09 | phosphatidylethanolamine measurement | | 6 | 10959940 | 10959941 | Human |
597383877 | GWAS1479951_H | total cholesterol measurement QTL GWAS1479951 (human) | | 1e-15 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16124329 | 16124330 | Human |
597506754 | GWAS1602828_H | atypical femoral fracture, response to bisphosphonate QTL GWAS1602828 (human) | | 0.0000009 | atypical femoral fracture, response to bisphosphonate | | 6 | 2560478 | 2560479 | Human |
597310149 | GWAS1406223_H | vaginal microbiome measurement QTL GWAS1406223 (human) | | 0.000002 | vaginal microbiome measurement | | 6 | 9569840 | 9569841 | Human |
597383876 | GWAS1479950_H | total cholesterol measurement QTL GWAS1479950 (human) | | 6e-16 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 6 | 16124329 | 16124330 | Human |
597211896 | GWAS1307970_H | systolic blood pressure QTL GWAS1307970 (human) | | 0.000007 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 6637628 | 6637629 | Human |
597211900 | GWAS1307974_H | educational attainment, systolic blood pressure QTL GWAS1307974 (human) | | 0.000005 | educational attainment, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 6637628 | 6637629 | Human |
597080831 | GWAS1176905_H | monocyte count QTL GWAS1176905 (human) | | 6e-40 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7140598 | 7140599 | Human |
597228265 | GWAS1324339_H | BMI-adjusted waist-hip ratio QTL GWAS1324339 (human) | | 4e-15 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597031655 | GWAS1127729_H | body mass index QTL GWAS1127729 (human) | | 6e-17 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597375727 | GWAS1471801_H | migraine disorder QTL GWAS1471801 (human) | | 0.000002 | migraine disorder | | 6 | 12903725 | 12903726 | Human |
597400301 | GWAS1496375_H | diabetic nephropathy QTL GWAS1496375 (human) | | 0.000005 | kidney integrity trait (VT:0010580) | | 6 | 6552761 | 6552762 | Human |
597474020 | GWAS1570094_H | shoulder impingement syndrome QTL GWAS1570094 (human) | | 3e-08 | shoulder impingement syndrome | | 6 | 8864633 | 8864634 | Human |
597613280 | GWAS1670140_H | seborrheic dermatitis QTL GWAS1670140 (human) | | 4e-57 | seborrheic dermatitis | | 6 | 396321 | 396322 | Human |
597277414 | GWAS1373488_H | insomnia QTL GWAS1373488 (human) | | 3e-08 | insomnia | | 6 | 7101851 | 7101852 | Human |
597433059 | GWAS1529133_H | protein measurement QTL GWAS1529133 (human) | | 7e-31 | protein measurement | | 6 | 16278159 | 16278160 | Human |
597178908 | GWAS1274982_H | protein measurement QTL GWAS1274982 (human) | | 5e-238 | protein measurement | | 6 | 3150869 | 3150870 | Human |
597531161 | GWAS1627235_H | Inguinal hernia QTL GWAS1627235 (human) | | 6e-10 | Inguinal hernia | | 6 | 6742916 | 6742917 | Human |
597465627 | GWAS1561701_H | colorectal cancer QTL GWAS1561701 (human) | | 0.000002 | colorectal cancer | | 6 | 998578 | 998579 | Human |
597391891 | GWAS1487965_H | gut microbiome measurement QTL GWAS1487965 (human) | | 0.000001 | gut microbiome measurement | | 6 | 4736945 | 4736946 | Human |
597293585 | GWAS1389659_H | phosphatidylethanolamine measurement QTL GWAS1389659 (human) | | 9e-09 | phosphatidylethanolamine measurement | | 6 | 11033392 | 11033393 | Human |
597588502 | GWAS1645362_H | macular degeneration QTL GWAS1645362 (human) | | 4e-14 | macular degeneration | | 6 | 17602639 | 17602640 | Human |
597211668 | GWAS1307742_H | balding measurement QTL GWAS1307742 (human) | | 4e-15 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9440653 | 9440654 | Human |
407265738 | GWAS914714_H | platelet count QTL GWAS914714 (human) | | 1e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 11593752 | 11593753 | Human |
597146138 | GWAS1242212_H | osteoarthritis, knee QTL GWAS1242212 (human) | | 2e-08 | osteoarthritis, knee | | 6 | 6894715 | 6894716 | Human |
597367317 | GWAS1463391_H | lymphocyte count QTL GWAS1463391 (human) | | 5e-13 | inflammatory bowel disease | blood lymphocyte count (CMO:0000031) | 6 | 14719265 | 14719266 | Human |
407265737 | GWAS914713_H | platelet count QTL GWAS914713 (human) | | 2e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 7085584 | 7085585 | Human |
597490195 | GWAS1586269_H | docosapentaenoate n3 DPA; 22:5n3-to-X-12627 ratio QTL GWAS1586269 (human) | | 1e-22 | docosapentaenoate n3 DPA; 22:5n3-to-X-12627 ratio | | 6 | 11072089 | 11072090 | Human |
597490190 | GWAS1586264_H | R-6-hydroxywarfarin to R-warfarin ratio measurement QTL GWAS1586264 (human) | | 0.000009 | R-6-hydroxywarfarin to R-warfarin ratio measurement | | 6 | 4970917 | 4970918 | Human |
597072384 | GWAS1168458_H | neuroticism measurement QTL GWAS1168458 (human) | | 4e-09 | neuroticism measurement | | 6 | 11959603 | 11959604 | Human |
597604873 | GWAS1661733_H | skin neoplasm QTL GWAS1661733 (human) | | 6e-181 | skin neoplasm | | 6 | 396321 | 396322 | Human |
596982287 | GWAS1101806_H | memory performance, sex interaction measurement QTL GWAS1101806 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 1133457 | 1133458 | Human |
597211710 | GWAS1307784_H | glaucoma QTL GWAS1307784 (human) | | 1e-09 | glaucoma | | 6 | 637465 | 637466 | Human |
596974130 | GWAS1093649_H | memory performance QTL GWAS1093649 (human) | | 0.000007 | memory performance | | 6 | 4283204 | 4283205 | Human |
597334589 | GWAS1430663_H | colorectal cancer, hormone replacement therapy QTL GWAS1430663 (human) | | 0.000004 | colorectal cancer, hormone replacement therapy | | 6 | 5919318 | 5919319 | Human |
407093739 | GWAS742715_H | hair color QTL GWAS742715 (human) | | 2e-12 | hair color | | 6 | 403799 | 403800 | Human |
597522997 | GWAS1619071_H | body mass index QTL GWAS1619071 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18575069 | 18575070 | Human |
597203509 | GWAS1299583_H | type 2 diabetes mellitus QTL GWAS1299583 (human) | | 2e-13 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597269046 | GWAS1365120_H | aortic measurement QTL GWAS1365120 (human) | | 0.000002 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12291749 | 12291750 | Human |
597096998 | GWAS1193072_H | testosterone measurement QTL GWAS1193072 (human) | | 4e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 7841888 | 7841889 | Human |
597031456 | GWAS1127530_H | adverse effect, response to xenobiotic stimulus QTL GWAS1127530 (human) | | 0.0000005 | adverse effect, response to xenobiotic stimulus | | 6 | 11014323 | 11014324 | Human |
597269038 | GWAS1365112_H | aortic measurement QTL GWAS1365112 (human) | | 6e-09 | aortic measurement | aorta measurement (CMO:0001474) | 6 | 12295754 | 12295755 | Human |
597121583 | GWAS1217657_H | electrocardiography QTL GWAS1217657 (human) | | 5e-10 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597121582 | GWAS1217656_H | electrocardiography QTL GWAS1217656 (human) | | 6e-10 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597121581 | GWAS1217655_H | electrocardiography QTL GWAS1217655 (human) | | 1e-08 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
407060985 | GWAS709961_H | docosahexaenoic acid measurement QTL GWAS709961 (human) | | 1e-15 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 10994782 | 10994783 | Human |
597121580 | GWAS1217654_H | electrocardiography QTL GWAS1217654 (human) | | 5e-09 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
407183748 | GWAS832724_H | unipolar depression, age at onset QTL GWAS832724 (human) | | 0.000009 | unipolar depression, age at onset | | 6 | 5389170 | 5389171 | Human |
597121621 | GWAS1217695_H | smoking status measurement, chronic obstructive pulmonary disease QTL GWAS1217695 (human) | | 2e-08 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597244507 | GWAS1340581_H | BMI-adjusted waist circumference QTL GWAS1340581 (human) | | 4e-09 | body size trait (VT:0100005) | | 6 | 14594779 | 14594780 | Human |
597203550 | GWAS1299624_H | open-angle glaucoma QTL GWAS1299624 (human) | | 0.000001 | open-angle glaucoma | | 6 | 1957768 | 1957769 | Human |
407183758 | GWAS832734_H | unipolar depression, age at onset QTL GWAS832734 (human) | | 0.000002 | unipolar depression, age at onset | | 6 | 5367040 | 5367041 | Human |
596982366 | GWAS1101885_H | memory performance QTL GWAS1101885 (human) | | 0.000008 | memory performance | | 6 | 16776095 | 16776096 | Human |
597416535 | GWAS1512609_H | major depressive disorder QTL GWAS1512609 (human) | | 0.000003 | major depressive disorder | | 6 | 2518745 | 2518746 | Human |
597252695 | GWAS1348769_H | non-melanoma skin carcinoma QTL GWAS1348769 (human) | | 4e-148 | non-melanoma skin carcinoma | | 6 | 396321 | 396322 | Human |
597252694 | GWAS1348768_H | non-melanoma skin carcinoma QTL GWAS1348768 (human) | | 0.0000004 | non-melanoma skin carcinoma | | 6 | 209980 | 209981 | Human |
597359189 | GWAS1455263_H | neuroticism measurement QTL GWAS1455263 (human) | | 0.000005 | neuroticism measurement | | 6 | 11711582 | 11711583 | Human |
597031494 | GWAS1127568_H | nevus count QTL GWAS1127568 (human) | | 4e-67 | nevus count | | 6 | 396321 | 396322 | Human |
597285441 | GWAS1381515_H | body weight QTL GWAS1381515 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 5276362 | 5276363 | Human |
597391938 | GWAS1488012_H | refractive error QTL GWAS1488012 (human) | | 3e-08 | refractive error | | 6 | 10035850 | 10035851 | Human |
597391937 | GWAS1488011_H | refractive error QTL GWAS1488011 (human) | | 1e-10 | refractive error | | 6 | 6901430 | 6901431 | Human |
597285446 | GWAS1381520_H | body weight QTL GWAS1381520 (human) | | 1e-18 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 7705771 | 7705772 | Human |
597187199 | GWAS1283273_H | X-17676 measurement QTL GWAS1283273 (human) | | 4e-17 | X-17676 measurement | | 6 | 3152171 | 3152172 | Human |
597105279 | GWAS1201353_H | cytokine measurement QTL GWAS1201353 (human) | | 0.000002 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 11628101 | 11628102 | Human |
597588594 | GWAS1645454_H | encounter with health service QTL GWAS1645454 (human) | | 7e-18 | encounter with health service | | 6 | 16415625 | 16415626 | Human |
597162618 | GWAS1258692_H | erythrocyte count QTL GWAS1258692 (human) | | 2e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16295116 | 16295121 | Human |
597211752 | GWAS1307826_H | protein measurement QTL GWAS1307826 (human) | | 2e-08 | protein measurement | | 6 | 10559718 | 10559719 | Human |
597506671 | GWAS1602745_H | cognitive function measurement QTL GWAS1602745 (human) | | 0.000003 | cognitive behavior trait (VT:0010450) | | 6 | 8116240 | 8116241 | Human |
597604970 | GWAS1661830_H | family history of cancer QTL GWAS1661830 (human) | | 2e-39 | family history of cancer | | 6 | 396321 | 396322 | Human |
597162595 | GWAS1258669_H | pipecolate measurement QTL GWAS1258669 (human) | | 0.000003 | pipecolate measurement | | 6 | 2744796 | 2744797 | Human |
597318242 | GWAS1414316_H | risk-taking behaviour QTL GWAS1414316 (human) | | 1e-08 | risk-taking behaviour | | 6 | 18917947 | 18917948 | Human |
597359200 | GWAS1455274_H | neuroticism measurement QTL GWAS1455274 (human) | | 0.000002 | neuroticism measurement | | 6 | 4223707 | 4223708 | Human |
597359201 | GWAS1455275_H | neuroticism measurement QTL GWAS1455275 (human) | | 0.000002 | neuroticism measurement | | 6 | 3961054 | 3961055 | Human |
597277284 | GWAS1373358_H | X-17676 measurement QTL GWAS1373358 (human) | | 2e-49 | X-17676 measurement | | 6 | 3143926 | 3143927 | Human |
597301658 | GWAS1397732_H | ribosyldihydronicotinamide dehydrogenase [quinone] measurement QTL GWAS1397732 (human) | | 4e-33 | ribosyldihydronicotinamide dehydrogenase [quinone] measurement | | 6 | 3013332 | 3013333 | Human |
597268889 | GWAS1364963_H | type 2 diabetes mellitus QTL GWAS1364963 (human) | | 5e-12 | type 2 diabetes mellitus | | 6 | 7196090 | 7196091 | Human |
597490078 | GWAS1586152_H | pulse pressure measurement QTL GWAS1586152 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 2355441 | 2355442 | Human |
597268890 | GWAS1364964_H | type 2 diabetes mellitus QTL GWAS1364964 (human) | | 4e-26 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597031314 | GWAS1127388_H | atrial fibrillation QTL GWAS1127388 (human) | | 6e-21 | atrial fibrillation | | 6 | 16415520 | 16415521 | Human |
597465493 | GWAS1561567_H | self reported educational attainment QTL GWAS1561567 (human) | | 5e-12 | self reported educational attainment | | 6 | 14729294 | 14729295 | Human |
597465494 | GWAS1561568_H | self reported educational attainment QTL GWAS1561568 (human) | | 1e-10 | self reported educational attainment | | 6 | 16965821 | 16965822 | Human |
597301652 | GWAS1397726_H | ribosyldihydronicotinamide dehydrogenase [quinone] measurement QTL GWAS1397726 (human) | | 4e-37 | ribosyldihydronicotinamide dehydrogenase [quinone] measurement | | 6 | 3012544 | 3012545 | Human |
596982151 | GWAS1101670_H | memory performance QTL GWAS1101670 (human) | | 0.000009 | memory performance | | 6 | 17799535 | 17799536 | Human |
406970962 | GWAS619938_H | basophil count, eosinophil count QTL GWAS619938 (human) | | 3e-21 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 6 | 376329 | 376330 | Human |
597481871 | GWAS1577945_H | blood protein measurement QTL GWAS1577945 (human) | | 2e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15913073 | 15913074 | Human |
597039491 | GWAS1135565_H | balding measurement QTL GWAS1135565 (human) | | 3e-09 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9575970 | 9575971 | Human |
597612937 | GWAS1669797_H | mean corpuscular hemoglobin concentration QTL GWAS1669797 (human) | | 6e-88 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16290530 | 16290531 | Human |
597039498 | GWAS1135572_H | blood metabolite measurement QTL GWAS1135572 (human) | | 2e-08 | blood metabolite measurement | blood metabolite measurement (CMO:0003699) | 6 | 541907 | 541908 | Human |
597203384 | GWAS1299458_H | eye color QTL GWAS1299458 (human) | | 2e-321 | eye color | | 6 | 396321 | 396322 | Human |
597506493 | GWAS1602567_H | self reported educational attainment QTL GWAS1602567 (human) | | 8e-09 | self reported educational attainment | | 6 | 16974229 | 16974230 | Human |
597506492 | GWAS1602566_H | self reported educational attainment QTL GWAS1602566 (human) | | 3e-08 | self reported educational attainment | | 6 | 14711730 | 14711731 | Human |
597612986 | GWAS1669846_H | Red cell distribution width QTL GWAS1669846 (human) | | 1e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597391805 | GWAS1487879_H | open-angle glaucoma QTL GWAS1487879 (human) | | 5e-12 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597219761 | GWAS1315835_H | behavioural disinhibition measurement QTL GWAS1315835 (human) | | 0.0000002 | behavioural disinhibition measurement | | 6 | 1106224 | 1106225 | Human |
597375414 | GWAS1471488_H | sphingomyelin 14:0 measurement QTL GWAS1471488 (human) | | 0.0000008 | blood phospholipid amount (VT:0006084) | | 6 | 14290858 | 14290859 | Human |
597047736 | GWAS1143810_H | BMI-adjusted waist-hip ratio QTL GWAS1143810 (human) | | 2e-08 | body size trait (VT:0100005) | | 6 | 14503990 | 14503991 | Human |
597293482 | GWAS1389556_H | phosphatidylcholine measurement QTL GWAS1389556 (human) | | 3e-14 | phosphatidylcholine measurement | | 6 | 11021921 | 11021922 | Human |
597473705 | GWAS1569779_H | asparaginase hypersensitivity QTL GWAS1569779 (human) | | 0.000008 | asparaginase hypersensitivity | | 6 | 3251547 | 3251548 | Human |
597293487 | GWAS1389561_H | phosphatidylcholine measurement QTL GWAS1389561 (human) | | 3e-08 | phosphatidylcholine measurement | | 6 | 11005453 | 11005454 | Human |
597244321 | GWAS1340395_H | glucose measurement QTL GWAS1340395 (human) | | 2e-23 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7247111 | 7247112 | Human |
407388786 | GWAS1037762_H | eosinophil count QTL GWAS1037762 (human) | | 2e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 209159 | 209160 | Human |
596957615 | GWAS1077134_H | thyroid peroxidase antibody measurement QTL GWAS1077134 (human) | | 1e-14 | thyroid peroxidase antibody measurement | | 6 | 417727 | 417728 | Human |
597416359 | GWAS1512433_H | human papilloma virus infection, oropharynx cancer QTL GWAS1512433 (human) | | 0.000005 | human papilloma virus infection, oropharynx cancer | | 6 | 13509787 | 13509788 | Human |
407060994 | GWAS709970_H | docosapentaenoic acid measurement QTL GWAS709970 (human) | | 1e-43 | docosapentaenoic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 10982740 | 10982741 | Human |
597039572 | GWAS1135646_H | pulse pressure measurement QTL GWAS1135646 (human) | | 4e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12295754 | 12295755 | Human |
407060992 | GWAS709968_H | eicosapentaenoic acid measurement QTL GWAS709968 (human) | | 2e-12 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 11008389 | 11008390 | Human |
406954498 | GWAS603474_H | self reported educational attainment QTL GWAS603474 (human) | | 1e-08 | self reported educational attainment | | 6 | 16662697 | 16662698 | Human |
597039573 | GWAS1135647_H | pulse pressure measurement QTL GWAS1135647 (human) | | 5e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 18913149 | 18913150 | Human |
597621210 | GWAS1678070_H | Phlebitis, Thrombophlebitis QTL GWAS1678070 (human) | | 3e-11 | Phlebitis, Thrombophlebitis | | 6 | 13868401 | 13868402 | Human |
597039571 | GWAS1135645_H | pulse pressure measurement QTL GWAS1135645 (human) | | 2e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 1648798 | 1648799 | Human |
597621202 | GWAS1678062_H | body weight QTL GWAS1678062 (human) | | 7e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 7715456 | 7715457 | Human |
597621203 | GWAS1678063_H | body weight QTL GWAS1678063 (human) | | 3e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12117111 | 12117112 | Human |
597088729 | GWAS1184803_H | coronary artery disease QTL GWAS1184803 (human) | | 0.000006 | coronary artery disease | | 6 | 13338763 | 13338764 | Human |
597481932 | GWAS1578006_H | reticulocyte measurement QTL GWAS1578006 (human) | | 2e-18 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 6923601 | 6923602 | Human |
597481933 | GWAS1578007_H | reticulocyte measurement QTL GWAS1578007 (human) | | 9e-13 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 7216820 | 7216821 | Human |
597244364 | GWAS1340438_H | blood protein measurement QTL GWAS1340438 (human) | | 8e-11 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 239806 | 239807 | Human |
597481930 | GWAS1578004_H | reticulocyte measurement QTL GWAS1578004 (human) | | 6e-15 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 2485234 | 2485235 | Human |
597481931 | GWAS1578005_H | reticulocyte measurement QTL GWAS1578005 (human) | | 1e-17 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 6682429 | 6682430 | Human |
597268942 | GWAS1365016_H | xanthosine measurement QTL GWAS1365016 (human) | | 6e-14 | xanthosine measurement | | 6 | 16288384 | 16288385 | Human |
407372304 | GWAS1021280_H | heel bone mineral density QTL GWAS1021280 (human) | | 1e-44 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7050702 | 7050703 | Human |
597391809 | GWAS1487883_H | open-angle glaucoma QTL GWAS1487883 (human) | | 3e-09 | cup-to-disc ratio measurement | | 6 | 1548134 | 1548135 | Human |
597465542 | GWAS1561616_H | offspring mortality measurement QTL GWAS1561616 (human) | | 1e-08 | offspring mortality measurement | offspring mortality measurement (CMO:0002381) | 6 | 2521766 | 2521767 | Human |
597391808 | GWAS1487882_H | open-angle glaucoma QTL GWAS1487882 (human) | | 3e-08 | open-angle glaucoma | | 6 | 1532881 | 1532882 | Human |
597490112 | GWAS1586186_H | Cholecystitis QTL GWAS1586186 (human) | | 2e-08 | Cholecystitis | | 6 | 2602123 | 2602124 | Human |
597096906 | GWAS1192980_H | sex hormone-binding globulin measurement QTL GWAS1192980 (human) | | 2e-20 | appendicular lean mass | | 6 | 7231610 | 7231611 | Human |
597596669 | GWAS1653529_H | eosinophil count QTL GWAS1653529 (human) | | 8e-49 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
597113332 | GWAS1209406_H | protein measurement QTL GWAS1209406 (human) | | 2e-13 | protein measurement | | 6 | 18152062 | 18152063 | Human |
597424639 | GWAS1520713_H | BMI-adjusted waist-hip ratio QTL GWAS1520713 (human) | | 1e-09 | body size trait (VT:0100005) | | 6 | 7056029 | 7056030 | Human |
597457400 | GWAS1553474_H | ulcerative colitis QTL GWAS1553474 (human) | | 6e-09 | ulcerative colitis | | 6 | 14719265 | 14719266 | Human |
597441012 | GWAS1537086_H | total blood protein measurement QTL GWAS1537086 (human) | | 1e-20 | total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 233648 | 233649 | Human |
597178864 | GWAS1274938_H | body mass index QTL GWAS1274938 (human) | | 8e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18497117 | 18497118 | Human |
597613046 | GWAS1669906_H | Red cell distribution width QTL GWAS1669906 (human) | | 3e-11 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 19171488 | 19171489 | Human |
597367282 | GWAS1463356_H | chronic obstructive pulmonary disease QTL GWAS1463356 (human) | | 0.0000006 | lung integrity trait (VT:0010906) | | 6 | 6742916 | 6742917 | Human |
407380513 | GWAS1029489_H | lymphocyte count QTL GWAS1029489 (human) | | 2e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 10526140 | 10526141 | Human |
597293554 | GWAS1389628_H | size QTL GWAS1389628 (human) | | 5e-29 | size | | 6 | 7718832 | 7718833 | Human |
597580275 | GWAS1637135_H | lymphocyte count QTL GWAS1637135 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 12124622 | 12124623 | Human |
597178856 | GWAS1274930_H | body mass index QTL GWAS1274930 (human) | | 8e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
596965861 | GWAS1085380_H | psoriasis QTL GWAS1085380 (human) | | 0.000002 | psoriasis | | 6 | 17729143 | 17729144 | Human |
597178858 | GWAS1274932_H | body mass index QTL GWAS1274932 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9537991 | 9537992 | Human |
597178859 | GWAS1274933_H | body mass index QTL GWAS1274933 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 10545495 | 10545496 | Human |
597178860 | GWAS1274934_H | body mass index QTL GWAS1274934 (human) | | 7e-24 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597178861 | GWAS1274935_H | body mass index QTL GWAS1274935 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12125539 | 12125540 | Human |
597178862 | GWAS1274936_H | body mass index QTL GWAS1274936 (human) | | 3e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13187889 | 13187890 | Human |
597178863 | GWAS1274937_H | body mass index QTL GWAS1274937 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13189043 | 13189044 | Human |
597604841 | GWAS1661701_H | prostate specific antigen amount QTL GWAS1661701 (human) | | 2e-23 | prostate specific antigen amount | | 6 | 16512112 | 16512113 | Human |
597457381 | GWAS1553455_H | inflammatory bowel disease QTL GWAS1553455 (human) | | 6e-12 | inflammatory bowel disease | | 6 | 250619 | 250620 | Human |
597309923 | GWAS1405997_H | body mass index QTL GWAS1405997 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 16398686 | 16398687 | Human |
597178852 | GWAS1274926_H | body mass index QTL GWAS1274926 (human) | | 8e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5260703 | 5260704 | Human |
407020095 | GWAS669071_H | Crohn's disease QTL GWAS669071 (human) | | 7e-09 | intestine integrity trait (VT:0010554) | | 6 | 3433084 | 3433085 | Human |
597178853 | GWAS1274927_H | body mass index QTL GWAS1274927 (human) | | 5e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5600205 | 5600206 | Human |
597178854 | GWAS1274928_H | body mass index QTL GWAS1274928 (human) | | 9e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5978836 | 5978837 | Human |
597113321 | GWAS1209395_H | platelet component distribution width QTL GWAS1209395 (human) | | 2e-20 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 6 | 6925838 | 6925839 | Human |
597334500 | GWAS1430574_H | COVID-19 QTL GWAS1430574 (human) | | 0.000003 | COVID-19 | | 6 | 19208246 | 19208247 | Human |
597096937 | GWAS1193011_H | protein measurement QTL GWAS1193011 (human) | | 2e-25 | protein measurement | | 6 | 3014249 | 3014250 | Human |
597178855 | GWAS1274929_H | body mass index QTL GWAS1274929 (human) | | 5e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 9390846 | 9390847 | Human |
597031189 | GWAS1127263_H | atrial fibrillation QTL GWAS1127263 (human) | | 9e-21 | atrial fibrillation | | 6 | 16413394 | 16413395 | Human |
597326104 | GWAS1422178_H | body mass index QTL GWAS1422178 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 396321 | 396322 | Human |
597121300 | GWAS1217374_H | urate measurement QTL GWAS1217374 (human) | | 4e-08 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7122703 | 7122704 | Human |
597121299 | GWAS1217373_H | urate measurement QTL GWAS1217373 (human) | | 1e-84 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7101851 | 7101852 | Human |
597104915 | GWAS1200989_H | neutrophil percentage of leukocytes QTL GWAS1200989 (human) | | 3e-12 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 6 | 16744456 | 16744457 | Human |
407143105 | GWAS792081_H | Ischemic stroke QTL GWAS792081 (human) | | 3e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
597121298 | GWAS1217372_H | urate measurement QTL GWAS1217372 (human) | | 2e-13 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 2064414 | 2064415 | Human |
597326111 | GWAS1422185_H | body mass index QTL GWAS1422185 (human) | | 3e-09 | esophageal adenocarcinoma, Barrett's esophagus | body mass index (BMI) (CMO:0000105) | 6 | 9509797 | 9509798 | Human |
597276956 | GWAS1373030_H | beverage consumption measurement QTL GWAS1373030 (human) | | 4e-08 | beverage consumption measurement | drink intake measurement (CMO:0000771) | 6 | 12157985 | 12157986 | Human |
597104914 | GWAS1200988_H | neutrophil percentage of leukocytes QTL GWAS1200988 (human) | | 7e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 6 | 13520498 | 13520499 | Human |
597326108 | GWAS1422182_H | body mass index QTL GWAS1422182 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 5390457 | 5390458 | Human |
597104913 | GWAS1200987_H | neutrophil percentage of leukocytes QTL GWAS1200987 (human) | | 8e-15 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 6 | 12159466 | 12159467 | Human |
597342485 | GWAS1438559_H | aging QTL GWAS1438559 (human) | | 7e-12 | aging | | 6 | 396321 | 396322 | Human |
597293321 | GWAS1389395_H | lymphocyte measurement, neutrophil measurement QTL GWAS1389395 (human) | | 2e-09 | lymphocyte measurement, neutrophil measurement | | 6 | 13530168 | 13530169 | Human |
597588239 | GWAS1645099_H | glucose measurement QTL GWAS1645099 (human) | | 7e-18 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7245225 | 7245226 | Human |
597448964 | GWAS1545038_H | BMI-adjusted hip circumference QTL GWAS1545038 (human) | | 5e-15 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6754893 | 6754894 | Human |
597260545 | GWAS1356619_H | phosphatidylinositol measurement QTL GWAS1356619 (human) | | 1e-11 | phosphatidylinositol measurement | | 6 | 10983738 | 10983739 | Human |
597448965 | GWAS1545039_H | BMI-adjusted hip circumference QTL GWAS1545039 (human) | | 2e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6761885 | 6761886 | Human |
597301504 | GWAS1397578_H | ribosyldihydronicotinamide dehydrogenase [quinone] measurement QTL GWAS1397578 (human) | | 6e-106 | ribosyldihydronicotinamide dehydrogenase [quinone] measurement | | 6 | 3000852 | 3000853 | Human |
597448966 | GWAS1545040_H | BMI-adjusted hip circumference QTL GWAS1545040 (human) | | 4e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6778441 | 6778442 | Human |
597227778 | GWAS1323852_H | BMI-adjusted waist-hip ratio QTL GWAS1323852 (human) | | 0.000005 | body size trait (VT:0100005) | | 6 | 7211585 | 7211586 | Human |
597260547 | GWAS1356621_H | phosphatidylinositol measurement QTL GWAS1356621 (human) | | 7e-11 | phosphatidylinositol measurement | | 6 | 10997590 | 10997591 | Human |
597448967 | GWAS1545041_H | BMI-adjusted hip circumference QTL GWAS1545041 (human) | | 3e-21 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6782065 | 6782066 | Human |
597448960 | GWAS1545034_H | BMI-adjusted hip circumference QTL GWAS1545034 (human) | | 3e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6727130 | 6727131 | Human |
597104907 | GWAS1200981_H | coronary artery disease QTL GWAS1200981 (human) | | 2e-08 | coronary artery disease | | 6 | 12907179 | 12907180 | Human |
597448961 | GWAS1545035_H | BMI-adjusted hip circumference QTL GWAS1545035 (human) | | 4e-22 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6737358 | 6737359 | Human |
597448962 | GWAS1545036_H | BMI-adjusted hip circumference QTL GWAS1545036 (human) | | 2e-37 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6737870 | 6737871 | Human |
597448963 | GWAS1545037_H | BMI-adjusted hip circumference QTL GWAS1545037 (human) | | 5e-16 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6754858 | 6754859 | Human |
597317945 | GWAS1414019_H | melanoma QTL GWAS1414019 (human) | | 3e-25 | melanoma | | 6 | 396321 | 396322 | Human |
597621053 | GWAS1677913_H | Atypical behavior QTL GWAS1677913 (human) | | 5e-12 | Atypical behavior | | 6 | 16928423 | 16928424 | Human |
597440825 | GWAS1536899_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1536899 (human) | | 0.0000003 | lifestyle measurement, maximum cigarettes per day measurement | | 6 | 475867 | 475868 | Human |
597055795 | GWAS1151869_H | BMI-adjusted waist circumference QTL GWAS1151869 (human) | | 5e-10 | body size trait (VT:0100005) | | 6 | 7220146 | 7220147 | Human |
597604655 | GWAS1661515_H | Red cell distribution width QTL GWAS1661515 (human) | | 1e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3423313 | 3423314 | Human |
597145894 | GWAS1241968_H | photoreceptor cell layer thickness measurement QTL GWAS1241968 (human) | | 9e-10 | photoreceptor cell layer thickness measurement | | 6 | 7229386 | 7229387 | Human |
597383471 | GWAS1479545_H | white matter hyperintensity measurement QTL GWAS1479545 (human) | | 0.0000001 | white matter hyperintensity measurement | | 6 | 1333879 | 1333880 | Human |
597096738 | GWAS1192812_H | sex hormone-binding globulin measurement QTL GWAS1192812 (human) | | 3e-10 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 6 | 7231610 | 7231611 | Human |
597104928 | GWAS1201002_H | alopecia QTL GWAS1201002 (human) | | 3e-08 | alopecia | | 6 | 10226000 | 10226001 | Human |
597424419 | GWAS1520493_H | BMI-adjusted waist circumference QTL GWAS1520493 (human) | | 5e-09 | body size trait (VT:0100005) | | 6 | 6739621 | 6739622 | Human |
597039407 | GWAS1135481_H | balding measurement QTL GWAS1135481 (human) | | 7e-13 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9489719 | 9489720 | Human |
597055791 | GWAS1151865_H | BMI-adjusted waist circumference QTL GWAS1151865 (human) | | 3e-08 | body size trait (VT:0100005) | | 6 | 17926093 | 17926094 | Human |
597358881 | GWAS1454955_H | self reported educational attainment QTL GWAS1454955 (human) | | 9e-09 | self reported educational attainment | | 6 | 14723377 | 14723378 | Human |
597424421 | GWAS1520495_H | BMI-adjusted waist circumference QTL GWAS1520495 (human) | | 2e-10 | body size trait (VT:0100005) | | 6 | 6757309 | 6757310 | Human |
597612833 | GWAS1669693_H | phototoxic dermatitis QTL GWAS1669693 (human) | | 2e-43 | phototoxic dermatitis | | 6 | 396321 | 396322 | Human |
597424420 | GWAS1520494_H | BMI-adjusted waist circumference QTL GWAS1520494 (human) | | 1e-14 | body size trait (VT:0100005) | | 6 | 6740400 | 6740401 | Human |
597104936 | GWAS1201010_H | alopecia QTL GWAS1201010 (human) | | 2e-08 | alopecia | | 6 | 9589685 | 9589686 | Human |
597023061 | GWAS1119135_H | breast carcinoma QTL GWAS1119135 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 6 | 7231610 | 7231611 | Human |
597096788 | GWAS1192862_H | sex hormone-binding globulin measurement QTL GWAS1192862 (human) | | 5e-23 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597203290 | GWAS1299364_H | type 2 diabetes mellitus QTL GWAS1299364 (human) | | 2e-12 | colorectal cancer | blood glucose level (CMO:0000046) | 6 | 7231610 | 7231611 | Human |
597481816 | GWAS1577890_H | ghrelin measurement QTL GWAS1577890 (human) | | 9e-12 | blood ghrelin amount (VT:0010695) | | 6 | 2914711 | 2914712 | Human |
597490008 | GWAS1586082_H | Inguinal hernia QTL GWAS1586082 (human) | | 3e-18 | Inguinal hernia | | 6 | 6740400 | 6740401 | Human |
596957521 | GWAS1077040_H | thyroid peroxidase antibody measurement QTL GWAS1077040 (human) | | 3e-08 | thyroid peroxidase antibody measurement | | 6 | 14092924 | 14092925 | Human |
597031260 | GWAS1127334_H | atrial fibrillation QTL GWAS1127334 (human) | | 4e-22 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597309776 | GWAS1405850_H | vaginal microbiome measurement QTL GWAS1405850 (human) | | 0.0000003 | vaginal microbiome measurement | | 6 | 12841524 | 12841525 | Human |
597326161 | GWAS1422235_H | body mass index QTL GWAS1422235 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18862209 | 18862210 | Human |
597391701 | GWAS1487775_H | pepsinogen I/II ratio QTL GWAS1487775 (human) | | 2e-13 | pepsinogen I/II ratio | | 6 | 9116124 | 9116125 | Human |
597596496 | GWAS1653356_H | eosinophil count QTL GWAS1653356 (human) | | 3e-28 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 17602639 | 17602640 | Human |
597031259 | GWAS1127333_H | atrial fibrillation QTL GWAS1127333 (human) | | 3e-25 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597195095 | GWAS1291169_H | memory performance QTL GWAS1291169 (human) | | 0.000003 | memory performance | | 6 | 16244593 | 16244594 | Human |
597481804 | GWAS1577878_H | complement factor D measurement QTL GWAS1577878 (human) | | 4e-09 | complement protein amount (VT:0010033) | | 6 | 2914711 | 2914712 | Human |
597326155 | GWAS1422229_H | body mass index QTL GWAS1422229 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13180222 | 13180223 | Human |
597358920 | GWAS1454994_H | caffeine metabolite measurement QTL GWAS1454994 (human) | | 3e-08 | caffeine metabolite measurement | | 6 | 14161203 | 14161204 | Human |
597088578 | GWAS1184652_H | Red cell distribution width QTL GWAS1184652 (human) | | 3e-25 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 5260461 | 5260462 | Human |
597481801 | GWAS1577875_H | complement factor D measurement QTL GWAS1577875 (human) | | 3e-08 | complement protein amount (VT:0010033) | | 6 | 2914711 | 2914712 | Human |
596957519 | GWAS1077038_H | thyroid peroxidase antibody measurement QTL GWAS1077038 (human) | | 2e-15 | thyroid peroxidase antibody measurement | | 6 | 410417 | 410418 | Human |
597326151 | GWAS1422225_H | body mass index QTL GWAS1422225 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12142584 | 12142585 | Human |
597522814 | GWAS1618888_H | lung disease severity measurement QTL GWAS1618888 (human) | | 0.000005 | lung integrity trait (VT:0010906) | | 6 | 8225758 | 8225759 | Human |
597162355 | GWAS1258429_H | ursodeoxycholate measurement QTL GWAS1258429 (human) | | 0.0000002 | bile acid amount (VT:0010917) | | 6 | 4682309 | 4682310 | Human |
597121407 | GWAS1217481_H | blood protein measurement QTL GWAS1217481 (human) | | 5e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6318562 | 6318563 | Human |
597318002 | GWAS1414076_H | vaginal microbiome measurement QTL GWAS1414076 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9569990 | 9569991 | Human |
597318003 | GWAS1414077_H | vaginal microbiome measurement QTL GWAS1414077 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9570926 | 9570927 | Human |
597481846 | GWAS1577920_H | open-angle glaucoma QTL GWAS1577920 (human) | | 1e-40 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597318006 | GWAS1414080_H | vaginal microbiome measurement QTL GWAS1414080 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9573047 | 9573048 | Human |
597506417 | GWAS1602491_H | diastolic blood pressure, systolic blood pressure QTL GWAS1602491 (human) | | 0.000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 19143913 | 19143914 | Human |
596949369 | GWAS1068888_H | Red cell distribution width QTL GWAS1068888 (human) | | 1e-13 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3162144 | 3162145 | Human |
597506416 | GWAS1602490_H | diastolic blood pressure, systolic blood pressure QTL GWAS1602490 (human) | | 0.0000003 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7332612 | 7332613 | Human |
596949370 | GWAS1068889_H | Red cell distribution width QTL GWAS1068889 (human) | | 5e-10 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 3375067 | 3375068 | Human |
407388838 | GWAS1037814_H | reticulocyte count QTL GWAS1037814 (human) | | 2e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 6679939 | 6679944 | Human |
597318004 | GWAS1414078_H | vaginal microbiome measurement QTL GWAS1414078 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9571055 | 9571056 | Human |
597318005 | GWAS1414079_H | vaginal microbiome measurement QTL GWAS1414079 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9572200 | 9572201 | Human |
597604714 | GWAS1661574_H | erythrocyte count QTL GWAS1661574 (human) | | 1e-26 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7195451 | 7195452 | Human |
597072225 | GWAS1168299_H | albumin:globulin ratio measurement QTL GWAS1168299 (human) | | 4e-12 | albumin:globulin ratio measurement | | 6 | 240856 | 240857 | Human |
597039466 | GWAS1135540_H | balding measurement QTL GWAS1135540 (human) | | 4e-79 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9449773 | 9449774 | Human |
597137558 | GWAS1233632_H | 4-vinylguaiacol sulfate measurement QTL GWAS1233632 (human) | | 0.0000003 | 4-vinylguaiacol sulfate measurement | | 6 | 1692104 | 1692105 | Human |
597358744 | GWAS1454818_H | non-dense area measurement, mammographic density measurement QTL GWAS1454818 (human) | | 0.000001 | non-dense area measurement, mammographic density measurement | | 6 | 6751826 | 6751827 | Human |
407028545 | GWAS677521_H | obesity QTL GWAS677521 (human) | | 0.0000005 | obesity | | 6 | 5600205 | 5600206 | Human |
597465236 | GWAS1561310_H | BMI-adjusted waist-hip ratio QTL GWAS1561310 (human) | | 1e-45 | body size trait (VT:0100005) | | 6 | 6742519 | 6742520 | Human |
407372608 | GWAS1021584_H | heel bone mineral density QTL GWAS1021584 (human) | | 2e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 7705771 | 7705772 | Human |
597309584 | GWAS1405658_H | vaginal microbiome measurement QTL GWAS1405658 (human) | | 0.00001 | vaginal microbiome measurement | | 6 | 15633201 | 15633202 | Human |
597457040 | GWAS1553114_H | Crohn's disease QTL GWAS1553114 (human) | | 1e-08 | intestine integrity trait (VT:0010554) | | 6 | 14719265 | 14719266 | Human |
597121156 | GWAS1217230_H | Red cell distribution width QTL GWAS1217230 (human) | | 6e-24 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16290617 | 16290620 | Human |
597121155 | GWAS1217229_H | Red cell distribution width QTL GWAS1217229 (human) | | 5e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16285830 | 16285831 | Human |
597252236 | GWAS1348310_H | serum gamma-glutamyl transferase measurement QTL GWAS1348310 (human) | | 4e-18 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 6 | 7242372 | 7242373 | Human |
597448841 | GWAS1544915_H | insomnia, total blood protein measurement QTL GWAS1544915 (human) | | 6e-13 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 6 | 9842772 | 9842773 | Human |
597514369 | GWAS1610443_H | testosterone measurement QTL GWAS1610443 (human) | | 4e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 6968126 | 6968127 | Human |
597612675 | GWAS1669535_H | medical procedure, trauma complication, complication QTL GWAS1669535 (human) | | 8e-12 | medical procedure, trauma complication, complication | | 6 | 5178232 | 5178233 | Human |
597244093 | GWAS1340167_H | sex hormone-binding globulin measurement QTL GWAS1340167 (human) | | 8e-13 | sex hormone-binding globulin measurement | | 6 | 7125296 | 7125297 | Human |
597022896 | GWAS1118970_H | colorectal health QTL GWAS1118970 (human) | | 0.000002 | colorectal health | | 6 | 18684640 | 18684641 | Human |
596981939 | GWAS1101458_H | memory performance QTL GWAS1101458 (human) | | 0.000008 | memory performance | | 6 | 16209404 | 16209405 | Human |
597416113 | GWAS1512187_H | coronary artery calcification QTL GWAS1512187 (human) | | 5e-11 | coronary artery calcification | | 6 | 12903725 | 12903726 | Human |
597440689 | GWAS1536763_H | lipid measurement QTL GWAS1536763 (human) | | 0.000001 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 2573202 | 2573203 | Human |
597514413 | GWAS1610487_H | smoking initiation QTL GWAS1610487 (human) | | 4e-09 | smoking initiation | | 6 | 17264750 | 17264751 | Human |
597514412 | GWAS1610486_H | smoking initiation QTL GWAS1610486 (human) | | 4e-09 | smoking initiation | | 6 | 14612641 | 14612642 | Human |
597604527 | GWAS1661387_H | prostate specific antigen amount QTL GWAS1661387 (human) | | 2e-25 | prostate specific antigen amount | | 6 | 16512112 | 16512113 | Human |
597022887 | GWAS1118961_H | aging, epigenetic status QTL GWAS1118961 (human) | | 2e-13 | aging, epigenetic status | | 6 | 18110325 | 18110326 | Human |
597022886 | GWAS1118960_H | aging, epigenetic status QTL GWAS1118960 (human) | | 4e-25 | aging, epigenetic status | | 6 | 18114015 | 18114016 | Human |
597514409 | GWAS1610483_H | smoking initiation QTL GWAS1610483 (human) | | 2e-13 | smoking initiation | | 6 | 8615236 | 8615237 | Human |
597514408 | GWAS1610482_H | smoking initiation QTL GWAS1610482 (human) | | 5e-12 | smoking initiation | | 6 | 4340570 | 4340571 | Human |
597440682 | GWAS1536756_H | lipid measurement QTL GWAS1536756 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 6495289 | 6495290 | Human |
597514411 | GWAS1610485_H | smoking initiation QTL GWAS1610485 (human) | | 3e-09 | smoking initiation | | 6 | 10036537 | 10036538 | Human |
597514410 | GWAS1610484_H | smoking initiation QTL GWAS1610484 (human) | | 3e-13 | smoking initiation | | 6 | 8631618 | 8631619 | Human |
597244071 | GWAS1340145_H | progression free survival, ovarian carcinoma QTL GWAS1340145 (human) | | 0.000005 | progression free survival, ovarian carcinoma | survival measurement (CMO:0001021) | 6 | 10841524 | 10841525 | Human |
597309604 | GWAS1405678_H | vaginal microbiome measurement QTL GWAS1405678 (human) | | 0.000004 | vaginal microbiome measurement | | 6 | 11639102 | 11639103 | Human |
597072041 | GWAS1168115_H | breast carcinoma QTL GWAS1168115 (human) | | 0.0000003 | mammary gland integrity trait (VT:0010552) | | 6 | 13722291 | 13722292 | Human |
597170392 | GWAS1266466_H | serine protease 27 measurement QTL GWAS1266466 (human) | | 3e-21 | serine protease 27 measurement | | 6 | 2245111 | 2245112 | Human |
597317850 | GWAS1413924_H | vaginal microbiome measurement QTL GWAS1413924 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9567108 | 9567109 | Human |
597367003 | GWAS1463077_H | lymphocyte count QTL GWAS1463077 (human) | | 1e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 13547726 | 13547727 | Human |
597367002 | GWAS1463076_H | lymphocyte count QTL GWAS1463076 (human) | | 5e-30 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6902706 | 6902707 | Human |
597317851 | GWAS1413925_H | vaginal microbiome measurement QTL GWAS1413925 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9567399 | 9567400 | Human |
597317848 | GWAS1413922_H | vaginal microbiome measurement QTL GWAS1413922 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9566015 | 9566016 | Human |
597227738 | GWAS1323812_H | protein measurement QTL GWAS1323812 (human) | | 2e-08 | protein measurement | | 6 | 10249977 | 10249978 | Human |
597317849 | GWAS1413923_H | vaginal microbiome measurement QTL GWAS1413923 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9566881 | 9566882 | Human |
597498072 | GWAS1594146_H | memory performance QTL GWAS1594146 (human) | | 0.000009 | memory performance | | 6 | 14371188 | 14371189 | Human |
597317852 | GWAS1413926_H | vaginal microbiome measurement QTL GWAS1413926 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9567839 | 9567840 | Human |
597399773 | GWAS1495847_H | Immunosuppressant use measurement QTL GWAS1495847 (human) | | 1e-08 | Immunosuppressant use measurement | | 6 | 14110383 | 14110385 | Human |
597317853 | GWAS1413927_H | vaginal microbiome measurement QTL GWAS1413927 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9569840 | 9569841 | Human |
597367004 | GWAS1463078_H | lymphocyte count QTL GWAS1463078 (human) | | 4e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 14715979 | 14715980 | Human |
597317842 | GWAS1413916_H | vaginal microbiome measurement QTL GWAS1413916 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9560287 | 9560288 | Human |
597317843 | GWAS1413917_H | vaginal microbiome measurement QTL GWAS1413917 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9561584 | 9561585 | Human |
406962952 | GWAS611928_H | granulocyte count QTL GWAS611928 (human) | | 8e-13 | granulocyte quantity (VT:0000334) | blood granulocyte count (CMO:0000111) | 6 | 16744456 | 16744457 | Human |
597317840 | GWAS1413914_H | vaginal microbiome measurement QTL GWAS1413914 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9557964 | 9557965 | Human |
597317841 | GWAS1413915_H | vaginal microbiome measurement QTL GWAS1413915 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9559154 | 9559155 | Human |
597227732 | GWAS1323806_H | protein measurement QTL GWAS1323806 (human) | | 9e-09 | protein measurement | | 6 | 3010915 | 3010916 | Human |
597317846 | GWAS1413920_H | vaginal microbiome measurement QTL GWAS1413920 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9565250 | 9565251 | Human |
597457105 | GWAS1553179_H | total lipids in IDL QTL GWAS1553179 (human) | | 2e-15 | total lipids in IDL | | 6 | 16113090 | 16113091 | Human |
597342420 | GWAS1438494_H | serum alanine aminotransferase measurement QTL GWAS1438494 (human) | | 1e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 7239820 | 7239821 | Human |
597317844 | GWAS1413918_H | vaginal microbiome measurement QTL GWAS1413918 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9563052 | 9563053 | Human |
597317845 | GWAS1413919_H | vaginal microbiome measurement QTL GWAS1413919 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 9564166 | 9564167 | Human |
597342421 | GWAS1438495_H | serum alanine aminotransferase measurement QTL GWAS1438495 (human) | | 2e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 6 | 15502042 | 15502043 | Human |
407094035 | GWAS743011_H | hair color QTL GWAS743011 (human) | | 8e-20 | hair color | | 6 | 385735 | 385736 | Human |
406954773 | GWAS603749_H | eosinophil count QTL GWAS603749 (human) | | 1e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 376329 | 376330 | Human |
597506249 | GWAS1602323_H | 1-oleoyl-2-docosapentaenoyl-GPC (18:1/22:5n3) measurement QTL GWAS1602323 (human) | | 9e-18 | glycerophosphocholine amount (VT:0011004) | | 6 | 10974799 | 10974800 | Human |
407094037 | GWAS743013_H | hair color QTL GWAS743013 (human) | | 2e-11 | hair color | | 6 | 403799 | 403800 | Human |
407094036 | GWAS743012_H | hair color QTL GWAS743012 (human) | | 2e-14 | hair color | | 6 | 386933 | 386934 | Human |
597579977 | GWAS1636837_H | hypothyroidism QTL GWAS1636837 (human) | | 1e-12 | hypothyroidism | | 6 | 410417 | 410418 | Human |
597022924 | GWAS1118998_H | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118998 (human) | | 0.000009 | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel | | 6 | 1492427 | 1492428 | Human |
406954778 | GWAS603754_H | eosinophil count QTL GWAS603754 (human) | | 5e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 577820 | 577821 | Human |
597162188 | GWAS1258262_H | gut microbiome measurement QTL GWAS1258262 (human) | | 5e-09 | gut microbiome measurement | | 6 | 5848943 | 5848944 | Human |
597612738 | GWAS1669598_H | phototoxic dermatitis QTL GWAS1669598 (human) | | 4e-76 | phototoxic dermatitis | | 6 | 396321 | 396322 | Human |
597596352 | GWAS1653212_H | family history of cancer QTL GWAS1653212 (human) | | 2e-30 | family history of cancer | | 6 | 396321 | 396322 | Human |
597031157 | GWAS1127231_H | squamous cell carcinoma QTL GWAS1127231 (human) | | 1e-169 | squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597260539 | GWAS1356613_H | phosphatidylinositol measurement QTL GWAS1356613 (human) | | 5e-12 | phosphatidylinositol measurement | | 6 | 11002577 | 11002578 | Human |
407388971 | GWAS1037947_H | androgenetic alopecia QTL GWAS1037947 (human) | | 3e-13 | androgenetic alopecia | | 6 | 9327323 | 9327324 | Human |
597260538 | GWAS1356612_H | phosphatidylinositol measurement QTL GWAS1356612 (human) | | 5e-12 | phosphatidylinositol measurement | | 6 | 10991702 | 10991703 | Human |
407061287 | GWAS710263_H | eicosapentaenoic acid measurement QTL GWAS710263 (human) | | 3e-08 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 10959925 | 10959926 | Human |
597260541 | GWAS1356615_H | phosphatidylinositol measurement QTL GWAS1356615 (human) | | 5e-12 | phosphatidylinositol measurement | | 6 | 11039769 | 11039770 | Human |
597260540 | GWAS1356614_H | phosphatidylinositol measurement QTL GWAS1356614 (human) | | 5e-12 | phosphatidylinositol measurement | | 6 | 11008389 | 11008390 | Human |
597170431 | GWAS1266505_H | gallstones QTL GWAS1266505 (human) | | 6e-15 | gallstones | | 6 | 17675015 | 17675016 | Human |
597367031 | GWAS1463105_H | lymphocyte count QTL GWAS1463105 (human) | | 7e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 13547726 | 13547727 | Human |
597367030 | GWAS1463104_H | lymphocyte count QTL GWAS1463104 (human) | | 6e-31 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6902706 | 6902707 | Human |
407364394 | GWAS1013370_H | body mass index, visceral:subcutaneous adipose tissue ratio QTL GWAS1013370 (human) | | 0.000009 | body mass index, visceral:subcutaneous adipose tissue ratio | body mass index (BMI) (CMO:0000105) | 6 | 7106083 | 7106084 | Human |
597498092 | GWAS1594166_H | memory performance, sex interaction measurement QTL GWAS1594166 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 7534921 | 7534922 | Human |
597219562 | GWAS1315636_H | alkaline phosphatase measurement QTL GWAS1315636 (human) | | 1e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 15598649 | 15598650 | Human |
597465320 | GWAS1561394_H | trimethyllysine measurement QTL GWAS1561394 (human) | | 0.0000002 | trimethyllysine measurement | | 6 | 13320294 | 13320295 | Human |
597498091 | GWAS1594165_H | memory performance, sex interaction measurement QTL GWAS1594165 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 7534896 | 7534897 | Human |
407061300 | GWAS710276_H | docosahexaenoic acid measurement QTL GWAS710276 (human) | | 8e-14 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 6 | 10968908 | 10968909 | Human |
597456924 | GWAS1552998_H | phospholipids in IDL measurement QTL GWAS1552998 (human) | | 3e-16 | phospholipids in IDL measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16113090 | 16113091 | Human |
597284880 | GWAS1380954_H | hemoglobin measurement QTL GWAS1380954 (human) | | 9e-20 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16289680 | 16289683 | Human |
406971339 | GWAS620315_H | monocyte count QTL GWAS620315 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7156526 | 7156527 | Human |
597284882 | GWAS1380956_H | hemoglobin measurement QTL GWAS1380956 (human) | | 4e-27 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2050557 | 2050558 | Human |
406971338 | GWAS620314_H | monocyte count QTL GWAS620314 (human) | | 5e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7144958 | 7144959 | Human |
597284887 | GWAS1380961_H | hemoglobin measurement QTL GWAS1380961 (human) | | 8e-24 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7229386 | 7229387 | Human |
597194764 | GWAS1290838_H | memory performance QTL GWAS1290838 (human) | | 0.000004 | memory performance | | 6 | 16775869 | 16775870 | Human |
597186575 | GWAS1282649_H | peak expiratory flow QTL GWAS1282649 (human) | | 3e-08 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 7108316 | 7108326 | Human |
407405520 | GWAS1054496_H | obsolete_red blood cell distribution width QTL GWAS1054496 (human) | | 1e-23 | obsolete_red blood cell distribution width | | 6 | 3162144 | 3162145 | Human |
596965385 | GWAS1084904_H | total cholesterol measurement, diet measurement QTL GWAS1084904 (human) | | 0.000004 | total cholesterol measurement, diet measurement | | 6 | 654075 | 654076 | Human |
597325880 | GWAS1421954_H | coronary artery disease QTL GWAS1421954 (human) | | 3e-08 | coronary artery disease | | 6 | 7975026 | 7975027 | Human |
597104700 | GWAS1200774_H | alopecia QTL GWAS1200774 (human) | | 1e-08 | alopecia | | 6 | 327331 | 327332 | Human |
597383222 | GWAS1479296_H | response to simvastatin, total cholesterol change measurement, response to fenofibrate QTL GWAS1479296 (human) | | 0.0000007 | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 6 | 3904005 | 3904006 | Human |
597366825 | GWAS1462899_H | waist-hip ratio QTL GWAS1462899 (human) | | 2e-52 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6751826 | 6751827 | Human |
597022759 | GWAS1118833_H | colorectal health QTL GWAS1118833 (human) | | 0.000009 | colorectal health | | 6 | 11241392 | 11241393 | Human |
597219374 | GWAS1315448_H | glucose measurement QTL GWAS1315448 (human) | | 3e-17 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7250037 | 7250038 | Human |
597030956 | GWAS1127030_H | basal cell carcinoma QTL GWAS1127030 (human) | | 6e-270 | basal cell carcinoma | | 6 | 396321 | 396322 | Human |
597456933 | GWAS1553007_H | low density lipoprotein cholesterol measurement QTL GWAS1553007 (human) | | 2e-16 | total lipids in large LDL | blood lipid measurement (CMO:0000050) | 6 | 16113090 | 16113091 | Human |
597112878 | GWAS1208952_H | systemic lupus erythematosus QTL GWAS1208952 (human) | | 0.0000001 | systemic lupus erythematosus | | 6 | 16636230 | 16636231 | Human |
597260377 | GWAS1356451_H | phosphatidylinositol measurement QTL GWAS1356451 (human) | | 1e-22 | phosphatidylinositol measurement | | 6 | 11017592 | 11017593 | Human |
597260376 | GWAS1356450_H | phosphatidylinositol measurement QTL GWAS1356450 (human) | | 7e-25 | phosphatidylinositol measurement | | 6 | 11018579 | 11018580 | Human |
597260380 | GWAS1356454_H | phosphatidylinositol measurement QTL GWAS1356454 (human) | | 4e-13 | phosphatidylinositol measurement | | 6 | 11005609 | 11005610 | Human |
597121118 | GWAS1217192_H | blood protein measurement QTL GWAS1217192 (human) | | 2e-16 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6174633 | 6174634 | Human |
597121117 | GWAS1217191_H | blood protein measurement QTL GWAS1217191 (human) | | 4e-15 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6318562 | 6318563 | Human |
597104733 | GWAS1200807_H | alopecia QTL GWAS1200807 (human) | | 1e-16 | alopecia | | 6 | 9464314 | 9464315 | Human |
597260375 | GWAS1356449_H | phosphatidylinositol measurement QTL GWAS1356449 (human) | | 4e-27 | phosphatidylinositol measurement | | 6 | 10982419 | 10982420 | Human |
597071961 | GWAS1168035_H | basal cell carcinoma QTL GWAS1168035 (human) | | 2e-152 | basal cell carcinoma | | 6 | 396321 | 396322 | Human |
597309519 | GWAS1405593_H | blood urea nitrogen measurement QTL GWAS1405593 (human) | | 1e-08 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 6 | 7131203 | 7131204 | Human |
597088334 | GWAS1184408_H | Red cell distribution width QTL GWAS1184408 (human) | | 8e-18 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 16267244 | 16267245 | Human |
597088335 | GWAS1184409_H | Red cell distribution width QTL GWAS1184409 (human) | | 1e-15 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 6 | 18757083 | 18757084 | Human |
597325889 | GWAS1421963_H | color vision disorder QTL GWAS1421963 (human) | | 0.0000009 | color vision disorder | | 6 | 3349864 | 3349865 | Human |
407143322 | GWAS792298_H | small vessel stroke QTL GWAS792298 (human) | | 0.000003 | small vessel stroke | | 6 | 1356681 | 1356682 | Human |
597604416 | GWAS1661276_H | erythrocyte count QTL GWAS1661276 (human) | | 6e-26 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 7195451 | 7195452 | Human |
597604474 | GWAS1661334_H | leukemia QTL GWAS1661334 (human) | | 4e-12 | leukemia | | 6 | 411064 | 411065 | Human |
597162111 | GWAS1258185_H | amino acid measurement QTL GWAS1258185 (human) | | 0.0000001 | amino acid measurement | | 6 | 2669839 | 2669840 | Human |
597596278 | GWAS1653138_H | eosinophil count QTL GWAS1653138 (human) | | 2e-25 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 17602639 | 17602640 | Human |
597039231 | GWAS1135305_H | risk-taking behaviour QTL GWAS1135305 (human) | | 5e-08 | risk-taking behaviour | | 6 | 19028392 | 19028393 | Human |
597391479 | GWAS1487553_H | open-angle glaucoma QTL GWAS1487553 (human) | | 2e-10 | open-angle glaucoma | | 6 | 1548134 | 1548135 | Human |
597596274 | GWAS1653134_H | family history, coronary artery disease QTL GWAS1653134 (human) | | 2e-12 | family history, coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597424234 | GWAS1520308_H | Central precocious puberty QTL GWAS1520308 (human) | | 6e-08 | Central precocious puberty | | 6 | 9894200 | 9894201 | Human |
597596267 | GWAS1653127_H | eosinophil count QTL GWAS1653127 (human) | | 1e-38 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 514991 | 514992 | Human |
597620834 | GWAS1677694_H | keratoconus QTL GWAS1677694 (human) | | 1e-11 | keratoconus | | 6 | 4576259 | 4576260 | Human |
597506144 | GWAS1602218_H | photoreceptor cell layer thickness measurement QTL GWAS1602218 (human) | | 8e-13 | photoreceptor cell layer thickness measurement | | 6 | 6901430 | 6901431 | Human |
597506146 | GWAS1602220_H | photoreceptor cell layer thickness measurement QTL GWAS1602220 (human) | | 4e-09 | photoreceptor cell layer thickness measurement | | 6 | 11394054 | 11394055 | Human |
596959120 | GWAS1078639_H | glomerular filtration rate QTL GWAS1078639 (human) | | 5e-35 | glomerular filtration rate | | 6 | 7109432 | 7109433 | Human |
596959121 | GWAS1078640_H | glomerular filtration rate QTL GWAS1078640 (human) | | 0.000001 | glomerular filtration rate | | 6 | 9547364 | 9547365 | Human |
596959122 | GWAS1078641_H | glomerular filtration rate QTL GWAS1078641 (human) | | 6e-08 | glomerular filtration rate | | 6 | 18777454 | 18777455 | Human |
406979657 | GWAS628633_H | thiopurine metabolite measurement, trait in response to mercaptopurine QTL GWAS628633 (human) | | 8e-10 | thiopurine metabolite measurement, trait in response to mercaptopurine | | 6 | 18151959 | 18151960 | Human |
597319572 | GWAS1415646_H | diastolic blood pressure, systolic blood pressure QTL GWAS1415646 (human) | | 5e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 2005235 | 2005236 | Human |
406979666 | GWAS628642_H | thiopurine metabolite measurement, trait in response to mercaptopurine QTL GWAS628642 (human) | | 1e-33 | thiopurine metabolite measurement, trait in response to mercaptopurine | | 6 | 18121083 | 18121084 | Human |
597614479 | GWAS1671339_H | nail anomaly QTL GWAS1671339 (human) | | 2e-12 | nail anomaly | | 6 | 702398 | 702399 | Human |
1358854 | MULTSCL4_H | Multiple sclerosis susceptibility QTL 4 (human) | | | Multiple sclerosis susceptibility | | 6 | 6911960 | 32911960 | Human |
597098368 | GWAS1194442_H | sex hormone-binding globulin measurement QTL GWAS1194442 (human) | | 1e-15 | sex hormone-binding globulin measurement | | 6 | 7231610 | 7231611 | Human |
597327757 | GWAS1423831_H | basal cell carcinoma QTL GWAS1423831 (human) | | 1e-255 | basal cell carcinoma | | 6 | 421281 | 421282 | Human |
597131150 | GWAS1227224_H | memory performance, sex interaction measurement QTL GWAS1227224 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12862012 | 12862013 | Human |
597131149 | GWAS1227223_H | memory performance, sex interaction measurement QTL GWAS1227223 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12861968 | 12861969 | Human |
596959119 | GWAS1078638_H | glomerular filtration rate QTL GWAS1078638 (human) | | 0.0000007 | glomerular filtration rate | | 6 | 2050557 | 2050558 | Human |
597204867 | GWAS1300941_H | lymphocyte count QTL GWAS1300941 (human) | | 2e-08 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 13353502 | 13353503 | Human |
407028830 | GWAS677806_H | sunburn QTL GWAS677806 (human) | | 0.000002 | sunburn | | 6 | 396321 | 396322 | Human |
597131147 | GWAS1227221_H | memory performance, sex interaction measurement QTL GWAS1227221 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12844543 | 12844544 | Human |
597213061 | GWAS1309135_H | multiple myeloma QTL GWAS1309135 (human) | | 6e-08 | multiple myeloma | | 6 | 408079 | 408080 | Human |
597385093 | GWAS1481167_H | coronary artery disease QTL GWAS1481167 (human) | | 5e-29 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597598142 | GWAS1655002_H | mean corpuscular hemoglobin concentration QTL GWAS1655002 (human) | | 4e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
407061601 | GWAS710577_H | docosapentaenoic acid measurement QTL GWAS710577 (human) | | 3e-36 | docosapentaenoic acid measurement | blood free fatty acids level (CMO:0000117) | 6 | 10968908 | 10968909 | Human |
597295034 | GWAS1391108_H | phosphatidylinositol measurement QTL GWAS1391108 (human) | | 5e-09 | phosphatidylinositol measurement | | 6 | 10994782 | 10994783 | Human |
597106611 | GWAS1202685_H | reticulocyte count QTL GWAS1202685 (human) | | 1e-27 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16290617 | 16290620 | Human |
407028839 | GWAS677815_H | hair color QTL GWAS677815 (human) | | 1e-28 | hair color | | 6 | 396321 | 396322 | Human |
597106610 | GWAS1202684_H | reticulocyte count QTL GWAS1202684 (human) | | 1e-33 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16285830 | 16285831 | Human |
597049264 | GWAS1145338_H | cutaneous squamous cell carcinoma QTL GWAS1145338 (human) | | 3e-43 | cutaneous squamous cell carcinoma | | 6 | 391623 | 391624 | Human |
597122993 | GWAS1219067_H | blood protein measurement QTL GWAS1219067 (human) | | 7e-13 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 6318562 | 6318563 | Human |
597106609 | GWAS1202683_H | reticulocyte count QTL GWAS1202683 (human) | | 3e-29 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16282287 | 16282288 | Human |
597106623 | GWAS1202697_H | reticulocyte count QTL GWAS1202697 (human) | | 2e-10 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 2047538 | 2047539 | Human |
597524400 | GWAS1620474_H | 1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) measurement QTL GWAS1620474 (human) | | 2e-12 | glycerophosphocholine amount (VT:0011004) | | 6 | 10978785 | 10978786 | Human |
407028845 | GWAS677821_H | suntan QTL GWAS677821 (human) | | 3e-23 | suntan | | 6 | 396321 | 396322 | Human |
597376948 | GWAS1473022_H | multiple sclerosis QTL GWAS1473022 (human) | | 0.000006 | multiple sclerosis | | 6 | 15088920 | 15088921 | Human |
597131170 | GWAS1227244_H | phosphatidylcholine measurement QTL GWAS1227244 (human) | | 3e-10 | phosphatidylcholine measurement | | 6 | 10994782 | 10994783 | Human |
597131169 | GWAS1227243_H | phosphatidylcholine measurement QTL GWAS1227243 (human) | | 2e-10 | phosphatidylcholine measurement | | 6 | 10982740 | 10982741 | Human |
597123030 | GWAS1219104_H | suicide behaviour measurement QTL GWAS1219104 (human) | | 0.000001 | suicide behaviour measurement | | 6 | 13843040 | 13843041 | Human |
597360585 | GWAS1456659_H | parental longevity QTL GWAS1456659 (human) | | 0.000001 | total life span (VT:0001661) | | 6 | 2860990 | 2860991 | Human |
597360588 | GWAS1456662_H | parental longevity QTL GWAS1456662 (human) | | 0.000004 | total life span (VT:0001661) | | 6 | 14337549 | 14337550 | Human |
597123023 | GWAS1219097_H | suicide behaviour measurement QTL GWAS1219097 (human) | | 0.0000004 | suicide behaviour measurement | | 6 | 13906363 | 13906364 | Human |
407053338 | GWAS702314_H | eosinophil percentage of leukocytes QTL GWAS702314 (human) | | 4e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 281676 | 281677 | Human |
597106638 | GWAS1202712_H | cytokine measurement QTL GWAS1202712 (human) | | 0.000005 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 16731221 | 16731222 | Human |
407053337 | GWAS702313_H | eosinophil percentage of leukocytes QTL GWAS702313 (human) | | 8e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 279695 | 279696 | Human |
597254083 | GWAS1350157_H | type 1 diabetes mellitus QTL GWAS1350157 (human) | | 2e-09 | type 1 diabetes mellitus | | 6 | 424915 | 424916 | Human |
407053336 | GWAS702312_H | eosinophil percentage of leukocytes QTL GWAS702312 (human) | | 4e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 211783 | 211784 | Human |
597516225 | GWAS1612299_H | FEV/FVC ratio QTL GWAS1612299 (human) | | 5e-51 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6741699 | 6741700 | Human |
597491708 | GWAS1587782_H | RS-warfarin measurement QTL GWAS1587782 (human) | | 0.00001 | RS-warfarin measurement | | 6 | 2278148 | 2278149 | Human |
597049335 | GWAS1145409_H | breast carcinoma QTL GWAS1145409 (human) | | 3e-14 | mammary gland integrity trait (VT:0010552) | | 6 | 13722291 | 13722292 | Human |
597377017 | GWAS1473091_H | low density lipoprotein cholesterol measurement QTL GWAS1473091 (human) | | 2e-17 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16127176 | 16127177 | Human |
597295101 | GWAS1391175_H | cholesteryl ester 24:6 measurement QTL GWAS1391175 (human) | | 5e-15 | cholesteryl ester 24:6 measurement | | 6 | 11027716 | 11027717 | Human |
597295100 | GWAS1391174_H | cholesteryl ester 24:5 measurement QTL GWAS1391174 (human) | | 1e-10 | cholesteryl ester 24:5 measurement | | 6 | 10963614 | 10963615 | Human |
407094309 | GWAS743285_H | hair color QTL GWAS743285 (human) | | 1e-09 | hair color | | 6 | 514991 | 514992 | Human |
597032957 | GWAS1129031_H | balding measurement QTL GWAS1129031 (human) | | 4e-12 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 7066248 | 7066249 | Human |
597417971 | GWAS1514045_H | self reported educational attainment QTL GWAS1514045 (human) | | 2e-08 | self reported educational attainment | | 6 | 13270713 | 13270714 | Human |
597417970 | GWAS1514044_H | self reported educational attainment QTL GWAS1514044 (human) | | 7e-16 | self reported educational attainment | | 6 | 3463840 | 3463841 | Human |
597204980 | GWAS1301054_H | type 2 diabetes mellitus QTL GWAS1301054 (human) | | 6e-08 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597237751 | GWAS1333825_H | hemorrhoid QTL GWAS1333825 (human) | | 2e-31 | hemorrhoid | | 6 | 1775480 | 1775481 | Human |
597344244 | GWAS1440318_H | vital capacity QTL GWAS1440318 (human) | | 8e-11 | vital capacity | | 6 | 7101851 | 7101852 | Human |
597049336 | GWAS1145410_H | breast carcinoma QTL GWAS1145410 (human) | | 0.0000006 | mammary gland integrity trait (VT:0010552) | | 6 | 16399326 | 16399327 | Human |
597237750 | GWAS1333824_H | hemorrhoid QTL GWAS1333824 (human) | | 1e-08 | hemorrhoid | | 6 | 624922 | 624923 | Human |
597295081 | GWAS1391155_H | carnitine measurement QTL GWAS1391155 (human) | | 3e-22 | blood carnitine amount (VT:0003977) | | 6 | 14131013 | 14131014 | Human |
597614569 | GWAS1671429_H | gout QTL GWAS1671429 (human) | | 1e-25 | gout | | 6 | 7118757 | 7118758 | Human |
597458923 | GWAS1554997_H | IGA glomerulonephritis QTL GWAS1554997 (human) | | 1e-09 | IGA glomerulonephritis | | 6 | 7214443 | 7214444 | Human |
2292824 | PRSTS5_H | Prostate tumor susceptibility QTL 5 (human) | | | Prostate tumor susceptibility | | 6 | 1 | 19232373 | Human |
597057514 | GWAS1153588_H | chronotype measurement QTL GWAS1153588 (human) | | 9e-15 | sleep behavior trait (VT:0001501) | | 6 | 13191215 | 13191216 | Human |
407061699 | GWAS710675_H | apolipoprotein B measurement QTL GWAS710675 (human) | | 8e-24 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 6 | 16126703 | 16126704 | Human |
597401368 | GWAS1497442_H | mean reticulocyte volume QTL GWAS1497442 (human) | | 2e-21 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 6 | 6706613 | 6706614 | Human |
597327646 | GWAS1423720_H | breast density QTL GWAS1423720 (human) | | 0.000009 | breast density | | 6 | 5560637 | 5560638 | Human |
597311260 | GWAS1407334_H | vaginal microbiome measurement QTL GWAS1407334 (human) | | 0.0000002 | vaginal microbiome measurement | | 6 | 14408881 | 14408882 | Human |
597278483 | GWAS1374557_H | insomnia QTL GWAS1374557 (human) | | 3e-08 | insomnia | | 6 | 7097304 | 7097305 | Human |
597606162 | GWAS1663022_H | HbA1c measurement QTL GWAS1663022 (human) | | 3e-22 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 6 | 7231610 | 7231611 | Human |
597278484 | GWAS1374558_H | insomnia QTL GWAS1374558 (human) | | 1e-08 | insomnia | | 6 | 7115300 | 7115301 | Human |
597532432 | GWAS1628506_H | systolic blood pressure QTL GWAS1628506 (human) | | 1e-21 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597450513 | GWAS1546587_H | major depressive disorder QTL GWAS1546587 (human) | | 7e-12 | major depressive disorder | | 6 | 17028442 | 17028443 | Human |
597163783 | GWAS1259857_H | skin neoplasm QTL GWAS1259857 (human) | | 6e-38 | skin neoplasm | | 6 | 392690 | 392691 | Human |
597065478 | GWAS1161552_H | cutaneous squamous cell carcinoma QTL GWAS1161552 (human) | | 3e-111 | cutaneous squamous cell carcinoma | | 6 | 396321 | 396322 | Human |
597532429 | GWAS1628503_H | systolic blood pressure QTL GWAS1628503 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 10034219 | 10034220 | Human |
597532428 | GWAS1628502_H | systolic blood pressure QTL GWAS1628502 (human) | | 0.000006 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 7518950 | 7518951 | Human |
597532431 | GWAS1628505_H | systolic blood pressure QTL GWAS1628505 (human) | | 9e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12578627 | 12578628 | Human |
597532430 | GWAS1628504_H | systolic blood pressure QTL GWAS1628504 (human) | | 0.0000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 11472612 | 11472613 | Human |
597221131 | GWAS1317205_H | alkaline phosphatase measurement QTL GWAS1317205 (human) | | 2e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 6 | 15524926 | 15524927 | Human |
597532427 | GWAS1628501_H | systolic blood pressure QTL GWAS1628501 (human) | | 3e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1619912 | 1619913 | Human |
597106432 | GWAS1202506_H | amygdala volume change measurement, age at assessment QTL GWAS1202506 (human) | | 0.000009 | amygdala volume change measurement, age at assessment | | 6 | 6162314 | 6162315 | Human |
597073676 | GWAS1169750_H | coronary artery disease QTL GWAS1169750 (human) | | 0.0000004 | coronary artery disease | | 6 | 11326788 | 11326789 | Human |
406922458 | GWAS571434_H | disease free survival QTL GWAS571434 (human) | | 8e-08 | disease free survival | | 6 | 9450964 | 9450965 | Human |
597073675 | GWAS1169749_H | coronary artery disease QTL GWAS1169749 (human) | | 2e-08 | coronary artery disease | | 6 | 1616908 | 1616909 | Human |
597081867 | GWAS1177941_H | gut microbiome measurement QTL GWAS1177941 (human) | | 0.0000004 | gut microbiome measurement | | 6 | 12391991 | 12391992 | Human |
597278520 | GWAS1374594_H | free cholesterol measurement QTL GWAS1374594 (human) | | 3e-13 | free cholesterol measurement | blood cholesterol level (CMO:0002280) | 6 | 16131066 | 16131067 | Human |
597581629 | GWAS1638489_H | coronary artery disease QTL GWAS1638489 (human) | | 8e-35 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597327679 | GWAS1423753_H | sexual dimorphism measurement QTL GWAS1423753 (human) | | 2e-14 | sexual dimorphism measurement | | 6 | 7718832 | 7718833 | Human |
597475124 | GWAS1571198_H | protein measurement QTL GWAS1571198 (human) | | 7e-09 | protein measurement | | 6 | 9082689 | 9082690 | Human |
407053550 | GWAS702526_H | asthma QTL GWAS702526 (human) | | 2e-08 | asthma | | 6 | 249788 | 249789 | Human |
597278516 | GWAS1374590_H | rheumatoid arthritis QTL GWAS1374590 (human) | | 3e-08 | rheumatoid arthritis | | 6 | 15195451 | 15195452 | Human |
597188393 | GWAS1284467_H | peak expiratory flow QTL GWAS1284467 (human) | | 1e-14 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 6 | 1775629 | 1775630 | Human |
597081890 | GWAS1177964_H | autoimmune thyroid disease QTL GWAS1177964 (human) | | 3e-14 | autoimmune thyroid disease | | 6 | 408079 | 408080 | Human |
597049122 | GWAS1145196_H | intraocular pressure measurement QTL GWAS1145196 (human) | | 1e-13 | intraocular pressure measurement | | 6 | 1775629 | 1775630 | Human |
597049123 | GWAS1145197_H | intraocular pressure measurement QTL GWAS1145197 (human) | | 1e-21 | intraocular pressure measurement | | 6 | 1988690 | 1988691 | Human |
597589800 | GWAS1646660_H | atherosclerosis QTL GWAS1646660 (human) | | 2e-11 | atherosclerosis | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597049121 | GWAS1145195_H | intraocular pressure measurement QTL GWAS1145195 (human) | | 1e-15 | intraocular pressure measurement | | 6 | 597203 | 597204 | Human |
597172001 | GWAS1268075_H | smoking initiation QTL GWAS1268075 (human) | | 1e-19 | smoking initiation | | 6 | 13029282 | 13029283 | Human |
597172002 | GWAS1268076_H | smoking initiation QTL GWAS1268076 (human) | | 2e-19 | smoking initiation | | 6 | 13030118 | 13030119 | Human |
597172003 | GWAS1268077_H | smoking initiation QTL GWAS1268077 (human) | | 2e-19 | smoking initiation | | 6 | 13032217 | 13032218 | Human |
597368615 | GWAS1464689_H | cup-to-disc ratio measurement QTL GWAS1464689 (human) | | 1e-13 | cup-to-disc ratio measurement | | 6 | 7211851 | 7211852 | Human |
597172004 | GWAS1268078_H | smoking initiation QTL GWAS1268078 (human) | | 1e-17 | smoking initiation | | 6 | 13097076 | 13097077 | Human |
597172005 | GWAS1268079_H | smoking initiation QTL GWAS1268079 (human) | | 2e-16 | smoking initiation | | 6 | 15445568 | 15445569 | Human |
597172006 | GWAS1268080_H | smoking initiation QTL GWAS1268080 (human) | | 1e-16 | smoking initiation | | 6 | 15726835 | 15726836 | Human |
597065558 | GWAS1161632_H | congenital heart disease QTL GWAS1161632 (human) | | 0.0000003 | congenital heart disease | | 6 | 9320073 | 9320074 | Human |
597409625 | GWAS1505699_H | 3-decenoylcarnitine measurement QTL GWAS1505699 (human) | | 6e-26 | 3-decenoylcarnitine measurement | | 6 | 4112889 | 4112890 | Human |
597524319 | GWAS1620393_H | QRS-T angle QTL GWAS1620393 (human) | | 1e-11 | heart excitatory physiology trait (VT:0000231) | | 6 | 7532188 | 7532189 | Human |
597163859 | GWAS1259933_H | lipid measurement QTL GWAS1259933 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 7960509 | 7960510 | Human |
597049171 | GWAS1145245_H | intraocular pressure measurement QTL GWAS1145245 (human) | | 3e-19 | intraocular pressure measurement | | 6 | 2095801 | 2095802 | Human |
597163858 | GWAS1259932_H | lipid measurement QTL GWAS1259932 (human) | | 0.00001 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 5488968 | 5488969 | Human |
597589842 | GWAS1646702_H | diabetic eye disease QTL GWAS1646702 (human) | | 1e-11 | diabetic eye disease | | 6 | 7245225 | 7245226 | Human |
597114695 | GWAS1210769_H | platelet count QTL GWAS1210769 (human) | | 5e-09 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 7767508 | 7767509 | Human |
597114694 | GWAS1210768_H | platelet count QTL GWAS1210768 (human) | | 7e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 6 | 7066248 | 7066249 | Human |
597483341 | GWAS1579415_H | sphingomyelin measurement QTL GWAS1579415 (human) | | 0.0000006 | sphingomyelin measurement | | 6 | 15239564 | 15239565 | Human |
596950848 | GWAS1070367_H | Red cell distribution width QTL GWAS1070367 (human) | | 3e-25 | Red cell distribution width | | 6 | 5260461 | 5260462 | Human |
597335887 | GWAS1431961_H | COVID-19 QTL GWAS1431961 (human) | | 0.000006 | COVID-19 | | 6 | 7466421 | 7466422 | Human |
597311311 | GWAS1407385_H | vaginal microbiome measurement QTL GWAS1407385 (human) | | 0.000006 | vaginal microbiome measurement | | 6 | 9569990 | 9569991 | Human |
597024578 | GWAS1120652_H | breast carcinoma QTL GWAS1120652 (human) | | 0.000007 | mammary gland integrity trait (VT:0010552) | | 6 | 1319077 | 1319078 | Human |
407053467 | GWAS702443_H | mean corpuscular hemoglobin QTL GWAS702443 (human) | | 9e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 10723216 | 10723217 | Human |
597319490 | GWAS1415564_H | propionylcarnitine measurement QTL GWAS1415564 (human) | | 4e-10 | propionylcarnitine measurement | | 6 | 14131013 | 14131014 | Human |
597376838 | GWAS1472912_H | lymphocyte percentage of leukocytes QTL GWAS1472912 (human) | | 4e-12 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 6 | 6902706 | 6902707 | Human |
597376837 | GWAS1472911_H | lymphocyte percentage of leukocytes QTL GWAS1472911 (human) | | 2e-09 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 6 | 231878 | 231879 | Human |
407053477 | GWAS702453_H | mean corpuscular hemoglobin QTL GWAS702453 (human) | | 7e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 15721122 | 15721123 | Human |
597163888 | GWAS1259962_H | serum metabolite measurement QTL GWAS1259962 (human) | | 0.000009 | serum metabolite measurement | | 6 | 14129399 | 14129400 | Human |
597041009 | GWAS1137083_H | digestive system infectious disorder QTL GWAS1137083 (human) | | 0.000006 | digestive system infectious disorder | | 6 | 16680847 | 16680848 | Human |
597286771 | GWAS1382845_H | free cholesterol in very small VLDL measurement QTL GWAS1382845 (human) | | 6e-11 | blood VLDL cholesterol amount (VT:0005144) | | 6 | 16131066 | 16131067 | Human |
407053480 | GWAS702456_H | mean corpuscular hemoglobin QTL GWAS702456 (human) | | 5e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 18804496 | 18804497 | Human |
597401463 | GWAS1497537_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1497537 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 3894081 | 3894082 | Human |
597376885 | GWAS1472959_H | inflammatory bowel disease QTL GWAS1472959 (human) | | 3e-11 | inflammatory bowel disease | | 6 | 14719265 | 14719266 | Human |
597466995 | GWAS1563069_H | inflammatory bowel disease QTL GWAS1563069 (human) | | 9e-11 | inflammatory bowel disease | | 6 | 14719265 | 14719266 | Human |
597278575 | GWAS1374649_H | hemoglobin measurement QTL GWAS1374649 (human) | | 1e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12294025 | 12294026 | Human |
597016431 | GWAS1112505_H | BMI-adjusted hip circumference QTL GWAS1112505 (human) | | 3e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 6738519 | 6738520 | Human |
407389362 | GWAS1038338_H | age at voice drop QTL GWAS1038338 (human) | | 0.0000001 | time of sexual maturation trait (VT:0001938) | age of puberty (CMO:0000392) | 6 | 19076186 | 19076187 | Human |
597581666 | GWAS1638526_H | monocyte count QTL GWAS1638526 (human) | | 3e-24 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7134168 | 7134169 | Human |
597024616 | GWAS1120690_H | nicotine dependence QTL GWAS1120690 (human) | | 0.000004 | nicotine dependence | | 6 | 3340483 | 3340484 | Human |
597302938 | GWAS1399012_H | neutrophil count QTL GWAS1399012 (human) | | 8e-14 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7201427 | 7201428 | Human |
597147284 | GWAS1243358_H | COVID-19 QTL GWAS1243358 (human) | | 5e-10 | COVID-19 | | 6 | 2742600 | 2742601 | Human |
597286559 | GWAS1382633_H | pulse pressure measurement QTL GWAS1382633 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 1303610 | 1303611 | Human |
597270165 | GWAS1366239_H | juvenile dermatomyositis QTL GWAS1366239 (human) | | 2e-08 | juvenile dermatomyositis | | 6 | 6594252 | 6594253 | Human |
597311127 | GWAS1407201_H | systolic blood pressure QTL GWAS1407201 (human) | | 3e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 1618731 | 1618732 | Human |
597302935 | GWAS1399009_H | neutrophil count QTL GWAS1399009 (human) | | 4e-27 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16744456 | 16744457 | Human |
597458578 | GWAS1554652_H | COVID-19 QTL GWAS1554652 (human) | | 0.000008 | COVID-19 | | 6 | 6536985 | 6536986 | Human |
597466771 | GWAS1562845_H | colorectal cancer QTL GWAS1562845 (human) | | 0.0000005 | colorectal cancer | | 6 | 11705467 | 11705468 | Human |
597335693 | GWAS1431767_H | COVID-19 QTL GWAS1431767 (human) | | 0.000007 | COVID-19 | | 6 | 18853436 | 18853437 | Human |
597311106 | GWAS1407180_H | vaginal microbiome measurement QTL GWAS1407180 (human) | | 0.00001 | vaginal microbiome measurement | | 6 | 9552301 | 9552302 | Human |
597311107 | GWAS1407181_H | vaginal microbiome measurement QTL GWAS1407181 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9553004 | 9553005 | Human |
597024399 | GWAS1120473_H | idiopathic pulmonary fibrosis QTL GWAS1120473 (human) | | 8e-28 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597384833 | GWAS1480907_H | age at menopause QTL GWAS1480907 (human) | | 3e-25 | age at menopause | | 6 | 10887020 | 10887021 | Human |
597040778 | GWAS1136852_H | low density lipoprotein cholesterol measurement QTL GWAS1136852 (human) | | 1e-39 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597343879 | GWAS1439953_H | diverticular disease QTL GWAS1439953 (human) | | 2e-09 | diverticular disease | | 6 | 15307889 | 15307890 | Human |
597491330 | GWAS1587404_H | R-warfarin measurement QTL GWAS1587404 (human) | | 0.000009 | R-warfarin measurement | | 6 | 3654022 | 3654023 | Human |
597311108 | GWAS1407182_H | vaginal microbiome measurement QTL GWAS1407182 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9556163 | 9556164 | Human |
597188231 | GWAS1284305_H | response to TNF antagonist QTL GWAS1284305 (human) | | 0.0000009 | response to TNF antagonist | | 6 | 7786452 | 7786453 | Human |
597311109 | GWAS1407183_H | vaginal microbiome measurement QTL GWAS1407183 (human) | | 0.000008 | vaginal microbiome measurement | | 6 | 9557964 | 9557965 | Human |
597302974 | GWAS1399048_H | mean corpuscular hemoglobin concentration QTL GWAS1399048 (human) | | 5e-41 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16289680 | 16289683 | Human |
597384881 | GWAS1480955_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS1480955 (human) | | 6e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 6 | 6738122 | 6738123 | Human |
407029104 | GWAS678080_H | age-related macular degeneration QTL GWAS678080 (human) | | 0.000001 | age-related macular degeneration | | 6 | 7118757 | 7118758 | Human |
597065380 | GWAS1161454_H | periodontal measurement QTL GWAS1161454 (human) | | 0.0000003 | periodontal ligament morphology trait (VT:0003668) | | 6 | 18954940 | 18954941 | Human |
597515950 | GWAS1612024_H | body mass index QTL GWAS1612024 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 18620941 | 18620942 | Human |
597532326 | GWAS1628400_H | smoking initiation QTL GWAS1628400 (human) | | 7e-09 | smoking initiation | | 6 | 11487301 | 11487302 | Human |
597614241 | GWAS1671101_H | sebaceous gland disease QTL GWAS1671101 (human) | | 6e-35 | sebaceous gland disease | | 6 | 396321 | 396322 | Human |
597130967 | GWAS1227041_H | memory performance, sex interaction measurement QTL GWAS1227041 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12854730 | 12854731 | Human |
597130965 | GWAS1227039_H | memory performance, sex interaction measurement QTL GWAS1227039 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12851393 | 12851394 | Human |
597343960 | GWAS1440034_H | hemoglobin measurement QTL GWAS1440034 (human) | | 4e-20 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16287961 | 16287962 | Human |
597130963 | GWAS1227037_H | memory performance, sex interaction measurement QTL GWAS1227037 (human) | | 0.000006 | memory performance, sex interaction measurement | | 6 | 12860468 | 12860469 | Human |
597130961 | GWAS1227035_H | memory performance, sex interaction measurement QTL GWAS1227035 (human) | | 0.000006 | memory performance, sex interaction measurement | | 6 | 12857161 | 12857162 | Human |
597532378 | GWAS1628452_H | pain QTL GWAS1628452 (human) | | 4e-28 | pain | | 6 | 12903725 | 12903726 | Human |
597130971 | GWAS1227045_H | memory performance, sex interaction measurement QTL GWAS1227045 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12860755 | 12860756 | Human |
597130970 | GWAS1227044_H | memory performance, sex interaction measurement QTL GWAS1227044 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12858672 | 12858673 | Human |
597532371 | GWAS1628445_H | alcohol use disorder measurement QTL GWAS1628445 (human) | | 6e-11 | alcohol use disorder measurement | | 6 | 11506670 | 11506671 | Human |
597130969 | GWAS1227043_H | memory performance, sex interaction measurement QTL GWAS1227043 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12849390 | 12849391 | Human |
597130968 | GWAS1227042_H | memory performance, sex interaction measurement QTL GWAS1227042 (human) | | 0.000007 | memory performance, sex interaction measurement | | 6 | 12858010 | 12858011 | Human |
597049028 | GWAS1145102_H | neuroticism measurement QTL GWAS1145102 (human) | | 3e-10 | neuroticism measurement | | 6 | 11980519 | 11980520 | Human |
597581517 | GWAS1638377_H | skin cancer QTL GWAS1638377 (human) | | 3e-265 | skin cancer | | 6 | 396321 | 396322 | Human |
597106372 | GWAS1202446_H | cytokine measurement QTL GWAS1202446 (human) | | 0.0000009 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 2903278 | 2903279 | Human |
597401294 | GWAS1497368_H | neutrophil percentage of leukocytes QTL GWAS1497368 (human) | | 7e-13 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 6 | 14724257 | 14724258 | Human |
597589704 | GWAS1646564_H | atrial flutter QTL GWAS1646564 (human) | | 3e-24 | atrial flutter | | 6 | 16414322 | 16414323 | Human |
597376707 | GWAS1472781_H | trait in response to platinum QTL GWAS1472781 (human) | | 0.000005 | trait in response to platinum | | 6 | 1573378 | 1573379 | Human |
597434053 | GWAS1530127_H | protein measurement QTL GWAS1530127 (human) | | 1e-20 | protein measurement | | 6 | 6151719 | 6151720 | Human |
597491394 | GWAS1587468_H | pulse pressure measurement QTL GWAS1587468 (human) | | 1e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12578627 | 12578628 | Human |
597106422 | GWAS1202496_H | caudate volume change measurement QTL GWAS1202496 (human) | | 0.000003 | caudate volume change measurement | | 6 | 1712072 | 1712073 | Human |
407053605 | GWAS702581_H | eosinophil percentage of leukocytes QTL GWAS702581 (human) | | 1e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 6 | 390658 | 390659 | Human |
597073662 | GWAS1169736_H | coronary artery disease QTL GWAS1169736 (human) | | 4e-08 | coronary artery disease | | 6 | 1616030 | 1616031 | Human |
597442293 | GWAS1538367_H | 1,3,7-trimethylurate measurement QTL GWAS1538367 (human) | | 0.000004 | 1,3,7-trimethylurate measurement | | 6 | 14743552 | 14743553 | Human |
597417712 | GWAS1513786_H | viral load QTL GWAS1513786 (human) | | 4e-16 | viral load | | 6 | 1545111 | 1545112 | Human |
597507830 | GWAS1603904_H | Antimigraine preparation use measurement QTL GWAS1603904 (human) | | 5e-20 | Antimigraine preparation use measurement | | 6 | 12903725 | 12903726 | Human |
407086382 | GWAS735358_H | low density lipoprotein cholesterol measurement QTL GWAS735358 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16130925 | 16130926 | Human |
597327592 | GWAS1423666_H | coronary artery calcification QTL GWAS1423666 (human) | | 5e-09 | coronary artery calcification | | 6 | 12890871 | 12890872 | Human |
597466857 | GWAS1562931_H | waist-hip ratio QTL GWAS1562931 (human) | | 1e-30 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 6745933 | 6745934 | Human |
597425901 | GWAS1521975_H | response to tyrosine kinase inhibitor QTL GWAS1521975 (human) | | 0.0000009 | response to tyrosine kinase inhibitor | | 6 | 2361836 | 2361837 | Human |
597327597 | GWAS1423671_H | coronary artery calcification QTL GWAS1423671 (human) | | 1e-13 | coronary artery calcification | | 6 | 12825642 | 12825643 | Human |
596950764 | GWAS1070283_H | Red cell distribution width QTL GWAS1070283 (human) | | 3e-11 | Red cell distribution width | | 6 | 2501301 | 2501302 | Human |
597327591 | GWAS1423665_H | coronary artery calcification QTL GWAS1423665 (human) | | 5e-08 | coronary artery calcification | | 6 | 12887233 | 12887234 | Human |
597204710 | GWAS1300784_H | low tension glaucoma QTL GWAS1300784 (human) | | 2e-11 | low tension glaucoma | | 6 | 1957768 | 1957769 | Human |
597417701 | GWAS1513775_H | electrocardiography QTL GWAS1513775 (human) | | 1e-08 | electrocardiography | | 6 | 7527036 | 7527037 | Human |
597171943 | GWAS1268017_H | hemoglobin measurement QTL GWAS1268017 (human) | | 8e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 12295643 | 12295644 | Human |
597171741 | GWAS1267815_H | protein measurement QTL GWAS1267815 (human) | | 7e-27 | protein measurement | | 6 | 3014597 | 3014598 | Human |
597171742 | GWAS1267816_H | protein measurement QTL GWAS1267816 (human) | | 2e-165 | protein measurement | | 6 | 3012544 | 3012545 | Human |
406939080 | GWAS588056_H | hemoglobin measurement QTL GWAS588056 (human) | | 2e-41 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 7232156 | 7232157 | Human |
597147165 | GWAS1243239_H | ovulation QTL GWAS1243239 (human) | | 3e-09 | ovulation | | 6 | 10886716 | 10886717 | Human |
406939083 | GWAS588059_H | hemoglobin measurement QTL GWAS588059 (human) | | 2e-28 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16290530 | 16290531 | Human |
406939082 | GWAS588058_H | hemoglobin measurement QTL GWAS588058 (human) | | 6e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 13509333 | 13509334 | Human |
597130777 | GWAS1226851_H | memory performance, sex interaction measurement QTL GWAS1226851 (human) | | 0.000004 | memory performance, sex interaction measurement | | 6 | 12866296 | 12866297 | Human |
597081606 | GWAS1177680_H | monocyte count QTL GWAS1177680 (human) | | 2e-10 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 2887979 | 2887980 | Human |
597581326 | GWAS1638186_H | type 2 diabetes mellitus QTL GWAS1638186 (human) | | 6e-12 | type 2 diabetes mellitus | | 6 | 15382287 | 15382288 | Human |
597081607 | GWAS1177681_H | monocyte count QTL GWAS1177681 (human) | | 5e-42 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7142658 | 7142659 | Human |
597581327 | GWAS1638187_H | type 2 diabetes mellitus QTL GWAS1638187 (human) | | 7e-10 | type 2 diabetes mellitus | | 6 | 15474820 | 15474821 | Human |
597581324 | GWAS1638184_H | type 2 diabetes mellitus QTL GWAS1638184 (human) | | 5e-31 | type 2 diabetes mellitus | | 6 | 7254724 | 7254725 | Human |
597581325 | GWAS1638185_H | type 2 diabetes mellitus QTL GWAS1638185 (human) | | 5e-14 | type 2 diabetes mellitus | | 6 | 7315607 | 7315608 | Human |
407021014 | GWAS669990_H | Stevens-Johnson syndrome, toxic epidermal necrolysis QTL GWAS669990 (human) | | 0.000009 | Stevens-Johnson syndrome, toxic epidermal necrolysis | | 6 | 3371057 | 3371058 | Human |
597597707 | GWAS1654567_H | hemoglobin measurement QTL GWAS1654567 (human) | | 2e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16287961 | 16287962 | Human |
597515783 | GWAS1611857_H | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine QTL GWAS1611857 (human) | | 0.000002 | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | blood anti-SARS-CoV-2 antibody level (CMO:0003966) | 6 | 9943012 | 9943013 | Human |
407389651 | GWAS1038627_H | obsolete_red blood cell distribution width QTL GWAS1038627 (human) | | 1e-13 | obsolete_red blood cell distribution width | | 6 | 3162144 | 3162145 | Human |
597581314 | GWAS1638174_H | type 2 diabetes mellitus QTL GWAS1638174 (human) | | 7e-09 | type 2 diabetes mellitus | | 6 | 1893912 | 1893913 | Human |
407389652 | GWAS1038628_H | obsolete_red blood cell distribution width QTL GWAS1038628 (human) | | 5e-10 | obsolete_red blood cell distribution width | | 6 | 3375067 | 3375068 | Human |
597376519 | GWAS1472593_H | PR interval QTL GWAS1472593 (human) | | 1e-15 | PR interval | PR interval (CMO:0000233) | 6 | 7518682 | 7518683 | Human |
597237253 | GWAS1333327_H | coronary stenosis QTL GWAS1333327 (human) | | 0.0000009 | coronary stenosis | | 6 | 13971464 | 13971465 | Human |
407389653 | GWAS1038629_H | obsolete_red blood cell distribution width QTL GWAS1038629 (human) | | 3e-10 | obsolete_red blood cell distribution width | | 6 | 3466533 | 3466534 | Human |
597179909 | GWAS1275983_H | BMI-adjusted hip circumference QTL GWAS1275983 (human) | | 2e-15 | body size trait (VT:0100005) | hip circumference (CMO:0000014) | 6 | 6738519 | 6738520 | Human |
597581315 | GWAS1638175_H | type 2 diabetes mellitus QTL GWAS1638175 (human) | | 7e-56 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597081608 | GWAS1177682_H | monocyte count QTL GWAS1177682 (human) | | 4e-59 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10526140 | 10526141 | Human |
597081609 | GWAS1177683_H | monocyte count QTL GWAS1177683 (human) | | 1e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 12056538 | 12056539 | Human |
406971877 | GWAS620853_H | basophil count, eosinophil count QTL GWAS620853 (human) | | 4e-19 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 6 | 577820 | 577821 | Human |
597057075 | GWAS1153149_H | multiple sclerosis QTL GWAS1153149 (human) | | 2e-13 | multiple sclerosis | | 6 | 16672529 | 16672530 | Human |
597343804 | GWAS1439878_H | mean fractional anisotropy measurement QTL GWAS1439878 (human) | | 5e-08 | mean fractional anisotropy measurement | | 6 | 19191228 | 19191229 | Human |
597515828 | GWAS1611902_H | body mass index QTL GWAS1611902 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 10025647 | 10025648 | Human |
596966973 | GWAS1086492_H | prostate specific antigen amount QTL GWAS1086492 (human) | | 2e-12 | prostate specific antigen amount | | 6 | 15462908 | 15462909 | Human |
596966974 | GWAS1086493_H | prostate specific antigen amount QTL GWAS1086493 (human) | | 9e-12 | prostate specific antigen amount | | 6 | 16514923 | 16514924 | Human |
597614133 | GWAS1670993_H | sodium measurement QTL GWAS1670993 (human) | | 4e-13 | sodium measurement | blood sodium level (CMO:0000499) | 6 | 10609212 | 10609213 | Human |
597507633 | GWAS1603707_H | X-12063 measurement QTL GWAS1603707 (human) | | 1e-08 | X-12063 measurement | | 6 | 1085635 | 1085636 | Human |
597179958 | GWAS1276032_H | glucose measurement QTL GWAS1276032 (human) | | 7e-10 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7275693 | 7275694 | Human |
597466671 | GWAS1562745_H | Takayasu arteritis QTL GWAS1562745 (human) | | 3e-09 | Takayasu arteritis | | 6 | 255562 | 255563 | Human |
407037435 | GWAS686411_H | body mass index QTL GWAS686411 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 12124622 | 12124623 | Human |
597343780 | GWAS1439854_H | glucose measurement QTL GWAS1439854 (human) | | 1e-12 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7231610 | 7231611 | Human |
597343781 | GWAS1439855_H | glucose measurement QTL GWAS1439855 (human) | | 2e-20 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7236430 | 7236431 | Human |
597392986 | GWAS1489060_H | heel bone mineral density QTL GWAS1489060 (human) | | 1e-33 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2492879 | 2492880 | Human |
597163606 | GWAS1259680_H | atrial fibrillation QTL GWAS1259680 (human) | | 1e-12 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597392985 | GWAS1489059_H | heel bone mineral density QTL GWAS1489059 (human) | | 1e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 6 | 2381258 | 2381259 | Human |
597163605 | GWAS1259679_H | atrial fibrillation QTL GWAS1259679 (human) | | 8e-18 | atrial fibrillation | | 6 | 16413394 | 16413395 | Human |
597319257 | GWAS1415331_H | proline measurement QTL GWAS1415331 (human) | | 0.0000003 | proline measurement | blood amino acid measurement (CMO:0003730) | 6 | 1886638 | 1886639 | Human |
597360220 | GWAS1456294_H | migraine disorder QTL GWAS1456294 (human) | | 2e-20 | Antimigraine preparation use measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597474900 | GWAS1570974_H | blood protein measurement QTL GWAS1570974 (human) | | 5e-18 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 2997841 | 2997842 | Human |
596975197 | GWAS1094716_H | myocardial infarction QTL GWAS1094716 (human) | | 2e-09 | myocardial infarction | | 6 | 12903906 | 12903907 | Human |
597442132 | GWAS1538206_H | Alzheimer disease, educational attainment QTL GWAS1538206 (human) | | 9e-09 | Alzheimer disease, educational attainment | | 6 | 14711730 | 14711731 | Human |
597474901 | GWAS1570975_H | blood protein measurement QTL GWAS1570975 (human) | | 2e-119 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 2996087 | 2996088 | Human |
597442133 | GWAS1538207_H | Alzheimer disease, educational attainment QTL GWAS1538207 (human) | | 0.000001 | Alzheimer disease, educational attainment | | 6 | 16763203 | 16763204 | Human |
406939025 | GWAS588001_H | hemoglobin measurement QTL GWAS588001 (human) | | 2e-38 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 2050557 | 2050558 | Human |
597515853 | GWAS1611927_H | color vision disorder QTL GWAS1611927 (human) | | 0.000001 | color vision disorder | | 6 | 3778075 | 3778076 | Human |
597450312 | GWAS1546386_H | urate measurement QTL GWAS1546386 (human) | | 1e-12 | urate measurement | blood uric acid level (CMO:0000501) | 6 | 7043103 | 7043104 | Human |
597515850 | GWAS1611924_H | color vision disorder QTL GWAS1611924 (human) | | 0.0000002 | color vision disorder | | 6 | 10269418 | 10269419 | Human |
597057102 | GWAS1153176_H | eosinophil count QTL GWAS1153176 (human) | | 8e-56 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 6 | 577820 | 577821 | Human |
597261888 | GWAS1357962_H | amino acid measurement QTL GWAS1357962 (human) | | 0.000009 | amino acid measurement | | 6 | 2689593 | 2689594 | Human |
597491326 | GWAS1587400_H | R-warfarin measurement QTL GWAS1587400 (human) | | 0.000008 | R-warfarin measurement | | 6 | 4550963 | 4550964 | Human |
597163636 | GWAS1259710_H | serum metabolite measurement QTL GWAS1259710 (human) | | 0.000006 | serum metabolite measurement | | 6 | 1455335 | 1455336 | Human |
597016189 | GWAS1112263_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1112263 (human) | | 1e-12 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
597016188 | GWAS1112262_H | smoking behavior, BMI-adjusted waist-hip ratio QTL GWAS1112262 (human) | | 7e-11 | body size trait (VT:0100005) | | 6 | 6738519 | 6738520 | Human |
596975230 | GWAS1094749_H | Ischemic stroke QTL GWAS1094749 (human) | | 3e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
596975225 | GWAS1094744_H | inflammatory bowel disease QTL GWAS1094744 (human) | | 6e-12 | inflammatory bowel disease | | 6 | 250619 | 250620 | Human |
596967033 | GWAS1086552_H | body height QTL GWAS1086552 (human) | | 8e-35 | body height | | 6 | 6886064 | 6886065 | Human |
597376619 | GWAS1472693_H | coronary artery calcification QTL GWAS1472693 (human) | | 4e-22 | angina pectoris | | 6 | 12903725 | 12903726 | Human |
597597802 | GWAS1654662_H | glaucoma QTL GWAS1654662 (human) | | 7e-27 | glaucoma | | 6 | 1548134 | 1548135 | Human |
597122659 | GWAS1218733_H | blood protein measurement QTL GWAS1218733 (human) | | 1e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 7808703 | 7808704 | Human |
597597800 | GWAS1654660_H | drug use measurement, glaucoma QTL GWAS1654660 (human) | | 3e-20 | drug use measurement, glaucoma | | 6 | 1548134 | 1548135 | Human |
597425763 | GWAS1521837_H | depressive symptom measurement, stressful life event measurement QTL GWAS1521837 (human) | | 0.000005 | depressive symptom measurement, stressful life event measurement | | 6 | 3114713 | 3114714 | Human |
597147246 | GWAS1243320_H | self reported educational attainment QTL GWAS1243320 (human) | | 4e-08 | self reported educational attainment | | 6 | 12961440 | 12961441 | Human |
406988216 | GWAS637192_H | mean corpuscular hemoglobin concentration QTL GWAS637192 (human) | | 9e-204 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 6 | 16294491 | 16294492 | Human |
597401190 | GWAS1497264_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1497264 (human) | | 0.0000003 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 6 | 8664924 | 8664925 | Human |
597417371 | GWAS1513445_H | breast carcinoma QTL GWAS1513445 (human) | | 4e-08 | mammary gland integrity trait (VT:0010552) | | 6 | 10456473 | 10456474 | Human |
597155222 | GWAS1251296_H | hair color QTL GWAS1251296 (human) | | 2e-50 | hair color | | 6 | 396321 | 396322 | Human |
406898246 | GWAS547222_H | ovarian reserve QTL GWAS547222 (human) | | 0.0000003 | ovarian reserve | | 6 | 14586772 | 14586773 | Human |
597114256 | GWAS1210330_H | erythrocyte count QTL GWAS1210330 (human) | | 2e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 16282287 | 16282288 | Human |
597106079 | GWAS1202153_H | reticulocyte measurement QTL GWAS1202153 (human) | | 4e-34 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16290617 | 16290620 | Human |
597106078 | GWAS1202152_H | reticulocyte measurement QTL GWAS1202152 (human) | | 1e-40 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16285830 | 16285831 | Human |
597368209 | GWAS1464283_H | balding measurement QTL GWAS1464283 (human) | | 2e-08 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 1367348 | 1367349 | Human |
597106077 | GWAS1202151_H | reticulocyte measurement QTL GWAS1202151 (human) | | 3e-39 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 6 | 16282287 | 16282288 | Human |
597474706 | GWAS1570780_H | cytokine measurement QTL GWAS1570780 (human) | | 0.000004 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 8823673 | 8823674 | Human |
597474701 | GWAS1570775_H | cytokine measurement QTL GWAS1570775 (human) | | 0.000007 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 8400668 | 8400669 | Human |
597376394 | GWAS1472468_H | reading and spelling ability QTL GWAS1472468 (human) | | 0.000003 | reading and spelling ability | | 6 | 11617934 | 11617935 | Human |
596966789 | GWAS1086308_H | body mass index QTL GWAS1086308 (human) | | 1e-10 | body mass index | | 6 | 13180222 | 13180223 | Human |
596966791 | GWAS1086310_H | body height QTL GWAS1086310 (human) | | 2e-29 | body height | | 6 | 7807189 | 7807190 | Human |
597196172 | GWAS1292246_H | memory performance QTL GWAS1292246 (human) | | 0.000007 | memory performance | | 6 | 4283204 | 4283205 | Human |
597097859 | GWAS1193933_H | coronary artery disease QTL GWAS1193933 (human) | | 6e-09 | coronary artery disease | | 6 | 12927312 | 12927313 | Human |
597286273 | GWAS1382347_H | calcium measurement QTL GWAS1382347 (human) | | 2e-12 | calcium measurement | blood calcium level (CMO:0000502) | 6 | 10877164 | 10877165 | Human |
597114255 | GWAS1210329_H | erythrocyte count QTL GWAS1210329 (human) | | 1e-22 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15176027 | 15176028 | Human |
597409155 | GWAS1505229_H | polyunsaturated fatty acid measurement QTL GWAS1505229 (human) | | 2e-09 | milk polyunsaturated fatty acid amount (VT:0010374) | milk polyunsaturated fatty acid measurement (CMO:0000821) | 6 | 16113090 | 16113091 | Human |
597114254 | GWAS1210328_H | erythrocyte count QTL GWAS1210328 (human) | | 1e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 15100108 | 15100109 | Human |
597335427 | GWAS1431501_H | atrial fibrillation QTL GWAS1431501 (human) | | 2e-14 | atrial fibrillation | | 6 | 16418331 | 16418332 | Human |
597114253 | GWAS1210327_H | erythrocyte count QTL GWAS1210327 (human) | | 7e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12295643 | 12295644 | Human |
597114252 | GWAS1210326_H | erythrocyte count QTL GWAS1210326 (human) | | 3e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 12159466 | 12159467 | Human |
597114251 | GWAS1210325_H | erythrocyte count QTL GWAS1210325 (human) | | 4e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 6 | 9530131 | 9530132 | Human |
597335428 | GWAS1431502_H | atrial fibrillation QTL GWAS1431502 (human) | | 6e-25 | atrial fibrillation | | 6 | 18209878 | 18209879 | Human |
597204413 | GWAS1300487_H | protein measurement QTL GWAS1300487 (human) | | 2e-09 | protein measurement | | 6 | 3110932 | 3110933 | Human |
597245375 | GWAS1341449_H | aging QTL GWAS1341449 (human) | | 1e-17 | aging | | 6 | 18101663 | 18101664 | Human |
597114299 | GWAS1210373_H | behavioural disinhibition measurement QTL GWAS1210373 (human) | | 0.000001 | behavioural disinhibition measurement | | 6 | 1950560 | 1950561 | Human |
597376437 | GWAS1472511_H | PR interval QTL GWAS1472511 (human) | | 2e-14 | PR interval | PR interval (CMO:0000233) | 6 | 2575673 | 2575674 | Human |
597073316 | GWAS1169390_H | response to radiation QTL GWAS1169390 (human) | | 0.000004 | response to radiation | | 6 | 12217189 | 12217190 | Human |
597409192 | GWAS1505266_H | small vessel stroke QTL GWAS1505266 (human) | | 0.000003 | small vessel stroke | | 6 | 1356681 | 1356682 | Human |
597368239 | GWAS1464313_H | systolic blood pressure QTL GWAS1464313 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597171629 | GWAS1267703_H | sex interaction measurement, longitudinal BMI measurement QTL GWAS1267703 (human) | | 0.000002 | sex interaction measurement, longitudinal BMI measurement | body mass index (BMI) (CMO:0000105) | 6 | 5169350 | 5169351 | Human |
597409197 | GWAS1505271_H | Ischemic stroke QTL GWAS1505271 (human) | | 2e-09 | Ischemic stroke | | 6 | 1356681 | 1356682 | Human |
597204399 | GWAS1300473_H | protein measurement QTL GWAS1300473 (human) | | 2e-08 | protein measurement | | 6 | 15192266 | 15192267 | Human |
597474723 | GWAS1570797_H | cytokine measurement QTL GWAS1570797 (human) | | 0.000003 | cytokine measurement | blood cytokine measurement (CMO:0001924) | 6 | 14231445 | 14231446 | Human |
597229016 | GWAS1325090_H | appendicular lean mass QTL GWAS1325090 (human) | | 5e-09 | appendicular lean mass | | 6 | 18467408 | 18467410 | Human |
597229017 | GWAS1325091_H | appendicular lean mass QTL GWAS1325091 (human) | | 3e-19 | appendicular lean mass | | 6 | 19053612 | 19053613 | Human |
597122515 | GWAS1218589_H | electrocardiography QTL GWAS1218589 (human) | | 4e-09 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
596966878 | GWAS1086397_H | systolic blood pressure QTL GWAS1086397 (human) | | 5e-10 | systolic blood pressure | | 6 | 1616538 | 1616542 | Human |
597229012 | GWAS1325086_H | appendicular lean mass QTL GWAS1325086 (human) | | 4e-10 | appendicular lean mass | | 6 | 2670364 | 2670365 | Human |
597229013 | GWAS1325087_H | appendicular lean mass QTL GWAS1325087 (human) | | 3e-57 | appendicular lean mass | | 6 | 7718832 | 7718833 | Human |
597310935 | GWAS1407009_H | vaginal microbiome measurement QTL GWAS1407009 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 16517726 | 16517727 | Human |
597229014 | GWAS1325088_H | appendicular lean mass QTL GWAS1325088 (human) | | 3e-24 | appendicular lean mass | | 6 | 7800879 | 7800880 | Human |
597425620 | GWAS1521694_H | phosphatidylcholine measurement QTL GWAS1521694 (human) | | 7e-10 | phosphatidylcholine measurement | | 6 | 11072089 | 11072090 | Human |
597417428 | GWAS1513502_H | neuroticism measurement QTL GWAS1513502 (human) | | 9e-09 | neuroticism measurement | | 6 | 11996817 | 11996818 | Human |
597229015 | GWAS1325089_H | appendicular lean mass QTL GWAS1325089 (human) | | 6e-15 | appendicular lean mass | | 6 | 15507019 | 15507020 | Human |
597204424 | GWAS1300498_H | type 2 diabetes mellitus QTL GWAS1300498 (human) | | 0.000003 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597204417 | GWAS1300491_H | type 2 diabetes mellitus QTL GWAS1300491 (human) | | 0.0000002 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597491136 | GWAS1587210_H | executive function measurement QTL GWAS1587210 (human) | | 7e-18 | executive function measurement | | 6 | 11480702 | 11480703 | Human |
597441985 | GWAS1538059_H | lipid measurement QTL GWAS1538059 (human) | | 0.00001 | lipid measurement | blood lipid measurement (CMO:0000050) | 6 | 10506743 | 10506744 | Human |
597581249 | GWAS1638109_H | drug use measurement, skin cancer QTL GWAS1638109 (human) | | 2e-51 | drug use measurement, skin cancer | | 6 | 396321 | 396322 | Human |
597458428 | GWAS1554502_H | neuroblastoma QTL GWAS1554502 (human) | | 0.000003 | neuroblastoma | | 6 | 6391140 | 6391141 | Human |
597458427 | GWAS1554501_H | neuroblastoma QTL GWAS1554501 (human) | | 0.000006 | neuroblastoma | | 6 | 5457263 | 5457264 | Human |
597458422 | GWAS1554496_H | neuroblastoma QTL GWAS1554496 (human) | | 0.000004 | neuroblastoma | | 6 | 5457263 | 5457264 | Human |
597442032 | GWAS1538106_H | esterified cholesterol measurement QTL GWAS1538106 (human) | | 4e-08 | esterified cholesterol measurement | | 6 | 3920825 | 3920826 | Human |
597360116 | GWAS1456190_H | synophrys measurement QTL GWAS1456190 (human) | | 4e-13 | coat/hair morphology trait (VT:0000367) | | 6 | 2452463 | 2452464 | Human |
597212663 | GWAS1308737_H | glaucoma QTL GWAS1308737 (human) | | 0.0000002 | glaucoma | | 6 | 597203 | 597204 | Human |
597073378 | GWAS1169452_H | coronary artery disease QTL GWAS1169452 (human) | | 0.0000002 | coronary artery disease | | 6 | 12295643 | 12295644 | Human |
597286369 | GWAS1382443_H | esterified cholesterol measurement, low density lipoprotein cholesterol measurement QTL GWAS1382443 (human) | | 9e-17 | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16114017 | 16114018 | Human |
597450214 | GWAS1546288_H | IGA glomerulonephritis QTL GWAS1546288 (human) | | 0.000002 | IGA glomerulonephritis | | 6 | 7214443 | 7214444 | Human |
597081580 | GWAS1177654_H | cognitive decline measurement QTL GWAS1177654 (human) | | 0.000003 | cognitive behavior trait (VT:0010450) | | 6 | 18229415 | 18229416 | Human |
597507357 | GWAS1603431_H | COVID-19 QTL GWAS1603431 (human) | | 0.0000007 | COVID-19 | | 6 | 4485537 | 4485538 | Human |
407250630 | GWAS899606_H | hematocrit QTL GWAS899606 (human) | | 3e-16 | hematocrit | hematocrit (CMO:0000037) | 6 | 12294025 | 12294026 | Human |
597335325 | GWAS1431399_H | COVID-19 QTL GWAS1431399 (human) | | 0.0000009 | COVID-19 | | 6 | 4671188 | 4671189 | Human |
597433627 | GWAS1529701_H | protein measurement QTL GWAS1529701 (human) | | 8e-44 | protein measurement | | 6 | 6585938 | 6585939 | Human |
597204244 | GWAS1300318_H | type 2 diabetes mellitus QTL GWAS1300318 (human) | | 0.000006 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597482761 | GWAS1578835_H | lymphocyte count QTL GWAS1578835 (human) | | 3e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901349 | 6901350 | Human |
597245196 | GWAS1341270_H | serum gamma-glutamyl transferase measurement QTL GWAS1341270 (human) | | 5e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 6 | 7240643 | 7240644 | Human |
597368077 | GWAS1464151_H | non-lobar intracerebral hemorrhage QTL GWAS1464151 (human) | | 0.0000007 | non-lobar intracerebral hemorrhage | | 6 | 1366483 | 1366484 | Human |
597613828 | GWAS1670688_H | sebaceous gland disease QTL GWAS1670688 (human) | | 1e-35 | sebaceous gland disease | | 6 | 396321 | 396322 | Human |
406963935 | GWAS612911_H | reticulocyte count QTL GWAS612911 (human) | | 4e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16285830 | 16285831 | Human |
597122359 | GWAS1218433_H | electrocardiography QTL GWAS1218433 (human) | | 1e-10 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597122358 | GWAS1218432_H | electrocardiography QTL GWAS1218432 (human) | | 9e-12 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597245243 | GWAS1341317_H | glaucoma QTL GWAS1341317 (human) | | 5e-12 | glaucoma | | 6 | 637465 | 637466 | Human |
597015863 | GWAS1111937_H | intraocular pressure measurement QTL GWAS1111937 (human) | | 4e-17 | intraocular pressure measurement | | 6 | 1548134 | 1548135 | Human |
597122357 | GWAS1218431_H | electrocardiography QTL GWAS1218431 (human) | | 3e-10 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597122356 | GWAS1218430_H | electrocardiography QTL GWAS1218430 (human) | | 2e-08 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
407381739 | GWAS1030715_H | BMI-adjusted waist circumference QTL GWAS1030715 (human) | | 7e-13 | body size trait (VT:0100005) | | 6 | 7702426 | 7702427 | Human |
406963938 | GWAS612914_H | reticulocyte count QTL GWAS612914 (human) | | 4e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 6 | 16322747 | 16322748 | Human |
597392703 | GWAS1488777_H | balding measurement QTL GWAS1488777 (human) | | 2e-64 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 453415 | 453416 | Human |
597122355 | GWAS1218429_H | electrocardiography QTL GWAS1218429 (human) | | 1e-09 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597310770 | GWAS1406844_H | vaginal microbiome measurement QTL GWAS1406844 (human) | | 0.000004 | vaginal microbiome measurement | | 6 | 10704488 | 10704489 | Human |
597155133 | GWAS1251207_H | hair color QTL GWAS1251207 (human) | | 2e-08 | hair color | | 6 | 530476 | 530477 | Human |
597122365 | GWAS1218439_H | electrocardiography QTL GWAS1218439 (human) | | 1e-11 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597122364 | GWAS1218438_H | electrocardiography QTL GWAS1218438 (human) | | 2e-11 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597400880 | GWAS1496954_H | myocardial infarction QTL GWAS1496954 (human) | | 9e-35 | myocardial infarction | | 6 | 12903725 | 12903726 | Human |
597122363 | GWAS1218437_H | electrocardiography QTL GWAS1218437 (human) | | 6e-09 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597146939 | GWAS1243013_H | coffee consumption measurement QTL GWAS1243013 (human) | | 7e-09 | coffee consumption measurement | | 6 | 5612642 | 5612643 | Human |
597507377 | GWAS1603451_H | sarcopenia QTL GWAS1603451 (human) | | 0.000009 | sarcopenia | | 6 | 14863898 | 14863899 | Human |
597122362 | GWAS1218436_H | electrocardiography QTL GWAS1218436 (human) | | 4e-11 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597122361 | GWAS1218435_H | electrocardiography QTL GWAS1218435 (human) | | 4e-12 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597122360 | GWAS1218434_H | electrocardiography QTL GWAS1218434 (human) | | 3e-12 | electrocardiography | | 6 | 3287747 | 3287748 | Human |
597163297 | GWAS1259371_H | glutamine measurement QTL GWAS1259371 (human) | | 0.000004 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 6 | 6283433 | 6283434 | Human |
597376300 | GWAS1472374_H | lymphoma QTL GWAS1472374 (human) | | 0.0000006 | lymphoma | | 6 | 14636732 | 14636733 | Human |
597286180 | GWAS1382254_H | body weight QTL GWAS1382254 (human) | | 5e-14 | body mass (VT:0001259) | body weight (CMO:0000012) | 6 | 12142584 | 12142585 | Human |
597024085 | GWAS1120159_H | breast carcinoma QTL GWAS1120159 (human) | | 8e-13 | mammary gland integrity trait (VT:0010552) | | 6 | 13722291 | 13722292 | Human |
597130582 | GWAS1226656_H | memory performance, sex interaction measurement QTL GWAS1226656 (human) | | 0.000009 | memory performance, sex interaction measurement | | 6 | 12860530 | 12860531 | Human |
407070338 | GWAS719314_H | risk-taking behaviour QTL GWAS719314 (human) | | 3e-12 | risk-taking behaviour | | 6 | 19065111 | 19065112 | Human |
597613916 | GWAS1670776_H | idiopathic pulmonary fibrosis QTL GWAS1670776 (human) | | 2e-22 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597130581 | GWAS1226655_H | memory performance, sex interaction measurement QTL GWAS1226655 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12850372 | 12850373 | Human |
407053952 | GWAS702928_H | essential hypertension, age at diagnosis QTL GWAS702928 (human) | | 3e-08 | essential hypertension, age at diagnosis | | 6 | 1614132 | 1614133 | Human |
596958544 | GWAS1078063_H | Red cell distribution width QTL GWAS1078063 (human) | | 4e-18 | Red cell distribution width | | 6 | 4717639 | 4717640 | Human |
596958545 | GWAS1078064_H | Red cell distribution width QTL GWAS1078064 (human) | | 9e-23 | Red cell distribution width | | 6 | 5137468 | 5137469 | Human |
596958546 | GWAS1078065_H | Red cell distribution width QTL GWAS1078065 (human) | | 4e-09 | Red cell distribution width | | 6 | 5262479 | 5262480 | Human |
596958547 | GWAS1078066_H | Red cell distribution width QTL GWAS1078066 (human) | | 4e-08 | Red cell distribution width | | 6 | 6924907 | 6924908 | Human |
597015890 | GWAS1111964_H | coronary artery disease QTL GWAS1111964 (human) | | 3e-77 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
406980234 | GWAS629210_H | thiopurine metabolite measurement, trait in response to mercaptopurine QTL GWAS629210 (human) | | 1e-20 | thiopurine metabolite measurement, trait in response to mercaptopurine | | 6 | 18121083 | 18121084 | Human |
597269843 | GWAS1365917_H | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement QTL GWAS1365917 (human) | | 0.0000001 | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | | 6 | 382537 | 382538 | Human |
406980232 | GWAS629208_H | trait in response to thiopurine, myelosuppression QTL GWAS629208 (human) | | 5e-09 | trait in response to thiopurine, myelosuppression | | 6 | 18104864 | 18104865 | Human |
597130586 | GWAS1226660_H | memory performance, sex interaction measurement QTL GWAS1226660 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12856255 | 12856256 | Human |
597130584 | GWAS1226658_H | memory performance, sex interaction measurement QTL GWAS1226658 (human) | | 0.000009 | memory performance, sex interaction measurement | | 6 | 12855772 | 12855773 | Human |
597056838 | GWAS1152912_H | intelligence QTL GWAS1152912 (human) | | 8e-10 | intelligence | | 6 | 3450814 | 3450815 | Human |
597368138 | GWAS1464212_H | nicotine dependence symptom count QTL GWAS1464212 (human) | | 0.000003 | nicotine dependence symptom count | | 6 | 2529176 | 2529177 | Human |
597491017 | GWAS1587091_H | pulse pressure measurement QTL GWAS1587091 (human) | | 4e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597015874 | GWAS1111948_H | coronary artery disease QTL GWAS1111948 (human) | | 3e-76 | coronary artery disease | | 6 | 12903725 | 12903726 | Human |
597237057 | GWAS1333131_H | Vertigo QTL GWAS1333131 (human) | | 0.000009 | Vertigo | | 6 | 10923840 | 10923841 | Human |
596958543 | GWAS1078062_H | Red cell distribution width QTL GWAS1078062 (human) | | 2e-21 | Red cell distribution width | | 6 | 3423353 | 3423354 | Human |
597515584 | GWAS1611658_H | FEV/FVC ratio QTL GWAS1611658 (human) | | 8e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 6857407 | 6857408 | Human |
597359943 | GWAS1456017_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1456017 (human) | | 0.000001 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 6 | 10195190 | 10195191 | Human |
597056840 | GWAS1152914_H | intelligence QTL GWAS1152914 (human) | | 2e-10 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 6 | 11543109 | 11543110 | Human |
597056841 | GWAS1152915_H | intelligence QTL GWAS1152915 (human) | | 4e-08 | intelligence | | 6 | 13775675 | 13775676 | Human |
597425531 | GWAS1521605_H | depressive symptom measurement, stressful life event measurement QTL GWAS1521605 (human) | | 0.000003 | depressive symptom measurement, stressful life event measurement | | 6 | 3114713 | 3114714 | Human |
596950388 | GWAS1069907_H | COVID-19 QTL GWAS1069907 (human) | | 0.000005 | COVID-19 | | 6 | 12017538 | 12017539 | Human |
597376377 | GWAS1472451_H | triacylglycerol 48:0 measurement QTL GWAS1472451 (human) | | 0.000001 | blood triglyceride amount (VT:0002644) | | 6 | 17046340 | 17046341 | Human |
597613946 | GWAS1670806_H | Epidermal Inclusion Cyst QTL GWAS1670806 (human) | | 1e-15 | Epidermal Inclusion Cyst | | 6 | 396321 | 396322 | Human |
597441910 | GWAS1537984_H | type 2 diabetes mellitus, major depressive disorder, coronary artery disease QTL GWAS1537984 (human) | | 3e-19 | pain | | 6 | 12903725 | 12903726 | Human |
597097853 | GWAS1193927_H | coronary artery disease QTL GWAS1193927 (human) | | 0.0000004 | coronary artery disease | | 6 | 12927312 | 12927313 | Human |
597147001 | GWAS1243075_H | antihyperlipidemic drug use measurement QTL GWAS1243075 (human) | | 9e-23 | antihyperlipidemic drug use measurement | | 6 | 16130925 | 16130926 | Human |
597515634 | GWAS1611708_H | response to radiation, hearing loss, response to antineoplastic agent QTL GWAS1611708 (human) | | 0.000004 | response to radiation, hearing loss, response to antineoplastic agent | | 6 | 8298563 | 8298564 | Human |
597613932 | GWAS1670792_H | family history of cancer QTL GWAS1670792 (human) | | 5e-32 | family history of cancer | | 6 | 396321 | 396322 | Human |
597114213 | GWAS1210287_H | protein measurement QTL GWAS1210287 (human) | | 1e-15 | protein measurement | | 6 | 18152588 | 18152589 | Human |
597024107 | GWAS1120181_H | breast carcinoma QTL GWAS1120181 (human) | | 1e-13 | mammary gland integrity trait (VT:0010552) | | 6 | 13713134 | 13713135 | Human |
597105815 | GWAS1201889_H | testosterone measurement QTL GWAS1201889 (human) | | 3e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 7231610 | 7231611 | Human |
597367962 | GWAS1464036_H | gut microbiome measurement QTL GWAS1464036 (human) | | 0.0000009 | gut microbiome measurement | | 6 | 4743999 | 4744000 | Human |
597482654 | GWAS1578728_H | birth weight QTL GWAS1578728 (human) | | 3e-08 | birth weight | neonatal body weight (CMO:0002079) | 6 | 15065890 | 15065891 | Human |
597130388 | GWAS1226462_H | memory performance, sex interaction measurement QTL GWAS1226462 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12864077 | 12864078 | Human |
597130386 | GWAS1226460_H | memory performance, sex interaction measurement QTL GWAS1226460 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12854649 | 12854650 | Human |
597195934 | GWAS1292008_H | triglyceride measurement QTL GWAS1292008 (human) | | 4e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 6 | 7227278 | 7227279 | Human |
597130385 | GWAS1226459_H | memory performance, sex interaction measurement QTL GWAS1226459 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12853747 | 12853748 | Human |
597130384 | GWAS1226458_H | memory performance, sex interaction measurement QTL GWAS1226458 (human) | | 0.000008 | memory performance, sex interaction measurement | | 6 | 12863018 | 12863019 | Human |
597400723 | GWAS1496797_H | corneal topography QTL GWAS1496797 (human) | | 0.0000008 | corneal topography | | 6 | 10028593 | 10028594 | Human |
597163142 | GWAS1259216_H | pro-hydroxy-pro measurement QTL GWAS1259216 (human) | | 0.000009 | pro-hydroxy-pro measurement | | 6 | 17061315 | 17061316 | Human |
597580938 | GWAS1637798_H | lymphocyte count QTL GWAS1637798 (human) | | 5e-18 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901426 | 6901427 | Human |
597335183 | GWAS1431257_H | RS-warfarin measurement QTL GWAS1431257 (human) | | 0.000008 | RS-warfarin measurement | | 6 | 10781222 | 10781223 | Human |
597081216 | GWAS1177290_H | lymphocyte count QTL GWAS1177290 (human) | | 3e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 13530168 | 13530169 | Human |
597081217 | GWAS1177291_H | lymphocyte count QTL GWAS1177291 (human) | | 1e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 15319074 | 15319075 | Human |
597073039 | GWAS1169113_H | androgenetic alopecia QTL GWAS1169113 (human) | | 2e-10 | androgenetic alopecia | | 6 | 9481139 | 9481140 | Human |
597466247 | GWAS1562321_H | BMI-adjusted waist-hip ratio QTL GWAS1562321 (human) | | 4e-12 | body size trait (VT:0100005) | | 6 | 14595642 | 14595643 | Human |
597212293 | GWAS1308367_H | intraocular pressure measurement QTL GWAS1308367 (human) | | 2e-12 | intraocular pressure measurement | | 6 | 1777530 | 1777531 | Human |
597212294 | GWAS1308368_H | intraocular pressure measurement QTL GWAS1308368 (human) | | 2e-17 | intraocular pressure measurement | | 6 | 1988690 | 1988691 | Human |
597458051 | GWAS1554125_H | information processing speed, cognitive function measurement QTL GWAS1554125 (human) | | 5e-08 | cognitive behavior trait (VT:0010450) | | 6 | 11480702 | 11480703 | Human |
597064887 | GWAS1160961_H | alopecia areata QTL GWAS1160961 (human) | | 0.0000009 | alopecia areata | | 6 | 411554 | 411555 | Human |
597531836 | GWAS1627910_H | hip geometry QTL GWAS1627910 (human) | | 5e-17 | hip geometry | hip circumference (CMO:0000014) | 6 | 2005357 | 2005358 | Human |
597613754 | GWAS1670614_H | psoriasis QTL GWAS1670614 (human) | | 5e-98 | psoriasis | | 6 | 17602639 | 17602640 | Human |
597163186 | GWAS1259260_H | interstitial lung disease QTL GWAS1259260 (human) | | 8e-10 | interstitial lung disease | | 6 | 7562999 | 7563000 | Human |
597179570 | GWAS1275644_H | metabolite measurement QTL GWAS1275644 (human) | | 3e-08 | metabolite measurement | | 6 | 10723495 | 10723496 | Human |
597589158 | GWAS1646018_H | monocyte count QTL GWAS1646018 (human) | | 8e-19 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 291291 | 291292 | Human |
597204129 | GWAS1300203_H | open-angle glaucoma QTL GWAS1300203 (human) | | 1e-09 | open-angle glaucoma | | 6 | 1948469 | 1948470 | Human |
597105838 | GWAS1201912_H | sex hormone-binding globulin measurement QTL GWAS1201912 (human) | | 2e-08 | sex hormone-binding globulin measurement | | 6 | 15398100 | 15398101 | Human |
597105837 | GWAS1201911_H | sex hormone-binding globulin measurement QTL GWAS1201911 (human) | | 2e-10 | body surface area | | 6 | 7231610 | 7231611 | Human |
597204131 | GWAS1300205_H | open-angle glaucoma QTL GWAS1300205 (human) | | 1e-11 | open-angle glaucoma | | 6 | 602983 | 602984 | Human |
597294244 | GWAS1390318_H | type 2 diabetes mellitus QTL GWAS1390318 (human) | | 0.0000007 | type 2 diabetes mellitus | | 6 | 7247111 | 7247112 | Human |
597392549 | GWAS1488623_H | balding measurement QTL GWAS1488623 (human) | | 3e-44 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9015865 | 9015866 | Human |
597277914 | GWAS1373988_H | carnitine measurement QTL GWAS1373988 (human) | | 4e-13 | blood carnitine amount (VT:0003977) | | 6 | 14131013 | 14131014 | Human |
596958428 | GWAS1077947_H | Red cell distribution width QTL GWAS1077947 (human) | | 3e-10 | Red cell distribution width | | 6 | 7695740 | 7695741 | Human |
597597399 | GWAS1654259_H | lymphocyte count QTL GWAS1654259 (human) | | 1e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901426 | 6901427 | Human |
407127817 | GWAS776793_H | urate measurement QTL GWAS776793 (human) | | 1e-09 | Varicose veins | blood uric acid level (CMO:0000501) | 6 | 7101851 | 7101852 | Human |
596958426 | GWAS1077945_H | Red cell distribution width QTL GWAS1077945 (human) | | 2e-16 | Red cell distribution width | | 6 | 16261045 | 16261046 | Human |
596958427 | GWAS1077946_H | Red cell distribution width QTL GWAS1077946 (human) | | 2e-14 | Red cell distribution width | | 6 | 18747474 | 18747475 | Human |
406923026 | GWAS572002_H | cup-to-disc ratio measurement QTL GWAS572002 (human) | | 0.000004 | cup-to-disc ratio measurement | | 6 | 625071 | 625072 | Human |
597408968 | GWAS1505042_H | vaginal microbiome measurement QTL GWAS1505042 (human) | | 0.000005 | vaginal microbiome measurement | | 6 | 15066900 | 15066901 | Human |
597359820 | GWAS1455894_H | systolic blood pressure QTL GWAS1455894 (human) | | 0.000004 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 6 | 12903725 | 12903726 | Human |
597310669 | GWAS1406743_H | vaginal microbiome measurement QTL GWAS1406743 (human) | | 0.000003 | vaginal microbiome measurement | | 6 | 16375433 | 16375434 | Human |
597605575 | GWAS1662435_H | aspartate aminotransferase to alanine aminotransferase ratio QTL GWAS1662435 (human) | | 4e-23 | aspartate aminotransferase to alanine aminotransferase ratio | serum aspartate aminotransferase activity level to alanine aminotransferase activity level ratio (CMO:0002245) | 6 | 13525133 | 13525134 | Human |
597212353 | GWAS1308427_H | low density lipoprotein cholesterol measurement QTL GWAS1308427 (human) | | 3e-12 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16126703 | 16126704 | Human |
597073100 | GWAS1169174_H | androgenetic alopecia QTL GWAS1169174 (human) | | 9e-29 | androgenetic alopecia | | 6 | 9333351 | 9333352 | Human |
597073099 | GWAS1169173_H | androgenetic alopecia QTL GWAS1169173 (human) | | 2e-52 | hair color | | 6 | 396321 | 396322 | Human |
597245177 | GWAS1341251_H | aging QTL GWAS1341251 (human) | | 1e-12 | aging | | 6 | 18130687 | 18130688 | Human |
597294333 | GWAS1390407_H | cardiac troponin T measurement QTL GWAS1390407 (human) | | 0.000004 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 6 | 17890057 | 17890058 | Human |
597073139 | GWAS1169213_H | feeling nervous measurement QTL GWAS1169213 (human) | | 2e-08 | feeling nervous measurement | | 6 | 396321 | 396322 | Human |
597613816 | GWAS1670676_H | skin disease QTL GWAS1670676 (human) | | 3e-291 | skin disease | | 6 | 396321 | 396322 | Human |
597441787 | GWAS1537861_H | testosterone measurement QTL GWAS1537861 (human) | | 8e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 1376813 | 1376814 | Human |
597277941 | GWAS1374015_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1374015 (human) | | 0.000002 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 426268 | 426269 | Human |
597138656 | GWAS1234730_H | 1-docosahexaenoyl-GPC (22:6) measurement QTL GWAS1234730 (human) | | 1e-12 | glycerophosphocholine amount (VT:0011004) | | 6 | 10986579 | 10986580 | Human |
406964027 | GWAS613003_H | neutrophil percentage of granulocytes QTL GWAS613003 (human) | | 7e-16 | neutrophil quantity (VT:0000222) | | 6 | 577820 | 577821 | Human |
406964026 | GWAS613002_H | neutrophil percentage of granulocytes QTL GWAS613002 (human) | | 6e-19 | neutrophil quantity (VT:0000222) | | 6 | 376329 | 376330 | Human |
597294306 | GWAS1390380_H | lysophosphatidylcholine 22:5 measurement QTL GWAS1390380 (human) | | 3e-10 | lysophosphatidylcholine 22:5 measurement | | 6 | 11036214 | 11036215 | Human |
597605602 | GWAS1662462_H | gout QTL GWAS1662462 (human) | | 9e-30 | gout | | 6 | 7109432 | 7109433 | Human |
407013183 | GWAS662159_H | body mass index QTL GWAS662159 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 6 | 13178027 | 13178028 | Human |
597245158 | GWAS1341232_H | glucose measurement QTL GWAS1341232 (human) | | 4e-14 | glucose measurement | blood glucose level (CMO:0000046) | 6 | 7125296 | 7125297 | Human |
597228570 | GWAS1324644_H | self reported educational attainment QTL GWAS1324644 (human) | | 2e-08 | self reported educational attainment | | 6 | 12883292 | 12883293 | Human |
597228571 | GWAS1324645_H | self reported educational attainment QTL GWAS1324645 (human) | | 4e-08 | self reported educational attainment | | 6 | 16636230 | 16636231 | Human |
597318686 | GWAS1414760_H | opioid dependence QTL GWAS1414760 (human) | | 0.000005 | opioid dependence | | 6 | 13781968 | 13781969 | Human |
597228572 | GWAS1324646_H | self reported educational attainment QTL GWAS1324646 (human) | | 2e-08 | self reported educational attainment | | 6 | 17127475 | 17127476 | Human |
597482521 | GWAS1578595_H | mathematical ability QTL GWAS1578595 (human) | | 2e-08 | mathematical ability | | 6 | 14895448 | 14895449 | Human |
597244959 | GWAS1341033_H | sex hormone-binding globulin measurement QTL GWAS1341033 (human) | | 3e-12 | sex hormone-binding globulin measurement | | 6 | 7247111 | 7247112 | Human |
407275457 | GWAS924433_H | hair color QTL GWAS924433 (human) | | 6e-18 | hair color | | 6 | 421196 | 421197 | Human |
597269521 | GWAS1365595_H | facial height measurement QTL GWAS1365595 (human) | | 0.000007 | facial morphology trait (VT:0003743) | | 6 | 16481494 | 16481495 | Human |
597302291 | GWAS1398365_H | mean corpuscular hemoglobin QTL GWAS1398365 (human) | | 8e-10 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 626835 | 626836 | Human |
597384209 | GWAS1480283_H | monocyte count QTL GWAS1480283 (human) | | 8e-59 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 10519657 | 10519658 | Human |
597384208 | GWAS1480282_H | monocyte count QTL GWAS1480282 (human) | | 1e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 2886561 | 2886562 | Human |
597294103 | GWAS1390177_H | cardiac troponin T measurement QTL GWAS1390177 (human) | | 0.000006 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 6 | 13142603 | 13142604 | Human |
597302293 | GWAS1398367_H | mean corpuscular hemoglobin QTL GWAS1398367 (human) | | 1e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 6 | 3166734 | 3166735 | Human |
597482508 | GWAS1578582_H | blood protein measurement QTL GWAS1578582 (human) | | 8e-09 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15858765 | 15858766 | Human |
597490699 | GWAS1586773_H | Inguinal hernia QTL GWAS1586773 (human) | | 4e-16 | Inguinal hernia | | 6 | 6740400 | 6740401 | Human |
597482507 | GWAS1578581_H | blood protein measurement QTL GWAS1578581 (human) | | 3e-11 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15913073 | 15913074 | Human |
597146638 | GWAS1242712_H | diabetes mellitus QTL GWAS1242712 (human) | | 2e-09 | pancreas integrity trait (VT:0010560) | | 6 | 7231610 | 7231611 | Human |
597113869 | GWAS1209943_H | intraocular pressure measurement QTL GWAS1209943 (human) | | 3e-12 | intraocular pressure measurement | | 6 | 597203 | 597204 | Human |
597138445 | GWAS1234519_H | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement QTL GWAS1234519 (human) | | 4e-16 | glycerophosphocholine amount (VT:0011004) | | 6 | 10996933 | 10996934 | Human |
597482503 | GWAS1578577_H | blood protein measurement QTL GWAS1578577 (human) | | 7e-10 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 6 | 15858765 | 15858766 | Human |
597359622 | GWAS1455696_H | oppositional defiant disorder measurement QTL GWAS1455696 (human) | | 0.000007 | oppositional defiant disorder measurement | | 6 | 12241592 | 12241593 | Human |
597023794 | GWAS1119868_H | pursuit maintenance gain measurement QTL GWAS1119868 (human) | | 0.0000002 | pursuit maintenance gain measurement | | 6 | 8413179 | 8413180 | Human |
597376052 | GWAS1472126_H | waist-hip ratio QTL GWAS1472126 (human) | | 3e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 6 | 7217284 | 7217285 | Human |
597056550 | GWAS1152624_H | reaction time measurement QTL GWAS1152624 (human) | | 0.000003 | cognitive behavior trait (VT:0010450) | | 6 | 1917455 | 1917456 | Human |
597056551 | GWAS1152625_H | reaction time measurement QTL GWAS1152625 (human) | | 0.000006 | cognitive behavior trait (VT:0010450) | | 6 | 13190980 | 13190981 | Human |
597490734 | GWAS1586808_H | testosterone measurement QTL GWAS1586808 (human) | | 2e-08 | testosterone measurement | serum testosterone level (CMO:0000568) | 6 | 11437533 | 11437534 | Human |
597343279 | GWAS1439353_H | hemoglobin measurement QTL GWAS1439353 (human) | | 2e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 6 | 16287961 | 16287962 | Human |
597597224 | GWAS1654084_H | lymphocyte count QTL GWAS1654084 (human) | | 4e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901426 | 6901427 | Human |
597277742 | GWAS1373816_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1373816 (human) | | 2e-09 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 6 | 14106966 | 14106967 | Human |
597318701 | GWAS1414775_H | JT interval QTL GWAS1414775 (human) | | 1e-25 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 6 | 16290530 | 16290531 | Human |
407144440 | GWAS793416_H | stroke QTL GWAS793416 (human) | | 1e-09 | stroke | | 6 | 1356681 | 1356682 | Human |
597531683 | GWAS1627757_H | cannabis dependence QTL GWAS1627757 (human) | | 4e-09 | cannabis dependence | | 6 | 11506670 | 11506671 | Human |
597597217 | GWAS1654077_H | lymphocyte count QTL GWAS1654077 (human) | | 3e-21 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 6901426 | 6901427 | Human |
597236825 | GWAS1332899_H | monocyte count QTL GWAS1332899 (human) | | 2e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 6 | 7140598 | 7140599 | Human |
597081182 | GWAS1177256_H | lymphocyte count QTL GWAS1177256 (human) | | 9e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 411064 | 411065 | Human |
597081183 | GWAS1177257_H | lymphocyte count QTL GWAS1177257 (human) | | 1e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 7085584 | 7085585 | Human |
597204050 | GWAS1300124_H | type 2 diabetes mellitus QTL GWAS1300124 (human) | | 2e-17 | type 2 diabetes mellitus | | 6 | 7231610 | 7231611 | Human |
597081181 | GWAS1177255_H | lymphocyte count QTL GWAS1177255 (human) | | 1e-13 | protein measurement | | 6 | 396321 | 396322 | Human |
596982878 | GWAS1102397_H | memory performance QTL GWAS1102397 (human) | | 0.000004 | memory performance | | 6 | 11732434 | 11732435 | Human |
597285975 | GWAS1382049_H | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1382049 (human) | | 2e-16 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 6 | 16128841 | 16128842 | Human |
597466188 | GWAS1562262_H | balding measurement QTL GWAS1562262 (human) | | 3e-16 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9116124 | 9116125 | Human |
597466189 | GWAS1562263_H | balding measurement QTL GWAS1562263 (human) | | 9e-20 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9519770 | 9519771 | Human |
597466190 | GWAS1562264_H | balding measurement QTL GWAS1562264 (human) | | 3e-47 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9608654 | 9608655 | Human |
597466184 | GWAS1562258_H | balding measurement QTL GWAS1562258 (human) | | 8e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 1407979 | 1407980 | Human |
597269580 | GWAS1365654_H | lung adenocarcinoma QTL GWAS1365654 (human) | | 0.0000002 | lung adenocarcinoma | | 6 | 410848 | 410849 | Human |
597466185 | GWAS1562259_H | balding measurement QTL GWAS1562259 (human) | | 2e-11 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 4383098 | 4383099 | Human |
597466186 | GWAS1562260_H | balding measurement QTL GWAS1562260 (human) | | 9e-10 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 4610532 | 4610533 | Human |
597466187 | GWAS1562261_H | balding measurement QTL GWAS1562261 (human) | | 6e-27 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 6 | 9010829 | 9010830 | Human |
597359693 | GWAS1455767_H | pulse pressure measurement QTL GWAS1455767 (human) | | 6e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 6 | 12903725 | 12903726 | Human |
597056590 | GWAS1152664_H | reaction time measurement QTL GWAS1152664 (human) | | 0.000007 | cognitive behavior trait (VT:0010450) | | 6 | 15438337 | 15438338 | Human |
597056591 | GWAS1152665_H | reaction time measurement QTL GWAS1152665 (human) | | 0.0000004 | cognitive behavior trait (VT:0010450) | | 6 | 17522755 | 17522756 | Human |
597244999 | GWAS1341073_H | aging QTL GWAS1341073 (human) | | 1e-17 | aging | | 6 | 18127970 | 18127971 | Human |
597449795 | GWAS1545869_H | diet measurement, apolipoprotein B measurement QTL GWAS1545869 (human) | | 0.000008 | eating behavior trait (VT:0001431) | blood apoliprotein B level (CMO:0000522) | 6 | 8369079 | 8369080 | Human |
597425220 | GWAS1521294_H | neuroticism measurement QTL GWAS1521294 (human) | | 4e-08 | neuroticism measurement | | 6 | 11711582 | 11711583 | Human |
596982903 | GWAS1102422_H | memory performance QTL GWAS1102422 (human) | | 0.000005 | memory performance | | 6 | 13657579 | 13657580 | Human |
597499006 | GWAS1595080_H | spontaneous coronary artery dissection QTL GWAS1595080 (human) | | 3e-32 | coronary artery integrity trait (VT:0010746) | | 6 | 12903725 | 12903726 | Human |
597376124 | GWAS1472198_H | PR interval QTL GWAS1472198 (human) | | 3e-16 | PR interval | PR interval (CMO:0000233) | 6 | 7527036 | 7527037 | Human |
597269609 | GWAS1365683_H | BMI-adjusted hip circumference QTL GWAS1365683 (human) | | 1e-17 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7718832 | 7718833 | Human |
597081191 | GWAS1177265_H | neutrophil count QTL GWAS1177265 (human) | | 5e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 7138831 | 7138832 | Human |
597269608 | GWAS1365682_H | BMI-adjusted hip circumference QTL GWAS1365682 (human) | | 5e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7277813 | 7277814 | Human |
597613679 | GWAS1670539_H | psoriasis QTL GWAS1670539 (human) | | 4e-95 | psoriasis | | 6 | 17602639 | 17602640 | Human |
597269611 | GWAS1365685_H | BMI-adjusted hip circumference QTL GWAS1365685 (human) | | 4e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7729381 | 7729382 | Human |
597269610 | GWAS1365684_H | BMI-adjusted hip circumference QTL GWAS1365684 (human) | | 2e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7704376 | 7704377 | Human |
597269613 | GWAS1365687_H | BMI-adjusted hip circumference QTL GWAS1365687 (human) | | 4e-14 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7800073 | 7800074 | Human |
597081186 | GWAS1177260_H | lymphocyte count QTL GWAS1177260 (human) | | 7e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 11987848 | 11987849 | Human |
597269612 | GWAS1365686_H | BMI-adjusted hip circumference QTL GWAS1365686 (human) | | 1e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7771737 | 7771738 | Human |
597081184 | GWAS1177258_H | lymphocyte count QTL GWAS1177258 (human) | | 2e-13 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 7157992 | 7157993 | Human |
597318764 | GWAS1414838_H | idiopathic pulmonary fibrosis QTL GWAS1414838 (human) | | 2e-48 | idiopathic pulmonary fibrosis | | 6 | 7562999 | 7563000 | Human |
597081185 | GWAS1177259_H | lymphocyte count QTL GWAS1177259 (human) | | 2e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 6 | 10545495 | 10545496 | Human |
597269614 | GWAS1365688_H | BMI-adjusted hip circumference QTL GWAS1365688 (human) | | 8e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 15497363 | 15497364 | Human |
597064815 | GWAS1160889_H | celiac disease QTL GWAS1160889 (human) | | 2e-09 | celiac disease | | 6 | 408079 | 408080 | Human |
597294178 | GWAS1390252_H | mean arterial pressure QTL GWAS1390252 (human) | | 2e-08 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 6 | 1616538 | 1616542 | Human |
597269605 | GWAS1365679_H | BMI-adjusted hip circumference QTL GWAS1365679 (human) | | 5e-08 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 1863640 | 1863641 | Human |
597326950 | GWAS1423024_H | prostate specific antigen amount QTL GWAS1423024 (human) | | 9e-12 | prostate specific antigen amount | | 6 | 16514923 | 16514924 | Human |
597154921 | GWAS1250995_H | total cholesterol measurement, diet measurement QTL GWAS1250995 (human) | | 0.000004 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 6 | 654075 | 654076 | Human |
597269607 | GWAS1365681_H | BMI-adjusted hip circumference QTL GWAS1365681 (human) | | 5e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7231610 | 7231611 | Human |
597081192 | GWAS1177266_H | neutrophil count QTL GWAS1177266 (human) | | 1e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 12159466 | 12159467 | Human |
597269606 | GWAS1365680_H | BMI-adjusted hip circumference QTL GWAS1365680 (human) | | 9e-12 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 6 | 7247111 | 7247112 | Human |
597326949 | GWAS1423023_H | prostate specific antigen amount QTL GWAS1423023 (human) | | 2e-12 | prostate specific antigen amount | | 6 | 15462908 | 15462909 | Human |
597081193 | GWAS1177267_H | neutrophil count QTL GWAS1177267 (human) | | 7e-42 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 6 | 16757771 | 16757772 | Human |